TW201041514A - Triazole compounds carrying a sulfur substituent II - Google Patents

Triazole compounds carrying a sulfur substituent II Download PDF

Info

Publication number
TW201041514A
TW201041514A TW099113195A TW99113195A TW201041514A TW 201041514 A TW201041514 A TW 201041514A TW 099113195 A TW099113195 A TW 099113195A TW 99113195 A TW99113195 A TW 99113195A TW 201041514 A TW201041514 A TW 201041514A
Authority
TW
Taiwan
Prior art keywords
compound
group
formula
alkyl
hydrogen
Prior art date
Application number
TW099113195A
Other languages
Chinese (zh)
Inventor
Jochen Dietz
Alice Glaettli
Thomas Grote
Wassilios Grammenos
Bernd Mueller
Jan Klaas Lohmann
Jens Renner
Sarah Ulmschneider
Marianna Vrettou-Schultes
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of TW201041514A publication Critical patent/TW201041514A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

The present invention relates to novel triazole compounds of the formulae I and II as defined in the claims and description which carry a sulfur substituent, to agricultural compositions containing them, to their use as fungicides and to intermediate compounds used in the method of producing them.

Description

201041514 六、發明說明: 【發明所屬之技術領域】 本發明係關於一種如下定義之具有硫取代基的式I及式II 之新穎三唑化合物、含有該等化合物之農業組合物、其作 為殺真菌劑之用途及其製備方法中所用之中間化合物。 【先前技術】 防治由植物病原性真菌引起之植物疾病對於實現高作物 效率極其重要。觀賞作物、蔬菜作物、大田作物、榖類作 物及水果作物之植物病害(Plant disease damage)可導致生 產力顯著降低且由此導致對費者之價格提高。 DE 19520098、DE 19617282、DE 19620407、DE 19620590 及WO 97/43269描述硫化三唑基衍生物。該等化合物係用 於對抗有害真菌。 持續需要更有效、成本更低、毒性更低、環境上更安全 及/或具有不同作用模式之新穎化合物。 【發明内容】 因此,本發明之目標在於提供具有較好殺真菌活性及/ 或較好作物植物相容性之化合物。 令人驚訝地,此等目標可藉由下文定義之通式I及II之三 唑化合物及藉由化合物I及II之農業上可接受之鹽來達成。 因此,本發明係關於式I及式II三唑化合物及其農業上適 用之鹽, 147474.doc 201041514201041514 VI. OBJECTS OF THE INVENTION: TECHNICAL FIELD The present invention relates to a novel triazole compound of the formula I and formula II having a sulfur substituent as defined below, an agricultural composition containing the same, which is used as a fungicide The use of the agent and the intermediate compound used in the preparation method. [Prior Art] Control of plant diseases caused by phytopathogenic fungi is extremely important for achieving high crop efficiency. Plant disease damage from ornamental crops, vegetable crops, field crops, pupa crops and fruit crops can result in a significant reduction in productivity and thus an increase in the price of the consumer. The triazolyl derivatives are described in DE 19520098, DE 19617282, DE 19620407, DE 19620590 and WO 97/43269. These compounds are used against harmful fungi. There is a continuing need for novel compounds that are more effective, less costly, less toxic, safer in the environment, and/or have different modes of action. SUMMARY OF THE INVENTION Accordingly, it is an object of the present invention to provide compounds having better fungicidal activity and/or better crop plant compatibility. Surprisingly, such targets can be achieved by the triazole compounds of the formulae I and II as defined below and by the agriculturally acceptable salts of the compounds I and II. Accordingly, the present invention relates to triazole compounds of formula I and formula II and their agriculturally acceptable salts, 147474.doc 201041514

NN

其中 L及L彼此獨立地選自氫、溴、碘、άτι◦烷基、Ci_Ci〇 2齒炫*基、Cl-Cl0烷氧基及(^-(:10鹵烷氧基; L及L彼此獨立地選自氫、鹵素、Ci_CM烷基、Ci_Ci〇鹵 烧基、Cl_Cl()燒氧基及^-心^烷氧基; 1限制條件為^、。、。及卜中至少一者不為氫; R及R彼此獨立地選自氫、C丨_Cw烷基、Ci_c丨。鹵烷基、 Cl-ClQ烷氧基及C1-C1G_烷氧基; R係選自氫、CVC10烷基、Ci_Ci〇鹵烷基、Ci_Cl〇烷氧基 及Ci-C10鹵烧氧基; R4 係選自氫、CVC滅基、Ci_CiQ_烷基、C2_ClQ烯基、 C2-C1()函烯基、C2_Ci〇 快基、c2_Ci〇 函炔基、C3_Ci〇 環 烷基、匸3_(:10鹵環烷基、苯基、苯基_Ci_C4烷基,其 中最後2個提及之基團中之苯基部分可具有丨、2、3、 或5個取代基汉8,及含有i2或3個選自N、〇及s之 雜原子作為環成員的5員或6員 族雜環,其中該雜環可具有j 飽和、部分不飽和或芳 、2或3個取代基R8 ;或 147474.doc -4- 201041514 在η為〇之情況下,亦可選自_c(=〇)R5、_c(=s)r5、 _S(0)2r5、-CN、-P(=Q)R6R7、μ及式 III基團,Wherein L and L are independently of each other selected from the group consisting of hydrogen, bromine, iodine, άτι◦ alkyl, Ci_Ci〇2 dentate, Cl-Cl0 alkoxy and (^-(:10 haloalkoxy; L and L each other) Independently selected from the group consisting of hydrogen, halogen, Ci_CM alkyl, Ci_Ci〇 halogen group, Cl_Cl() alkoxy group and ^-cardoyloxy group; 1 limitation condition is at least one of ^, ., and Hydrogen; R and R are independently of each other selected from the group consisting of hydrogen, C丨_Cw alkyl, Ci_c丨, haloalkyl, Cl-ClQ alkoxy and C1-C1G-alkoxy; R is selected from hydrogen, CVC10 alkyl , Ci_Ci〇 haloalkyl, Ci_Cl〇 alkoxy and Ci-C10 halo alkoxy; R4 is selected from hydrogen, CVC exo, Ci_CiQ_alkyl, C2_ClQ alkenyl, C2-C1() alkenyl, C2_Ci 〇 fast radical, c2_Ci〇 alkynyl, C3_Ci〇cycloalkyl, 匸3_(:10 halocycloalkyl, phenyl, phenyl-Ci_C4 alkyl, wherein the phenyl moiety in the last two mentioned groups It may have a ruthenium, 2, 3, or 5 substituents, and a 5- or 6-membered heterocyclic ring containing i2 or 3 hetero atoms selected from N, oxime and s as ring members, wherein the heterocyclic ring may be Has j saturated, partially unsaturated or aromatic, 2 or 3 substituents R8; or 147474.doc -4- 2 01041514 In the case where η is 〇, it may also be selected from _c(=〇)R5, _c(=s)r5, _S(0)2r5, -CN, -P(=Q)R6R7, μ and formula III group,

L、L2、L3、L4 ' R1、R2&R3係如對於式〗及式π所定 義;且 ΟL, L2, L3, L4 ' R1, R2 & R3 are as defined for the formula and the formula π; and Ο

其中 #為與分子之其餘部分的連接點; R係&自氫、Ci-Cio烧基、Ci-C!。鹵烷基、CrC,。烯基、 c2-c“ 烯基、C2_Ciq快基、C2_C^ 炔基、c3_(^環 烷基、C3_Cl〇鹵環烷基、苯基、苯基-CVC4烷基,其 中最後2個提及之基團中之苯基部分可具有1、2、3、 4或5個取代基^含有1、2或3個選自N、〇及S之雜 原子作為&成員的5M或6員飽和、部分不飽和或芳族 ’裒了中該雜環可具有1、2或3個取代基R8, ()R ~c(=s)r5、-s(〇)2r5、_CN、_p(=q)R6r7 M ; R5係選自氫、c r p甘 i-c1()烧基、Ci_Ci()鹵烧基、Ci_Ci。燒氧 二、Cl Ci。_燒氧基、Ci_c】。胺基烧基、c3_Ci。環烧 土 C3 C]0_ J展烷基、苯基、苯基_Ci_C4烷基、笨氧 147474.doc 201041514 基,其中最後3個提及之基團中之苯基部分可具有卜 3 4或5個取代基汉8,含有1、2或3個選自N、0及 s之雜原子作為環成員的5員或6員飽和、部分不飽和 或芳無雜壤’其中該雜環可具有1、2或3個取代基 r8 ’ 及 NR9R10 ; R及R彼此獨立地選自Ci_Ci〇烷基、鹵烷基、c广 烯基、C2-C1G幽烯基、C2_CiG炔基、C2_CiQ鹵炔基、 C3-Cn>壤院基、c3_ciq齒環烧基、C1_C1G烧氧基、Ci_ Cl〇鹵烷氧基、C1-C4烷氧基-c丨-C丨〇烷基、C丨-c4烷氧 基<1-(:10院氧基、Cl_Ci(^硫基、Ci_Ci〇鹵烷硫基、 c2-c1()稀氧基、C2-Ci()稀硫基、c2_Ci。快氧基、c2_Ci〇 块硫基、C3-C1G環烷氧基、c3_ClQ環烷硫基、苯基、 苯基-CrC4烷基、苯氧基、苯硫基、苯基_Ci_c4烷氧 基及 NRnR12 ; 各R8獨立地選自鹵素、硝基、CN、烷基、CVC4鹵烷 基、CVC4烷氧基、CVC4鹵烷氧基及nr13r14 ; R9係選自氫及q-Cs烷基;Where # is the point of attachment to the rest of the molecule; R is & from hydrogen, Ci-Cio alkyl, Ci-C!. Haloalkyl, CrC,. Alkenyl, c2-c "alkenyl, C2_Ciq fast radical, C2_C^ alkynyl, c3_(cycloalkyl, C3_Cl〇 halocycloalkyl, phenyl, phenyl-CVC4 alkyl, the last two of which are mentioned The phenyl moiety in the group may have 1, 2, 3, 4 or 5 substituents, containing 1, 2 or 3 heteroatoms selected from N, oxime and S as 5M or 6 member saturated, & Partially unsaturated or aromatic, the heterocyclic ring may have 1, 2 or 3 substituents R8, ()R~c(=s)r5, -s(〇)2r5, _CN, _p(=q) R6r7 M ; R5 is selected from the group consisting of hydrogen, crp-gan i-c1 () alkyl, Ci_Ci () halogen group, Ci_Ci, oxygen-dissolved oxygen, Cl Ci. - alkoxy group, Ci_c], amine-based alkyl group, c3_Ci. Ring-burning earth C3 C]0_J alkyl, phenyl, phenyl-Ci_C4 alkyl, oxy 147474.doc 201041514 base, wherein the phenyl moiety in the last three mentioned groups may have 5 substituents, containing 5, 6 or 3 heteroatoms selected from N, 0 and s as ring members, 5 or 6 members saturated, partially unsaturated or aromatic-free, wherein the heterocyclic ring may have 1, 2 or 3 substituents r8 ' and NR9R10; R and R are independently selected from the group consisting of Ci_Ci〇alkyl, haloalkyl, c-wide Base, C2-C1G pentacenyl, C2_CiG alkynyl, C2_CiQ haloalkynyl, C3-Cn> soil base, c3_ciq cyclyl, C1_C1G alkoxy, Ci_Cl〇 haloalkoxy, C1-C4 alkoxy --c丨-C丨〇alkyl, C丨-c4 alkoxy<1-(: 10 oxime, Cl_Ci(^thio, Ci_Ci 〇halothio, c2-c1() diloxy , C2-Ci() dilute sulfur group, c2_Ci. a fast oxy group, a c2_Ci 〇 thiol group, a C3-C1G cycloalkoxy group, a c3_ClQ cycloalkylthio group, a phenyl group, a phenyl-CrC4 alkyl group, a phenoxy group, Phenylthio, phenyl-Ci_c4 alkoxy and NRnR12; each R8 is independently selected from the group consisting of halogen, nitro, CN, alkyl, CVC4 haloalkyl, CVC4 alkoxy, CVC4 haloalkoxy and nr13r14; Selected from hydrogen and q-Cs alkyl;

RlC)係選自氫、Ci-Cs烷基、苯基及苯基-CVC4烷基; 或R9與R1G —起形成直鏈c4或C5伸烷基橋或基團 -CH2CH2OCH2CH2-或-CH2CH2NR15CH2CH2-; R11係選自氫及(VCs烷基; R12係選自氫、(VCs烷基、苯基及苯基-CVC4烷基; 或R11與R12 —起形成直鏈C4或C5伸烷基橋或基團 -CH2CH2OCH2CH2-或-CH2CH2NR15CH2CH2-; 147474.docRlC) is selected from the group consisting of hydrogen, Ci-Cs alkyl, phenyl and phenyl-CVC4 alkyl; or R9 together with R1G form a linear c4 or C5 alkylene bridge or group -CH2CH2OCH2CH2- or -CH2CH2NR15CH2CH2-; R11 is selected from the group consisting of hydrogen and (VCs alkyl; R12 is selected from the group consisting of hydrogen, (VCs alkyl, phenyl and phenyl-CVC4 alkyl; or R11 together with R12 forms a linear C4 or C5 alkylene bridge or group)团-CH2CH2OCH2CH2- or -CH2CH2NR15CH2CH2-; 147474.doc

201041514 R“在,次出現時獨立地選自氫及c,-c8烷基,· R在每-人出現時獨立地選自氫、G-C8烷基、苯基及苯 基_ci-C4烷基; 或R1 3血p J 4 一起形成直鏈(^或^伸烷基橋或基團 CH2CH2〇CH2CH2-^-CH2CH2NR15CH2CH2-; R在每次出現時獨立地選自氫及(^-(:4烷基; Q 為0或S ; Μ為金屬陽離子相等物或式(NRaRbReRd) +之銨陽離子, 其中Ra、Rb、RC及Rd彼此獨立地選自氳、Ci_Ci〇烷 基、苯基及苯甲基,其中最後2個提及之基團中之苯 基部分可具有1、2或3個獨立地選自以下之取代基: 鹵素、CN、硝,基、Cl_c4烧基、Ci_c4齒燒基、 烧氧基、Ci-C*鹵烷氧基及nr13r14 ; η 為Ο、1、2或3 ;且 =(鍵/點鍵组合)為單鍵或雙鍵。 本發明亦係關於式Ϊ及式Π三唑化合物及其農業 鹽, ' 上適用之201041514 R "in the second occurrence, independently selected from hydrogen and c, -c8 alkyl, · R is independently selected from hydrogen, G-C8 alkyl, phenyl and phenyl _ci-C4 in the presence of human Alkyl; or R1 3 blood p J 4 together form a straight chain (^ or ^alkyl bridge or group CH2CH2〇CH2CH2-^-CH2CH2NR15CH2CH2-; R is independently selected from hydrogen and (^-( : 4 alkyl; Q is 0 or S; Μ is a metal cation equivalent or an ammonium cation of the formula (NRaRbReRd) +, wherein Ra, Rb, RC and Rd are independently selected from the group consisting of hydrazine, Ci_Ci 〇 alkyl, phenyl and A benzyl group, wherein the phenyl moiety in the last two mentioned groups may have 1, 2 or 3 substituents independently selected from the group consisting of: halogen, CN, nitrate, aryl, Cl_c4 alkyl, Ci_c4 tooth burning a group, an alkoxy group, a Ci-C* haloalkoxy group, and nr13r14; η is Ο, 1, 2 or 3; and = (bond/point bond combination) is a single bond or a double bond. The present invention is also related to the formula Ϊ And oxatriazole compounds and their agricultural salts, 'applicable

147474.doc 201041514 其中 L及L4彼此獨立地選自氫、溴、碘、Ci_Ci〇烷基、 齒烧基、(^-(:10烷氧基及Cl_Cl〇鹵烷氧基; L2及L3彼此獨立地選自氫、鹵素、Ci_Ci〇烷基、Ci_c〗〇鹵 烧基、Cl-Ci〇烷氧基及(^-(:10鹵烷氧基; 限制條件為L1、L2、L3及L4中至少一者不為氫; R1及R2彼此獨立地選自氫、Ci_Ci〇烷基、Ci_Ci〇鹵烷基、 ^-(:10烧氧基及Ci_Ci〇鹵烷氧基; R3係選自氫、CVC,。烧基、Cl_Cl()_烷基、Cl_ClG燒氧基及 Ci-C10鹵烧氧基; R4係選自氫、eve!。烧基、Ci-Cioii烧基、c2-c1Q稀基、 C2-C10_ 烯基、c2_Ci〇 炔基、c2_Ci〇 鹵炔基、c3_ci〇 環 烧基、CVC10_環烷基、苯基、苯基_Cl_c4烷基,其 中最後2個提及之基團中之苯基部分可具有1、2、3、 4或5個取代基R8,及含有1、2或3個選自N、〇及S之 雜原子作為環成員的5員或6員飽和、部分不飽和或芳 族雜環’其中該雜環可具有1、2或3個取代基R8 ;或 在η為〇之情況下,亦可選自_c(=〇)R5、_c(=s)r5、 -S(0)2R5、-CN、-P(=q)r6R7、μ及式 III基團, 147474.doc 201041514147474.doc 201041514 wherein L and L4 are independently of each other selected from the group consisting of hydrogen, bromine, iodine, Ci_Ci〇alkyl, dentate, (^-(:10 alkoxy and Cl_Cl〇halo alkoxy; L2 and L3 are independent of each other) Is selected from the group consisting of hydrogen, halogen, Ci_Ci 〇 alkyl, Ci_c 〇 halogen group, Cl-Ci decyloxy and (^-(: 10 haloalkoxy; at least L1, L2, L3 and L4) One is not hydrogen; R1 and R2 are independently selected from hydrogen, Ci_Ci 〇 alkyl, Ci_Ci 〇 haloalkyl, ^-(: 10 alkoxy and Ci_Ci 〇 haloalkoxy; R3 is selected from hydrogen, CVC , calcination, Cl_Cl()-alkyl, Cl_ClG alkoxy and Ci-C10 halo alkoxy; R4 is selected from hydrogen, eve!. alkyl, Ci-Cioii alkyl, c2-c1Q, C2 -C10_ alkenyl, c2_Ci decynyl, c2_Ci 〇 haloalkynyl, c3_ci 〇 cycloalkyl, CVC10_cycloalkyl, phenyl, phenyl-Cl_c4 alkyl, of which benzene in the last two mentioned groups The base moiety may have 1, 2, 3, 4 or 5 substituents R8, and 5 or 6 member saturated, partially unsaturated, containing 1, 2 or 3 heteroatoms selected from N, yttrium and S as ring members Or an aromatic heterocyclic ring wherein the heterocyclic ring may have 1, 2 or 3 substituents R 8 or in the case where η is 〇, it may also be selected from _c(=〇)R5, _c(=s)r5, -S(0)2R5, -CN, -P(=q)r6R7, μ and Group III, 147474.doc 201041514

其中 L1、L2、L3、L4、R1、RiR3係如對於式!及式u所定 ^ 義;且 Ο #為與分子之其餘部分的連接點; R4a係選自氫、cvcw烧基、Cl_Ci。函烷基、^_〜稀基、 c2-c1()鹵烯基、C2-C1G炔基、c2_ClQ齒块基、c3_Ci〇環 烷基、C3-C1G_環烷基、苯基、苯基_Ci_c4烷基,其 中最後2個提及之基團中之苯基部分可具有丨、2、3了 4或5個取代基R8,含有1、2或3個選自N、〇及8之雜 原子作為環成員的5員或6員飽和、部分不飽和或芳族 〇 雜環,其中該雜環可具有1、2或3個取代基1^, -C(=0)R5、-C(=S)R5、-S(0)2R5、_CN、_p(=q)r6r、 M ; R5係選自氫、CVC1()烧基、Cl_Clj烷基、貌氧 基、CVCwi烷氧基、Ci_^胺基烧基、c3_Cig環烷 基、<:3_(:10鹵環烷基、苯基、苯基_Ci_C4烷基、苯氧 基’其中最後3個提及之基團中之苯基部分可具有1、 2、3、4或5個取代基尺8,含有丨、2或3個選自N、〇及 S之雜原子作為環成員的5員或6員飽和、部分不飽和 147474.doc 201041514 或芳族雜環,其中該雜環可具有1、2或3個取代基 R8,及 NR9r10 ; R及R7彼此獨立地選自Ci-Ci〇烧基、Ci-Ci〇鹵烧基、C2-Ci〇 稀基、C2-C10鹵稀基、C2-C10快基、C2-C10鹵快基、 C3_Ci〇 環烧基、C3_CiG_ 環炫•基、Ci-Cio^ 氧基、Ci_ 匸1〇_烧氧基、C1-C4烧氧基_Ci_Cig烧基、C1-C4烧氧 基-CrCw烷氧基、CVCm烷硫基、CrCw鹵烷硫基、 c2-c1Q烯氧基、c2-c1Q烯硫基、c2-c1G炔氧基、c2-c10 快硫基、C3-C1Q環烧氧基、C3-C1G環烧硫基、苯基、 苯基烷基、苯氧基、苯硫基、苯基烷氧 基及nrur12 ; 各R8獨立地選自鹵素、硝基、CN、CVC4烷基、Ci-CU鹵烷 基、α-(:4烷氧基、CVC4鹵烷氧基及nr13r14 ; r9係選自氫及CVC8烷基; R10係選自CrCs烷基、苯基及苯基_Cl_c4烷基; 或R9與RlG 一起形成直鏈c4或c5伸烷基橋或基團 -CH2CH2〇CH2CH2-或-CH2CH2NR15CH2CH2-; R11係選自氫及CVC8烷基; R12係選自烷基、苯基及苯基_Ci_c4烷基; 或尺^與Rl2一起形成直鏈c4或(:5伸烷基橋或基團 -CH2CH2〇CH2CH2-^ -CH2CH2NR15CH2CH2-; R在每次出現時獨立地選自氫及CrCs烷基; R在每次出現時獨立地選自CrCs烷基、苯基及苯基-C,- C4烧基; 147474.doc 201041514 或R13及R14 —起形成直鏈C4或C5伸烷基橋或基團 -CH2CH2〇CH2CH2_ 或-CH2CH2NR15CH2CH2-; R15在每次出現時獨立地選自氫及^厂山烷基; Q為Ο或S ; M 為金屬陽離子相等物或式(NRaRbReRd)+之銨陽離子, 其中Ra、Rb、Re及Rd彼此獨立地選自氫、Ci_Ci〇烷 基、苯基及苯甲基,其中最後2個提及之基團中之苯 基部分可具有1、2或3個獨立地選自以下之取代美. _ 素、CN、硝基、Cl-C4烷基、Cl_c4 _ 烷基、c^c 烷氧基、c「c4鹵烷氧基及nr13r14 ; 4 η 為0、1、2或3 ;且 =(鍵/點鍵組合)為單鍵或雙鍵。 因此,式I及式II為表示以下結構之統一方 々式,該等結構 亦命名為式ΙΑ、ΙΙΑ、ΙΒ及ΙΙΒ化合物, '°Among them, L1, L2, L3, L4, R1, RiR3 are as follows! And u is defined as the meaning; and Ο # is the point of attachment to the rest of the molecule; R4a is selected from hydrogen, cvcw, and Cl_Ci. Alkenyl, ^_~ dilute, c2-c1()haloenyl, C2-C1G alkynyl, c2_ClQ dentate, c3_Ci 〇cycloalkyl, C3-C1G_cycloalkyl, phenyl, phenyl _ a Ci_c4 alkyl group, wherein the phenyl moiety in the last two mentioned groups may have an anthracene, 2, 3, 4 or 5 substituents R8, containing 1, 2 or 3 selected from the group consisting of N, hydrazine and 8 A 5- or 6-membered saturated, partially unsaturated or aromatic amidine heterocyclic ring having a ring as a ring member, wherein the heterocyclic ring may have 1, 2 or 3 substituents 1^, -C(=0)R5, -C( =S) R5, -S(0)2R5, _CN, _p(=q)r6r, M; R5 is selected from the group consisting of hydrogen, CVC1 () alkyl, Cl_Clj alkyl, morphoxy, CVCwi alkoxy, Ci_^ Aminoalkyl, c3_Cig cycloalkyl, <:3_(:10 halocycloalkyl, phenyl, phenyl-Ci_C4 alkyl, phenoxy) phenyl moiety of the last three of the groups mentioned It may have 1, 2, 3, 4 or 5 substituent bases 8, containing 5, 6 or 3 hetero atoms selected from N, 〇 and S as ring members, saturated or partially unsaturated 147,474. Doc 201041514 or an aromatic heterocyclic ring, wherein the heterocyclic ring may have 1, 2 or 3 substituents R8, and NR9r10; R and R7 are independently selected from Ci-Ci Terpene, Ci-Ci oxime, C2-Ci 〇, C2-C10 halogen, C2-C10 fast radical, C2-C10 halogen radical, C3_Ci〇 cycloalkyl, C3_CiG_ cyclod , Ci-Cio^oxy, Ci_ 匸1〇_alkoxy, C1-C4 alkoxy _Ci_Cig alkyl, C1-C4 alkoxy-CrCw alkoxy, CVCm alkylthio, CrCw haloalkylthio , c2-c1Q alkenyloxy, c2-c1Q-enylthio, c2-c1G alkynyloxy, c2-c10 thiol, C3-C1Q cycloalkoxy, C3-C1G cycloalkylthio, phenyl, phenyl Alkyl, phenoxy, phenylthio, phenylalkoxy and nrur12; each R8 is independently selected from the group consisting of halogen, nitro, CN, CVC4 alkyl, Ci-CU haloalkyl, α-(:4 alkoxy a group, CVC4 haloalkoxy and nr13r14; r9 is selected from the group consisting of hydrogen and CVC8 alkyl; R10 is selected from the group consisting of CrCs alkyl, phenyl and phenyl-Cl_c4 alkyl; or R9 together with RlG forms a linear c4 or c5 extension An alkyl bridge or group -CH2CH2〇CH2CH2- or -CH2CH2NR15CH2CH2-; R11 is selected from the group consisting of hydrogen and CVC8 alkyl; R12 is selected from the group consisting of alkyl, phenyl and phenyl-Ci_c4 alkyl; or the ruler ^ is formed together with Rl2 Linear c4 or (:5 alkyl bridge or group -CH2CH2〇CH2CH2-^ -CH2CH2NR15CH2CH2-; R is unique at each occurrence Selected from hydrogen and CrCs alkyl; R is independently selected from the group consisting of CrCs alkyl, phenyl and phenyl-C, -C4 alkyl at each occurrence; 147474.doc 201041514 or R13 and R14 together form a linear C4 Or a C5 alkylene bridge or a group -CH2CH2〇CH2CH2_ or -CH2CH2NR15CH2CH2-; R15 is independently selected from hydrogen and ethene at each occurrence; Q is hydrazine or S; M is a metal cation equivalent or formula (NRaRbReRd) + an ammonium cation, wherein Ra, Rb, Re and Rd are independently of each other selected from the group consisting of hydrogen, Ci_Ci 〇 alkyl, phenyl and benzyl, wherein the phenyl moiety of the last two mentioned groups may Having 1, 2 or 3 independently substituted from the following: _, CN, nitro, Cl-C4 alkyl, Cl_c4 _ alkyl, c^c alkoxy, c "c4 haloalkoxy" Nr13r14 ; 4 η is 0, 1, 2 or 3; and = (key/point key combination) is a single bond or a double bond. Therefore, Formula I and Formula II are uniform formulas representing the following structures, which are also named as ΙΑ, ΙΙΑ, ΙΒ and ΙΙΒ compounds, '°

147474.doc -11- 201041514 ^Ny-s(〇)nR4 n~n147474.doc -11- 201041514 ^Ny-s(〇)nR4 n~n

(IB)(IB)

若在化合物IA中’ R4為式III基團’則其為sniA基團If in the compound IA, 'R4 is a group of the formula III', it is a sniA group.

本發明亦提供式I及式II三唑化合物及/或其農業上適用 之鹽用於防治有害真菌之用途。 本發明進一步提供殺真菌組合物,其包含式I及/或式 11(及/或亦式IV ;參看下文)之此等三唑化合物及/或其農業 上可接受之鹽及適合載劑。下文描述適合之農業上可接受 147474.doc •12· 201041514 之載劑。The invention also provides the use of a triazole compound of formula I and formula II and/or an agriculturally acceptable salt thereof for controlling harmful fungi. The invention further provides a fungicidal composition comprising such a triazole compound of formula I and / or formula 11 (and / or also formula IV; see below) and / or an agriculturally acceptable salt thereof and a suitable carrier. Suitable carriers for agriculturally acceptable 147474.doc •12· 201041514 are described below.

化合物I及II可以一或多種立體異構體形式存在。各種立 體異構體包括對映異構體、非對映異構體、滯轉異構體及 幾何異構體。熟習此項技術者應瞭解,一種立體異構體當 相對於其他立體異構體增濃時或當與其他立體異構體分^ 時可更具活性及/或可顯示有利作用。另夕卜’熟習此項技 術者已知如何分離、增濃及/或選擇性製備該等立體異構 體。本發明之化合物可以立體異構體之混合物(例如外消 旋體)、個別立體異構體形式或以光學活性形式存在。特 定言式认及1^化合物可關於環戊烷環上OH基團與基 诗:: 團 L之相對位置以異構體形式存在,其可為順式或 反式。本發明涵蓋順式異構體、反式異構體及其混合物。 然而,較佳為順式異構體(式1 A-順式及式IIA-順式化合 物):Compounds I and II may exist in one or more stereoisomeric forms. The various stereoisomers include enantiomers, diastereomers, singly isomers and geometric isomers. Those skilled in the art will appreciate that a stereoisomer may be more active and/or may exhibit an advantageous effect when concentrated relative to other stereoisomers or when combined with other stereoisomers. It is also known to those skilled in the art how to isolate, enrich, and/or selectively prepare such stereoisomers. The compounds of the invention may exist as a mixture of stereoisomers (e.g., racemates), as individual stereoisomers, or as optically active forms. The specific formula recognizes that the compound can be related to the OH group on the cyclopentane ring and the base:: The relative position of the group L exists as an isomer, which may be cis or trans. The invention encompasses cis isomers, trans isomers, and mixtures thereof. However, preferred are the cis isomers (Formula 1 A-cis and Formula IIA-cis compounds):

至少在基團R4/R“相同之情況下,可將化合物1及π彼此 視為位置/雙鍵異構體。在R4(當然以及R4a)為氫之情況 147474.doc -13- 201041514 下,各別化合物I及II為互變異構體。 適口辰業上適用之鹽尤其為彼等陽離子之鹽或彼等酸之 酸加成鹽,其陽離子及陰離子分別對化合物則之殺真菌 作用不具有不良影響。因此,適合陽離子尤其為驗金屬 (較佳為鈉及鉀)、驗土金屬(較佳為詞、鎂及鋇)及過渡金 屬(較佳為锰、銅、鋅及鐵)之離子,以及錢離子,該錢離 子必要時可具有—至四個Ci_C4烷基取代基及/或一個苯基 或苯曱基取代基’較佳為二異丙銨、"銨、四丁銨、三 曱基苯甲基銨,此外為鱗離子、毓離子,較佳為三(C1_C4 烷基)巯及氧化錡離子,較佳為三(Ci_c4烷基)氧化锍。 適用酸加成鹽之陰離子主要為氯離子、溴離子、氟離 子、硫酸氫根、硫酸根、磷酸二氫根、磷酸氫根、磷酸 根、硝酸根、碳酸氫根、碳酸根、六氟矽酸根、六氟磷酸 根、苯曱酸根,以及Cl_C4烷酸之陰離子,較佳為甲酸 根、乙酸根、丙酸根及丁酸根。其可藉由使1或11與相應陰 離子之酸(較佳為鹽酸、氫溴酸、硫酸、填酸或硝酸)反應 來形成。 在上文式中給出之變數的定義中’使用一般代表所討論 之取代基的集合術語。術語cn-cm指示在各情況下在所討 論之取代基或取代部分中可能之碳原子數: 鹵素:氟、氣、溴及碘; 烷基及烷氧基、烷基羰基、烷基疏基羰基、烷基胺基、 二烷基胺基、烷基胺基羰基、二烷基胺基羰基、烷硫基、 烧基績醯基及其類似基團中之烧基部分:具有1至2個(Cl- 147474.doc • 14· 201041514 C2烷基)、2或3個(C2-C3烷基)、1至4個((VC*烷基)、1至6 個(CVC6烧基)、1至8個(CVCs烧基)或1至1〇個(q-Cio烧基) 碳原子之飽和直鏈或分支鏈烴基。c2-c3烷基為乙基、正 丙基或異丙基。CrC2烷基為甲基或乙基。CrQ烷基另外 亦為丙基、異丙基、丁基、1-甲基丙基(第二丁基)、2_甲 基丙基(異丁基)或1,1-二甲基乙基(第三丁基)。烷基 另外亦為例如戊基、1-甲基丁基、2-甲基丁基、3-甲基丁 基、2,2-二曱基丙基、1-乙基丙基、1,1-二甲基丙基、1,2_ 二曱基丙基、己基、1-曱基戊基、2-曱基戊基、3-甲基戊 基、4-曱基戊基、1,1-二曱基丁基、丨,2_二甲基丁基、13_ 二甲基丁基、2,2-二曱基丁基、2,3-二曱基丁基、3,3-二甲 基丁基、1-乙基丁基、2-乙基丁基、ι,ι,2-三曱基丙基、 1,2,2-三甲基丙基、1-乙基_ι_甲基丙基或丨_乙基_2甲基丙 基。Ct-Cs烷基另外亦為例如庚基、辛基、2_乙基己基及其 位置異構體。Ci-Cio烧基另外亦為例如壬基、癸基、2_丙 基庚基、3 -丙基庚基及其位置異構體。 鹵烷基:具有1至2個(CVC2!!烷基)、1至3個鹵烷 基)、1至4個(CVCU齒烧基)、1至6個(Ci-C6鹵烧基)、 個(CVCj烧基)、1至1〇個(Cl_Ci〇_烧基)或2至⑺個⑴广 C1〇i烷基)碳原子之直鏈或分支鏈烷基(如上所述),其中 此專基團中之一些或全部氫原子可經如上所述之齒素原子 置換.特疋a之為C^-C2鹵烧基,諸如氯甲基、溴甲基、 二氣甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基、氯 氟曱基、二氯氟甲基、二氟氣甲基、卜氯乙基、丨_溴乙 147474.doc 15- 201041514 基、1-氟乙基、2-氟乙基、2,2-二氟乙基、2,2,2-三氟乙 基、2_氯-2-氟乙基、2_氯_2,2_二氟乙基、2,2_二氯_2_氟乙 基、2,2,2-二氯乙基或五氟乙基。Cl-C3鹵烷基另外為例如 1,1,1-二氟丙_2-基、3,3,3-三氟丙基或七氟丙基。(^_c4鹵 院基另外為例如1·氯丁基、2-氣丁基、3-氣丁基或4-氯丁 基。At least in the case where the group R4/R is the same, the compounds 1 and π can be regarded as position/double bond isomers to each other. In the case where R4 (and of course R4a) is hydrogen, 147474.doc -13- 201041514, The respective compounds I and II are tautomers. The salts which are suitable for use in the succinct industry are, in particular, the salts of their cations or the acid addition salts of these acids, the cations and anions of which have no fungicidal action on the compounds respectively. Adverse effects. Therefore, suitable cations are especially metals for metal (preferably sodium and potassium), soil-measuring metals (preferably words, magnesium and strontium) and transition metals (preferably manganese, copper, zinc and iron). And the money ion, the money ion may have - to four Ci_C4 alkyl substituents and/or one phenyl or phenylhydrazine substituent 'preferably diisopropylammonium, "ammonium, tetrabutylammonium, Trimethyl benzyl ammonium chloride, further preferably scaly ion, cerium ion, preferably tris(C1_C4 alkyl) fluorene and cerium oxide ion, preferably tris(Ci_c4 alkyl) cerium oxide. Mainly chloride, bromide, fluoride, hydrogen sulfate, sulfate, phosphorus Dihydrogen, hydrogen phosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluoroantimonate, hexafluorophosphate, benzoate, and anion of Cl_C4 alkanoic acid, preferably formate, acetate , propionate and butyrate, which can be formed by reacting 1 or 11 with a corresponding anionic acid, preferably hydrochloric acid, hydrobromic acid, sulfuric acid, acid or nitric acid. The definition of a variable 'uses a collective term that generally refers to the substituent in question. The term cn-cm indicates the number of carbon atoms possible in each case in the substituent or substitution moiety in question: Halogen: fluorine, gas, bromine and Iodine; alkyl and alkoxy, alkylcarbonyl, alkylthiocarbonyl, alkylamino, dialkylamino, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthio, calcined The alkyl group in the fluorenyl group and the like: having 1 to 2 (Cl-147474.doc • 14·201041514 C2 alkyl), 2 or 3 (C2-C3 alkyl), 1 to 4 ( (VC* alkyl), 1 to 6 (CVC6 alkyl), 1 to 8 (CVCs alkyl) or 1 to 1 (q-Cio alkyl) carbon a saturated linear or branched hydrocarbon group. The c2-c3 alkyl group is an ethyl group, a n-propyl group or an isopropyl group. The CrC2 alkyl group is a methyl group or an ethyl group. The CrQ alkyl group is also a propyl group, an isopropyl group or a butyl group. a group, 1-methylpropyl (second butyl), 2-methylpropyl (isobutyl) or 1,1-dimethylethyl (t-butyl). The alkyl group is also, for example, pentyl. Base, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimercaptopropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2_ Dimercaptopropyl, hexyl, 1-decylpentyl, 2-decylpentyl, 3-methylpentyl, 4-mercaptopentyl, 1,1-didecylbutyl, hydrazine , 2_ dimethylbutyl, 13-dimethylbutyl, 2,2-dimercaptobutyl, 2,3-dimercaptobutyl, 3,3-dimethylbutyl, 1-ethyl Butyl, 2-ethylbutyl, ι,ι,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-ι-methylpropyl or oxime-ethyl _2 methyl propyl. The Ct-Cs alkyl group is also additionally, for example, heptyl, octyl, 2-ethylhexyl and positional isomers thereof. The Ci-Cio alkyl group is also, for example, an anthracenyl group, a fluorenyl group, a 2-propylheptyl group, a 3-propylheptyl group, and a positional isomer thereof. Haloalkyl: having 1 to 2 (CVC 2!! alkyl), 1 to 3 haloalkyl groups, 1 to 4 (CVCU dentate), 1 to 6 (Ci-C6 haloalkyl), a linear or branched alkyl group (as described above) of (CVCj alkyl), 1 to 1 (Cl_Ci〇-alkyl) or 2 to (7) (1) wide C1〇i alkyl) carbon atoms (as described above) Some or all of the hydrogen atoms in the specific group may be replaced by a dentate atom as described above. The 疋a is a C^-C2 halogen group, such as chloromethyl, bromomethyl, dioxomethyl, trichloro Methyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, difluoromethyl, chloroethyl, oxime bromide 147474.doc 15- 201041514 , 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2 _Difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-dichloroethyl or pentafluoroethyl. The Cl-C3 haloalkyl group is additionally, for example, 1,1,1-difluoropropan-2-yl, 3,3,3-trifluoropropyl or heptafluoropropyl. The (^_c4 halogen) group is additionally, for example, 1·chlorobutyl, 2-cyclobutyl, 3-cyclobutyl or 4-chlorobutyl.

Ci-Cio羥烷基:具有1至2個(CrC〗羥烷基)、1至4個(CV C4羥烷基)、2至4個(C2-C4羥烷基)、1至6個(CrG羥烷 基)、2至6個(C2-C6羥烷基)、1至8個(CVCs羥烷基)、2至8 個(C2-C8羥烷基)、1至1〇個(q-CM羥烷基)或2至10個(C2-C10羥炫基)碳原子之直鏈或分支鏈烧基(如上所述),其中 至少一個氫原子經羥基置換,諸如2-羥乙基或3-羥丙基。 烯基及稀氧基、稀基幾基及其類似基團中之稀基部分: 具有2至4個(CrC4烯基)、2至6個(C2-C6烯基)、2至8個(C2-C8烯基)、3至8個(C3-C8烯基)、2至10個(CVCi。烯基)或3至 1 0個(C;3-C 10烯基)礙原子及在任何位置之雙鍵的單不飽和 直鏈或分支鏈烴基’例如C2-C6烯基,諸如乙烯基、丙浠 基、2 -丙浠基、1-曱基乙烯基、1-丁烯基、2 -丁烯基、3-丁稀基、1-曱基-1-丙稀基、2-曱基-1-丙嫦基、ι_甲基_2_ 丙烯基、2-甲基-2-丙烯基、1-戊烯基、2-戊烯基、3-戊烯 基、4-戊烯基、1-曱基-1-丁烯基、2-甲基-1-丁烯基、3-甲 基-1-丁稀基、1-曱基-2-丁烯基、2-曱基-2-丁稀基、3 -曱 基-2-丁稀基、1-甲基-3-丁稀基、2-曱基-3 -丁稀基、3 -甲 基-3-丁烯基、1,1-二甲基-2-丙烯基、ι,2-二曱基-i_丙烯 147474.doc -16- * v 201041514 基、1,2-· —曱基-2-丙稀基、1 -乙基-;[•丙稀基、1 _乙基 稀基、1-己浠基、2-己稀基、3 -己浠基、4-己稀基、己 烯基、1-曱基-1-戊烯基、2-甲基-1-戊稀基、3 -曱基q•戊 稀基、4-甲基-1-戊烯基、1-甲基-2-戊烯基、2-曱基戊 稀基、3 -甲基-2-戊烯基' 4-甲基-2-戊浠基、ι_甲基_3_戊 烯基、2-曱基_3_戊烯基、3-甲基-3-戊烯基、4-甲基_3_戊 烯基、1-甲基-4-戊烯基、2-甲基-4-戊烯基、3_甲基_4_戊 ^ 烯基、4-甲基_4_戊烯基、1,1_二甲基-2-丁烯基、二甲 基-3-丁烯基、1,2_二甲基-1-丁烯基、ι,2_二甲基_2_ 丁埽 基、1,2-二曱基-3-丁烯基、l,3-二甲基_ι_ 丁烯基、i,3-二 曱基-2-丁烯基、1,3-二曱基-3-丁烯基、2,2-二甲基_3_丁烯 基、2,3-二甲基-1-丁烯基、2,3-二甲基-2-丁烯基、2,3_二 曱基-3-丁烯基、3,3-二曱基-1-丁烯基、3,3-二甲基_2_丁埽 基、1-乙基-1-丁嫦基、1-乙基-2-丁浠基、ι_乙基_3_ 丁埽 基、2 -乙基-1-丁稀基、2 -乙基-2 -丁烯基、2-乙基_3_ 丁烯 基、1,1,2-二甲基-2-丙稀基、1-乙基-1-甲基_2_丙婦基、1 乙基-2-甲基-1-丙烯基、i_乙基_2_甲基_2-丙稀基及其類似 基團; 鹵烯基及鹵稀氧基、齒烯基羰基及其類似基團中之鹵烯 基部分:具有2至4個(C2_C4i烯基)、2至6個(c2_C6_烯 基)、2至8個(C2-C8 _烯基)或2至! 〇個(C2_Ci◦齒烯基)碳原 子及在任何位置之雙鍵的不飽和直鏈或分支鏈烴基(如上 所述)’其中此等基團中之一些或全部氫原子可經如上所 述之齒素原子(尤其氟、氯及溴)置換,例如氯乙烯基、氯 147474.doc •17- 201041514 烯丙基及其類似基團; 炔基及炔氧基、炔基羰基及其類似基圑中之炔基部分: 具有2至4個(C2-C4炔基)、2至6個(C2-C6炔基)、2至8個(C2-C8炔基)、3至8個(C3-C8炔基)、2至10個(C2-C1()炔基)或3至 10個(C3-C10快基)碳原子及一或兩個在任何位置之參鍵的 直鏈或分支鏈烴基,例如c2-c6炔基,諸如乙炔基、1 -丙炔 基、2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基、1-甲基-2-丙炔基、1-戊炔基、2-戊炔基、3-戊炔基、4-戊炔基、1-甲基-2-丁炔基、1-曱基_3_丁炔基、2-甲基-3-丁炔基、3-甲基-1-丁炔基、1,1-二甲基-2-丙炔基、1-乙基-2-丙炔基、 1-己炔基、2-己炔基、3-己炔基、4-己炔基、5-己炔基、1-甲基-2-戊炔基、1-曱基_3-戊炔基、1-曱基-4-戊炔基、2-甲基-3-戊炔基、2-曱基-4-戊炔基、3 -曱基-1-戊炔基、3-甲基-4-戊炔基、4-甲基-1-戊炔基、4-甲基-2-戊炔基、1,1_ 二曱基-2-丁炔基、l,i_二甲基_3_丁炔基、12_二甲基_3 丁 快基、2,2 - 一甲基-3-丁炔基、3,3-二曱基-1-丁炔基、乙 基-2-丁炔基、1-乙基_3_ 丁炔基、2_乙基_3_ 丁炔基、卜乙 基-1-甲基-2-丙炔基及其類似基團; i炔基及鹵炔氧基、齒炔基羰基及其類似基團中之鹵炔 基部分.具有2至4個鹵炔基)、2至6個(C2-C6鹵炔 基)、2至8個(C2-C8鹵炔基)或2至1(Hlil(C2_Ci。鹵炔基)碳原 子及一或兩個在任何位置之參鍵的不飽和直鏈或分支鏈烴 基(如上所述),其中此等基團中之一些或全部氫原子可經 如上所述之i素原子(尤其氟 '氯及溴)置換; 147474.doc -18- 201041514 環烷基及環烷氧基、環烷基羰基及其類似基團中之環烷 基部分:具有3至6個(CrC6環烷基)、3至8個(C3_C8環烷基) 或3至10個(C3_C1Q環烷基)碳環成員之單環飽和烴基,諸如 環丙基、環丁基、環戊基、環己基、環庚基、環辛基、環 壬基及環癸基; 鹵環烷基及_環烷氧基、_環烷基羰基及其類似基團中 之函環烧基部分:具有3至6個(C3-C6鹵環烷基)、3至8個 0 (C3_Cs鹵環烷基)或3至1〇個(C3_C10鹵環烷基)碳環成員之單 環飽和烴基(如上所述),其中一些或全部氫原子可經如上 所述之鹵素原子(尤其氟、氯及溴)置換; 烧氧基:經由氧連接之烷基。Cl_C2烷氧基為甲氧基或 乙氧基。Ci-C4烧氧基另外為例如正丙氧基、ι_曱基乙氧基 (異丙氧基)、丁氧基、1_甲基丙氧基(第二丁氧基)、2_甲基 丙氧基(異丁氧基)或1,1_二甲基乙氧基(第三丁氧基)。Cl_ C6烧氧基另外為例如戊氧基、丨_曱基丁氧基、2_甲基丁氧 〇 基、3_曱基丁氧基、1,1-二甲基丙氧基、1,2-二甲基丙氧 基、2,2-二甲基丙氧基、1-乙基丙氧基、己氧基、1-甲基 戊氧基、2-甲基戊氧基、3_甲基戊氧基、4_甲基戊氧基、 M-二甲基丁氧基、1,2-二甲基丁氧基、1,3_二甲基丁氧 基、二甲基丁氧基、2,3-二甲基丁氧基、3,3-二甲基丁 氧基、1-乙基丁氧基、2-乙基丁氧基、l,i,2-三曱基丙氧 基、1,2,2-二甲基丙氧基、i_乙基_ι·曱基丙氧基或丨_乙基_ 2-甲基丙氧基。Ci-Cs烷氧基另外為例如庚氧基、辛氧基、 2-乙基己氧基及其位置異構體。烷氧基另外為例如 147474.doc -19- 201041514 壬氧基、癸氧基及其位置異構體。C2_Ciq烷氧基係如€ι_ c10烷氧基,甲氧基除外。 函烧氧基:部分或完全經氟、氯、溴及/或碘取代,較 佳經氣取代之如上所述之烧氧基。Cl_C2_烷氧基例如為 〇CH2F、OCHF2、OCF3、〇CH2Ch 0CHC12、0ccl3、氯氟 甲氧基、一氣氟曱氧基、氯二氟甲氧基、2_氟乙氧基、2_ 氯乙氧基、2-溴乙氧基、2-碟乙氧基、2,2-二氟乙氧基、 2,2,2-三氟乙氧基、2_氯_2_氟乙氧基、2_氯_2,2_二氟乙氧 基、2,2-二氣-2-氟乙氧基、2,2,2_三氯乙氧基或oqh。 Cj-C4鹵烷氧基另外為例如2_氟丙氧基、3_氟丙氧基、n 二氟丙氧基、2,3-二氟丙氧基、2_氣丙氧基、%氣丙氧 基、2,3-二氣丙氧基、2_溴丙氧基、3_溴丙氧基、3,3,3_三 氟丙氧基、3,3,3-三氣丙氧基、〇CH2_C2F5、〇CF2_C2F5、 1- (CH2F)-2-敗乙氧基、氯乙氧基、卜仰㈣- 2- 演乙氧基、4_氟丁氧基、4-氯丁氧基、4_漠了氧基或九 氟丁氧基。q-c:6鹵烷氧基另外為例如5_氟戊氧基、5_氯戊 氧基、5-演戊氧基、5_峨戊氧基、十一氣戍氧基、6•氣己 氧基、6-氣己氧基、6_漠己氧基、6_石典己氧基或十二氣己 氧基。 烤氧基丄由氧原子連接之如上所述之浠基,例如c2_ Cl0烯氧基,諸如丨·乙烯氧基、1-丙烯氧基、2-丙烯氧基、 1-甲基乙稀氧基、卜丁稀氧基' 2_ 丁烯氧基、3_ 丁婦氧 基、1-甲基-1-丙烯氧基、2_曱基_丨_丙烯氧基、丨_甲基-2_ 丙烯氧基2_甲基-2-丙烯氧基、卜戊烯氧基、2_戊烯氧 147474.doc -20- 201041514 :、广戍歸氧基、4-戊烯氧基、基切婦氧基、2_甲 丁烯氧基…稀氧基、3-甲基_2-丁稀氧基、"基-3-土、2_甲基_3_丁烯氧基、3mT烯基、 甲…丙烯氧基Ί,二甲基小丙烯氧基 丙烯氧基、乙美]而膝s盆 甲基-2- 烯氧A, 1_乙基_2·丙烯氧基、1-己 Ο Ο =基广己稀氧基、3-己稀氧基、4_己稀氧基、5•己稀 羊土 甲基_1_戊烯氧基、2_甲基-1_戊:)^4其. 1 Λ ^ «. 戊烯乳基、3-甲基一 二2 Λ,基小戊稀氧基、'甲基_2-戊稀氧基、2- 某:i甲\m戊烯氧基m戊浠氧 LC戊烯氧基、”基_3-戊稀氧基、… =二基戊烯氧基、”“戊烯氧基、” 一二甲基…氧基,基甲戊稀氧 以二甲基H氧基、12-ΨΓ9 ,3…·丁烯氧一二曱“ 丁稀氧 二V: 丁婦氧基、2,3·二甲…稀氧基、 甲美m婦氧基、3,3m丁烯氧基、二 甲基-2- 丁稀氧基、美 基、1-乙基-3· 丁烯氧^乙Γ 乙基〜稀氧 丁稀氧基、2-乙基:丁稀氧:丁稀氧基、2_乙基_2- 基、!-乙基丙烯= « . , 7 A 0 邱虱基丨_乙基-2-甲基-1-丙烯氧 " * —尹基_2_丙婦氧基及其類似基團; 147474.doc •21- 201041514 鹵烯氧基:部分或完全經氟、氣、溴/或及碘取代,較 佳經氟取代之如上所述之烯氧基。 炔氧基:經由氧原子連接之如上所述之炔基,例如匕-Cio炔氧基’諸如2 -丙快氧基、2 -丁炔氧基、3 -丁快氧美、 1-甲基-2-丙炔氧基、2_戊炔氧基、3_戊炔氧基、4_戊炔氧 基、1-甲基-2-丁炔氧基、丨_甲基_3_丁炔氧基、2_甲基-% 丁炔氧基、1·乙基-2-丙炔氧基、2-己炔氧基、3_己炔氧 基、4-己炔氧基、5_己快氧基、丨·甲基_2•戊炔氧基、卜甲 基-3-戊炔氧基及其類似基團; 鹵炔氧基:部分或完全經氟、氯、溴/或及碘取代,較 佳經氟取代之如上所述之炔氧基。 環烧氧基:.經由氧原子連接之如上所&之環院氧基,例 如C3-C1G環烷氧基或(:3_C8環烷氧基,諸如環丙氧基、環戊 氧基、環己氧基、環庚氧基、環辛氧基、環壬氧基、環癸 氧基及其類似基團; %稀氧基.㉟由氧原子連接之如上所4之環烯氧基,例 如C3_C1()%烯氧基、C3_Cs環烯氧基,或較佳為^6環烯 氧基,諸如環戊-1-烯氧基、環戊-2-烯氧基、環己烯氧 基及環己-2-烯氧基; 烷氧基烷基:具有1至10個、1至8個、】至6個或1至斗 個,尤其1至3個碳原子之如上定義之院基,其中一個氯原 子經具有1至8個、1至6個或尤其⑷個碳原子之燒氧基置 換,例如甲氧基甲甲氧基乙基、乙氧基甲基、3_甲 氧基丙基、3-乙氧基丙基及其類似基團。 147474.doc •22- 201041514 烧氧基烧氧基.具有1至10個、1至8個、!至6個或2至4 個,尤其1至3個碳原子之如上定義之烷氧基,其中一個氫 原子經具有1至8個' 1至6個或尤其丨至4個碳原子之烷氧基 • 置換,例如2-甲氧基乙氧基、2_乙氧基乙氧基、3_甲氧基 丙氧基、3-乙氧基丙氧基及其類似基團。 烷基羰基:式R-CO-之基團,其中尺為如上定義之烷 基,例如Ci-c1G院基、Cl_C8院基、Ci_C6院基、Ci_c^ 0 基、Ci_C2烷基或CrC4烷基。實例為乙醯基、丙醯基及其 類似基團。CyC4烷基羰基之實例為丙基羰基、異丙基羰 基、正丁基羰基、第二丁基羰基、異丁基羰基及第三丁基 羰基。 烷氧羰基:式R-CO-之基團,其中R為如上定義之烷氧 基,例如C丨-C丨0烷氧基、氧基、心-匕烷氧基、 C:4烷氧基或CrC2烷氧基。Ci_C4烷氧羰基之實例為曱氡羰 基、乙氧羰基、丙氧羰基、異丙氧羰基、正丁氧羰基、第 〇 二丁氧幾基、異丁氡羰基及第三丁氧羰基。 烷基磺醯基:式R_s(0)2_之基團,其中R為如上定義之 烷基,例如(VC1G院基、Cl_C8烷基、Ci_c6烷基、C1_C4烷 基或Cl_C2烷基。C1_C4烷氧基磺醯基之實例為甲磺醯基、 乙磺醯基、丙磺醯基、異丙磺醯基、正丁磺醯基、第二丁 嶒醯基、異丁磺醯基及第三丁磺醯基》 烧硫基:經由硫原子連接之如上定義之烷基。 函烧硫基:經由硫原子連接之如上定義之鹵烷基。 烯硫基:經由硫原子連接之如上定義之烯基。 147474.doc -23- 201041514 齒稀硫基:經由硫原子連接之如上^義之㈣基。 快硫基:經由硫原子連接之如上定義之快基。 鹵快硫基:經由硫原子連接之如上定義之_炔基。 環烷硫基:經由硫原子連接之如上定義之環烷基。 苯基-C^C4烷基:氫原子經苯基置換之烷基(如上 定義)’諸如苯曱基、笨乙基及其類似基團。 苯基-CrC4烷氧基:一個氫原子經苯基置換之Ci_C4烷氧 基(如上疋義)’諸如苯曱基氧基、苯乙基氧基及其類似基 團。 3員、4員、5員、6員、7員、8員、9員或10員飽和、部 分不飽和或芳族雜環,其含有1、2、3或4個來自由氧、氮 (呈N或NR形式)及硫(呈s、8〇或s〇2形式)組成之群的雜原 子及視情況選用之i或2個選自c(=⑺及c(=s)之基團作為環 成員: -二員、四員、五員或六員飽和或部分不飽和雜環(下文 中亦稱作雜環基),其含有一、二、三或四個來自由 氧、氮(呈N或NR形式)及硫(呈S、s〇或S02形式)纟且成之 群的雜原子及視情況選用之1或2個選自C(=0)及C(=S)之 基團作為環成員:例如單環飽和或部分不飽和雜環,其 除碳環成員之外還含有一至三個氮原子及/或—個氧或 硫原子或—或兩個氧及/或硫原子及視情況選用之1或2 個選自C(=〇)及C(==s)之基團,例如2_環氧乙烷基、2_硫 雜環丙烧基、1-氮丙啶基或2_氮丙啶基、卜氮雜環丁 基、2-氮雜環丁基或3_氮雜環丁基、2_四氫呋喃基、% 147474.doc -24 - 201041514Ci-Cio hydroxyalkyl: having 1 to 2 (CrC hydroxyalkyl), 1 to 4 (CV C4 hydroxyalkyl), 2 to 4 (C2-C4 hydroxyalkyl), 1 to 6 ( CrG hydroxyalkyl), 2 to 6 (C2-C6 hydroxyalkyl), 1 to 8 (CVCs hydroxyalkyl), 2 to 8 (C2-C8 hydroxyalkyl), 1 to 1 ( (q -CM hydroxyalkyl) or a linear or branched alkyl group of 2 to 10 (C2-C10 hydroxyxanthyl) carbon atoms (as described above) wherein at least one hydrogen atom is replaced by a hydroxy group, such as 2-hydroxyethyl Or 3-hydroxypropyl. a dilute moiety in an alkenyl group and a diloxyoxy group, a dilute yl group, and the like: having 2 to 4 (CrC4 alkenyl groups), 2 to 6 (C2-C6 alkenyl groups), 2 to 8 ( C2-C8 alkenyl), 3 to 8 (C3-C8 alkenyl), 2 to 10 (CVCi. alkenyl) or 3 to 10 (C; 3-C 10 alkenyl) inhabiting atoms and at any A monounsaturated linear or branched hydrocarbon group at the position of a double bond, such as a C2-C6 alkenyl group, such as a vinyl group, a propyl group, a 2-propenyl group, a 1-mercaptovinyl group, a 1-butenyl group, 2 -butenyl, 3-butylenyl, 1-mercapto-1-propenyl, 2-mercapto-1-propenyl, i-methyl-2-propenyl, 2-methyl-2-propene 1, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-decyl-1-butenyl, 2-methyl-1-butenyl, 3- Methyl-1-butylenyl, 1-mercapto-2-butenyl, 2-mercapto-2-butyridyl, 3-mercapto-2-butyridyl, 1-methyl-3-butyl Dilute, 2-mercapto-3-butylenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, iota, 2-didecyl-i-propene 147474 .doc -16- * v 201041514 base, 1,2-·-mercapto-2-propenyl, 1-ethyl-; [• propyl, 1 _ethyl, 1- Indenyl, 2-hexyl, 3-hexyl, 4-hexyl, hexenyl, 1-decyl-1-pentenyl, 2-methyl-1-pentyl, 3-indene Base q•pentyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-mercaptopentyl, 3-methyl-2-pentenyl 4- Methyl-2-pentanyl, iota-methyl-3-pentenyl, 2-mercapto-3-enopentyl, 3-methyl-3-pentenyl, 4-methyl-3-pentane Alkenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1, 1-dimethyl-2-butenyl, dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, iota, 2-dimethyl-2-butanthyl, 1,2 - Dimercapto-3-butenyl, l,3-dimethyl-I-butenyl, i,3-dimercapto-2-butenyl, 1,3-didecyl-3-butene Base, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3_di 3-butenyl, 3,3-dimercapto-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2- Butyl, ι_ethyl_3_butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl 1,1,2-dimethyl-2-propylidene, 1-ethyl-1-methyl-2-propanyl, 1-ethyl-2-methyl-1-propenyl, i-ethyl _2_Methyl-2-propylene group and the like; a haloalkenyl group and a haloalkenyloxy group, a heteroalkenylcarbonyl group and the like; a haloalkenyl moiety in the group: 2 to 4 (C2_C4i alkene) Base), 2 to 6 (c2_C6-alkenyl), 2 to 8 (C2-C8-alkenyl) or 2 to! a (C2_Ci dentate alkenyl) carbon atom and an unsaturated linear or branched hydrocarbon group at a position of a double bond (as described above) wherein some or all of the hydrogen atoms of such groups may be as described above Replacement of dentate atoms (especially fluorine, chlorine and bromine), such as vinyl chloride, chlorine 147474.doc • 17- 201041514 allyl and the like; alkynyl and alkynyloxy, alkynylcarbonyl and the like Alkynyl moiety in oxime: having 2 to 4 (C2-C4 alkynyl), 2 to 6 (C2-C6 alkynyl), 2 to 8 (C2-C8 alkynyl), 3 to 8 (C3) -C8 alkynyl), 2 to 10 (C2-C1()alkynyl) or 3 to 10 (C3-C10 fast radical) carbon atoms and one or two straight or branched chains at any position Hydrocarbyl group, for example c2-c6 alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2- Propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-indolyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexyl Alkynyl 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-indenyl-3-pentynyl, 1-indenyl 4-pentynyl, 2-methyl-3-pentynyl, 2-mercapto-4-pentynyl, 3-mercapto-1-pentynyl, 3-methyl-4-pentynyl , 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-didecyl-2-butynyl, l,i-dimethyl-3-butynyl, 12_Dimethyl_3 Butanyl, 2,2-methyl-3-butynyl, 3,3-dimercapto-1-butynyl, ethyl-2-butynyl, 1- Ethyl-3-butynyl, 2-ethyl-3-butynyl, ethyl-1-methyl-2-propynyl and the like; i alkynyl and haloalkoxy, alkynylcarbonyl and a haloalkyyl moiety in the like group. 2 to 4 haloalkynyl groups, 2 to 6 (C2-C6 haloalkynyl), 2 to 8 (C2-C8 haloalkynyl) or 2 to 1 (Hlil(C2_Ci. haloalkynyl) carbon atom and one or two unsaturated linear or branched chain hydrocarbon groups at any position (as described above), wherein some or all of the hydrogen atoms in such groups may Substituted by an imine atom as described above (especially fluorine 'chlorine and bromine'); 147474.doc -18- 201041514 cycloalkyl a cycloalkyl moiety in a cycloalkoxy group, a cycloalkylcarbonyl group, and the like: having 3 to 6 (CrC6 cycloalkyl groups), 3 to 8 (C3_C8 cycloalkyl groups), or 3 to 10 (C3_C1Q) a monocyclic saturated hydrocarbon group of a cycloalkyl)carbocyclic member such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodecyl and cyclodecyl; halocycloalkyl and a cyclohexyl moiety in a cycloalkyloxy group, a cycloalkylcarbonyl group, and the like: having 3 to 6 (C3-C6 halocycloalkyl) groups, 3 to 8 0 (C3_Cs halocycloalkyl groups) Or a monocyclic saturated hydrocarbon group of 3 to 1 (C3_C10 halocycloalkyl)carbocyclic ring member (as described above), wherein some or all of the hydrogen atoms may be through a halogen atom as described above (especially fluorine, chlorine and bromine) Replacement; alkoxy: an alkyl group attached via an oxygen. The Cl_C2 alkoxy group is a methoxy group or an ethoxy group. Ci-C4 alkoxy is additionally, for example, n-propoxy, iota-ethoxyethoxy (isopropoxy), butoxy, 1-methylpropoxy (second butoxy), 2-A Propyloxy (isobutoxy) or 1,1-dimethylethoxy (t-butoxy). The Cl_C6 alkoxy group is additionally, for example, a pentyloxy group, a fluorenyl fluorenyloxy group, a 2-methylbutoxycarbonyl group, a 3-methoxymethyloxy group, a 1,1-dimethylpropoxy group, 2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexyloxy, 1-methylpentyloxy, 2-methylpentyloxy, 3_ Methylpentyloxy, 4-methylpentyloxy, M-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, dimethylbutoxy , 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, l,i,2-trimethylpropane Oxyl, 1,2,2-dimethylpropoxy, i_ethyl_ι·decylpropoxy or 丨_ethyl-2-methylpropoxy. The Ci-Cs alkoxy group is additionally, for example, heptyloxy, octyloxy, 2-ethylhexyloxy and positional isomers thereof. The alkoxy group is additionally, for example, 147474.doc -19- 201041514 decyloxy, decyloxy and positional isomers thereof. The C2_Ciq alkoxy group is such as a __c10 alkoxy group, with the exception of a methoxy group. The alkoxy group is partially or completely substituted by fluorine, chlorine, bromine and/or iodine, and is preferably substituted with an alkoxy group as described above. Cl_C2_alkoxy is, for example, 〇CH2F, OCHF2, OCF3, 〇CH2Ch 0CHC12, 0ccl3, chlorofluoromethoxy, monofluorofluorooxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy Base, 2-bromoethoxy, 2-disc ethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2 _Chloro-2,2-difluoroethoxy, 2,2-dioxa-2-fluoroethoxy, 2,2,2-trichloroethoxy or oqh. The Cj-C4 haloalkoxy group is additionally, for example, 2-fluoropropoxy, 3-fluoropropoxy, n-difluoropropoxy, 2,3-difluoropropoxy, 2-propoxyl, % Propyloxy, 2,3-dipropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-tripropoxy Base, 〇CH2_C2F5, 〇CF2_C2F5, 1-(CH2F)-2-decyloxy, chloroethoxy, pu (4-)-2-ethyl, 4-fluorobutoxy, 4-chlorobutoxy 4_ desert oxy or nonafluorobutoxy. Qc: 6 haloalkoxy is additionally, for example, 5-fluoropentyloxy, 5-chloropentyloxy, 5-pentyloxy, 5-p-pentyloxy, undecyloxy, 6-hexyloxy Base, 6-gas hexyloxy, 6- hexyloxy, 6- texyl hexyloxy or 12-hexyl hexyloxy. A sulfhydryl group which is bonded to the above by an oxygen atom, such as a c2_Cl0 alkenyloxy group, such as an anthracene-vinyloxy group, a 1-propenyloxy group, a 2-propenyloxy group, a 1-methylethyleneoxy group. , butyleneoxy ' 2 - butenyloxy, 3 - butyloxy, 1-methyl-1-propenyloxy, 2 - fluorenyl hydrazine - propyleneoxy, hydrazine - methyl - 2 - propyleneoxy 2_Methyl-2-propenyloxy, pentenyloxy, 2-pentenyloxy 147474.doc -20- 201041514 :, oxime, 4-pentenyloxy, acesulfate, 2_Methoxybutoxy...dioxyoxyl, 3-methyl-2-butoxyoxy, "yl-3-carb, 2-methyl-3-butenyloxy, 3mT-alkenyl, A... Propylene oxime, dimethyl propylene propylene oxy oxy group, ethyl phthalate] and knee s basin methyl-2- olefin oxygen A, 1_ethyl 2 propyleneoxy, 1-hexan Ο = base Widely dilute oxy, 3-hexyloxy, 4-hexamethoxy, 5 hexamethylene methyl-1_pentenyloxy, 2_methyl-1_pent:)^4. 1 Λ ^ «. pentene lactyl, 3-methyl 1-2 fluorene, pentyl pentyloxy, 'methyl 2 - pentyloxy, 2- ̄: i methyl \ m penteneoxy m Pentyloxyl LC penteneoxy, "yl-3-butenoxy, ... = two a pentenyloxy group, a "pentenyloxy group," a dimethyl group ... oxy group, a methyl pentyloxy group with a dimethyl H oxy group, a 12- fluorene 9, 3 ... Diluted oxygen two V: butanyloxy, 2,3. dimethyl... diloxy, methyl methoxy, 3,3m butenyloxy, dimethyl-2-butenyloxy, mesyl, 1-Ethyl-3·butene Oxygen Ethyl Ethyl Ethyl Ethyl Oxide Oxide Oxide, 2-Ethyl: Butyl Oxygen: Butoxyl, 2-Ethyl-2-yl, !-Ethyl Propylene = « . , 7 A 0 Qiu Keji丨_Ethyl-2-methyl-1-propenyloxy" * — Yinji_2_propyleneoxy group and the like; 147474.doc •21- 201041514 Alkenyloxy: Alkenyloxy as described above, partially or completely substituted by fluorine, gas, bromine and/or iodine, preferably substituted by fluorine. Alkynyloxy: alkynyl group as described above attached via an oxygen atom, for example匕-Cio alkynyloxy such as 2-propoxy, 2-butynyloxy, 3-butoxyxime, 1-methyl-2-propynyloxy, 2-pentynyloxy, 3_ Pentynyloxy, 4-pentynyloxy, 1-methyl-2-butynyloxy, 丨-methyl-3-butynyloxy, 2-methyl-% butynyloxy, 1·B Ke-2-propynyloxy, 2-hexyl Alkynyloxy, 3-hexynyloxy, 4-hexynyloxy, 5-hexaoxyoxy, fluorenylmethyl-2-pentynyloxy, benzyl-3-pentynyloxy and the like Haloalkoxy: partially or completely substituted by fluorine, chlorine, bromine and/or iodine, preferably alkoxylated as described above, substituted by fluorine. Ring alkoxy: bonded via an oxygen atom as above & Alkoxy, such as C3-C1G cycloalkoxy or (: 3_C8 cycloalkoxy, such as cyclopropoxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy, cyclooctyloxy, cyclo a decyloxy group, a cyclodecyloxy group, and the like; a dilute oxy group. 35 is a cycloalkenyloxy group as defined above, which is bonded to an oxygen atom, such as a C3_C1()% alkenyloxy group, a C3_Cs cycloalkenyloxy group, or Preferred is a cyclohexeneoxy group such as a cyclopent-1-enyloxy group, a cyclopent-2-enyloxy group, a cyclohexenyloxy group and a cyclohex-2-enyloxy group; an alkoxyalkyl group: a hospital base having 1 to 10, 1 to 8, -6 to 1 or 1 to 3, especially 1 to 3 carbon atoms as defined above, wherein one chlorine atom has 1 to 8, 1 to 6 Or in particular an alkoxy group of (4) carbon atoms, such as methoxymethylmethoxyethyl Ethoxymethyl, 3_ methoxy propyl, 3-ethoxypropyl group and the like. 147474.doc •22- 201041514 Alkoxy alkoxy. Having 1 to 10, 1 to 8,! Up to 6 or 2 to 4, in particular 1 to 3, carbon atoms of the alkoxy group as defined above, wherein one hydrogen atom has an alkoxy group having from 1 to 8 '1 to 6 or especially to 4 carbon atoms Substituents such as 2-methoxyethoxy, 2-ethoxyethoxy, 3-methoxypropoxy, 3-ethoxypropoxy and the like. Alkylcarbonyl: a group of the formula R-CO-, wherein the sizing is an alkyl group as defined above, for example, a Ci-c1G, a Cl_C8, a Ci_C6, a Ci_c^0, a Ci_C2 or a CrC4 alkyl. Examples are ethyl acetyl, propyl thiol and the like. Examples of the CyC4 alkylcarbonyl group are a propylcarbonyl group, an isopropylcarbonyl group, a n-butylcarbonyl group, a second butylcarbonyl group, an isobutylcarbonyl group and a tert-butylcarbonyl group. Alkoxycarbonyl: a group of the formula R-CO-, wherein R is alkoxy as defined above, for example C丨-C丨0 alkoxy, oxy, cardio-alkoxy, C:4 alkoxy Or CrC2 alkoxy. Examples of the Ci_C4 alkoxycarbonyl group are a hydrazine carbonyl group, an ethoxycarbonyl group, a propoxycarbonyl group, an isopropoxycarbonyl group, a n-butoxycarbonyl group, a di-n-butoxycarbonyl group, an isobutyl carbonyl group and a third butoxycarbonyl group. Alkylsulfonyl: a group of the formula R_s(0)2_, wherein R is alkyl as defined above, for example (VC1G, C-C8 alkyl, Ci_c6 alkyl, C1_C4 alkyl or Cl_C2 alkyl. C1_C4 alkane Examples of oxysulfonyl groups are methylsulfonyl, ethylsulfonyl, propanesulfonyl, isopropylsulfonyl, n-butylsulfonyl, dibutylsulfonyl, isobutylsulfonyl and the third Butyr sulfonyl group. A sulfur-based group: an alkyl group as defined above which is bonded via a sulfur atom. A thiol group: a haloalkyl group as defined above which is bonded via a sulfur atom. Alkylthio group: an alkene as defined above via a sulfur atom 147474.doc -23- 201041514 Tetrasylthio: a (4) group as defined above via a sulfur atom. Fast thio group: a fast group as defined above via a sulfur atom. Halogen thio group: attached via a sulfur atom Alkynyl group as defined above. Cycloalkylthio: a cycloalkyl group as defined above attached via a sulfur atom. Phenyl-C^C4 alkyl: an alkyl group in which a hydrogen atom is replaced by a phenyl group (as defined above) such as phenylhydrazine a phenyl-CrC4 alkoxy group: a Ci_C4 alkoxy group in which a hydrogen atom is replaced by a phenyl group. Such as 疋)) such as benzoquinoneoxy, phenethyloxy and the like. 3 members, 4 members, 5 members, 6 members, 7 members, 8 members, 9 members or 10 members are saturated, partially not a saturated or aromatic heterocyclic ring containing 1, 2, 3 or 4 heteroatoms from a group consisting of oxygen, nitrogen (in the form of N or NR) and sulfur (in the form of s, 8 or s? 2) Depending on the situation, i or 2 groups selected from c (= (7) and c (= s) as ring members: - two, four, five or six members of saturated or partially unsaturated heterocyclic rings (hereinafter also a heterocyclic group, which contains one, two, three or four heteroatoms from the group consisting of oxygen, nitrogen (in the form of N or NR) and sulfur (in the form of S, s or S02) and Optionally, one or two groups selected from C(=0) and C(=S) are used as ring members: for example, a monocyclic saturated or partially unsaturated heterocyclic ring, which contains one to three in addition to the carbon ring members. a nitrogen atom and / or an oxygen or sulfur atom or - or two oxygen and / or sulfur atoms and optionally 1 or 2 groups selected from C (= 〇) and C (= = s), For example, 2_oxiranyl, 2-thiaridinyl, 1-aziridine or 2-aziridine Base, azetidinyl, 2-azetidinyl or 3-azetidinyl, 2_tetrahydrofuranyl, % 147474.doc -24 - 201041514

四氫吱喃基、3 -四氫吱喃-2-酮基、4-四氫°夫喃-2-酮基、 5-四氫σ夫喃-2-酮基、2-四氫吱喃-3-酮基、4-四氫咬喃-3 -酮基、5 -四氫β夫喃-3-酮基、2-四氫°塞吩基、3 -四氫0塞 吩基、3 -四氮°基吩_ 2 -嗣基、4 -四鼠π塞吩-2-嗣基、5 -四氮 0塞吩-2-酮基、2-四氳°塞吩-3 -酮基、4-四氫°塞吩-3-酮 基、5 -四氮°塞吩-3 -嗣基、2 -。比洛咬基、3 -Β比洛π定基、1 -吡咯啶-2-酮基、3-吡咯啶-2-酮基、4-吡咯啶-2-酮基、 5- 0比咯咬-2-酮基、1 -α比洛。定-3 -酮基、2-。比η各。定-3 -酮 基、4-DitD各咬-3-酮基、5-°比11各咬-3-酮基、1-°比11各咬-2,5-二酮基、3-吡咯啶-2,5-二酮基、3-異噁唑啶基、4-異噁 °坐π定基、5 -異°惡π坐唆基、3 -異°塞α坐α定基、4-異°塞嗤咬 基、5 -異°塞°坐σ定基、3 -D比唾。定基、4 -σ比。坐α定基、5 - °比。坐 π定基、2 - °惡。坐咬基、4 -嗔。坐咬基、5 -σ惡。坐α定基、2 -D塞α坐 。定基、4-°塞唆淀基、5-°塞唾咬基、2-β米嗤唆基、4-咪。坐 啶基、1,2,4-噁二唑啶-3-基、1,2,4-噁二唑啶-5-基、 1,2,4-°塞二吐咬-3-基、1,2,4-°塞二唾咬-5-基、1,2,4-三。坐 啶-3-基、1,3,4-噁二唑啶-2-基、1,3,4-噻二唑啶-2-基、 1,3,4 -二°坐°定-2-基、2,3 -二氫π夫喃-2 -基、2,3 -二氯咬喃-3-基、2,4-二鼠咬喃-2 -基、2,4 -二氮σ夫喃-3 -基、2,3 -二 鼠α塞吩-2 -基、2,3 -二鼠α塞吩-3 -基、2,4 -二氮α塞吩-2 -基、 2,4 -二鼠α塞吩-3 -基、2 -α比咯嚇 - 2 -基、2 - °比鳴· - 3 -基、3 - 吡咯啉-2-基、3-吡咯啉-3-基、2-異噁唑啉-3-基、3-異 噁唑啉-3-基、4-異噁唑啉-3-基、2-異噁唑啉-4-基、3-異噁唑啉-4-基、4-異噁唑啉-4-基、2-異噁唑啉-5-基、 147474.doc -25- 201041514 3 -異°惡α坐琳_ 5 -基、4 -異°惡唾琳_ $ - I 暴、2-異嘍 基、3-異噻唑啉-3-基、4-異噻唑琳_3_義 %咻-3、 4-基、3-異噻唑啉-4-基、4-異噻唑啉_4美異嘍唑唯、 琳-5-基、3-異嗟唑琳-5-基、4-異嘴嗤琳 2異。塞唤 ·、基、2 1 0比0坐-1-基、2,3 -二氫n比唾_2_基、23 _ — ’ ~二氫 ,-二敷吡呼災·3-基、 2,3-二氫吡唑-4-基、2,3-二氫吡唑_5_基、Ί 1-基、3,4 -二氣 °比嗤-3-基、3,4 -二(气 氫 氫吡唑-5-基、4,5-二氫吡唑-1-基、4 5 4,5-二氫°比°坐_4-基、4,5-二 比°坐+基、 3,4- 氣%嗅_3 吡唑-5-基、2,3一 >基、 2-基、2,3-二氫噁唑-3-基、2,3-二氣。惡啥j〜氣噁唑、 氫噁唑-5-基、3,4-二氫噁唑-2-基、3 4 基、2,3 3,4-二氫嗯°坐-4-基、3,4-二氫嚼嗅_5•義 3 2_基、3,4-二氫噁唑_3_基、3,仁二氫噁唑義 基、3-哌啶基、4-哌啶基、l,3-二。惡境^ 喃基、4-四氫11底喃基、2-四氫。塞吩基、3 θ氧呢 4-六氫°連唤基、六氫嘧唆基、氣"達n秦基、 、虱嘧啶基、 嘧啶基、2-哌嗪基、1,3,5-六氫三嗪 5'^ ft 2-基及1,24 嗪_3-基以及相應亞基; ’、六氣三 ,4、二 氧。惡唉、 2、°辰啶 基、2 四 -七員飽和或部分不飽和雜環,其含有一 來自由乳、氮及硫組成之群的雜原子你& ^或四個 ’、丁 為環成員· :有7個環成員之單環及雙環雜環,其除碳環成員一 還含有—至三個氮原子及/或-個氧或硫原子威,成: 個氧及/或硫原子,例如四氫氮呼基及六氫氮谇基^ 如 2,3,4,5·四氫 ΠΗ]氫呼小、-2-、-3-、·4-、I、一6一 147474.doc -26 - 201041514 -7-基,3,4,5,6-四氫[2H]氮呼 _2_ -4- -7-基’2,3,4,7-四氫_氮呼_1_、_2_、_3_、)~6-或 -6-或-7-基,2,3,6,7-四氫[1H]氮呼小、2 ^、 _5_、-6-或-7_基,六氣氮呼小、一或:二、/4'、 氧呼基及六氫氧呼基,諸如叫,5,氫_氧二四氣 、-4_、-5_、心或_7_基,2,3,4,7_四氣_氧呼七、1 4 -5-、-6-或 _7_ 基,2,3,6,7_四氫加]氧 ❹Tetrahydrofuranyl, 3-tetrahydrofuran-2-one, 4-tetrahydrofuran-2-one, 5-tetrahydroindol-2-one, 2-tetrahydrofuran 3-keto group, 4-tetrahydro-butan-3-one, 5-tetrahydro-β-pentan-3-one, 2-tetrahydro-septyl, 3-tetrahydro-zero-septyl, 3 -tetrazoyl thiophene-2-indenyl, 4-tetramethyl π-cephen-2-yl, 5-tetrazino-2-cephen-2-one, 2-tetrahydro-cepan-3-keto , 4-tetrahydro-desophen-3-one, 5-tetrazonia ° cephen-3-indenyl, 2-. Bilobital, 3-indolyl π-decyl, 1-pyrrolidin-2-one, 3-pyrrolidin-2-one, 4-pyrrolidin-2-one, 5- 0 ratio bite- 2-keto group, 1-α-bilo. D--3-keto, 2-. More than η. 3-keto-keto, 4-DitD each 3-keto-3-keto group, 5-° ratio 11 each 3-keto-3-keto group, 1-° ratio 11 bite-2,5-dione, 3-pyrrole Pyridin-2,5-diketonyl, 3-isoxazolidinyl, 4-isooxo-supplemented π-decidence, 5-iso-dopo-π-mercaptopurine, 3-isopy-α-α-α-based, 4-iso ° Sputum bite base, 5-isose plug ° sitting σ fixed base, 3-D than saliva. Base, 4 -σ ratio. Sit a fixed base, 5 - ° ratio. Sit π base, 2 - ° evil. Sit on the base, 4 - 嗔. Sitting on the base, 5-σ evil. Sitting on the α-base, 2-D plug α sitting. Base, 4-° sulphate, 5-° sputum, 2-β mercapto, 4-m. Succinyl, 1,2,4-oxadiazolidine-3-yl, 1,2,4-oxadiazolidine-5-yl, 1,2,4-° 1,2,4-° sputum bite 5-base, 1,2,4-three. Succinyl-3-yl, 1,3,4-oxadiazolidine-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4-di-[2] -yl, 2,3-dihydroπ-pentan-2-yl, 2,3-dichloro-anthran-3-yl, 2,4-di-mole-2-meryl, 2,4-diazo σ Furan-3-yl, 2,3-dimur alpha-ceto-2-yl, 2,3-di-rat alpha-cepan-3-yl, 2,4-diazo alpha-cepan-2-yl, 2 , 4 - bis-α-ephedo-3-yl, 2-α-pyranyl- 2 -yl, 2 - ° pyloryl-3-amino, 3 -pyrolin-2-yl, 3-pyrroline-3 -yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-iso Oxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 147474.doc -25- 201041514 3 -iso- 恶α坐琳_ 5 -based, 4 - iso- 恶 唾 _ $ - I violent, 2-isoindolyl, 3-isothiazolin-3-yl, 4-isothiazolidine _3_yi%咻-3, 4-yl, 3-iso Thiazolin-4-yl, 4-isothiazoline _4 imistrozole, lin-5-yl, 3-isoxazole lin-5-yl, 4-iso-nosed lin-line 2 different.塞 ·, base, 2 1 0 to 0 sitting -1- group, 2,3 - dihydro n than sal _2 _ group, 23 _ — ' ~ dihydrogen, - bismuthin 2,3-Dihydropyrazol-4-yl, 2,3-dihydropyrazole-5-yl, Ί1-yl, 3,4-di-gas ratio 嗤-3-yl, 3,4-di (Gas hydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4 5 4,5-dihydrogen ratio ° _4-base, 4,5-two ratio ° sit + Base, 3,4-gas% olfactory-3 pyrazol-5-yl, 2,3->, 2-yl, 2,3-dihydrooxazol-3-yl, 2,3-digas.啥 啥 j ~ oxazole, hydrooxazole-5-yl, 3,4-dihydrooxazol-2-yl, 3 4 yl, 2,3 3,4-dihydro 坐 -4- group, 3,4-dihydropic sniffing _5•yi 3 2_yl, 3,4-dihydrooxazole _3_yl, 3, diol dihydrooxazolyl, 3-piperidinyl, 4-piperidinyl , l, 3-two. Odd environment ^ meryl, 4-tetrahydro 11 decyl, 2-tetrahydro. thiophene, 3 θ oxol 4-hexahydro °, hexahydropyrimidinyl, Gas " nal n-methyl, pyrimidinyl, pyrimidinyl, 2-piperazinyl, 1,3,5-hexahydrotriazine 5'^ ft 2-yl and 1,24-azine-3-yl and corresponding Subunit; ', six gas three, four, two oxygen. 唉, 2, ° 啶 pyridine, 2 four - seven members saturated or An unsaturated heterocyclic ring containing a hetero atom from a group consisting of milk, nitrogen and sulfur. You & ^ or four ', butyl is a ring member: a monocyclic and bicyclic heterocyclic ring having 7 ring members, In addition to the carbon ring member one also contains - to three nitrogen atoms and / or - an oxygen or sulfur atom, into: an oxygen and / or sulfur atom, such as tetrahydro nitrogen and hexahydrozinyl groups such as 2, 3,4,5·tetrahydroindene]hydrogen, small, -2-, -3-, ·4-, I, one, six, 147,474.doc -26 - 201041514 -7-based, 3, 4, 5, 6 -tetrahydro[2H]azepine_2_-4--7-yl'2,3,4,7-tetrahydro-azhen_1_,_2_,_3_,)~6- or -6- or -7- Base, 2,3,6,7-tetrahydro[1H]azepine, 2^, _5_, -6- or -7-yl, hexa-nitrogen, small, one or two, /4', oxygen And hexahydrooxo group, such as, for example, 5, hydrogen-oxygen tetra-tetragen, -4_, -5_, heart or _7_ group, 2,3,4,7_four gas_oxygen qi, 1 4 -5-, -6- or _7_ base, 2,3,6,7_tetrahydrogen]oxyquinone

、-4-、-5-、-6_或_7_基;六氫氮呼小、2 …i 基,四氯-及六一氮呼基’四氣-及六氣二或T =,四氫-及六氫-U-氮呼基,略及六氫姑:: ::美…六氫…3-二氧呼基’四氯-及六氫-14 乳呼基,及相應亞基; ’-一 五員或六員芳族雜環(=雜芳族基團),其含有一 三或四個來自由氧、氮及硫組成之群之雜:子:::: 由碳連接且含有-至三個氮原子或_或兩個氮原子及^ 個硫或氧原子作為環成員之5員雜芳基,諸如2呋喃 基、3-呋喃基、2-噻吩基、3-噻吩基、2-°比嘻基、3-吡 洛基、3-異噁唑基、4-異噁唑基、5-異噁唑基、3-異噻 0坐基、4-異β塞唾基、5 -異π塞η坐基、3_ β比《坐基、4- »比啥 基、5 - η比唾基、2 - °惡嗤基、4 -嗯唾基、5 - °惡α坐基、2 _ °塞 °坐基、4-嗟嗤基、5-°塞吐基、2-咪D坐基、4-咪α坐基、 1,2,4-噁二唑 _3-基、丨,2,4-噁二唑-5-基、1,2,4-噻二唑-3-基、1,2,4-噻二唑-5-基、1,2,4-三唑-3-基、1,3,4-噁二唑 _ 2-基、1,3,4-噻二唑-2-基及1,3,4-三唑-2-基;經由氮連 147474.doc •27- 201041514 接且含有一至三個氮 作為裱成員之5員雜芳某,* 如吡咯· 1 _基、吼唑 土 3者 生基、咪唑基、丨2 3_二 及 1.2-4- :r A !甘.* . ,,—坐-1-基 及1,2,4-三唑_1_基;含有_、 或二個jfli原子作為xg. ;之6員雜芳基,諸如…基、…基、=3.噠嗪基、4•噠嗓基、2⑽基、4_㈣基、M Γ疋基、2,基、…·三嗪_2_基及W三嗪-3_基; 2 5伸烷基.具有2至5個碳原子之二價分支鏈或 “支鏈,C職2、颂叫、C_2CH2 CH(CHCH2CH(CH3) ^ ch2ch2ch2ch2 . ch2ch2ch2ch2ch2 〇 基團-SM更確切而言為基團S_M、其中M+為如上定義之 金屬陽離子相等物或銨陽離子。金屬陽離子相等物更確切 而言為1/aMa+’其中a為金屬之原子價且-般為卜2或3。 下文關於本發明化合物之適合及較 取代基R1、R2、D3、n4 一 . 九丹關於其 R 、R4、R4i R10、R11、R12、R13、rH、Rl5、τ、, -4-, -5-, -6_ or _7_ group; hexahydro-nitrogen oxime, 2 ... i-based, tetrachloro- and hexa-azalyl-four gas- and six gas two or T =, Tetrahydro- and hexahydro-U-azinyl, slightly hexahydro gu::::... hexahydro...3-dioxoyl 'tetrachloro- and hexahydro-14 whey, and corresponding subunits ;--a five- or six-membered aromatic heterocyclic ring (=heteroaromatic group) containing one or three or four from a group consisting of oxygen, nitrogen and sulfur: sub:::: connected by carbon And a 5-membered heteroaryl group having - to three nitrogen atoms or _ or two nitrogen atoms and a sulfur or oxygen atom as a ring member, such as 2 furyl, 3-furyl, 2-thienyl, 3-thiophene Base, 2-° thiol, 3-pyrrolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 3-isothiathiol, 4-iso-β-saliva Basis, 5-iso-π-spin η, 3_β ratio "sitting base, 4-» than thiol, 5-n-r-saltyl, 2-cyanosyl, 4-meryl, 5-" Sitting base, 2 _ ° plug ° sitting base, 4-mercapto, 5-° stopper, 2-mid D sitting, 4-mi-α-based, 1,2,4-oxadiazole_3- Base, hydrazine, 2,4-oxadiazol-5-yl, 1,2,4-thiadiazol-3-yl, 1,2,4 -thiadiazol-5-yl, 1,2,4-triazol-3-yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl and 1,3,4-triazol-2-yl; 5-membered heteroaryl, which is a member of 裱 147474.doc •27- 201041514 and contains one to three nitrogens as a member of 裱, * such as pyrrole 1 _ group, carbazole Soil 3, imidazolyl, hydrazine 2 3_ 2 and 1.2-4-:r A !甘.* . , , —-1-yl and 1,2,4-triazole-1-yl; _, or two jfli atoms as xg.; 6 member heteroaryl, such as ... base, ... base, = 3. pyridazinyl, 4 fluorenyl, 2 (10), 4 (tetra), M thiol, 2 , a group, a triazine 2-yl group and a W-triazin-3-yl group; a 2 alkyl group; a divalent branched chain having 2 to 5 carbon atoms or a "branched chain, C, 2, howling, C_2CH2 CH(CHCH2CH(CH3)^ch2ch2ch2ch2. ch2ch2ch2ch2ch2 〇 group-SM is more specifically a group S_M, wherein M+ is a metal cation equivalent or an ammonium cation as defined above. The metal cation equivalent is more specifically 1/ aMa+' where a is the valence of the metal and is generally 2 or 3. The suitable and substituted substituents R1, R2, D3, n4 of the compounds of the invention are as follows. On its R, R4, R4i R10, R11, R12, R13, rH, Rl5, τ,

R L R'I; R9 R£R L R'I; R9 R£

Rb、Re、Rd及指數n及其用途之陳 、 — 不身有效,且尤其在 母一可能之相互組合中有效。 在化合物IB及IIB中’較佳為以下展 ^異構體IB-1及im_2, R 3 N 4 1 V^S(〇)nR \tVs n-nRb, Re, Rd, and the index n and their use are not valid, and are especially effective in the mutual combination of the mothers. In the compounds IB and IIB, it is preferred that the isomers IB-1 and im_2, R 3 N 4 1 V^S(〇)nR \tVs n-n

ClCl

L2 147474.doc -28- 201041514 相應地,較佳為基團ΙΙΙΒ之以下異構體,L2 147474.doc -28- 201041514 Accordingly, it is preferred that the following isomers of the group ΙΙΙΒ,

(11旧-1〉 Ο Ο /本發明之一較佳實施例中,L2及L3彼此獨立地選自 氫鹵素、CVC4烧基、Cl_C4幽燒基、Ci_C4烧氧基及c「 c4函烧氧基,更佳選自氫、氯、甲基、乙基、異丙基氣 甲基、二氟甲基、三氟甲基、2,2,…乙基、咖四 乳“、甲氧基、乙氧基、"氧基、二氟甲氧基、三I 甲虱基及2,2,2-三氟乙氧基,特定言之選自氫、氯、甲 土氟甲基—氟甲基、二氟甲基、甲氧基、氣甲氧基、 二氟甲氧基及三氟甲氧基,且特別選自氫及氯。 >在本發明之—較佳實施例中’ L1及1/彼此獨立地選自 ^ C, C4 烧基、cvc4_ 烧基、Cl_C4;^氧基及 氧基’更佳選自氫、Ci_C3烧基、氟甲基、二氟曱基、三 氟甲基、2,2,2-二氟乙基、氟乙基、甲氧基、乙 氧基、氟曱氧基、=氟曱氧基、三氟甲氧基及2,2,2_三氟 乙氧基,特定言之選自氫、曱基、乙基'異丙基、三氟曱 基、2,2,2-二氟乙基、1,1,2,2-四氟乙基、曱氧基、乙氧 基、二氟甲氧基及2,2,2-三氟乙氧基,且特別選自氫及三 氟曱基。 為 在本發明之一較佳實施例中,L1及L4中至少一者不 147474.doc -29- 201041514 氫。 在本發明之另一較佳實施例中,L2及L3均為氫。 在本發明之—更佳實施例中,L1及L4中至少一者不為 氮,且L2及L3均為氫。根據一甚至更佳實施例,"及广中 之一者不為氫,且其餘取代基L(亦即L2、L3及Ll*L4)為 氫。 . 在本發明之一替代較佳實施例中,L2及L3中至少一者不 為氣。 在本發明之另一替代較佳實施例中,L1及L4均為氫。 在本發明之一替代更佳實施例中,L2及L3中至少一者不 為氫且L及L均為氫。根據一甚至更佳實施例,[2及l3 中之-者不為氫,且其餘取代基1(亦即l1、匕4及[2或匕3)為 氫。 ‘、、、 在本發明之一 為氫,且L3及L4 中之一者不為氫 氫。 替代較佳實施例中,L1及L2中至少一者不 均為氫。根據一甚至更佳實施例,。及L2 ’且其餘取代基L(亦即L3 ' L4及L1或L2)為 特定言2之,3L1、4L2、L3及1/中僅一者不為氫。 L L及L之尤其較佳的組合彙編於下表中(11 Old-1) Ο Ο In a preferred embodiment of the invention, L2 and L3 are independently selected from the group consisting of hydrogen halogen, CVC4 alkyl, Cl_C4 halogen, Ci_C4 alkoxy and c"c4 functional oxygen More preferably, it is selected from the group consisting of hydrogen, chlorine, methyl, ethyl, isopropyl gas methyl, difluoromethyl, trifluoromethyl, 2, 2, ... ethyl, coffee tetra", methoxy, Ethoxy, "oxy, difluoromethoxy, tri-i-methylindenyl and 2,2,2-trifluoroethoxy, specifically selected from the group consisting of hydrogen, chlorine, and fluoromethyl-fluoro Base, difluoromethyl, methoxy, methoxy, difluoromethoxy and trifluoromethoxy, and especially selected from hydrogen and chlorine. > In the preferred embodiment of the invention 'L1 And 1/independently selected from the group consisting of ^ C, C 4 alkyl, cvc 4 — alkyl, Cl — C 4 ; oxy and oxy are more preferably selected from hydrogen, Ci—C 3 alkyl, fluoromethyl, difluorodecyl, trifluoromethyl Base, 2,2,2-difluoroethyl, fluoroethyl, methoxy, ethoxy, fluoromethoxy, = fluoromethoxy, trifluoromethoxy and 2,2,2-trifluoro Ethoxy, specifically selected from hydrogen, decyl, ethyl 'isopropyl, trifluoromethyl, 2,2,2-difluoroethyl, 1,1,2,2- Fluoroethyl, decyloxy, ethoxy, difluoromethoxy and 2,2,2-trifluoroethoxy, and in particular selected from hydrogen and trifluoromethyl. Preferred embodiment of the invention In the example, at least one of L1 and L4 is not 147474.doc -29- 201041514 hydrogen. In another preferred embodiment of the invention, both L2 and L3 are hydrogen. In a preferred embodiment of the invention, At least one of L1 and L4 is not nitrogen, and both L2 and L3 are hydrogen. According to an even more preferred embodiment, one of "and a wide range is not hydrogen, and the remaining substituents L (i.e., L2, L3) And Ll*L4) is hydrogen. In an alternative preferred embodiment of the invention, at least one of L2 and L3 is not gas. In another alternative preferred embodiment of the invention, both L1 and L4 are Hydrogen. In an alternative embodiment of the invention, at least one of L2 and L3 is not hydrogen and both L and L are hydrogen. According to an even more preferred embodiment, the [2 and l3 are not Hydrogen, and the remaining substituents 1 (i.e., l1, 匕4, and [2 or 匕3) are hydrogen. ',,, one of the present inventions is hydrogen, and one of L3 and L4 is not hydrogen hydrogen. In a preferred embodiment, at least one of L1 and L2 Not all hydrogen. According to an even better embodiment, and L2' and the remaining substituents L (ie, L3 'L4 and L1 or L2) are specific 2, only one of 3L1, 4L2, L3 and 1/ Not hydrogen. The particularly preferred combination of LL and L is compiled in the table below.

編號 ^--- — L2 T 3 T 4 1. 2. ch3 ---~--- CH?CH^ H L4 H 3 ----- CHiCH,V H 1— H H 4 ------ CF^ H H 5 ------- CH^PF. H H ------J H H 147474.doc •30· 201041514No.^--- — L2 T 3 T 4 1. 2. ch3 ---~--- CH?CH^ H L4 H 3 ----- CHiCH,VH 1— HH 4 ------ CF ^ HH 5 ------- CH^PF. HH ------JHH 147474.doc •30· 201041514

編號 L1 L2 L3 L4 6. cf2chf2 Η H H 7. och3 Η H —-- H 8. ocf3 Η H H 9. OCH2CF3 Η H H 10. OCH2CH3 Η H H 11. Η ch3 H H 12. Η ch2ch3 H H 13. Η CH(CH,)2 H lH 14. Η cf3 H H 15. Η ch2cf3 H H 16. Η CF2CHF2 H H 17. Η OCH, H H 18. Η OCF3 H H 19. Η OCH2CF3 H H 20. Η 〇CH2CH3 H H 21. Η Cl H H 在上述組合中’尤其較佳為第4及21號組合。No. L1 L2 L3 L4 6. cf2chf2 Η HH 7. och3 Η H —- H H ocf3 Η HH 9. OCH2CF3 Η HH 10. OCH2CH3 Η HH 11. Η ch3 HH 12. Η ch2ch3 HH 13. Η CH(CH ,) 2 H lH 14. Η cf3 HH 15. Η ch2cf3 HH 16. Η CF2CHF2 HH 17. Η OCH, HH 18. Η OCF3 HH 19. Η OCH2CF3 HH 20. Η 〇CH2CH3 HH 21. Η Cl HH in the above combination Medium is particularly preferred for the combination of Nos. 4 and 21.

R及R較佳彼此獨立地選自氫、q-C4烧基、c^-c〗_烧 基、CrCU烷氧基及(^-(:2鹵烷氧基。更佳地,尺1及汉2彼此 獨立地選自氫、甲基、乙基及三氟甲基。甚至更佳地,r1 及R2彼此獨立地選自氫及甲基。特定言之,Rl&R2均為甲 基。 * 較佳地,R3係選自氫、Cl_C4烷基、Ci_C2鹵烷基、 烷氧基及。〜烷氧基。更佳地,選自氮、甲基' 乙基及三氟甲基。甚至更佳地’ R、選自氫及甲基。特定 δ之,R3為氮。 基團-C(=0)R5及-S(0)2R5中之r5較佳選自Ci_c4烷基、 Ci-C2_烷基、Cl_C4烧氧基、Ci-C2_烷氧基、苯基、苯氧 147474.doc -31 · 201041514 基及NR9Rl°’更佳選自CrC4烷基' c心烷基、㈣烷 氧基、CKC2鹵烷氧基及NR9RlG且甚至更佳選自Ci_C4烷基 及皿V。。在基團评〇)R5中,r5特定言之為以烧 基,更特定言之為異丙基、異丁基或第三丁基,且在基 團-s(〇)2R5中,R5特定言之為甲基。較佳地,R9為氫且Ri〇 係選4自氫、ci-c4烧基及苯基,較佳選自氯ACi_c4烧基。 R4較佳選自氫、Cl_c4烷基、_c(=〇)r5、_s(〇)2R5、_cn、 Μ及式III基團’其中R5具有上述通用含義之—或特定言之 上述較佳含義之频具有上述通用含義之—或特定言 之下文給出之較佳含義之一。 R更佳選自氫、CVC4烷基、CVC4烷基羰基、Ci_c4烷氧 羰基、-(:(=〇)Ν(Η)〇ν(:4烷基、Cl_C4烷基磺醯基、CN及式 III基團且甚至更佳選自氫及Ci_c4烧基。特定言之,尺4係 選自氫、CN及曱基。R4特別為氫。 Μ杈佳選自鹼金屬陽離子、鹼土金屬陽離子相等物、 Cu、Zn、Fe或Νι之陽離子相等物,或式(NRaRbRCRd)+之銨 陽離子,其中Ra、Rb、RC及Rd中之一者為氫且Ra、R_b、RC 及Rd中之三者彼此獨立地選自Ci_Ciq烷基。河更佳選自R and R are preferably independently selected from hydrogen, q-C4 alkyl, c^-c-alkyl, CrCU alkoxy and (^-(: 2 haloalkoxy). More preferably, ruler 1 and Han 2 is independently selected from hydrogen, methyl, ethyl and trifluoromethyl. Even more preferably, r1 and R2 are independently selected from hydrogen and methyl. In particular, Rl & R2 are both methyl. Preferably, R3 is selected from the group consisting of hydrogen, Cl_C4 alkyl, Ci_C2 haloalkyl, alkoxy and .alkoxy. More preferably, it is selected from the group consisting of nitrogen, methyl 'ethyl and trifluoromethyl. Even More preferably, R is selected from the group consisting of hydrogen and methyl. Specific δ, R3 is nitrogen. R5 in the group -C(=0)R5 and -S(0)2R5 is preferably selected from Ci_c4 alkyl, Ci-. C2_alkyl, Cl_C4 alkoxy, Ci-C2_alkoxy, phenyl, phenoxy 147474.doc -31 · 201041514 base and NR9Rl°' more preferably selected from CrC4 alkyl 'c-cardiyl, (tetra) alkane Oxy, CKC2 haloalkoxy and NR9RlG and even more preferably selected from Ci_C4 alkyl and dish V. In the group R), r5 is specifically referred to as an alkyl group, more specifically an isopropyl group. , isobutyl or tert-butyl, and in the group -s(〇) 2R5, R5 is specifically methyl. Preferably, R9 is hydrogen and Ri The hydrazine is selected from the group consisting of hydrogen, ci-c4 alkyl and phenyl, preferably selected from the group consisting of chloro ACI-c4. R4 is preferably selected from the group consisting of hydrogen, Cl_c4 alkyl, _c(=〇)r5, _s(〇)2R5, _cn. And a group of the formula III wherein R5 has the above general meaning - or the above-mentioned preferred meanings of the above-mentioned preferred meanings have the above-mentioned general meaning - or one of the preferred meanings given hereinafter. From hydrogen, CVC4 alkyl, CVC4 alkylcarbonyl, Ci_c4 alkoxycarbonyl, -(:(=〇)Ν(Η)〇ν(:4 alkyl, Cl_C4 alkylsulfonyl, CN and the group of formula III and Even more preferably, it is selected from the group consisting of hydrogen and Ci_c4. In particular, the rule 4 is selected from the group consisting of hydrogen, CN and sulfhydryl. R4 is especially hydrogen. Μ杈 preferably selected from alkali metal cations, alkaline earth metal cation equivalents, Cu, Zn a cation equivalent of Fe or Νι, or an ammonium cation of the formula (NRaRbRCRd)+, wherein one of Ra, Rb, RC and Rd is hydrogen and three of Ra, R_b, RC and Rd are independently selected from each other Ci_Ciq alkyl. River is better selected from

Li Na K、/2Mg ,Cu、Zn、Fe或Ni之陽離子相等 物’及式(NRaRbReRY之銨陽離子,其中Ra、Rb、RC&Rd 中之一者為氫且Ra、Rb、RC&Rd中之三者彼此獨立地選自 CVCw烧基。Μ甚至更佳選自 Na+、K+、1/2Mg2+、1/2(:u2+、 KZn 、ZFe2、WNi2*、三乙銨及三曱録。 在式III之基團中,變數較佳具有與分子1之其餘部分中 147474.doc -32- 201041514 相同之含義。因此,上文關於基團之較佳含義所作之陳述 亦適用於此部分。 Ο Ο R4a較佳選自氫、Cl_ClG烷基、Ci_c4_烷基、笨基、苯 基-c〖-C4烷基及_c(=0)r5,其中r5具有上文給 義之一或特定言之上文給出之較佳含義之一。吵=; 自氫、CA烧基、CrC4_烧基、苯基、苯甲基、_c㈣)R5 及-s(o)2R5 ’其中R5具有上文給出之通用含義之—或特定 :之上文給出之較佳含義之-’且更佳選自氣、CVC4燒 基、CrCd烧基及_S(0)2R5,其中r5具有上文給出之通用 含義t或特U之上文給出之較佳含義之-。特定言 之,R為!I、cvc4燒基或Cl_c4齒烧基,更特定 或〇^04烷基,且特別為氫。 。马虱 右η為1,則氧原子較佳經由雙鍵鍵結於硫原子 -S(〇)n-R4因此產生基團_s(= r4。 基團 子較佳均經由雙鍵鍵則兩個氧原 叉鍵鍵結於硫原子,基團_Sd 基團-S(=0)2-R4。^ ^ 口 此產生 〇_r4。 心為3,則基團為基團_S(=〇)2_ η較佳為0。 在化合㈣Π中,化合w較佳。在化合 ΙΑ較佳。 τ 化合物 特定化合物ΙΑ為以下: 5-(2-甲基-4 -氯-苯甲其 节基)-1-(5-巯基-[υ/]三唑 2,2-二曱基環戊醇; 暴甲基)- 5-(2·二氣甲基-4·氯-笼田 甲基)小(5,基-[1,2,4]三唑小基甲 147474.doc -33· 201041514 基)-2,2-二甲基環戊醇; 5-(2-二氟甲氧基氯-# 甲基)-2,2-二甲基環戊醇本甲基)_1'(5·巯基-Π,2,4]三唑-1-基 •親基-[1,2,4]三唑-1-基曱基) 吵曱基)邻_ 2,2-一曱基環戊醇; 5-(3·三氟甲基-4·氣,笼田 基⑷二甲基環戊醇;(5·縣·[1,2,4]三。坐-1-基甲 甲基)-2,2-一曱基環戊醇;及 5-(3,4-二氯-苯甲基 二甲基環戊醇。 三⑸·基甲基)-2,2- 較佳化合物I及II之實例為 物,其中變數具有通用含義之 佳含義之一。較佳化合物之實 個別化合物。此外,下表中關 為所討論之取代基的尤其較佳^ 無關。 式Ll至1.16及II.1至II.8化合 —或特定言之上文給出之較 例為下文表1至6 8 8中彙編之 於個別變數提及之含義本身 的實施例,與提及其之組合Li Na K, /2Mg, cation equivalent of Cu, Zn, Fe or Ni' and formula (ammonium cation of NRaRbReRY, wherein one of Ra, Rb, RC & Rd is hydrogen and Ra, Rb, RC & Rd The three are independently selected from the CVCw alkyl group. The ruthenium is even more preferably selected from the group consisting of Na+, K+, 1/2Mg2+, 1/2 (:u2+, KZn, ZFe2, WNi2*, triethylammonium, and triterpene. In the group of III, the variable preferably has the same meaning as 147474.doc -32- 201041514 in the remainder of molecule 1. Therefore, the above statements regarding the preferred meaning of the group also apply to this section. R4a is preferably selected from the group consisting of hydrogen, Cl_ClG alkyl, Ci_c4_alkyl, stupyl, phenyl-c--C4 alkyl and _c(=0)r5, wherein r5 has one or more of the above meanings One of the preferred meanings given in the text. Noisy =; from hydrogen, CA alkyl, CrC4_alkyl, phenyl, benzyl, _c (tetra) R5 and -s(o)2R5 'where R5 has the above given The general meaning - or specific: the preferred meaning given above - and more preferably selected from the group consisting of gas, CVC4 alkyl, CrCd alkyl and _S(0)2R5, wherein r5 has the above The general meaning t or special U is given above Preferably, R is !I, cvc4 alkyl or Cl_c4 dentate, more specific or 〇04 alkyl, and especially hydrogen. The right η of the horse is 1, then the oxygen atom is It is preferably bonded to the sulfur atom -S(〇)n-R4 via a double bond, thereby generating a group _s(= r4. Preferably, the group is bonded to the sulfur atom via a double bond, and the two oxygenogen bonds are bonded to the sulfur atom. The group _Sd group -S(=0)2-R4.^^ This produces 〇_r4. When the heart is 3, the group is a group _S(=〇)2_ η is preferably 0. (4) In the oxime, the compounding w is preferred. It is preferred in the compounding group. τ The compound-specific compound ΙΑ is as follows: 5-(2-methyl-4-chloro-benzoic acid benzylidene)-1-(5-fluorenyl-[υ /] Triazole 2,2-dimercaptocyclopentanol; violent methyl)- 5-(2·di-gasmethyl-4·chloro-cagefield methyl) small (5, yl-[1,2,4] Triazole small group 147474.doc -33· 201041514 base)-2,2-dimethylcyclopentanol; 5-(2-difluoromethoxy chloride-#methyl)-2,2-dimethyl Cyclopentanol, methyl)_1'(5. fluorenyl-hydrazine, 2,4)triazol-1-yl-philophilic-[1,2,4]triazol-1-ylindenyl) O- 2,2-monodecylcyclopentanol; 5-(3·trifluoromethyl-4· gas, cage field base (4) Methylcyclopentanol; (5·county·[1,2,4]3. sit-1-ylmethyl)-2,2-indenylcyclopentanol; and 5-(3,4-di Chloro-benzyldimethylcyclopentanol. Examples of the preferred compounds I and II are tris(5)-ylmethyl)-2,2-, wherein the variables have one of the general meanings of the general meaning. Preferred compounds are individual compounds. In addition, the substituents discussed in the table below are particularly preferred. Formulas L1 to 1.16 and II.1 to II.8 - or in particular, the examples given above are the examples of the meanings referred to in the individual variables mentioned in Tables 1 to 680 below, and And its combination

147474.doc -34- 201041514147474.doc -34- 201041514

147474.doc -35- 201041514 表1 式1.1化合物’其中化合物之Rl、R2、L1、L2、L3&L4之組 合在各情況下對應於表A之一列,且R4為Η 表2 式化合物,其中化合物之尺1、r2、Li、L2、l^l4之組 合在各情況下對應於表A之一列,且R4為甲基 表3 式化合物,其中化合物之Rl、R2、L!、L2、。及。之組 合在各情況下對應於表A之一列,且R4為乙基 表4 式Ι·1化合物,其中化合物之尺1、R2、Ll、L2、[3及[4之組 合在各情況下對應於表A之一列,且R4為丙基 表5 式化合物,其中化合物之尺1、R2、L丨、L2、l^l4之組 合在各情況下對應於表A之一列,且R4為異丙 表6 式化合物,其中化合物之Ri、R2、Ll、L2、L3&L4之組 合在各情況下對應於表A之一列,且r4為正丁基 表7 土 式L1化合物’其中化合物之尺丨、r2、L〗、L2、L^L4之組 合在各情況下對應於表A之一列,且R4為第二丁基 表8 土 式1.1化合物,其中化合物之…、“、。、。、。及广之組 合在各情況下對應於表A之一列,且R4為異丁基 147474.doc -36· 201041514 表9 式1.1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且r4為第三丁基 表10 式1.1化合物,其中化合物之R1、r2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為苯基 表11 Q 式L1化合物’其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為4-甲基苯基 表12 式1.1化合物’其中化合物之R1、r2、L1、L2、L3&L4之組 合在各情況下對應於表A之一列,且R4為Li + 表13 式J.1化合物,其中化合物之R1、r2、L1、L2、L3&L4之組 合在各情況下對應於表A之一列,且R4為Na+ 〇 表14 式1,1化合物’其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為κ+ 表15 式Ι·1化合物’其中化合物之Rl、r2、Ll、L2、。及。之組 合在各情況下對應於表A之一列,且R/為》/2Mg2+ 表16 式L1化合物’其中化合物之R1、R2、L1、L2、L3及L4之組 «在各情況下對應於表A之一列,且R4為1/2(:u2+ 147474.doc -37- 201041514 表17 式1_1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且114為1/22112 + 表18 式1_1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且尺4為1/462+ 表19 式1.1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且尺4為i/2Ni2+ 表20 式1.1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為NH(CH3)3+ 表21 式1.1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為NH(C2H5)3 + 表22 式1.1化合物,其中化合物之Rl、、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為 NH(CH2CH2CH2)3 + 表23 式1.1化合物,其中化合物之R1、r2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為NH(CH(CH3)2)3 + 表24 式Ι·1化合物,其中化合物之R1、r2、Li、L2、以及以之組 147474.doc -38. 201041514 合在各情況下對應於表A之一列,且R4為 nh(ch2ch2ch2ch2)3+ 表25 式1.1化合物,其中化合物之Ri、r2、Li、L2、L3&L4之組 合在各情況下對應於表A之一列,且R4為甲基羰基 表26 式1.1化合物’其中化合物之ri、r2、、l2、L3及L4之組 0 合在各情況下對應於表A之一列,且R4為乙基羰基 表27 式1.1化合物’其中化合物之Rl、r2、L1、L2、L3&L4之組 合在各情況下對應於表A之一列,且R4為丙基羰基 表28 式1.1化合物,其中化合物之Rl、r2、Ll、L2、。及。之組 合在各情況下對應於表A之一列,且R4為異丙基羰基 表29 〇 式L1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為甲氧戴基 表30 式I· 1化合物,其中化合物之、R2、[1、[2、L3及匕4之組 合在各情況下對應於表A之一列,且R4為乙氧幾基 表31 式1.1化合物,其中化合物之尺1、R2、Ll、L2、L^L4之組 合在各情況下對應於表A之一列,且R4為丙氧羰基 表32 147474.doc •39· 201041514 式L1化合物’其中化合物之R1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為異丙氧羰基 表33 式1,1化合物’其中化合物之R1、R2、L1、L2、L3及L4之組 σ在各情況下對應於表A之一列,且R4為苯氧羰基 表34 式1化合物,其中化合物之R1、R2、L1、L2、L3及L4之組 口在各情况下對應於表A之一列,且R4為曱基胺基羰基 表35 式L1化合物,其中化合物之尺]、R2、Ll、L2、L3&L4之組 σ在各情況下對應於表A之一列,且R4為乙基胺基羰基 表3 6 化合物,其中化合物之…、…、。、^、。及广之組 合在各情況下對應於表A之一列,且Μ為丙基胺基羰基 表37 fLl化合物,其中化合物之…、^[丨^及“之組 合在各情況下對應於表A之一列,且R4為異丙基胺基羰基 表38 式U化合物,其中化合物之R1、R2、L丨、L2、l3&l4之組 合在各情況下對應於表A之一列,且R4為苯基胺基羰基 表39 ^•1化合物’其中化合物之r1、r2、li、l2、l^ly- 合在各情況下對應於表八之一列,且R4為甲 表40 ' 147474.doc 201041514 組 弋1化合物,其中化合物之R1、R2、L1、L2、l3及L4之 合在各情況下對應於表A之—列,且r4為乙確酿基 表41 ' 式U化合物,其中化合物之111、尺2、1^、1^、1^及1/之組 合在各情況下對應於表A之一列’且R4為丙磺醯基 表42 式U化合物,其中化合物之…、R2、Ll、L2 ' ^及。之組147474.doc -35- 201041514 Table 1 Compound of formula 1.1 wherein the combination of R1, R2, L1, L2, L3 & L4 of the compound corresponds in each case to one of Table A, and R4 is a compound of the formula 2, wherein The combination of the ruler 1, r2, Li, L2, l^l4 of the compound corresponds in each case to one of the columns of Table A, and R4 is a compound of the formula M, wherein R1, R2, L!, L2 of the compound. and. The combination corresponds in each case to one of the columns of Table A, and R4 is an ethyl group 4 formula ,·1 compound, wherein the combination of the ruler 1, R2, L1, L2, [3, and [4] of the compound corresponds in each case. In the column of Table A, and R4 is a propyl form 5 compound, wherein the combination of the ruler 1, R2, L丨, L2, and l^4 of the compound corresponds in each case to one of the tables A, and R4 is isopropyl. Table 6 Compounds of the formula wherein the combination of Ri, R2, L1, L2, L3 & L4 of the compound corresponds in each case to one of the columns of Table A, and r4 is a n-butyl group of 7 compounds of the formula L1 The combination of r2, L, L2, L^L4 corresponds in each case to one of the columns of Table A, and R4 is a compound of the second butyl group 8 formula 1.1, wherein the compound is ..., ", . The combination of the combination and the combination in each case corresponds to one of the tables A, and R4 is isobutyl 147474.doc -36· 201041514 Table 9 The compound of the formula 1.1, wherein the combination of the compound R1, R2, L1, L2, L3 and L4 In each case corresponds to one of the columns of Table A, and r4 is a compound of the formula 1-3, wherein R1, r2, L1, L2, L3 and L4 of the compound In each case, it corresponds to one of the columns of Table A, and R4 is a phenyl group. 11 Q Formula L1 compound 'wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the tables A And R4 is 4-methylphenyl group 12 compound of formula 1.1 wherein the combination of R1, r2, L1, L2, L3 & L4 of the compound corresponds in each case to one of the columns of Table A, and R4 is Li + Table 13 A compound of formula J.1, wherein the combination of R1, r2, L1, L2, L3 & L4 of the compound corresponds in each case to one of the columns of Table A, and R4 is Na+ 〇 Table 14 Formula 1, Compound 1 wherein R1 of the compound The combination of R2, L1, L2, L3 and L4 corresponds in each case to one of the columns of Table A, and R4 is κ+ Table 15 Formula Ι1 Compound 'where R1, r2, L1, L2, and . The combination corresponds in each case to one of the columns of Table A, and R/ is "/2Mg2+" Table 16 Formula L1 compound 'where the group of R1, R2, L1, L2, L3 and L4 of the compound« corresponds in each case to the table A column of A, and R4 is 1/2 (: u2+ 147474.doc -37- 201041514 Table 17 Formula 1_1 compound, wherein the combination of compounds R1, R2, L1, L2, L3 and L4 in each case Corresponding to one of the columns of Table A, and 114 is 1/22112 + Table 18 Formula 1_1 compound, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of Table A, and Rule 4 1/462+ Table 19 Formula 1.1 compounds wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of Table A, and Rule 4 is i/2Ni2+ Table 20 Formula 1.1 Compound Wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A, and R4 is NH(CH3)3+, wherein the compound of formula 1.1, wherein R1, R2 of the compound The combination of L1, L2, L3 and L4 corresponds in each case to one of the columns of Table A, and R4 is NH(C2H5)3 + Table 22 Formula 1.1 Compound, wherein the combination of compounds R1, L1, L2, L3 and L4 In each case corresponds to one of the columns of Table A, and R4 is NH(CH2CH2CH2)3 + Table 23 Formula 1.1, wherein the combination of R1, r2, L1, L2, L3 and L4 of the compound corresponds in each case to Table A One of the columns, and R4 is NH(CH(CH3)2)3 + Table 24 Formula Ι·1 compound, wherein the compound R1, r2, Li, L2, and the group 147474.doc -38. 201041514 The lower one corresponds to one of the columns of Table A, and R4 is nh(ch2ch2ch2ch2)3+ Table 25 Formula 1.1 Compound, wherein the combination of Ri, r2, Li, L2, L3 & L4 of the compound corresponds in each case to one of Table A, And R4 is a methylcarbonyl group. The compound of the formula 1.1 wherein the compound ri, r2, l2, L3 and L4 are combined in each case corresponds to one of the tables A, and R4 is ethylcarbonyl. The compound 'wherein the combination of R1, r2, L1, L2, L3 & L4 of the compound corresponds in each case to one of the columns of Table A, and R4 is a propylcarbonyl group. The compound of the formula 1.1, wherein the compound is R1, r2, L1, L2. and. The combination corresponds in each case to one of the columns of Table A, and R4 is an isopropylcarbonyl group 29 〇 L1 compound, wherein the combination of the compounds R1, R2, L1, L2, L3 and L4 corresponds in each case to the table a column of A, and R4 is a compound of the formula methoxyl group 30, wherein the combination of the compound, R2, [1, [2, L3, and 匕4 corresponds in each case to one of the tables A, and R4 Is a compound of formula 1.1, wherein the combination of the ruler 1, R2, L1, L2, L^L4 of the compound corresponds in each case to one of the columns of Table A, and R4 is a propoxycarbonyl table 32 147474.doc • 39· 201041514 The compound of formula L1 wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A, and R4 is isopropoxycarbonyl. Table 33 Formula 1, Compound 1 Wherein the group σ of the compounds R1, R2, L1, L2, L3 and L4 corresponds in each case to one of the tables A, and R4 is a phenoxycarbonyl group. The compound of the formula 1 wherein the compound is R1, R2, L1, L2 The group of L3 and L4 corresponds in each case to one of the columns of Table A, and R4 is a compound of the formula L1 of the mercaptoaminocarbonyl group, wherein the compound is in the form of a compound] The group σ of R2, L1, L2, L3 & L4 corresponds in each case to one of the columns of Table A, and R4 is an ethylaminocarbonyl group of the compound of Table 36, wherein the compound is ..., ..., . , ^,. The combination of the combination and the combination in each case corresponds to one of the tables A, and the hydrazine is a propylaminocarbonyl group 37 fLl compound, wherein the combination of the compound, ^[丨^ and "in each case corresponds to Table A a column, and R4 is an isopropylaminocarbonyl group, a compound of the formula U wherein the combination of the compounds R1, R2, L?, L2, l3 & l4 corresponds in each case to one of the columns of Table A, and R4 is phenyl. Aminocarbonyl Table 39 ^•1 compound 'wherein the compound r1, r2, li, l2, l^ly- combination corresponds to one of the eight tables in each case, and R4 is a table 40 ' 147474.doc 201041514 group 弋a compound wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to the column of Table A, and r4 is a compound of the formula U in the formula 41', wherein the compound 111, The combination of ruler 2, 1^, 1^, 1^ and 1 in each case corresponds to one of the columns of Table A and R4 is a compound of the formula U in the form of a sulfonyl group, wherein the compound..., R2, L1, L2 ' ^ and. Group

合在各情況下對應於表A之一列,且R4為異丙磺醯基 表43 式1.1化合物,其中化合物之…、r2、Ll、l2、。及。之組 合在各情況下對應於表A之一列,且R4為苯磺醯基 表44 式Ι·1化合物,其中化合物之尺1、R2、Ll、L2、L3&L4之組 合在各情況下對應於表A之一列,且R4為甲氧基磺醯基 表45 式Ι·1化合物’其中化合物之Ri、r2、Li、l2、L3及L4之組 合在各情況下對應於表A之一列,且R4為乙氧基磺醯基 表46 式1.1化合物,其中化合物之R1、r2、L!、L2、。及。之組 合在各情況下對應於表A之一列,且R4為丙氧基磺醯基 表47 式1.1化合物,其中化合物之R1、r2、Li、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為異丙氧基續酿基 表48 147474.doc -41- 201041514 式I. 1化合物’其中化合物之R1、r2、L1、L2、[3及[4之組 合在各情況下對應於表A之一列,且R4為苯氧基磺醯基 表49 式1.1化合物’其中化合物之Ri、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列,且R4為CN 表50至98 式1.2化合物’其中化合物之Ri、r2、Li、L2、L3&L4之組 合在各情況下對應於表A之一列且R4係如在表1至49中任一 者中所定義 表99至147 式1.3化合物’其中化合物之尺1、r2、L1、L2、L3&L4之組 合在各情況下對應於表A之一列且R4係如在表1至49中任一 者中所定義 表148至196 式1.4化合物’其中化合物之尺!、r2、Ll、l2、[3及[4之組 合在各情況下對應於表A之一列且R4係如在表1至49中任一 者中所定義 表197至245 式1.5化合物’其中化合物之Ri、r2、Ll、、[3及〇之組 合在各情況下對應於表A之一列且R4係如在表1至49中任一 者中所定義 表246至294 式1.6化合物,其中化合物之r1、R2、L1、L2、L3及L4之組 合在各情況下對應於表A之一列且R4係如在表1至4 9中任一 147474.doc •42- 201041514 者中所定義 表295至343 式1.7化合物,其中化合物之尺丨、r2、Ll 3 a τ 4 ζ L、L及L之組 合在各情況下對應於表Α之一列且R4係如在表1至49中任一 者中所定義 表344至392 式1.8化合物,其中化合物之ri、r2、、l2、L3及1/之組 〇 &在各丨月況下對應於表A之一列且R4係如在表1至4 9中任一 者中所定義 表393 式1.9化合物,其中化合物之尺1、R2、L丨、L2、L3&L4之組 合在各情況下對應於表A之一列 表394 式1.10化合物,其中化合物之R1、r2、L!、L2、L3&L4之 組合在各情況下對應於表A之一列 〇 表395 式1.1 1化合物,其中化合物之R1、、L1、L2、[3及L4之 組合在各情況下對應於表A之一列 表396 • 式L12化合物’其中化合物之R1、R2、l1、L2、L3及L4之 組合在各情況下對應於表A之一列 表397 式L13化合物,其中化合物之尺1、r2、Ll、L2、L3及[4之 組合在各情況下對應於表A之一列 147474.doc •43· 201041514 表398 式Ι·14化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列 表399 式1.15化合物,其中化合物之][11、112、1^、1/、1/及1/之 組合在各情況下對應於表A之一列 表400 式L16化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列 表401 式H.1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且Rh為η 表402 式Η·1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表Α之一列且R4a為曱基 表403 式Π·1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表Α之一列且R4a為乙基 表404 式IL1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為丙基 表405 式II.1化合物,其中化合物之尺!、R2、Ll、L2、£3及[4之 組合在各情況下對應於表A之一列且為異丙基 147474.doc -44 - 201041514 表406 式II. 1化合物,其中化合物之RI、r2、L丨、及之 組合在各情況下對應於表A之一列且R4a為正丁某 表407 式H·1化合物,其中化合物之R1、R2、L1、L2、[3及L4之 組合在各情況下對應於表A之一列且R 4 a為第二丁基 表 408 ^In each case, it corresponds to one of the columns of Table A, and R4 is an isopropylsulfonyl group. The compound of the formula 1.1 is a compound of the formula 1.1, wherein the compound is ..., r2, L1, l2. and. The combination corresponds in each case to one of the columns of Table A, and R4 is a compound of the formula phenylsulfonyl group 44, wherein the combination of the ruler 1, R2, L1, L2, L3 & L4 of the compound corresponds in each case In the column of Table A, and R4 is a methoxysulfonyl group, the compound of the formula Ι1, wherein the combination of Ri, r2, Li, l2, L3 and L4 of the compound corresponds in each case to one of the tables A, And R4 is an ethoxysulfonyl group of the compound of the formula 1.1, wherein the compound is R1, r2, L!, L2. and. The combination corresponds in each case to one of the columns of Table A, and R4 is a propoxy fluorenyl group of the compound of the formula 1.1, wherein the combination of the compounds R1, r2, Li, L2, L3 and L4 corresponds in each case to Table A, and R4 is an isopropoxy group. Table 48 147474.doc -41- 201041514 Formula I. 1 compound 'where the compound R1, r2, L1, L2, [3 and [4 combinations in each In the case of a column corresponding to Table A, and R4 is a phenoxysulfonyl group, the compound of formula 1.1, wherein the combination of Ri, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A. And R4 is CN Table 50 to 98 Formula 1.2 Compound 'wherein the combination of Ri, r2, Li, L2, L3 & L4 of the compound corresponds in each case to one of Table A and R4 is as in Tables 1 to 49. Tables 99 to 147 of the formula 1.3 are defined as one of the compounds wherein the combination of the ruler 1, r2, L1, L2, L3 & L4 of the compound corresponds in each case to one of the columns of Table A and R4 is as shown in Tables 1 to 49. Tables 148 to 196 of formula 1.4 are defined in either of them 'the size of the compound! , r2, L1, l2, [3 and [4 combinations in each case correspond to one of the columns of Table A and R4 is as defined in any of Tables 1 to 49, Tables 197 to 245, formula 1.5 compounds] The combination of Ri, r2, L1, [3, and hydrazine corresponds in each case to one of the columns of Table A and R4 is a compound of the formula 1.6 as defined in any one of Tables 1 to 49, wherein the compound The combination of r1, R2, L1, L2, L3 and L4 corresponds in each case to one of the columns of Table A and R4 is as defined in any of Tables 1 to 49, 147474.doc • 42- 201041514. To a compound of formula 1.7, wherein the combination of the compound of the formula, r2, Ll 3 a τ 4 ζ L, L and L corresponds in each case to one of the labels and R4 is as in any of Tables 1 to 49. The compounds of formula 344 to 392 are defined in the formula 344 to 392, wherein the ri, r2, l2, L3 and 1/ of the compound 〇& in each case correspond to one of the tables A and R4 are as shown in Table 1 Table 393 Compounds of formula 1.9 as defined in any one of 4, wherein the combination of the ruler 1, R2, L, L, L3 & L4 of the compound corresponds in each case to a list 394 of the formula A. The compound, wherein the combination of R1, r2, L!, L2, L3 & L4 of the compound corresponds in each case to a compound of the formula 1.11, wherein R1, L1, L2, [3 and The combination of L4 corresponds in each case to a list of Table A 396. • The compound of formula L12 wherein the combination of R1, R2, l1, L2, L3 and L4 of the compound corresponds in each case to one of the tables A, list 397, formula L13 The compound, wherein the combination of the ruler 1, r2, L1, L2, L3 and [4 of the compound corresponds in each case to the column of Table A 147474.doc • 43· 201041514 Table 398 Formula Ι 14 compound, wherein the compound R1 The combination of R2, L1, L2, L3 and L4 corresponds in each case to the compound of the formula 159, formula 1.15, wherein the combination of the compound [11, 112, 1^, 1/, 1/1 and 1/1 In each case corresponds to a list of compounds of formula L16 in Table A, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to the compound of formula H.1 in Table 401, wherein The combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A and Rh is η. Table 402 Formula Η·1 a compound wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the labels and R4a is a compound of the formula 403, wherein the compound is R1, R2, L1 The combination of L2, L3 and L4 corresponds in each case to one of the columns and R4a is an ethyl group 404 formula IL1 compound, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case Listed in Table A and R4a is a propyl form 405 compound of formula II.1, wherein the compound is a ruler! The combination of R2, L1, L2, £3 and [4 corresponds in each case to the column of Table A and is isopropyl 147474.doc -44 - 201041514 Table 406 Formula II.1 compound, wherein the compound RI, r2 , L丨, and combinations thereof in each case correspond to one of the columns of Table A and R4a is a compound of the formula 407 Formula H·1, wherein the combination of the compound R1, R2, L1, L2, [3 and L4 is in each In the case corresponding to one of the columns of Table A and R 4 a is the second butyl table 408 ^

〇 式Π.1化合物,其中化合物之Rl、r2、l1、[2、[3及[4之 組合在各情況下對應於表A之一列且R4a為異丁基 表409 ' ^ 式Π.1化合物,其中化合物之…、r2、Li、、。及[4之 組合在各情況下對應於表A之一列且Rh為第三丁基 表410 — ^ 式IL1化合物,其中化合物之R〗、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且為苯基 表 411 ^ 式IL1化合物,其中化合物之R1、R2、L1、l2、L3及L4之 組合在各情況下對應於表A之一列且R4a為甲基苯基 表412 其中化合物之R1、r2、L1、l2、L3及L4之 式II. 1化合物 組合在各情况下對餘表A之—列且R4a為曱基· 表413 弋化〇物,其中化合物之R1、R2、L·1、、L3&L4之 、且口在各情况下對應於表A之一列且R4a為乙基羰基 147474.doc •45- 201041514 表414 式IL1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表八之一列且R4a為丙基羰基 表415 式II.1化合物’其中化合物之R1、R2、L!、L2、匕3及匕4之 組合在各情況下對應於表A之一列且為異丙基羰基 表416 式II.1化合物,其中化合物之R1、r2、L!、[2、L3&L4之 組合在各情況下對應於表A之一列且為曱氧羰基 表417 式Π. 1化合物’其中化合物之ri、r2、[I、L]、l3及L4之 組合在各情況下對應於表A之一列且為乙氧羰基 表418 式II.1化合物’其中化合物之r1、r2、匕1、l2、l3及L4之 組合在各情況下對應於表A之一列且為丙氧羰基 表419 式II.1化合物,其中化合物之r1、R2、Li、l2、"及。之 組合在各情況下對應於表A之一列且Rh為異丙氧羰基 表420 式II.1化合物’其中化合物之Ri、r2、Ll、l2、[3及[4之 組合在各情況下對應於表A之一列且R4a為苯氧幾基 表421 式II. 1化合物,其中化合物之R1、R2、L1、L2、二3及L4之 組合在各情況下對應於表A之一列且R4a為甲基胺基羰基 147474.doc -46- 201041514 表422 式11,1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為乙基胺基羰基 表423 式II.1化合物,其中化合物之Rl、R2、Ll、L2、"及^之 組合在各情況下對應於表A之一列且R4a為丙基胺基羰基 表424 0 式IL1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為異丙基胺基羰基 表425 式IL1化合物,其中化合物之R丨、R2、Li、L2、L3及L4之 組合在各情況下對應於表A之一列且尺43為苯基胺基羰基 表426 式IL1化合物’其中化合物之R1、R2、Li、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為曱磺醢基 〇 表427 式11,1化合物,其中化合物之R1、R2、Li、L2、L3及L4之 組合在各情況下對應於表八之一列且R4a為乙磺醯基 表428 式IL1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為丙磺醯基 表439 式11-1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為異丙磺醯基 147474.doc •47- 201041514 表43Ό 式ΙΙ·1化合物’其中化合物之R1、R2、Li、L2、L3及广之 組合在各情況下對應於表A之一列且R4a為苯確酿基 表431 式ΙΙ·1化合物,其中化合物之R1、R2、L1、L2、[3及L4之 組合在各情況下對應於表A之一列且R4a為甲氧基續醯基 表432 式II.1化合物,其中化合物之R1、R2、Li、L2、"及“之 組合在各情況下對應於表A之一列且R4a為乙氧基續醯基 表433 式II. 1化合物,其中化合物之ri、r2、L!、l2、l3及L4之 組合在各情況下對應於表A之一列且R4a為丙氧基磺醯基 表434 式IL1化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表A之一列且R4a為異丙氧基磺醯基 表435 式II.1化合物,其中化合物之R1、R2、L]、L2、。及广之 組合在各情況下對應於表A之一列且為苯氧基磺酿基 表436 式Π.1化合物,其中化合物之…、r2、Ll、l2、^及^之 組合在各情況下對應於表A之一列且R4a為 表437至472 式Η·2化合物,其中化合物之…、r2、Ll、[2、"及广之 組合在各情況下對應於表A之一列且R4a係如在表4〇ι至州 147474.doc -48- 201041514 中任一者中所定義 表473至508 式Π.3化合物,其中化合物之R1、R2、L1、l2、L3及L4之 、组合在各情況下對應於表A之-列且R4、如在表4〇1至436 中任一者中所定義 表509至544 式Π.4化合物,其中化合物之R1、R2、L1、L2、L3及L4之 ❽ 組合在各情況下對應於表Α之一列且尺43係如在表4〇1至436 中任一者中所定義 表545至580 式Π·5化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表Α之一列且尺43係如在表4〇1至436 中任一者中所定義 表581至616 式Π·6化合物’其中化合物之R1、R2、Li、l2、L3及L4之 〇 組合在各情況下對應於表A之一列且尺43係如在表4〇1至436 中任一者中所定義 表617至652 式Π.7化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表Α之一列且R4a係如在表4〇1至436 中任一者中所定義 表653至688 式Π.8化合物,其中化合物之R1、R2、L1、L2、L3及L4之 組合在各情況下對應於表Α之一列且R“係如在表4〇1至4% 147474.doc -49- 201041514A compound of the formula 11, wherein the compound R1, r2, l1, [2, [3 and [4 combinations in each case correspond to one of the tables A and R4a is an isobutyl table 409 ' ^ Π.1 a compound, wherein the compound is..., r2, Li, . And the combination of [4 corresponds in each case to one of the columns of Table A and Rh is a third butyl group 410 - ^ formula IL1 compound, wherein the combination of the compound R, R2, L1, L2, L3 and L4 in each case The following corresponds to a column of Table A and is a phenyl group 411 ^ formula IL1 compound, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A and R4a is methylbenzene. Base Table 412 wherein R1, r2, L1, L2, L3 and L4 of the compound of formula II. 1 are combined in each case for the remainder of Table A and R4a is a fluorenyl group. R1, R2, L·1, L3 & L4, and the mouth in each case corresponds to one of the columns of Table A and R4a is ethylcarbonyl 147474.doc • 45- 201041514 Table 414 Compound of formula IL1, wherein compound R1 The combination of R2, L1, L2, L3 and L4 corresponds in each case to one of the columns of Table 8 and R4a is a propylcarbonyl group 415. The compound of the formula II.1 wherein R1, R2, L!, L2, 匕3 of the compound And the combination of 匕4 corresponds in each case to one of the columns of Table A and is a compound of the formula isopropyl Formula 416, Formula II.1, wherein the compound R1, r2, L!, [2 The combination of L3 & L4 corresponds in each case to one of the columns of Table A and is a methoxycarbonyl group of the formula 417. The compound of the compound ri, r2, [I, L], l3 and L4 in each case The following corresponds to one of the columns of Table A and is an ethoxycarbonyl table 418. The compound of the formula II.1 wherein the combination of the compounds r1, r2, 匕1, l2, l3 and L4 corresponds in each case to one of the tables A and is C. Oxycarbonyl Group 419 A compound of the formula II.1, wherein the compound is r1, R2, Li, l2, " The combination in each case corresponds to one of the columns of Table A and Rh is isopropoxycarbonyl table 420. The compound of formula II.1 'where the compound Ri, r2, Ll, l2, [3 and [4 combinations correspond in each case) And a combination of R1, R2, L1, L2, ternary 3 and L4 of the compound in each case corresponds to one of the columns of Table A and R4a is a column of Table A and R4a is a phenoxyl group. Methylaminocarbonyl 147474.doc -46- 201041514 Table 422 Compound of formula 11,1 wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of Table A and R4a is B. The amino group carbonyl group 423 is a compound of the formula II.1, wherein the combination of the compounds R1, R2, L1, L2, " and ^ corresponds in each case to one of the columns of Table A and R4a is a propylaminocarbonyl table 424 0 A compound of the formula IL1, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A and R4a is an isopropylaminocarbonyl group 425 compound of the formula IL1, wherein the compound is R丨The combination of R2, Li, L2, L3 and L4 corresponds in each case to one of the columns of Table A and the ruler 43 is a phenylaminocarbonyl group 426 Formula IL1 compound 'In which case the combination of R1, R2, Li, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A and R4a is a sulfonyl hydrazide 〇 Table 427, a compound of the formula 11,1, wherein the compound R1, R2 The combination of Li, L2, L3 and L4 corresponds in each case to one of the columns of Table 8 and R4a is a compound of the formula 148, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound is In the case of a column corresponding to Table A and R4a is a compound of the formula 11-1, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the tables A and R4a is isopropylsulfonyl 147474.doc • 47- 201041514 Table 43 Ό Formula 1 Compound 1 wherein the combination of R1, R2, Li, L2, L3 and broadly corresponds to each of Table A and R4a Is a compound of the formula 431, wherein the combination of R1, R2, L1, L2, [3 and L4 of the compound corresponds in each case to one of the columns of Table A and R4a is a methoxy group. 432 A compound of the formula II.1, wherein the combination of the compounds R1, R2, Li, L2, " and "in each case corresponds to one of the columns of Table A and R4a Ethoxylated thiol 433 is a compound of formula II.1 wherein the combination of ri, r2, L!, l2, l3 and L4 of the compound corresponds in each case to one of the columns of Table A and R4a is propoxysulfonyl Table 434 Compounds of the formula IL1 wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns of Table A and R4a is isopropoxysulfonyl group 435 of the compound of the formula II.1, Wherein the compounds are R1, R2, L], L2. The combination of the combination and the combination in each case corresponds to one of the tables A and is a compound of the formula 436, wherein the combination of the compound, r2, L1, l2, ^ and ^ in each case Corresponding to one of the columns of Table A and R4a is a compound of the formula 437 to 472, wherein the combination of the compound, r2, L1, [2, " and broadly corresponds to each of the tables A and R4a in each case. The compounds of Tables 473 to 508, as defined in any one of Tables 4 to 147474. doc - 48 to 201041514, wherein R1, R2, L1, L2, L3 and L4 of the compound are combined In each case, corresponding to the column of Table A and R4, as shown in any of Tables 4 to 1 to 436, the compounds of the formula 509 to 544, wherein R1, R2, L1, L2, L3 of the compound And the combination of L4 in each case corresponds to one of the columns and the rule 43 is a compound of the formula 545 to 580 as defined in any of Tables 4 to 1 to 436, wherein the compound R1, R2 The combination of L1, L2, L3 and L4 corresponds in each case to one of the columns and the rule 43 is as defined in any of Tables 4 to 1 to 436. The combination of R1, R2, Li, L2, L3 and L4 of the compound in each case corresponds to one of the columns of Table A and Rule 43 is as defined in Tables 〇1 to 436, Tables 617 to 652 A compound of the formula 77, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns and R4a is as defined in any of Tables 4 to 436. Tables 653 to 688 are compounds of the formula 88, wherein the combination of R1, R2, L1, L2, L3 and L4 of the compound corresponds in each case to one of the columns and R" is as in Table 4〇1 to 4% 147474 .doc -49- 201041514

中任一者中所定義 表ADefined in either of them, Table A

編號 R1 R2 L1 L2 L3 L4 A-1. ch3 ch3 ch3 H H H A-2. ch3 ch3 CH2CH3 H H H A-3. ch3 ch3 ch(ch3)2 H H H A-4. ch3 ch3 cf3 H H H A-5. ch3 ch3 CH2CF3 H H H A-6. ch3 ch3 CF2CHF2 H H H A-7. ch3 ch3 OCH3 H H H A-8. ch3 ch3 OCF3 H H H A-9. ch3 ch3 OCH2CF3 H H H A-10. ch3 ch3 OCH2CH3 H H H A-11. ch3 ch3 H ch3 H H A-12. ch3 ch3 H ch2ch3 H H A-13. ch3 ch3 H ch(ch3)2 H H A-14. ch3 ch3 H cf3 H H A-15. ch3 ch3 H CH2CF3 H H A-16. ch3 ch3 H CF2CHF2 H H A-17. ch3 ch3 H OCH3 H H A-18. ch3 ch3 H OCF3 H H A-19. ch3 ch3 H OCH2CF3 H H A-20. ch3 ch3 H OCH2CH3 H H A-21. ch3 ch3 H Cl H H A-22. H ch3 ch3 H H H A-23. H ch3 CH2CH3 H H H A-24. H ch3 CH(CH3)2 H H H A-25. H ch3 cf3 H H H A-26. H ch3 ch2cf3 H H H A-27. H ch3 CF2CHF2 H H H A-28. H ch3 OCH3 H H H A-29. H ch3 OCF3 H H H A-30. H ch3 OCH2CF3 H H H 147474.doc -50- 201041514No. R1 R2 L1 L2 L3 L4 A-1. ch3 ch3 ch3 HHH A-2. ch3 ch3 CH2CH3 HHH A-3. ch3 ch3 ch(ch3)2 HHH A-4. ch3 ch3 cf3 HHH A-5. ch3 ch3 CH2CF3 HHH A-6. ch3 ch3 CF2CHF2 HHH A-7. ch3 ch3 OCH3 HHH A-8. ch3 ch3 OCF3 HHH A-9. ch3 ch3 OCH2CF3 HHH A-10. ch3 ch3 OCH2CH3 HHH A-11. ch3 ch3 H ch3 HH A-12. ch3 ch3 H ch2ch3 HH A-13. ch3 ch3 H ch(ch3)2 HH A-14. ch3 ch3 H cf3 HH A-15. ch3 ch3 H CH2CF3 HH A-16. ch3 ch3 H CF2CHF2 HH A -17. ch3 ch3 H OCH3 HH A-18. ch3 ch3 H OCF3 HH A-19. ch3 ch3 H OCH2CF3 HH A-20. ch3 ch3 H OCH2CH3 HH A-21. ch3 ch3 H Cl HH A-22. H ch3 Ch3 HHH A-23. H ch3 CH2CH3 HHH A-24. H ch3 CH(CH3)2 HHH A-25. H ch3 cf3 HHH A-26. H ch3 ch2cf3 HHH A-27. H ch3 CF2CHF2 HHH A-28. H ch3 OCH3 HHH A-29. H ch3 OCF3 HHH A-30. H ch3 OCH2CF3 HHH 147474.doc -50- 201041514

編號 R1 R2 L1 L2 L3 L4 A-31. H ch3 OCH2CH3 H H H A-32. H ch3 H ch3 H H A-33. H ch3 H CH2CH3 H H A-34. H ch3 H CH(CH3)2 H H A-35. H ch3 H cf3 H H A-36. H ch3 H CH2CF3 H H A-37. H ch3 H CF2CHF2 H H A-38. H ch3 H OCH3 H H A-39. H CH3 H OCF3 H H A-40. H ch3 H OCH2CF3 H H A-41. H ch3 H OCH2CH3 H H A-42. H ch3 H Cl H H A-43. H H ch3 H H H A-44. H H CH2CH3 H H H A-45. H H CH(CH3)2 H H H A-46. H H cf3 H H H A-47. H H CH2CF3 H H H A-48. H H CF2CHF2 H H H A-49. H H OCH3 H H H A-50. H H OCF3 H H H A-51. H H OCH2CF3 H H H A-52. H H OCH2CH3 H H H A-53. H H H ch3 H H A-54. H H H CH2CH3 H H A-55. H H H ch(ch3)2 H H A-56. H H H cf3 H H A-57. H H H ch2cf3 H H A-58. H H H CF2CHF2 H H A-59. H H H OCH3 H H A-60. H H H OCF3 H H A-61. H H H OCH2CF3 H H A-62. H H H OCH2CH3 H H A-63. H H H Cl H H 147474.doc •51 - 201041514No. R1 R2 L1 L2 L3 L4 A-31. H ch3 OCH2CH3 HHH A-32. H ch3 H ch3 HH A-33. H ch3 H CH2CH3 HH A-34. H ch3 H CH(CH3)2 HH A-35. H ch3 H cf3 HH A-36. H ch3 H CH2CF3 HH A-37. H ch3 H CF2CHF2 HH A-38. H ch3 H OCH3 HH A-39. H CH3 H OCF3 HH A-40. H ch3 H OCH2CF3 HH A-41. H ch3 H OCH2CH3 HH A-42. H ch3 H Cl HH A-43. HH ch3 HHH A-44. HH CH2CH3 HHH A-45. HH CH(CH3)2 HHH A-46. HH cf3 HHH HH CH2CFF HHH A-49. HH OCH3 HHH A-51. HH OCH2H3HH A-52. HH OCH2CF3 HHH A-52. HH OCH2CH3 HHH A-53. HHH ch3 HH A -H. HHH CH2CH3 HH A-55. HHH ch(ch3)2 HH A-56. HHH cf3 HH A-57. HHH ch2cf3 HH A-58. HHH CF2CHF2 HH A-59. HHH OCH3 HH A-60. HHH OCF3 HH A-61. HHH OCH2CF3 HH A-62. HHH OCH2CH3 HH A-63. HHH Cl HH 147474.doc •51 - 201041514

編號 R1 R2 L1 L2 L3 L4 A-64. H cf3 ch3 H H H A-65. H cf3 CH2CH3 H H H A-66. H cf3 CH(CH3)2 H H H A-67. H cf3 cf3 H H H A-68. H cf3 CH2CF3 H H H A-69. H cf3 cf2chf2 H H H A-70. H cf3 och3 H H H A-71. H cf3 OCF3 H H H A-72. H cf3 OCH2CF3 H H H A-73. H cf3 OCH2CH3 H H H A-74. H cf3 H ch3 H H A-75. H cf3 H CH2CH3 H H A-76. H cf3 H CH(CH3)2 H H A-77. H cf3 H cf3 H H A-78. H cf3 H CH2CF3 H H A-79. H cf3 H CF2CHF2 H H A-80. H cf3 H OCH3 H H A-81. H cf3 H OCF3 H H A-82. H cf3 H OCH2CF3 H H A-83. H cf3 H OCH2CH3 H H A-84. H cf3 H Cl H H A-85. H CH2CH3 ch3 H H H A-86. H CH2CH3 CH2CH3 H H H A-87. H CH2CH3 ch(ch3)2 H H H A-88. H CH2CH3 cf3 H H H A-89. H CH2CH3 ch2cf3 H H H A-90. H CH2CH3 CF2CHF2 H H H A-91. H CH2CH3 OCH3 H H H A-92. H CH2CH3 OCF3 H H H A-93. H CH2CH3 OCH2CF3 H H H A-94. H CH2CH3 OCH2CH3 H H H A-95. H CH2CH3 H ch3 H H A-96. H CH2CH3 H CH2CH3 H H 147474.doc -52- 201041514No. R1 R2 L1 L2 L3 L4 A-64. H cf3 ch3 HHH A-65. H cf3 CH2CH3 HHH A-66. H cf3 CH(CH3)2 HHH A-67. H cf3 cf3 HHH A-68. H cf3 CH2CF3 H cf3 cf3 HHH A-71. H cf3 OCF3 HHH A-72. H cf3 OCH2CF3 HHH A-73. H cf3 OCH2CH3 HHH A-74. H cf3 H ch3 HH H cf3 H CH2CH3 HH A-76. H cf3 H CH(CH3)2 HH A-77. H cf3 H cf3 HH A-78. H cf3 H CH2CF3 HH A-79. H cf3 H CF2CHF2 HH A H cf3 H OCH3 HH A-82. H cf3 H OCH2CF3 HH A-83. H cf3 H OCH2CH3 HH A-84. H cf3 H Cl HH A-85. H CH2CH3 CH3HHH A-86. H CH2CH3 CH2CH3 HHH A-87. H CH2CH3 ch(ch3)2 HHH A-88. H CH2CH3 cf3 HHH A-89. H CH2CH3 ch2cf3 HHH A-90. H CH2CH3 CF2CHF2 HHH A-91. H CH2CH3 OCH3 HHH A-92. H CH2CH3 OCF3 HHH A-93. H CH2CH3 OCH2CF3 HHH A-94. H CH2CH3 OCH2CH3 HHH A-95. H CH2CH3 H ch3 HH A-96. H CH2CH3 H CH2CH3 HH 147474.doc - 52- 201041514

編號 R1 R2 L1 L2 L3 L4 A-97. H CH2CH3 H ch(ch3)2 H H A-98. H CH2CH3 H cf3 H H A-99. H ch2ch3 H CH2CF3 H H A-100. H CH2CH3 H CF2CHF2 H H A-101. H CH2CH3 H OCH3 H H A-102. H CH2CH3 H OCF3 H H A-103. H CH2CH3 H OCH2CF3 H H A-104. H CH2CH3 H OCH2CH3 H H A-105. H CH2CH3 H Cl H H A-106. ch3 cf3 ch3 H H H A-107. ch3 cf3 CH2CH3 H H H A-108. ch3 cf3 CH(CH3)2 H H H A-109. ch3 cf3 cf3 H H H A-110. ch3 cf3 CH2CF3 H H H A-lll. ch3 cf3 CF2CHF2 H H H A-112. ch3 cf3 OCH3 H H H A-113. ch3 cf3 OCF3 H H H A-114. ch3 cf3 OCH2CF3 H H H A-115. ch3 cf3 OCH2CH3 H H H A-116. ch3 cf3 H ch3 H H A-117. ch3 cf3 H CH2CH3 H H A-118. ch3 cf3 H CH(CH3)2 H H A-119. ch3 cf3 H cf3 H H A-120. ch3 cf3 H CH2CF3 H H A-121. ch3 cf3 H CF2CHF2 H H A-122. ch3 cf3 H OCH3 H H A-123. ch3 cf3 H OCF3 H H A-124. ch3 cf3 H OCH2CF3 H H A-125. ch3 cf3 H OCH2CH3 H H A-126. ch3 cf3 H Cl H H A-127. ch3 CH2CH3 ch3 H H H A-128. ch3 CH2CH3 CH2CH3 H H H A-129. ch3 ch2ch3 CH(CH3)2 H H H 147474.doc -53- 201041514No. R1 R2 L1 L2 L3 L4 A-97. H CH2CH3 H ch(ch3)2 HH A-98. H CH2CH3 H cf3 HH A-99. H ch2ch3 H CH2CF3 HH A-100. H CH2CH3 H CF2CHF2 HH A-101 H CH2CH3 H OCH3 HH A-102. H CH2CH3 H OCF3 HH A-103. H CH2CH3 H OCH2CF3 HH A-104. H CH2CH3 H OCH2CH3 HH A-105. H CH2CH3 H Cl HH A-106. ch3 cf3 ch3 HHH CH-CH3 CH2CH3 HHH A-108. ch3 cf3 CH(CH3)2 HHH OCH3 HHH A-113. ch3 cf3 OCF3 HHH A-114. ch3 cf3 OCH2CF3 HHH A-115. ch3 cf3 OCH2CH3 HHH A-116. ch3 cf3 H ch3 HH A-117. ch3 cf3 H CH2CH3 HH A-118. ch3 cf3 H CH(CH3)2 HH A-119. ch3 cf3 H cf3 HH A-120. ch3 cf3 H CH2CF3 HH A-121. ch3 cf3 H CF2CHF2 HH A-122. ch3 cf3 H OCH3 HH A-123. ch3 cf3 H OCF3 HH A-124. ch3 cf3 H OCH2CF3 HH A-125. ch3 cf3 H OCH2CH3 HH A-126. ch3 cf3 H Cl HH A-127. ch3 CH2CH3 ch3 HHH A-128. ch3 CH2CH3 CH2CH3 HHH A-129. Ch2ch3 CH(CH3)2 HHH 147474.doc -53- 20104151 4

編號 R1 R2 L1 L2 L3 L4 A-130. ch3 CH2CH3 cf3 H H H A-131. ch3 CH2CH3 ch2cf3 H H H A-132. ch3 CH2CH3 CF2CHF2 H H H A-133. ch3 CH2CH3 OCH3 H H H A-134. ch3 CH2CH3 OCF3 H H H A-135. ch3 CH2CH3 OCH2CF3 H H H A-136. ch3 CH2CH3 OCH2CH3 H H H A-137. ch3 CH2CH3 H ch3 H H A-138. ch3 CH2CH3 H CH2CH3 H H A-139. ch3 CH2CH3 H CH(CH3)2 H H A-140. ch3 CH2CTI3 H cf3 H H A-141. ch3 CH2CH3 H CH2CF3 H H A-142. ch3 CH2CH3 H CF2CHF2 H H A-143. ch3 ch2ch3 H OCH3 H H A-144. ch3 CH2CH3 H OCF3 H H A-145. ch3 CH2CH3 H OCH2CF3 H H A-146. ch3 CH2CH3 H OCH2CH3 H H A-147. ch3 CH2CH3 H Cl H H A-148. cf3 cf3 ch3 H H H A-149. cf3 cf3 CH2CH3 H H H A-150. cf3 cf3 ch(ch3)2 H H H A-151. cf3 cf3 cf3 H H H A-152. cf3 cf3 ch2cf3 H H H A-153. cf3 cf3 CF2CHF2 H H H A-154. cf3 cf3 OCH3 H H H A-155. cf3 cf3 OCF3 H H H A-156. cf3 cf3 OCH2CF3 H H H A-157. cf3 cf3 OCH2CH3 H H H A-158. cf3 cf3 H ch3 H H A-159. cf3 cf3 H CH2CH3 H H A-160. cf3 cf3 H CH(CH3)2 H H A-161. cf3 cf3 H cf3 H H A-162. cf3 cf3 H CH2CF3 H H 147474.doc -54- 201041514No. R1 R2 L1 L2 L3 L4 A-130. ch3 CH2CH3 cf3 HHH A-131. ch3 CH2CH3 ch2cf3 HHH A-132. ch3 CH2CH3 CF2CHF2 HHH A-133. ch3 CH2CH3 OCH3 HHH A-134. ch3 CH2CH3 OCF3 HHH A-135 CH3 CH2CH3 OCH2CF3 HHH A-136. ch3 CH2CH3 OCH2CH3 HHH A-137. ch3 CH2CH3 H ch3 HH A-138. ch3 CH2CH3 H CH2CH3 HH A-139. ch3 CH2CH3 H CH(CH3)2 HH A-140. ch3 CH2CTI3 H cf3 HH A-141. ch3 CH2CH3 H CH2CF3 HH A-142. ch3 CH2CH3 H CF2CHF2 HH A-143. ch3 ch2ch3 H OCH3 HH A-144. ch3 CH2CH3 H OCF3 HH A-145. ch3 CH2CH3 H OCH2CF3 HH A- 146. ch3 CH2CH3 H OCH2CH3 HH A-147. ch3 CH2CH3 H Cl HH A-148. cf3 cf3 ch3 HHH A-149. cf3 cf3 CH2CH3 HHH A-150. cf3 cf3 ch(ch3)2 HHH A-151. cf3 cf3 Cf3 HHH A-152. cf3 cf3 ch2cf3 HHH A-153. cf3 cf3 CF2CHF2 HHH A-154. cf3 cf3 OCH3 HHH A-155. cf3 cf3 OCF3 HHH A-156. cf3 cf3 OCH2CF3 HHH A-157. cf3 cf3 OCH2CH3 HHH A-158. cf3 cf3 H ch3 HH A-159. cf3 cf3 H CH2CH3 HH A-160. cf3 cf3 H CH(CH3)2 HH A-161. cf3 cf3 H cf3 HH A-162. cf3 cf 3 H CH2CF3 H H 147474.doc -54- 201041514

編號 R1 R2 L1 L2 L3 L4 A-163. cf3 cf3 H CF2CHF2 H H A-164. cf3 cf3 H OCH3 H H A-165. cf3 cf3 H OCF3 H H A-166. cf3 cf3 H OCH2CF3 H H A-167. cf3 cf3 H OCH2CH3 H H A-168. cf3 cf3 H Cl H H A-169. cf3 CH2CH3 ch3 H H H A-170. cf3 CH2CH3 CH2CH3 H H H A-171. cf3 CH2CH3 ch(ch3)2 H H H A-172. cf3 CH2CH3 cf3 H H H A-173. cf3 CH2CH3 CH2CF3 H H H A-174. cf3 CH2CH3 CF2CHF2 H H H A-175. cf3 CH2CH3 OCH3 H H H A-176. cf3 CH2CH3 OCF3 H H H A-177. cf3 CH2CH3 OCH2CF3 H H H A-178. cf3 CH2CH3 OCH2CH3 H H H A-179. cf3 CH2CH3 H ch3 H H A-180. cf3 CH2CH3 H CH2CH3 H H A-181. cf3 CH2CH3 H CH(CH3)2 H H A-182. cf3 CH2CH3 H cf3 H H A-183. cf3 CH2CH3 H CH2CF3 H H A-184. cf3 CH2CH3 H cf2chf2 H H A-185. cf3 ch2ch3 H OCH3 H H A-186. cf3 CH2CH3 H OCF3 H H A-187. cf3 CH2CH3 H OCH2CF3 H H A-188. cf3 CH2CH3 H OCH2CH3 H H A-189. cf3 CH2CH3 H Cl H H A-190. CH2CH3 CH2CH3 ch3 H H H A-191. CH2CH3 CH2CH3 CH2CH3 H H H A-192. CH2CH3 CH2CH3 CH(CH3)2 H H H A-193. CH2CH3 CH2CH3 cf3 H H H A-194. ch2ch3 CH2CH3 CH2CF3 H H H A-195. CH2CH3 CH2CH3 CF2CHF2 H H H 147474.doc -55- 201041514No. R1 R2 L1 L2 L3 L4 A-163. cf3 cf3 H CF2CHF2 HH A-164. cf3 cf3 H OCH3 HH A-165. cf3 cf3 H OCF3 HH A-166. cf3 cf3 H OCH2CF3 HH A-167. cf3 cf3 H CY3 CH2CH3 CH3CH3 HHH A-170. cf3 CH2CH3 ch(ch3)2 HHH A-172. cf3 CH2CH3 cf3 HHH A-173 Cf3 CH2CH3 CH2CF3 HHH A-174. cf3 CH2CH3 CF2CHF2 HHH A-175. cf3 CH2CH3 OCH3 HHH A-176. cf3 CH2CH3 OCF3 HHH A-177. cf3 CH2CH3 OCH2CF3 HHH A-178. cf3 CH2CH3 OCH2CH3 HHH A-179. cf3 Cf3 CH2CH3 H CH2CH3 HH A-181. cf3 CH2CH3 H CH(CH3)2 HH A-182. Cf3 CH2CH3 H OCF3 HH A-187. cf3 CH2CH3 H OCH2CF3 HH A-188. 190. CH2CH3 CH2CH3 ch3 HHH A-191. CH2CH3 CH2CH3 CH2CH3 HHH A-192. CH2CH3 CH2CH3 CH(CH3)2 HHH A-193. CH2CH3 CH2CH3 cf3 HHH A-194. ch2c H3 CH2CH3 CH2CF3 H H H A-195. CH2CH3 CH2CH3 CF2CHF2 H H H 147474.doc -55- 201041514

編號 R1 R2 L1 L2 L3 L4 Α-196. CH2CH3 CH2CH3 OCH3 H H H Α-197. ch2ch3 CH2CH3 OCF3 H H H Α-198. ch2ch3 CH2CH3 OCH2CF3 H H H Α-199. CH2CH3 CH2CH3 OCH2CH3 H H H Α-200. CH2CH3 CH2CH3 H ch3 H H Α-201. CH2CH3 CH2CH3 H CH2CH3 H H Α-202. CH2CH3 CH2CH3 H ch(ch3)2 H H Α-203. CH2CH3 CH2CH3 H cf3 H H Α-204. CH2CH3 CH2CH3 H CH2CF3 H H Α-205. CH2CH3 CH2CH3 H CF2CHF2 H H Α-206. CH2CH3 CH2CH3 H OCH3 H H Α-207. CH2CH3 CH2CH3 H OCF3 H H Α-208. CH2CH3 CH2CH3 H OCH2CF3 H H Α-209. CH2CH3 CH2CH3 H OCH2CH3 H H Α-210. CH2CH3 CH2CH3 H Cl H H 式I及式II化合物可藉由一或多種如下文在流程1至13中 及在合成描述中所述之以下方法及變化形式來製備。變數 係如上文對於式I及式II所定義。 可如流程1中所概述藉由相應三α坐衍生物7硫化來製備式 ΙΑ化合物,其中R4為Η且η為0(=化合物ΙΑ')(或化合物ΙΙΑ, 其中1143為Η)。硫化可以類似於例如WO 96/3 8423中所述之 已知方法進行。舉例而言,可首先以強鹼(例如有機鋰 鹼,諸如正丁基鋰、第三丁基鋰或第二丁基鋰、二異丙基 胺化鋰,氫化鈉、胺化鈉或第三丁醇鉀,與四曱基乙二胺 (TMEDA)混合)將三唑基環去質子化,且接著使所得陰離 子與元素硫反應。硫一般係以粉末形式使用。該反應一般 在惰性溶劑(諸如醚,例如乙醚、甲基第三丁基醚、四氫 呋喃或二噁烷,二甲氧基乙烷、液氨、二曱亞颯或二曱基 147474.doc -56- 201041514 甲醯胺)中進行。反應溫度並不非常關鍵,可在例如霍 至:贼,較佳鐵至代之範圍内。或者,可在無驗存在 下藉由7與元素硫在高滞點溶劑(諸如n_甲基料相、二 • °·或N,N<f基甲醯胺)中加熱反應來進行硫化。在反 應、兀成後’使所得混合物水解,例如藉由添加水或酸水溶 液’諸如無機酸(例如稀硫酸或鹽酸)、乙酸或氯化錢,以 得到化合物I。 〇 可以類似於諸如即^韻而中所述之已知方法製備三 唑化合物7。舉例而t•,可使環氧乙院化合物6與⑴2,仆 1H-三峻在驗存在下反應,該驗諸如驗金屬氫化物(例如氯 化鈉、氫化鉀)、驗金屬氫氧化物(例如氫氧化納、氯氧化 鉀)或鹼金屬碳酸鹽(例如碳酸鈉、碳酸鉀、碳酸鎚)。該反 應適合在溶劑中進行。適合溶劑為例如曱苯、N—甲基吼咯 啶酮、醚(例如乙醚、四氫呋喃)、乙腈或N,N_二甲基甲醯 胺。 〇 可以類似於諸如 EP-A-〇267778, Org. Syn. 49, 78 (1968) 或J. Am. Chem. Soc. 1975, 1353中所述之已知方法製備環 氧乙烧6。舉例而言,可使環戊_ 5與亞貌基疏㈣f〇nium ylide)或亞烷基氧銃(oxosuif〇nium yUdex諸如二甲基亞甲 基氧銃或二甲基亞甲基銃)在溶劑中反應。或者,可以類 似於 Tetrahedron Lett. 23, 5283 (1982)或 EP-A-0655443 中所 述之方法在環氧化反應中藉由5與三甲銃鹽(諸如溴化三甲 銃、碘化三甲銃或硫酸曱基三曱銕)在金屬氧化物(諸如鹼 金屬氧化物(例如氧化鈉、氧化鉀)、鹼土金屬氧化物(例^ 147474.doc -57- 201041514 氧化鎂、氧化鈣、氧化鋇)或氧化辞)及視情況鹼(諸如鹼金 屬氫化物(例如氫化鈉、氫化鉀)、鹼金屬氫氧化物(例如氫 氧化納、氫氧化鉀)、鹼金屬碳酸鹽(例如碳酸鈉、碳酸 鉀、碳酸铯))存在下在包含有機溶劑(諸如甲苯、N_曱基吼 咯啶酮、醚(例如乙醚、四氫呋喃)、乙腈或N,N_:曱基甲 醯胺)之兩相固/液系統中反應來製備環氧乙烧6。或者,可 與Tetrahedron 1985,1259中所述之方法類似地藉由以三甲 銕鹽(諸如溴化三甲錡、碘化三甲錡或硫酸甲基三甲錡)或 一甲基氧化鎮鹽(诸如演化二曱基氧化鎮、礙化三甲基氧 化銃或硫酸曱基三甲基氧化錡)及硫酸鉀/氧化鋁將5環氧化 來製備環氧乙烷6。 可藉由酯水解及後續脫除羧基作用自環戊酮4獲得環戊 酮5。酯水解可在標準條件下進行,該等標準條件諸如為 使用適合鹼(諸如鹼金屬氫氧化物(例如氫氧化鈉、氫氧化 鉀)或驗金屬碳酸鹽(例如碳酸鈉、碳酸鉀、碳酸鉋))在水 中進行鹼水解。當在鹼(例如上述鹼之一)存在下加熱所得 酸時發生脫除羧基作用。 可自環戊酮3藉由使環戊酮3與化合物R2x(其中χ為脫離 基,諸如鹵基(例如Cl、Br、I)、曱苯磺酸酯基或甲磺酸酯 基)在鹼存在下反應來製備環戊酮4。適合鹼為例如鹼金屬 烷醇鹽(例如甲醇鈉、甲醇鉀、曱醇鈉、乙醇鉀、第三丁 醇鉀)及鹼金屬氫化物(例如氫化鈉、氫化鉀)。該反應—般 在溶劑(諸如醇(例如曱醇、乙醇)、醚(例如乙醚、四氫呋 喃)、N-甲基吡咯啶酮或N,N_二甲基曱醯胺)中進行。 147474.doc •58- 201041514 可自環戊酮1藉由在鹼存在下以化合物2將其烷基化來製 備環戊酮3 ’其中γ為脫離基,諸如鹵基(例如Cl、Br、I)、 甲苯磺酸酯基或曱磺酸酯基。適合鹼為例如鹼金屬烷醇鹽 (例如曱醇鈉、曱醇鉀、曱醇鈉、乙醇鉀、第三丁醇鉀)及 驗金屬氫化物(例如氫化鈉、氫化鉀)。該反應一般在溶劑 (諸如醇(例如甲醇、乙醇)、醚(例如乙醚、四氫呋喃)、N_ ❹ 甲基°比洛咬酮、N,N_二甲基甲醯胺或二氯甲烷)中進行。 流程1No. R1 R2 L1 L2 L3 L4 Α-196. CH2CH3 CH2CH3 OCH3 HHH Α-197. ch2ch3 CH2CH3 OCF3 HHH Α-198. ch2ch3 CH2CH3 OCH2CF3 HHH Α-199. CH2CH3 CH2CH3 OCH2CH3 HHH Α-200. CH2CH3 CH2CH3 H ch3 HH Α- 201. CH2CH3 CH2CH3 H CH2CH3 HH Α-202. CH2CH3 CH2CH3 H ch(ch3)2 HH Α-203. CH2CH3 CH2CH3 H cf3 HH Α-204. CH2CH3 CH2CH3 H CH2CF3 HH Α-205. CH2CH3 CH2CH3 H CF2CHF2 HH Α-206 CH2CH3 CH2CH3 H OCH3 HH Α-207. CH2CH3 CH2CH3 H OCF3 HH Α-208. CH2CH3 CH2CH3 H OCH2CF3 HH Α-209. CH2CH3 CH2CH3 H OCH2CH3 HH Α-210. CH2CH3 CH2CH3 H Cl HH Formula I and Formula II compounds can be borrowed It is prepared from one or more of the following methods and variations as described below in Schemes 1 through 13 and in the synthetic description. The variables are as defined above for Formula I and Formula II. The oxime compound can be prepared by vulcanization of the corresponding tri-α-spin derivative 7 as outlined in Scheme 1, wherein R4 is oxime and η is 0 (=compound ΙΑ') (or compound oxime, wherein 1143 is ruthenium). Vulcanization can be carried out analogously to known methods as described, for example, in WO 96/3 8423. For example, a strong base (for example, an organic lithium base such as n-butyllithium, a third butyllithium or a second butyllithium, a lithium diisopropylamide, a sodium hydride, a sodium azide or a third may be used first. Potassium butoxide, mixed with tetradecylethylenediamine (TMEDA), deprotonates the triazolyl ring and then reacts the resulting anion with elemental sulfur. Sulfur is generally used in powder form. The reaction is generally carried out in an inert solvent such as an ether such as diethyl ether, methyl tert-butyl ether, tetrahydrofuran or dioxane, dimethoxyethane, liquid ammonia, diterpenoid or dimercapto 147474.doc-56 - 201041514 Carbenamide). The reaction temperature is not critical and can be, for example, in the range of thief, thief, preferably iron. Alternatively, the vulcanization may be carried out by heating the reaction with elemental sulfur in a high hysteresis solvent such as n-methyl phase, dioxin, or N, N<f-carbamamine in the absence of the test. The resulting mixture is hydrolyzed after the reaction, after the formation, for example, by adding water or an aqueous acid solution such as a mineral acid (e.g., dilute sulfuric acid or hydrochloric acid), acetic acid or chlorinated money to obtain a compound I. The triazole compound 7 can be produced in a manner similar to the known methods such as those described in the art. For example, the compound of the epoxy compound can be reacted with (1) 2, servant 1H-sanjun in the presence of a test such as metal hydride (such as sodium chloride, potassium hydride), metal hydroxide ( For example, sodium hydroxide, potassium oxychloride) or an alkali metal carbonate (for example, sodium carbonate, potassium carbonate, carbonic acid hammer). This reaction is suitably carried out in a solvent. Suitable solvents are, for example, toluene, N-methylpyrrolidone, ethers (e.g., diethyl ether, tetrahydrofuran), acetonitrile or N,N-dimethylformamide.环 Ether 6 can be prepared analogously to known methods such as those described in EP-A-〇 267 778, Org. Syn. 49, 78 (1968) or J. Am. Chem. Soc. 1975, 1353. For example, it is possible to make cyclopenta-5 and the subfamily fluorene (tetra) fluorene (oxosuif〇nium yUdex such as dimethylmethylene oxime or dimethylmethylene oxime) Reaction in a solvent. Alternatively, it may be similar to the method described in Tetrahedron Lett. 23, 5283 (1982) or EP-A-0655443 by means of 5 with a trimethylsulfonium salt (such as trimethylammonium bromide, trimethylammonium iodide or sulfuric acid).曱基三曱銕) in metal oxides (such as alkali metal oxides (such as sodium oxide, potassium oxide), alkaline earth metal oxides (such as 147474.doc -57- 201041514 magnesium oxide, calcium oxide, cerium oxide) or oxidation And alkalinity (such as alkali metal hydride (such as sodium hydride, potassium hydride), alkali metal hydroxide (such as sodium hydroxide, potassium hydroxide), alkali metal carbonate (such as sodium carbonate, potassium carbonate, carbonic acid)铯)) in the presence of a two-phase solid/liquid system containing an organic solvent such as toluene, N-mercaptopurrotone, ether (eg diethyl ether, tetrahydrofuran), acetonitrile or N,N_:mercaptocaramine The reaction was carried out to prepare an epoxy bromide 6. Alternatively, similar to the method described in Tetrahedron 1985, 1259, by trimethylsulfonium salt (such as trimethylammonium bromide, trimethylsulfonium iodide or methyltrimethylsulfate) or monomethyl oxidized salt (such as evolution II) Ethylene oxide 6 is prepared by oxidizing 5 rings by sulfhydryl oxidized town, obstructing trimethyl cerium oxide or cerium sulfate trimethyl cerium oxide) and potassium sulfate/alumina. The cyclopentanone 5 can be obtained from cyclopentanone 4 by ester hydrolysis and subsequent decarboxylation. Ester hydrolysis can be carried out under standard conditions such as the use of a suitable base such as an alkali metal hydroxide (e.g., sodium hydroxide, potassium hydroxide) or a metal carbonate (e.g., sodium carbonate, potassium carbonate, carbonic acid planer). )) Alkaline hydrolysis in water. The decarboxylation occurs when the resulting acid is heated in the presence of a base such as one of the above bases. From cyclopentanone 3 by reacting cyclopentanone 3 with compound R2x (wherein deuterium is a cleavage group such as a halo group (eg Cl, Br, I), an anthracenyl sulfonate group or a mesylate group) The reaction is carried out to prepare cyclopentanone 4. Suitable bases are, for example, alkali metal alkoxides (e.g., sodium methoxide, potassium methoxide, sodium decoxide, potassium ethoxide, potassium t-butoxide) and alkali metal hydrides (e.g., sodium hydride, potassium hydride). The reaction is generally carried out in a solvent such as an alcohol (e.g., decyl alcohol, ethanol), an ether (e.g., diethyl ether, tetrahydrofuran), N-methylpyrrolidone or N,N-dimethyl decylamine. 147474.doc •58- 201041514 Cyclopentanone 3 can be prepared from cyclopentanone 1 by alkylation thereof with compound 2 in the presence of a base, wherein γ is a leaving group, such as a halogen group (eg Cl, Br, I) ), a tosylate group or an oxime sulfonate group. Suitable bases are, for example, alkali metal alkoxides (e.g., sodium decoxide, potassium decoxide, sodium decoxide, potassium ethoxide, potassium t-butoxide) and metal hydrides (e.g., sodium hydride, potassium hydride). The reaction is generally carried out in a solvent such as an alcohol (e.g., methanol, ethanol), an ether (e.g., diethyl ether, tetrahydrofuran), N? 甲基methyl pirone, N,N-dimethylformamide or dichloromethane. . Process 1

克曼縮合⑼製備化合物^在驗存在下在狄 適人驗為心man"1 e°ndenSati°n)中使己二酸8環化為9。 如驗金屬燒醇鹽(例如曱醇納 鈉、乙醇鉀、第二丁^ τ τ ^ 醇(例如甲醇、W =鉀)。該縮合—般在適合溶劑(諸如 知)、醚(例如乙醚、四氫呋喃)或…甲基 147474.doc •59· 201041514 〇比咯咬酮)中進杆。 丁 或者,在路易斯酸(Lewis acid)(諸如氣 化銘或三漠化硼、、 、 切)、過渡金屬鹽(諸如銀鹽、鐵鹽、銅鹽、 金鹽、結鹽、, 麵鹽(例如 Ag2〇、AgC104、FeCl3、NiCl2、The Kerman condensation (9) is used to prepare a compound which, in the presence of the test, cyclizes adipic acid 8 to 9 in a human heart"1 e°ndenSati°n). Such as the test of metal alkoxide (such as sodium steroxide, potassium ethoxide, second butyl τ ^ alcohol (such as methanol, W = potassium). The condensation is generally in a suitable solvent (such as known), ether (such as ether, Tetrahydrofuran) or ... methyl 147474.doc • 59· 201041514 〇 咯 咯 咬)) D, or, in Lewis acid (such as gasification or three desert boron, ,, cut), transition metal salts (such as silver salt, iron salt, copper salt, gold salt, salt, salt) For example, Ag2〇, AgC104, FeCl3, NiCl2

CuC12、Cu(〇Ac)2、CuS〇4、CuI))及鹼(尤其為有 機鐘驗(例如-g石 —兵丙^鋰))存在下在適合溶劑(諸如醚(例如 乙轉四氫吱。南)、甲笨、N-曱基吼洛。定酮或二氣甲燒)中 進仃%化。接著使9與化合物r1x(其中X為脫離基,諸如幽 基(例如Cl、Br、T、 m奸从 )、甲本石頁酸醋基或甲續酸酯基)在適合 鹼(諸如鹼金屬烷醇鹽(例如甲醇鈉、曱醇鉀、曱醇鈉、乙 醇鉀、第二丁醇鉀))存在下反應。烧基化反應—般在適合 合萬1 (諸如醇(例如甲醇、乙醇)、鍵(例如乙醚、四氯咬喃) 或N-甲基吡咯啶酮)中進行。 流程2CuC12, Cu(〇Ac)2, CuS〇4, CuI)) and a base (especially in the case of an organic clock (eg, -gshi-Bingong)) in a suitable solvent (such as ether (such as ethylene tetrahydrogen)吱. South), A stupid, N- 曱 吼 。 。 定 定 定 定 定 定 定 定 定 定 定 定 定 定. Subsequent to 9 and compound r1x (wherein X is a cleavage group, such as a cleavage group (eg, Cl, Br, T, m), a sulfonate or a carbaryl group) in a suitable base (such as an alkali metal) The reaction is carried out in the presence of an alkoxide (for example, sodium methoxide, potassium decoxide, sodium decoxide, potassium ethoxide, potassium dibutoxide). The alkylation reaction is generally carried out in a suitable form such as an alcohol (e.g., methanol, ethanol), a bond (e.g., diethyl ether, tetrachloromethane) or N-methylpyrrolidone. Process 2

RORO

鹼或路易斯酸 或金屬鹽+驗 ΟAlkali or Lewis acid or metal salt + test

99

作為流程1中所述之方法的替代方案,亦可如下文流程3 中所概述與EP_A_〇329397中所述之方法類似地製備化合物 1。可使環戊酮10與苯甲醛衍生在標準條件下在醇醛 縮合中反應。該反應-般在驗性條件下,例如藉由使用驗 金屬氫氧化物(例如氫氧化鈉、氫氧化卸)、驗金屬烧醇鹽 (例如甲醇鈉、甲醇鉀、乙醇鈉、乙醇鉀、第三丁醇鉀)或 鹼金屬氫化物(例如氫化鈉、氫化鉀),在適合溶劑(諸如醇 (例如甲醇、乙醇、第三丁醇)或醚(例如四氫呋喃))中進 i47474.d< •60· 201041514 行。例如使用鈀或鎳催化劑在標準氫化條件下還原醇醛縮 合物12得到5。 流程3As an alternative to the process described in Scheme 1, Compound 1 can also be prepared analogously to the process described in Scheme 3 below, as described in EP_A_〇 329,397. The cyclopentanone 10 can be reacted with benzaldehyde under standard conditions in an aldol condensation. The reaction is generally carried out under test conditions, for example, by using a metal hydroxide (for example, sodium hydroxide, hydroxide), and a metal alkoxide (for example, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, Potassium tributoxide) or an alkali metal hydride (such as sodium hydride, potassium hydride), in a suitable solvent (such as an alcohol (such as methanol, ethanol, tert-butanol) or ether (such as tetrahydrofuran) into i47474.d< 60· 201041514 OK. The aldol condensate 12 is reduced, for example, using a palladium or nickel catalyst under standard hydrogenation conditions to give 5. Process 3

可如下文流程4所概述與Tetrahedron 1998,54 (28),8075 中所述之方法類似地製備化合物10。使4-氯丁醛與鹼金屬 氰化物MYN(諸如NaCN或KCN)反應以得到相應氰醇,其 接著經Ο保護以得到氰醇醚13。在鹼(尤其為有機鋰鹼(例 如二異丙胺鋰),或六曱基二矽氮烷鈉)存在下,在醚溶劑 (例如乙醚、四氫呋喃)中環化得到14,首先將其選擇性還 原為15,接著還原為16。脫除羥基之保護基得到17且進行 氧化擴環反應最終得到10。 流程4Compound 10 can be prepared analogously to the method described in Tetrahedron 1998, 54 (28), 8075, as outlined in Scheme 4 below. 4-Chlorobutyraldehyde is reacted with an alkali metal cyanide MYN (such as NaCN or KCN) to give the corresponding cyanohydrin, which is then protected with hydrazine to give the cyanohydrin ether 13. Cyclization in an ether solvent (eg diethyl ether, tetrahydrofuran) in the presence of a base (especially an organolithium base (eg lithium diisopropylamide) or sodium hexyldiazoxide) affords 14 which is first selectively reduced to 15, then restored to 16. The protecting group for removing the hydroxyl group gives 17 and undergoes an oxidative ring expansion reaction to finally obtain 10. Process 4

或者可如下文流程5中所概述與WO 95/09830中所述之方 147474.doc -61 · 201041514 法類似地製備R1為CH3之化合物1〇( = 1〇,)。丁二烯衍生物 18與乙醯乙酸酯衍生物17(其中R,為Cl-C6烷基或烷氧 基且11為CrC6烷基)之催化C-C偶合得到雙鍵異構體19及 20。適合催化劑為铑與膦配位體之錯合物,其主要自以下 現場產生:铑化合物,諸如Rh2〇3、RhCl3、RhBr3、Alternatively, a compound 1 〇 (= 1 〇,) wherein R1 is CH3 can be prepared analogously to the method described in Scheme 5, 174474.doc-61 · 201041514, as described in WO 95/09830. Catalytic C-C coupling of butadiene derivative 18 with acetamidine acetate derivative 17 (wherein R is a Cl-C6 alkyl or alkoxy group and 11 is a CrC6 alkyl group) gives the double bond isomers 19 and 20. Suitable catalysts are complexes of ruthenium and phosphine ligands, which are mainly produced from the following sites: ruthenium compounds such as Rh2〇3, RhCl3, RhBr3,

Rh2(S04)3、(Rh(CO)4)4、(Rh(CO)2Cl)2、Rh(CH3C02)3、 Rh(N03)3或Rh(C8H12Cl)2 ’及膦鹽,諸如三苯膦、(續酸基 苯基)二苯膦、二(磺酸基苯基)苯膦或三(磺酸基苯基)膦之 鈉鹽、鉀鹽、鈣鹽、鋇鹽、銨鹽、四曱銨鹽或四乙銨鹽。 該反應一般在兩相水性/有機溶劑系統中進行。宜在驗性 "質中進行加成反應以有助於乙醯乙酸酯衍生物17之亞曱 基去質子化。適合鹼為例如水溶性無機鹼,諸如鹼金屬氫 氧化物(例如氫氧化鈉、氫氧化鉀)、碳酸鹽(例如碳酸鈉、 碳酸鉀、碳酸铯)或碳酸氫鹽(例如碳酸氫鈉、碳酸氫鉀、 石厌S欠氫鉋),其係以水溶液形式使用。在ri為烷基之情況 下,使所得化合物19及20經受鹼性去醯化。適合鹼尤其為 鹼金屬醇化物,諸如於各別醇中之曱醇鈉 '乙醇鈉或第三 丁醇鉀。去醯化化合物21及22接著水解為各別酸23及24。 水解-般在驗性介質t,使_如與上文關於加成反應所 述相同之驗來進行。在R’為燒氧基之情況下,首先水解兩 個醋基且接著將所得二酸脫除緩基以得到—元酸似⑽ 有矛匕在存在強酸(例如鹽酸、氫漠酸、石肖酸、硫酸)或強 驗(氫氧化鈉、氫氧化鉀)作為催化劑下,使用甲酸及水或 氣態C Ο對2 3及2 4進行氫甲醯化,得到二酸2 5。在酸性條 147474.d〇i -62- 201041514 件(諸如鹽酸、氫溴酸、硫酸、硝酸)下,在極性溶劑(諸如 甲醇、乙醇、異丙醇或第三丁醇)中將25環化最終得到環 戊酮10’。 流程5Rh2(S04)3, (Rh(CO)4)4, (Rh(CO)2Cl)2, Rh(CH3C02)3, Rh(N03)3 or Rh(C8H12Cl)2' and a phosphonium salt such as triphenylphosphine , (supply acid phenyl) diphenylphosphine, di(sulfophenyl)phenylphosphine or tris(sulfophenyl)phosphine sodium, potassium, calcium, barium, ammonium, tetraterpene Ammonium or tetraethylammonium salt. This reaction is generally carried out in a two-phase aqueous/organic solvent system. It is preferred to carry out an addition reaction in the qualitative "quality to aid in the deprotonation of the fluorenylene group of the acetamidine acetate derivative 17. Suitable bases are, for example, water-soluble inorganic bases such as alkali metal hydroxides (for example sodium hydroxide, potassium hydroxide), carbonates (for example sodium carbonate, potassium carbonate, cesium carbonate) or hydrogencarbonates (for example sodium hydrogencarbonate, carbonic acid) Potassium hydrogen, stone sm is less than hydrogen planing, which is used in the form of an aqueous solution. In the case where ri is an alkyl group, the obtained compounds 19 and 20 were subjected to alkaline deuteration. Suitable bases are especially alkali metal alkoxides such as sodium decanoate or potassium t-butoxide in the respective alcohols. The deuterated compounds 21 and 22 are then hydrolyzed to the respective acids 23 and 24. The hydrolysis is generally carried out in an experimental medium t such that it is the same as described above for the addition reaction. In the case where R' is an alkoxy group, the two vine groups are first hydrolyzed and then the resulting diacid is removed to obtain a meta-acid (10). There is a strong acid in the presence of a spear (for example, hydrochloric acid, hydrogen acid acid, and stone Hydrogen formazanization of 2 3 and 2 4 using formic acid and water or gaseous C , under acid (sulfuric acid) or strong (sodium hydroxide or potassium hydroxide) as a catalyst to obtain diacid 25. Cyclization of 25 in a polar solvent such as methanol, ethanol, isopropanol or tert-butanol under acidic strips 147474.d〇i -62- 201041514 (such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid) Finally, cyclopentanone 10' is obtained. Process 5

作為流程1中所述之方法的替代方案,可與Org. Syn. 40, 66,1966 ; J. Org. Chem. 28, 1128, 1963及 Org· Syn. Coll. 第4卷,552, 1963中所述之方法類似地,如下文流程6中所 概述藉由首先對環戊酮5進行維蒂希反應(Wittig reaction),因此得到相應外亞曱基化合物41,且接著對其 進行環氧化反應來製備環氧乙烷6。維蒂希反應可在標準 條件下,諸如使用溴化甲基三苯鱗或碘化甲基三苯鱗,在 鹼金屬鹼(諸如正丁基鋰、第二丁基鋰或第三丁基鋰)存在 下進行。亦可用諸如過氧乙酸、過苯甲酸、間氯過苯曱 147474.doc -63 - 201041514 酸、過鄰苯二曱酸及其類似物之標準試劑進行環氧化。$ 之烯化(亦即將00轉化為〇CH2基團)或者可藉由使用特 伯試劑(Tebbe’s reagent)((C5H5)2TiCH2ClA1(CH3)2)來^ 成。 流程6As an alternative to the method described in Scheme 1, it can be compared with Org. Syn. 40, 66, 1966; J. Org. Chem. 28, 1128, 1963 and Org. Syn. Coll., Vol. 4, 552, 1963. The method described is similarly, as outlined in Scheme 6 below, by first performing a Wittig reaction on cyclopentanone 5, thereby obtaining the corresponding exo-indenyl compound 41, and then subjecting it to an epoxidation reaction. To prepare ethylene oxide 6. The Wittig reaction can be carried out under standard conditions, such as the use of methyltriphenyl bromide or methylated triphenyl scales, in an alkali metal base such as n-butyllithium, second butyllithium or tert-butyllithium. ) Exist in the presence. Epoxidation can also be carried out using standard reagents such as peracetic acid, perbenzoic acid, m-chloroperbenzoquinone 147474.doc-63 - 201041514 acid, per-phthalic acid and the like. The olefination (i.e., the conversion of 00 to the oxime CH2 group) can be carried out by using Tebbe's reagent ((C5H5)2TiCH2ClA1(CH3)2). Process 6

作為流程!中所述之方法的替代方案,亦可與下文流程7 中所述之方法類似地製備化合物7。在使環戊酮12環氧化 (可如上文流幻中所述來進行)之後,可與流程丄中關於㈣ 述之程序類似地使所得環氧化物26與[1,2,4]1^1•三唑反 應。所得化合物27之還原可如上文關於流程3所述在鈀或 鎳催化劑存在下以標準氫化形式進行,或可藉由使用金屬 氫化物(例如删氫化納、氫化經紹)來進行以得到7。環_ 12可如上文流程3中所述來製備。As an alternative to the process described in Scheme!, Compound 7 can also be prepared analogously to the process described in Scheme 7 below. After epoxidizing cyclopentanone 12 (which can be carried out as described above), the resulting epoxide 26 can be made similar to the procedure described in relation to (4) in Scheme [[1,2,4]1^ 1 • Triazole reaction. The reduction of the resulting compound 27 can be carried out in the form of a standard hydrogenation in the presence of a palladium or nickel catalyst as described above for Scheme 3, or can be carried out by using a metal hydride (e.g., sodium hydride, hydrogenation). Ring 12 can be prepared as described in Scheme 3 above.

流程7Process 7

147474.doc -64 - 201041514 中所概述與EP-A-03 57404、EP-A-05 76834及EP-A-0648751 中所述之方法類似地製備化合物7。以2(其中γ為脫離基, 諸如齒基(例如Cl、Br、I)、曱苯磺酸酯基或甲磺酸酯基) 將28烷基化,在適合溶劑中以鹼使活化亞甲基去質子化之 後得到29。適合鹼為例如鹼金屬烷醇鹽(例如曱醇鈉、甲 醇鉀、乙醇#9、乙醇鉀、第三丁醇钟)、驗金屬氮化物(例 如氫化鈉、氫化鉀)或鹼金屬碳酸鹽(例如碳酸鈉、碳酸 0 鉀、碳酸铯)。適合溶劑為例如醇(例如甲醇、乙醇、第三 丁醇)、謎(例如四氫吱喃)、N,N_:曱基甲酿胺或仏甲基口比 咯啶酮。在酸(例如鹽酸、氫溴酸、硫酸、對甲苯磺酸)存 在下,用醇(諸如曱醇、乙醇、丙醇、異丙醇、丁醇或第 三丁醇,尤其為曱醇或乙醇)來轉化為相應烯醇醚3〇(其中 R為CA燒基,尤其為甲基或乙基),且例如用錯合金屬 氳化物(諸如硼氫化鈉或氫化鋰鋁)進行後續還原,得到環 己烯酮31。在酸(例如氫溴酸、乙酸)存在下以溴或碘進行 〇 鹵化得到32,其中八及0為以或1。接著用驗金屬醇化物(諸 如甲醇鈉、乙醇鈉、甲酵鉀或乙醇鉀)在相應醇(亦即 例如Na或K; R,=例如甲基、乙基)中對其進行法沃斯基重 排(Favorskii rearrangement)以得到酿取代之環戊烯 如用過氧乙酸、過苯曱酸、間氯過苯曱酸或過鄰笨二: 酸,在標準條件下將環戊烯雙鍵環氧化得到W,例如使用 錯合金屬氫化物(諸如硼氫化鈉或氫化鋰鋁)將其還原為用 醇35。在將結合於亞甲基之經基轉化為脫離基(諸如^ (例如Cl、Br、I)、甲苯績酸醋基或甲磺酸酯基)之後,^ 147474.doc -65- 201041514 流程1中所述之6之反應類似地使所得化合物36(D=脫離 基,例如鹵基(例如Cl、Br、I)、曱笨磺酸酯基或甲磺酸酯 基)與[1,2,4]-1H-三唑反應以得到化合物7。 流程8Compound 7 is prepared analogously to the methods described in EP-A-03 57404, EP-A-05 76834 and EP-A-0648751, as described in 147, 474. Alkylation of 28 with 2 (wherein γ is a cleavage group, such as a dentate group (e.g., Cl, Br, I), an anthracenyl sulfonate group or a mesylate group), and activating the subunit with a base in a suitable solvent After the protonation of the radical, 29 is obtained. Suitable bases are, for example, alkali metal alkoxides (for example sodium decoxide, potassium methoxide, ethanol #9, potassium ethoxide, third butanol), metal nitrides (such as sodium hydride, potassium hydride) or alkali metal carbonates (for example). For example, sodium carbonate, potassium carbonate, cesium carbonate). Suitable solvents are, for example, alcohols (e.g., methanol, ethanol, butanol), mystery (e.g., tetrahydrofuran), N,N_: mercaptocarbanamide or hydrazine methylpyrrolidone. In the presence of an acid such as hydrochloric acid, hydrobromic acid, sulfuric acid, p-toluenesulfonic acid, an alcohol such as decyl alcohol, ethanol, propanol, isopropanol, butanol or tert-butanol, especially decyl alcohol or ethanol To convert to the corresponding enol ether 3〇 (wherein R is a CA alkyl group, especially a methyl or ethyl group), and for example, a subsequent metal reduction with a miscible metal halide such as sodium borohydride or lithium aluminum hydride is obtained. Cyclohexenone 31. The hydrazine is halogenated with bromine or iodine in the presence of an acid such as hydrobromic acid or acetic acid to give 32, wherein eight and zero are or. Subsequent use of a metal alkoxide (such as sodium methoxide, sodium ethoxide, potassium methoxide or potassium ethoxide) in the corresponding alcohol (ie, for example, Na or K; R, = for example, methyl, ethyl) Rearrangement (Favorskii rearrangement) to obtain a substituted cyclopentene such as peroxyacetic acid, perbenzoic acid, m-chloroperbenzoic acid or peroxy 2:acid, cyclopentene double bond ring under standard conditions Oxidation gives W, for example using a miscible metal hydride such as sodium borohydride or lithium aluminum hydride to reduce it to alcohol 35. After converting a mesogenic group bonded to a methylene group to a leaving group such as ^ (for example, Cl, Br, I), toluene acid vinegar or mesylate group, ^ 147474.doc -65- 201041514 Scheme 1 The reaction of 6 described above similarly gives the resulting compound 36 (D = a leaving group such as a halo group (e.g., Cl, Br, I), a sulfonate group or a mesylate group) with [1, 2, 4]-1H-triazole reaction to give compound 7. Process 8

作為流程1中所述之方法的替代方案’亦可與下文流程9 中所述之方法類似地製備化合物36。首先在水中之酸性條 件(例如鹽酸、氫溴酸、乙酸、硫酸或對甲苯磺酸)下將環 氧化物6開環以得到35,接著如上文關於流程8所述將其轉 化為36,或藉由使用cr、Br-或〗-之適合來源將6直接開環 147474.doc -66- 201041514 得到36。 流程9As an alternative to the process described in Scheme 1, compound 36 can also be prepared analogously to the process described in Scheme 9 below. First opening the epoxide 6 under acidic conditions in water (eg, hydrochloric acid, hydrobromic acid, acetic acid, sulfuric acid or p-toluenesulfonic acid) to give 35, which is then converted to 36 as described above for Scheme 8, or 6 is directly opened by 147474.doc -66-201041514 by using a suitable source of cr, Br- or -. Process 9

作為流程1中所述之方法的替代方案,亦可如下文流程 1〇中所概述與WO 99/18088中所述之方法類似地製備化合 物IA,其中R4為Η且η為0(或化合物1;[八,其中為η)。視 f月况在酸(例如鹽酸、氫溴酸、乙酸、硫酸或對曱苯績酸) 或鹼(例如三乙胺、二異丙基乙胺、碳酸鈉或碳酸鉀)存在 下’在適合溶劑(諸如醇(例如甲醇、乙醇、異丙醇、第三 丁醇)、N-甲基吡咯啶酮、醚(例如乙醚、四氫呋喃、二噁 烧丨,2-—甲氧基乙烧)、乙腈、n,n_二曱基曱醯胺或二甲 亞砜)中用肼將6環氧化物開環,得到37。其接著藉由與硫 氰酸鹽(諸如硫氰酸鈉、硫氰酸鉀或硫氰酸銨(亦即M+:=例 如Na、κ、NH4+))在適合溶劑(諸如醇(例如曱醇、乙醇、 ^丙醇第二丁醇)、N-曱基吡咯咬酮、醚(例如乙醚、四 氫呋喃、二噁烷、1>2_二甲氧基乙烷)、乙腈、n,n_二曱基 曱醯^、二甲亞砜、曱苯或二甲苯)中反應來轉化為半卡 ®Ksemiearbazide)38。半卡肼接著經由與甲酸烷酯 酸^甲西m ' 曰、曱馼乙酯)在溶劑中反應轉化為IA,。適合溶 例如醇(例如曱醇、乙醇、異丙醇、第三丁醇)、Ν-曱式:、 咯啶酿j、M , 土 D比 ^ (例如乙縫、四氫α夫喃、二0惡烧、1,2-二甲氫 乙fT乳基 几、己腈、Ν,Ν-二曱基甲醯胺、二曱亞砜、曱笨或一 147474.doc •67- 201041514 曱苯。或者,可使37與硫氰酸氫鹽及曱醛在溶劑中反應 適合溶劑為例如醇(例如甲醇、乙醇、異丙醇、第三 醇)、N-甲基吡咯啶酮、醚(例如乙醚、四氫咳喃、二承 烷、L2-二甲氧基乙烷)、乙腈、N,N-二甲基甲醯胺、二 甲亞碾、甲苯或二甲苯。接著在鹼金屬氫氧化物(例如氫 氧化納 氣氧化卸)及元素硫存在下使用例如含F e c 13之 酸水溶液(例如鹽酸)或氧氣將所得三唑咬硫酮 (tnaZ〇Udinthi〇ne)39氧化為IA,。在又一替代方案中,使37 與一烷基蒙| (例如丙酮、二乙酮、甲基乙基酮)及硫氰酸鹽 (例如硫氰酸鈉、硫氰酸鉀、硫氰酸銨)在溶劑中反應得到 —坐定k酮40。適合溶劑為例如醇(例如曱醇、乙醇、異 -、第二丁醇)、N-曱基吡咯啶酮、醚(例如乙醚、四氫 …燒、1,2 -一甲氧ι基乙烧)、乙腈、n,N-二甲基甲 醜胺、二甲¢5咖 r〇 ^ 兑風、曱本或二曱苯。三唑啶硫酮4〇接著藉由 在,(例如鹽酸、氫溴酸、乙酸、硫酸、對曱苯磺酸)或金 I氧化物(例如非晶型Ti〇2)存在下與甲酸反應轉化為IA,。 147474.doc •68- 201041514 流程ίοAs an alternative to the process described in Scheme 1, compound IA can also be prepared analogously to the process described in Scheme 1 与, as described in WO 99/18088, wherein R4 is Η and η is 0 (or compound 1) ; [eight, which is η). Depending on the condition of the acid in the presence of an acid (such as hydrochloric acid, hydrobromic acid, acetic acid, sulfuric acid or p-benzoic acid) or a base (such as triethylamine, diisopropylethylamine, sodium carbonate or potassium carbonate) Solvents (such as alcohol (such as methanol, ethanol, isopropanol, tert-butanol), N-methylpyrrolidone, ether (such as ether, tetrahydrofuran, dioxo, 2-methoxyethyl), The 6-epoxide is ring-opened with hydrazine in acetonitrile, n, n-didecylguanamine or dimethyl sulfoxide to give 37. It is then carried out with a thiocyanate such as sodium thiocyanate, potassium thiocyanate or ammonium thiocyanate (ie M+:= for example Na, κ, NH4+) in a suitable solvent such as an alcohol (eg sterol, Ethanol, ^propanol tert-butanol), N-decylpyrrole, ether (eg diethyl ether, tetrahydrofuran, dioxane, 1>2-dimethoxyethane), acetonitrile, n, n-dioxene The reaction is converted to a half-calorie® Ksemiearbazide 38 by reaction in hydrazine, dimethyl sulfoxide, toluene or xylene. The semi-calendar is then converted to IA by reaction with alkanoic acid alkyl sulfonate m' oxime, hydrazine ethyl ester in a solvent. Suitable for dissolving, for example, alcohols (eg, decyl alcohol, ethanol, isopropanol, tert-butanol), Ν-曱:, arsenic, j, M, soil D ratio ^ (eg, Ethyl, Tetrahydrogen, Fen, II) 0 oxacin, 1,2-dimethylhydroethyl fT milyl, hexonitrile, hydrazine, hydrazine-dimercaptocarbamide, disulfoxide, hydrazine or a 147474.doc •67- 201041514 Benzene. Alternatively, 37 can be reacted with hydrogen thiocyanate and furfural in a solvent such as an alcohol (for example, methanol, ethanol, isopropanol, a third alcohol), N-methylpyrrolidone, an ether (such as diethyl ether). , tetrahydrogenethane, dihydrogenane, L2-dimethoxyethane), acetonitrile, N,N-dimethylformamide, dimethyl sulfite, toluene or xylene, followed by alkali metal hydroxide The resulting triazole thione (tnaZ〇Udinthi〇ne) 39 is oxidized to IA using, for example, an aqueous acid solution containing F ec 13 (for example, hydrochloric acid) or oxygen in the presence of elemental sulfur. In still another alternative, 37 is combined with an alkyl group (eg, acetone, diethyl ketone, methyl ethyl ketone) and thiocyanate (eg, sodium thiocyanate, potassium thiocyanate, ammonium thiocyanate) in The reaction is carried out to obtain a k-ketone 40. Suitable solvents are, for example, alcohols (for example, decyl alcohol, ethanol, iso-, second butanol), N-decyl pyrrolidone, ethers (for example, diethyl ether, tetrahydrogen, etc. 1,2-Methoxy-4-yloxy), acetonitrile, n,N-dimethylmethamine, dimethylhydrazine, 5 〇 〇 兑 兑 兑 曱 兑 兑 兑 兑 兑 兑 兑 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 The ruthenium is then converted to IA by reaction with formic acid in the presence of (e.g., hydrochloric acid, hydrobromic acid, acetic acid, sulfuric acid, p-toluenesulfonic acid) or gold I oxide (e.g., amorphous Ti〇2). 147474. Doc •68- 201041514 Process ίο

中所述之方法的替代方案,亦可如下文流程 中所概述與购99/18_中所述之方法類似地製備化合 物1A及1B ’其中R4為^ 化合物IA.勝)(或化合物 ΠΑ及ΠΒ,其中R、H)。視情況在酸(例如鹽酸、氮淳 酸、乙酸、硫酸或對甲苯續酸)或驗(例如三乙胺、二显丙 ΟAlternatively to the method described in the above, compounds 1A and 1B can be prepared analogously to the methods described in Scheme 99/18_ wherein R4 is ^ compound IA. Sheng) (or compound oxime and ΠΒ, where R, H). Depending on the situation, acid (such as hydrochloric acid, nitrogen, acetic acid, sulfuric acid or p-toluene) or test (such as triethylamine, di-propylamine)

基乙胺、碳酸納或碳酸鉀)存在下,在適合溶劑(諸如醇(例 如甲醇、乙醇、異丙醇、第三丁醇)、冰甲基吡咯啶酮、 醚(例如乙醚、四氫呋喃、二噁烷、丨,2_二甲氧基乙烷)、 乙腈、N,N-二甲基甲醯胺或二罗亞砜)中用肼將%環氧化 物開裱,得到42。其接著藉由與硫氰酸鹽(諸如硫氰酸 147474.doc -69- 201041514 鈉、硫氰酸鉀或硫氰酸銨(亦即M+=例如Na+、κ+ χτ.τ + ' ^^4 )) 在適合溶劑(諸如醇(例如甲醇、乙醇、異丙醇、第二丁 醇)、Ν-曱基吡咯啶酮、醚(例如乙醚、四氫吱喃、二嗓 烷、1,2-二甲氧基乙烷)、乙腈、ν,Ν-二甲基甲醯胺、二曱 亞砜、甲苯或二曱苯)中反應來轉化為半卡肼43。半卡肼 接著經由與甲酸烷酯(例如甲酸甲酯、曱酸乙酯)在溶劑中 反應轉化為ΙΒ,。適合溶劑為例如醇(例如甲醇、乙醇、異 丙醇、第三丁醇)、Ν-曱基吡咯啶酮、醚(例如乙醚、四氫 呋喃、二噁烷、L2-二甲氧基乙烷)、乙腈、ν,Ν-二甲基甲 醯胺、二曱亞砜、曱苯或二曱苯。或者,可使42與硫氰酸 氫鹽及曱醛在溶劑中反應。適合溶劑為例如醇(例如曱 醇、乙醇、異丙醇、第三丁醇)、Ν_曱基吡咯啶輞、醚(例 如乙醚、四氫呋喃、二噁烷、1>2_二甲氧基乙烷)、乙腈、 ν,ν-二甲基曱醯胺、二甲亞砜、曱苯或二曱苯。接著在鹼 金屬氫氧化物(例如氫氧化鈉、氫氧化鉀)及元素硫存在下 使用例如含FeCh之酸水溶液(例如鹽酸)或氧氣將所得三唾 啶硫酮44氧化為IB,。在又一替代方案中,使“與二烷基 酮(例如丙酮、二乙酮、曱基乙基酮)及硫氰酸鹽(例如硫氰 酸鈉、硫氰酸鉀、硫氰酸銨)在溶劑中反應得到三唑啶硫 酮45。適合溶劑為例如醇(例如曱醇、乙醇、異丙醇、第 二丁醇)、N-甲基吡咯啶酮、醚(例如乙醚、四氫呋喃、二 α烷、1,2-二甲氧基乙烷)、乙腈、N,N_二甲基甲醯胺、二 甲亞碾、甲苯或二甲苯。三唑啶硫酮45接著藉由在酸(例 如鹽酸、氫溴酸、乙酸、硫酸、對甲苯磺酸)或金屬氧化 147474.doc -70- 201041514 物(例如非晶型Ti〇2)存在下與曱酸反應轉化為IB,^ Ιβ,可 藉由使用鈀或鎳催化劑進行氫化或藉由用錯合金屬氣化物 (例如硼氫化鈉、氫化鋰鋁)進行還原轉化為IA,。 流程11In the presence of ethylethylamine, sodium carbonate or potassium carbonate, in a suitable solvent (such as alcohol (such as methanol, ethanol, isopropanol, tert-butanol), ice methylpyrrolidone, ether (such as ether, tetrahydrofuran, two In oxane, hydrazine, 2-dimethoxyethane), acetonitrile, N,N-dimethylformamide or ruthenium sulfoxide, the epoxide was opened with hydrazine to give 42. It is then passed with thiocyanate (such as thiocyanate 147474.doc -69- 201041514 sodium, potassium thiocyanate or ammonium thiocyanate (ie M+= for example Na+, κ+ χτ.τ + ' ^^4 )) in suitable solvents (such as alcohol (such as methanol, ethanol, isopropanol, second butanol), fluorenyl-pyridyl ketone, ether (such as ether, tetrahydrofuran, dioxane, 1,2- In the case of dimethoxyethane), acetonitrile, ν, hydrazine-dimethylformamide, disulfoxide, toluene or dinonylbenzene, it is converted into a half-calendar 43. The semi-calendar is then converted to hydrazine by reaction with an alkyl formate such as methyl formate or ethyl decanoate in a solvent. Suitable solvents are, for example, alcohols (for example methanol, ethanol, isopropanol, tert-butanol), fluorenyl-pyridyl ketone, ethers (for example diethyl ether, tetrahydrofuran, dioxane, L2-dimethoxyethane), Acetonitrile, ν, Ν-dimethylformamide, disulfoxide, terpene or diphenyl. Alternatively, 42 can be reacted with thiocyanate and furfural in a solvent. Suitable solvents are, for example, alcohols (e.g., decyl alcohol, ethanol, isopropanol, tert-butanol), Ν-mercaptopyrrolidine, ethers (e.g., diethyl ether, tetrahydrofuran, dioxane, 1> 2-dimethoxy Alkane), acetonitrile, ν, ν-dimethyl decylamine, dimethyl sulfoxide, toluene or dinonylbenzene. The resulting trithiopyridine 44 is then oxidized to IB using, for example, an aqueous solution of an acid containing FeCh (e.g., hydrochloric acid) or oxygen in the presence of an alkali metal hydroxide (e.g., sodium hydroxide, potassium hydroxide) and elemental sulfur. In yet another alternative, "with a dialkyl ketone (such as acetone, diethyl ketone, mercapto ethyl ketone) and thiocyanate (such as sodium thiocyanate, potassium thiocyanate, ammonium thiocyanate) The reaction in a solvent gives triazolidinethione 45. Suitable solvents are, for example, alcohols (e.g., decyl alcohol, ethanol, isopropanol, second butanol), N-methylpyrrolidone, ethers (e.g., diethyl ether, tetrahydrofuran, Alpha alkane, 1,2-dimethoxyethane), acetonitrile, N,N-dimethylformamide, dimethyl sulfite, toluene or xylene. Triazolidinethione 45 is then used in acid ( For example, hydrochloric acid, hydrobromic acid, acetic acid, sulfuric acid, p-toluenesulfonic acid) or metal oxidation 147474.doc -70-201041514 (for example, amorphous Ti〇2) reacts with tannic acid to convert to IB, ^ Ιβ, Hydrogenation by using a palladium or nickel catalyst or conversion to IA by reduction with a miscible metal vapor (e.g., sodium borohydride, lithium aluminum hydride).

作為流程11中所述之方法的替代方t,亦可如下文流程 12中所概述藉由與流程i中將7轉化為认,所述之方法類似 地將化合物27硫化來製備化合物m,其中r4為Η&η為〇(= Ο 〇 化合物IB,)(或化合物„B,其中R4a為H)。 147474.doc 71- 201041514 流程12As a substitute for the method described in Scheme 11, the compound m can also be prepared by the conversion of the compound 27 to the same as outlined in Scheme 12 below, which is similarly modified by the method i. R4 is Η&η is 〇(= Ο 〇 compound IB,) (or compound „B, where R4a is H) 147474.doc 71- 201041514 Scheme 12

可如流程7或下文流程1 3中所示,藉由首先在水中之酸 性條件(例如鹽酸、氫溴酸、乙酸、硫酸或對曱苯磺酸)下 將環氧化物26開環得到46,接著如上文關於流程8所述將 其轉化為47,或藉由使用cr、Br_或Γ之適合來源將26直接 開環得47 ’來製備化合物27。接著使47與流程1中所述之6 之反應類似地與[1,2,4]- 1H-三唑反應以得到27。 流程13The epoxide 26 can be opened 46 under the acidic conditions of water (e.g., hydrochloric acid, hydrobromic acid, acetic acid, sulfuric acid or p-toluenesulfonic acid) as shown in Scheme 7 or Scheme 13 below. Compound 27 is then converted to 47 as described above for Scheme 8, or by directly opening the ring to 47' using a suitable source of cr, Br or hydrazine. Subsequent reaction of 47 with the reaction of 6 described in Scheme 1 was carried out similarly to [1,2,4]-1H-triazole to give 27. Process 13

上述反應中所用之笨甲其&人,, 本T基化合物2及經羰基取代苯化< 物11可購得或可藉由熟習此項 唄技術者已知之標準方法來j 備0 不為氫且η為〇)可自化合物IA, 式IA及式IB化合物(其中rz 及IB’(其中R4=H且n=〇)來製備 可與DE-A-19520098中所述 之方法類似地藉由使化合物 147474.doc •72· 201041514 ΙΑ·或IB’與化合物R4_LG(其中R4具有上述含義之一iLG為 脫離基,諸如鹵基(例如Cl、Br、1}、甲笨磺酸酯基或甲磺 酸酯基)在鹼存在下反應來製備式IA及式IB化合物(其中η 為0且R為匸!·〜烧基、烷基、C2_Ci〇稀基、c” c10鹵烯基、c2-c1G炔基、c2-c1Q_快基、C3_ClQ環烷基、 匸3-(:〗0鹵裱烷基、苯基、苯基_Ci_C4烷基,其中最後2個提 及之基團中之苯基部分可如上所述經取代,及含有丨、2或 ◎ 3個選自Ν、Ο及S之雜原子作為環成員的5員或6員飽和、 部分不飽和或芳族雜環,其中雜環可如上所述經取代)。 適合鹼為例如鹼金屬氫化物(例如氫化鈉、氫化鉀)、鹼金 屬氫氧化物(例如氫氧化鈉、氫氧化鉀)、鹼金屬碳酸鹽(例 如碳酸鈉、碳酸鉀、碳酸铯)、鹼金屬烷醇鹽(例如甲醇 鈉、甲醇鉀、乙醇鈉、乙醇鉀、第三丁醇鉀)或有機鋰鹼 (例如正丁基鋰、第二丁基鋰、第三丁基鋰及二異丙胺 鋰)。一般在適合溶劑中進行反應。適合溶劑為例如甲 Q 苯、N_甲基°比σ各咬酮 '醚(例如乙鍵、四氫呋喃、二„惡 烧、—曱乳基乙烧)、乙腈' Ν,Ν-二曱基甲醯胺或二甲 亞礙。 可與DE-A-19617461中所述之方法類似地藉由使化合物 ΙΑ·或 ΙΒ·與化合物R5-C(=0)-W、R5-C(=S)-W、R5,-N=C=〇 或R5 -N=C=S(其中R5具有上述含義之一,r5_為Ci_Ci〇烷基 或Ci-Cw鹵烷基且w為良好脫離基,諸如鹵基(例如C1、 Br、I)、院氧化物(例如甲氧化物、乙氧化物)或五氟苯氧 化物)在鹼在下反應來製備式ΙΑ及式ΙΒ化合物(其中η為〇且 147474.doc -73- 201041514 為C( 0)R或_c(=s)R5)。適合驗為例如驗金屬氫化物 (Ή 士 SL化納虱化钟)、驗金屬氫氧化物(例如氫氧化鈉、 氫氧化鉀)、鹼金屬碳酸鹽(例如碳酸鈉、碳酸鉀、碳酸 鉋)、鹼金屬烷醇鹽(例如甲醇鈉、曱醇鉀、乙醇鈉、乙醇 鉀、第三丁醇鉀)或有機鋰鹼(例如正丁基鋰、第二丁基 第一 丁基鐘、一異丙胺經)。一般在適合溶劑中進行 反應。適合溶劑為例如甲苯、N_甲基吡咯啶酮、醚(例如 乙醚、四氫呋喃、二噁烷、12_二甲氧基乙烷)、乙腈、 N,N-一甲基甲醯胺或二曱亞石風。 可與DEH9620590中所述之方法類似地藉由使化合物 IA,或瓜與化合物R5_s〇2_w(其中r5具有上述含義卜且^ 為良好脫離基,諸如_基(例如a、BH氧化物(例 Q化物)或五氣苯氧化物)在驗存在下反應 來製備式IA及式IB化合物(其中^且^叫的。適合 蛤為例如鹼金屬氫化物(例如_ 卿I例如虱化鈉、氫化鉀)、鹼金屬氫 氧化物(例如氫氧化鈉、氫氣仆 „ 飞虱化鉀)、鹼金屬碳酸鹽(例如碳 酸納、碳酸鉀、碳酸铯)、鹼今 晚生屬烷醇鹽(例如甲醇鈉、甲 醇鉀、乙醇鈉、乙醇鉀、第= 弟—丁醇鉀)或有機鋰鹼(例如正 丁基鋰、第二丁基鐘、第三丁 _ 土鐘、一異丙胺鐘)。一般 在適合溶劑中進行反應。適合、、交 办Μ為例如甲苯、N_曱基吡 咯啶酮、醚(例如乙醚、四惫岵 轧夭喃、二噁烷、1,2-二曱氧基 乙烷)、乙腈、N,N-二甲基甲醯胺或二甲亞砜。 可與DE-A-19620407中所流令+ 述之方法類似地藉由使化合 ΙΑ,或ΙΒ,與化合物CN_W(其中 便化。物 為良好脫離基,諸如鹵 147474.doc •74- 201041514 土例如C1 Br、I)在鹼存在下反應來製備式ΙΑ及式1]8化 合物(其中η為0且尺4為-叫。適合驗為例如驗金属氫化物 (例域仙、氫化鉀)、*金屬氫氧化物(例如氫氧化納、 氫氧化鉀)、鹼金屬碳酸鹽(例如碳酸鈉、碳酸鉀、碳酸 铯)、鹼金屬烷醇鹽(例如甲醇納、甲醇鉀、乙醇納、乙醇 鉀、第三丁醇鉀)或有機鋰鹼(例如正丁基鋰 '第二丁基 丁土鐘—異丙胺鐘)。一般在適合溶劑中進行 Ο ❹ 反應適口命劑為例如甲苯、Ν_甲基吡咯啶酮、醚(例如 乙越、四氫吱喃、-啞、岭 ,. ^ 一惡烷、1,2·二甲氧基乙烷)、乙腈、 Ν,Ν-二甲基甲醯胺或二甲亞硬。 可與DE-A-19617282中所述之方法類似地藉由使化合物 ΙΑ’或1Β,與胺NRaRbRC(其中m 如上所定義)或與 &屬鹽(諸如氫氧化納、氫氧化鉀或乙酸銅)反應來製備式 IA及式IB化合物(其中11為〇且尺4為。The compound used in the above reaction, the present T-based compound 2, and the carbonyl-substituted benzoic acid <11, are commercially available or can be prepared by a standard method known to those skilled in the art. Is hydrogen and η is 〇) can be prepared from compounds IA, compounds of formula IA and formula IB (wherein rz and IB' (wherein R4 = H and n = 〇) can be similar to the method described in DE-A-19520098 By making the compound 147474.doc • 72· 201041514 ΙΑ· or IB′ with the compound R4_LG (wherein R 4 has one of the above meanings iLG is a leaving group such as a halogen group (for example, Cl, Br, 1}, a sulfonate group) Or a mesylate group) is prepared by reacting in the presence of a base to prepare a compound of the formula IA and formula IB (wherein η is 0 and R is 匸!·~alkyl, alkyl, C2_Ci〇, c, c10 haloalkenyl, c2-c1G alkynyl, c2-c1Q_ fast radical, C3_ClQ cycloalkyl, 匸3-(: 0 haloalkyl, phenyl, phenyl-Ci_C4 alkyl, of which the last two are mentioned The phenyl moiety may be substituted as described above, and a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring containing ruthenium, 2 or ◎ 3 hetero atoms selected from the group consisting of ruthenium, osmium and S as ring members. its The heterocyclic ring may be substituted as described above. Suitable bases are, for example, alkali metal hydrides (such as sodium hydride, potassium hydride), alkali metal hydroxides (such as sodium hydroxide, potassium hydroxide), alkali metal carbonates (for example) Sodium carbonate, potassium carbonate, cesium carbonate), alkali metal alkoxide (such as sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, potassium butoxide) or organic lithium base (such as n-butyl lithium, second butyl) Lithium, tert-butyllithium and lithium diisopropylamine). Generally, the reaction is carried out in a suitable solvent. Suitable solvents are, for example, methyl benzene, N-methyl σ σ each bite ketone 'ether (eg, ethyl bond, tetrahydrofuran, two „ 烧 、 曱 曱 曱 曱 、 、 、 、 、 、 、 、 、 、 、 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 Or 化合物· with compound R5-C(=0)-W, R5-C(=S)-W, R5, -N=C=〇 or R5 -N=C=S (wherein R5 has one of the above meanings, R5_ is Ci_Ci〇alkyl or Ci-Cw haloalkyl and w is a good leaving group such as halo (eg C1, Br, I), a house oxide (eg methoxide, ethoxylate) or pentafluoro Benzene oxide) is reacted under a base to prepare a compound of the formula ΙΒ and ΙΒ (where η is 〇 and 147474.doc -73- 201041514 is C(0)R or _c(=s)R5). Metal hydride (Mr. SL), metal hydroxide (such as sodium hydroxide, potassium hydroxide), alkali metal carbonate (such as sodium carbonate, potassium carbonate, carbonic acid planing), alkali metal alkanol a salt (for example, sodium methoxide, potassium decoxide, sodium ethoxide, potassium ethoxide, potassium butoxide) or an organic lithium base (for example, n-butyllithium, a second butyl first butyl group, and a monoisopropylamine). The reaction is usually carried out in a suitable solvent. Suitable solvents are, for example, toluene, N-methylpyrrolidone, ethers (for example diethyl ether, tetrahydrofuran, dioxane, 12-dimethoxyethane), acetonitrile, N,N-methylformamide or dioxime A stone wind. It can be similar to the method described in DEH9620590 by using compound IA, or melon with compound R5_s〇2_w (wherein r5 has the above meaning and is a good leaving group, such as a group (for example, a, BH oxide (example Q) Compounds or penta-gas phenoxides are reacted in the presence of the test to prepare compounds of the formula IA and formula IB (wherein 蛤 ^ ). Suitable for hydrazines such as alkali metal hydrides (for example, _ qing I such as sodium hydride, potassium hydride ), an alkali metal hydroxide (such as sodium hydroxide, hydrogen servant potassium), an alkali metal carbonate (such as sodium carbonate, potassium carbonate, cesium carbonate), a base tonight to alkane salt (such as sodium methoxide) , potassium methoxide, sodium ethoxide, potassium ethoxide, potassium = potassium butoxide) or organic lithium base (such as n-butyl lithium, second butyl clock, third butyl celestial clock, monoisopropylamine clock). It is suitable for the reaction in a solvent. Suitable, for example, toluene, N-decylpyrrolidone, ether (such as diethyl ether, tetradecyl fluorene, dioxane, 1,2-dimethoxy ethane) , acetonitrile, N,N-dimethylformamide or dimethyl sulfoxide. Can be used in DE-A-19620407 The flow order + the method described is similarly by the compound ΙΑ, or ΙΒ, with the compound CN_W (wherein the matter is a good detachment group, such as halogen 147474.doc • 74- 201041514 soil such as C1 Br, I) in the presence of a base The reaction is carried out to prepare a compound of the formula ] and the compound of the formula 1] (where η is 0 and the rule 4 is - called. It is suitable for, for example, a metal hydride (eg, potassium hydride), * a metal hydroxide (for example, hydr Nano, potassium hydroxide), alkali metal carbonates (such as sodium carbonate, potassium carbonate, cesium carbonate), alkali metal alkoxides (such as sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, potassium butoxide) or organic Lithium base (for example, n-butyllithium 'second butyric acid clock - isopropylamine clock). Generally used in a suitable solvent. The suitable prophylactic agent is, for example, toluene, hydrazine-methylpyrrolidone, ether (such as B).越, tetrahydrofuran, -mute, ridge, . ^ monooxane, 1,2. dimethoxyethane), acetonitrile, hydrazine, hydrazine-dimethylformamide or dimethylene hard. The method described in DE-A-19617282 is similarly by making the compound ΙΑ' or 1Β, with the amine NRaRbRC (where m is as defined above) or with & A salt (such as sodium hydroxide, potassium hydroxide or copper acetate) is reacted to prepare a compound of the formula IA and formula IB (wherein 11 is ruthenium and the rule 4 is.

可與WO 97/43269中所述之方法類似地藉由使化合物iA, 或IB與鹵素(尤其為碘)在鹼存在下反應來製備式认及式JR 化:物’其為式m之基團。適合鹼為例如鹼金 屬氯化物(例如氫化鈉、氫化釺)、驗金屬氫氧化物(例如氫 氧化鈉、11氧化鉀)、鹼金屬碳酸鹽(例如碳酸鈉、石炭酸 鉀、碳酸鉋)、鹼金屬烷醇鹽(例如甲醇鈉、曱醇鉀、乙醇 納、乙醇卸、帛三丁醇鉀)或有機鐘驗(例如正丁基鐘、第 一丁基鋰、第三丁基鋰、二異丙胺鋰ρ 一般在適合溶劑 中進行反應。適合溶劑為例如甲苯、Ν_甲基料。定綱、鱗 (例如乙醚、四氫呋喃、二噁烷、1,2-二甲氧基乙烷)、乙 147474.doc -75- 201041514 腈、N,N-二甲基甲醯胺或二甲亞砜。 可與WO 99/05 149中所述之方法類似地製備式ia及式把 化合物,其中n為〇且r44_p(;=q)r6r7。 可與W〇 "测78中所述之方法類似地藉由使 酮39或44與氧化劑視情況在催化劑存在下反應來製備式【A 及式IB化σ物’其中R為氫(或化合物Μ及,其中心 為氫)。適合氧化劑為例如氧氣、硫及超氧化卸。:盆在 使用氧氣作為氧化劑之情況下,宜在催化劑存在下進行氧 化反應。適合催化劑為例如粉狀硫與k〇h之混合物。一般 在適合溶劑中進行反應。適合溶劑為例如脂族烴(例如戊 烷、己烷)、環脂族烴(例如環己烷)、芳族烴(例如苯、甲 苯、二甲苯)、鍵(例如乙_、甲基第三丁基⑹及醋(例如 乙酸乙酯、乙酸丙酯、乙酸正丁 g旨)。 亦可用含氯化鐵(FeCl3)之酸性水溶液與〜〇 〇1/46158中 所述之方法類似地進行三唑啶硫酮39或44之氧化。一般在 適合溶劑中進行反應。適合溶劑為例如乙醇、乙酸乙酯及 乙醇與曱苯之混合物。 亦可與WO 99/18086或冒〇 99/18〇88中所述之方法類似 地,視情況在催化劑存在下用曱酸進行三唑啶硫酮外或料 之氧化。適合催化劑為例如酸,如鹽酸、硫酸或對曱苯磺 酸;及金屬氧化物’如非晶型二氧化鈦。一般在適合溶劑 中進行反應。適合溶劑為弱極性溶劑,如例如醇,諸如丙 醇、丁醇及戊醇;酯,如乙酸乙酯、乙酸丁酯及甲酸異丁 酯;醚,如1,2-二曱氧基乙烷、曱基第三丁基醚及曱基第 147474.doc -76- 201041514 三戊基喊;及過量使用之曱酸。 與上述將R4為Η之化合物IA,及IB,轉化為R4不為H之化合 物類似,可藉由使NR4a基團(其中尺^為印反應來製備式ΠΑ 及式ΗΒ化合物(其中R4a不為氫)。 • 可藉由氧化自11為〇之各別化合物製備n為1或2之化合物 I。或者,可自化合物7或27藉由首先將三唑基環去質子化 且接著與磺醯氯R4S〇2Cl反應來製備!!為2之化合物][。η為3 〇 之化合物1可自化合物7或27藉由首先將三唑基環去質子化 且接著與硫酸氣或式r4〇S〇2C1之硫酸酯氣化物反應來製 備’其中R4係選自氫、Cl_CiG院基、Ci_Ci。鹵烷基、 烯基、C2-C1()鹵烯基、c2-C1()炔基、c2-C1()鹵快基、c3-C10 裱烷基、C3_c10鹵環烷基、苯基、苯基_Ci_C4烷基,其中 最後2個提及之基團中之苯基部分可如上所述經取代及 含有1、2或3個選自N、〇及8之雜原子的5員或6員飽和、 部分不飽和或芳族雜環,其中該雜環可如上所述經取代。 〇 若個別化合物不可經由上述途徑製備,則其可藉由其他 化合物I及II之衍生化或藉由所述合成途徑之慣用修改形式 來製備。 以慣用方式,例如藉由與水混合、分離各相及適當時利 ’ 用層析(例如氧化紹或石夕膠層析)純化粗產物來處理反應混 合物。一些中間物及最終產物可以無色或淡褐色黏性油狀 物开> 式獲得’其可在減壓下及在適度高溫下自揮發性組分 釋放或純化。若中間物及最終產物係以固體形式獲得,則 其可藉由再結晶或浸提來純化。 147474.doc •77- 201041514 本發明之另一態樣係關於式ιν化合物,The formula JR can be prepared by reacting the compound iA, or IB with a halogen (especially iodine) in the presence of a base analogously to the method described in WO 97/43269: which is the base of the formula m group. Suitable bases are, for example, alkali metal chlorides (such as sodium hydride, cesium hydride), metal hydroxides (such as sodium hydroxide, potassium oxide 11), alkali metal carbonates (such as sodium carbonate, potassium carbamate, carbonic acid planing), alkalis. Metal alkoxides (such as sodium methoxide, potassium decoxide, sodium ethoxide, ethanol, potassium tributoxide) or organic tests (eg n-butyl quinone, first butyl lithium, tert-butyl lithium, diiso) Lithium propylamine ρ is generally reacted in a suitable solvent. Suitable solvents are, for example, toluene, hydrazine-methyl, squaring, scales (e.g., diethyl ether, tetrahydrofuran, dioxane, 1,2-dimethoxyethane), 147,474 .doc -75- 201041514 Nitrile, N,N-dimethylformamide or dimethyl sulfoxide. Compounds of formula ia and formula can be prepared analogously to the methods described in WO 99/05 149, where n is hydrazine And r44_p(;=q)r6r7. The formula [A and IB σ can be prepared by reacting ketone 39 or 44 with an oxidizing agent in the presence of a catalyst, similarly to the method described in W. Where 'R is hydrogen (or a compound Μ and its center is hydrogen). Suitable oxidizing agents are, for example, oxygen, Sulfur and super-oxidation.: In the case of using oxygen as the oxidant, the oxidation reaction should be carried out in the presence of a catalyst. Suitable catalysts are, for example, a mixture of powdered sulfur and k〇h. Generally, the reaction is carried out in a suitable solvent. For example, aliphatic hydrocarbons (such as pentane, hexane), cycloaliphatic hydrocarbons (such as cyclohexane), aromatic hydrocarbons (such as benzene, toluene, xylene), bonds (such as B-, methyl tert-butyl) (6) and vinegar (e.g., ethyl acetate, propyl acetate, n-butyl acetate). It is also possible to carry out triazolidine similarly to the method described in ~〇〇1/46158 using an acidic aqueous solution containing ferric chloride (FeCl3). Oxidation of thione 39 or 44. The reaction is generally carried out in a suitable solvent. Suitable solvents are, for example, ethanol, ethyl acetate and mixtures of ethanol and toluene. Also in WO 99/18086 or 〇99/18〇88 The method described is similarly, the oxidation of the triazole pyrithione or the material is carried out with citric acid as the case may be. Suitable catalysts are, for example, acids such as hydrochloric acid, sulfuric acid or p-toluenesulfonic acid; and metal oxides such as Amorphous titanium dioxide. General The reaction is carried out in a suitable solvent. Suitable solvents are weakly polar solvents such as, for example, alcohols such as propanol, butanol and pentanol; esters such as ethyl acetate, butyl acetate and isobutyl formate; ethers such as 1,2- Dimethoxyethane, decyl tertiary butyl ether and fluorenyl 147474.doc -76- 201041514 Tripentyl yoke; and citric acid used in excess. With the above formula R4 is Η, IA, and IB, The conversion to a compound in which R4 is not H is similar to that of the compound of the formula NR4a (wherein R4a is not hydrogen) by the NR4a group (wherein R4a is not hydrogen). Each compound produces a compound I wherein n is 1 or 2. Alternatively, a compound of 2 can be prepared from compound 7 or 27 by first deprotonating the triazolyl ring and then reacting with sulfonium chloride R4S〇2Cl. Compound 1 wherein η is 3 可 can be prepared from compound 7 or 27 by first deprotonating the triazolyl ring and then reacting with sulfuric acid gas or a sulfate gas stream of the formula r4〇S〇2C1, wherein R4 is selected from Hydrogen, Cl_CiG, and Ci_Ci. Haloalkyl, alkenyl, C2-C1()haloenyl, c2-C1()alkynyl, c2-C1()halo-based, c3-C10-decyl, C3_c10 halocycloalkyl, phenyl, benzene a group of -Ci_C4 alkyl, wherein the phenyl moiety of the last two mentioned groups may be substituted as described above and contains 5, 6 or 3 members of 1, 2 or 3 heteroatoms selected from N, 〇 and 8. A saturated, partially unsaturated or aromatic heterocyclic ring wherein the heterocyclic ring can be substituted as described above.个别 If individual compounds are not prepared by the above routes, they may be prepared by derivatization of other compounds I and II or by conventional modifications of the synthetic routes. The reaction mixture is treated in a conventional manner, for example, by mixing with water, isolating the phases, and, if appropriate, purifying the crude product by chromatography (e.g., Oxidation or Shiki gum chromatography). Some of the intermediates and final products can be obtained as colorless or light brown viscous oils &> which can be released or purified from volatile components under reduced pressure and at moderately elevated temperatures. If the intermediate and final product are obtained in solid form, they can be purified by recrystallization or leaching. 147474.doc •77- 201041514 Another aspect of the invention pertains to a compound of formula ιν,

其中…、…、〜'加具有通用含義之一或特 定言之上文對於化合給出之較佳含義之一. 如下化合物除外,其中 L為氣且 R1及R2均為甲基,r3為氫,l1、l、l4為氫 ----為雙鍵。 較佳化合物IV為化合物IVA,Wherein ..., ..., ~' plus one of the general meanings or the specific meanings given above for one of the preferred meanings of the compound. Except for the following compounds, wherein L is gas and R1 and R2 are both methyl and r3 is hydrogen , l1, l, l4 are hydrogen ---- double bond. Preferred compound IV is compound IVA,

特定言之上文對於化合物出之較佳含義之一。 或者,較佳為化合物1¥,其中R】、R2、R3、Ll&L4具有 通用含義之一或特定言之上文對於化合物給出之較佳 3義之,且L2及L3係選自氫、氟、溴、碘、C广(:10烷 基、^-(:⑺鹵烷基、Ci_Ci〇烷氧基及Ci_Ci〇鹵烷氧基。 147474.doc -78- 201041514 化合物ιν—方面為製備化合物^中 (參看化合物7及27) — f B物 ... —另一方面亦顯示顯著殺真菌活性。 R2尤二化,物:V為式Ιν·^Ιν.8化合物,其中R1、 L、LAL之組合在各情況下對應於上文表A中 之一列。In particular, one of the preferred meanings for the compound above. Alternatively, it is preferably a compound 1 wherein R], R2, R3, L1 & L4 have one of the general meanings or, in particular, the preferred ones given above for the compound, and the L2 and L3 are selected from hydrogen, Fluorine, bromine, iodine, C-wide (: 10 alkyl, ^-(:(7)haloalkyl, Ci_Ci decyloxy, and Ci_Ci 〇haloalkoxy. 147474.doc -78- 201041514 Compound ιν-in the preparation of compounds ^ (see compounds 7 and 27) - f B ... - on the other hand also shows significant fungicidal activity. R2 is particularly dimorphic, and the substance: V is a compound of the formula Ιν·^Ιν.8, where R1, L, The combination of LALs corresponds in each case to one of the columns in Table A above.

Ο ❹Ο ❹

(V) 其中 R、r2、R3、L1、L2、L3 及 L4 呈古、s m 入、 ^ /、有通用含義之一或特 疋言之上文對於化合物〗及„給出之較佳含義之一. 較佳地,如下化合物除外,其中 R1及R2均為甲基,R3為氫,Li、乙3 一 為虱,L2為氯,且 ——為雙鍵。 較佳化合物V為化合物VA, 147474.doc -79· 201041514(V) where R, r2, R3, L1, L2, L3 and L4 are ancient, sm in, ^ /, have one of the general meanings or special words above for the compound and „ give the better meaning Preferably, the following compounds are excluded, wherein R1 and R2 are both methyl, R3 is hydrogen, Li, B3 is hydrazine, L2 is chloro, and - is a double bond. Preferred compound V is compound VA, 147474.doc -79· 201041514

特定言之上文對於化合物I及II給出之較佳含義之一。 化合物V為製備化合物I及II中之有價值中間物(參看化合 物6及26)。 本發明之另一態樣係關於式VI化合物, ^ ^ η 2 .In particular, one of the preferred meanings given above for compounds I and II. Compound V is a valuable intermediate in the preparation of compounds I and II (see compounds 6 and 26). Another aspect of the invention pertains to a compound of formula VI, ^^ η 2 .

定言之上文對於化合物I及II給出之較佳含義之 較佳地,如下化合物除外,其中 具有通用含義之一或特 L2為氯且 R1及R2均為曱基,R3為氫,L1、L3及L4為氯 =為雙鍵。 較佳化合物VI為化合物VIA,Preferably, the preferred meanings given above for compounds I and II are preferred, except for one of the following general meanings, or one of the general meanings or L2 is chlorine and R1 and R2 are both fluorenyl, R3 is hydrogen, L1 L3 and L4 are chlorine = double bond. Preferred compound VI is compound VIA,

(VIA) | % /η 特定言之上文對於化合物I及II給出之較佳含義之 147474.doc -80- 201041514 化合物νι為製備化合物„中之有價值中間物(參看化 合物41)。 本發明之另一態樣係關於式VII化合物,(VIA) | % /η In particular, the preferred meanings given above for compounds I and II are 147474.doc -80- 201041514 The compound νι is a valuable intermediate in the preparation of the compound „ (see compound 41). Another aspect of the invention relates to a compound of formula VII,

(VII)(VII)

「X、CI L3"X, CI L3

其中R1、R2、R3、Li、L2、"及!^具有通用含義之一或特 定言之上文對於化合物給出之較佳含義之一,且 R14 為 Η或 C(〇)〇R15,其中 R係選自氫、<ν(:10烷基、· <^-(:10鹵烷基、c3-c10環烷 基、C3-c10_環烷基、苯基、苯基_Ci_C4烷基,其 中最後2個提及之基團中之苯基部分可具有1、2、 3、4或5個取代基R8 ’及含有1、2或3個選自n、〇 及S之雜原子作為環成員的5員或6員飽和、部分不 飽和或芳族雜環,其中該雜環可具有1、2或3個取 代基R8 ’其中R8係如上文所定義。 化合物VII為製備化合物中之有價值中間物(參看化 合物4)。 本發明之另一態樣係關於式νπι化合物,Where R1, R2, R3, Li, L2, " and! ^ has one of the general meanings or specifically one of the preferred meanings given above for the compound, and R14 is Η or C(〇)〇R15, wherein R is selected from hydrogen, <ν(:10 alkyl , · <^-(: 10 haloalkyl, c3-c10 cycloalkyl, C3-c10_cycloalkyl, phenyl, phenyl-Ci_C4 alkyl, of which benzene in the last two mentioned groups The base moiety may have 1, 2, 3, 4 or 5 substituents R8' and 5 or 6 member saturated, partially unsaturated, containing 1, 2 or 3 heteroatoms selected from n, yttrium and S as ring members Or an aromatic heterocyclic ring wherein the heterocyclic ring may have 1, 2 or 3 substituents R8' wherein R8 is as defined above. Compound VII is a valuable intermediate in the preparation of a compound (see Compound 4). Another aspect relates to a compound of the formula νπι,

147474.doc -81- (VIII) 201041514 其中…^、广以以有通时義之—或特定 言之上文對於化合物I及II給出之較佳含義之一,且RM係 如上文所定義。 化合物ΥΙΠ為製備化合物I及π中之有價值中間物(參看 化合物3)。 本發明之另一態樣係關於式IX化合物,147474.doc -81- (VIII) 201041514 wherein ...^, is broadly defined as one of the preferred meanings given above for the compounds I and II, and the RM is as defined above. The compound oxime is a valuable intermediate in the preparation of compounds I and π (see compound 3). Another aspect of the invention pertains to a compound of formula IX,

其中R、R、R、L、L、L及L4具有通用含義之一或特 定言之上文對於化合物I及II給出之較佳含義之一; 如下化合物除外,其中 R1及R2均為曱基,R3為氫’ L1、L3及L4為氫,l2為氣且 ^為雙鍵。 化合物IX為製備化合物I及II中之有價值中間物(參看化 合物5及12)。 當然,化合物I及II之上述限制條件(亦即Li、L2、^及 L4中至少一者不為氫)對於化合物iv、iVA、v、VA、、 VIA、VII、VIII及 IX亦有效。 本發明進一步係關於一種農業組合物,其包含至少一種 如上定義之式I、II及/或IV化合物或其農業上可接受之 鹽,及液體或固體載劑。下文定義本發明之組合物中亦可 含有之適合載劑以及助劑及其他活性化合物。 147474.doc -82 - 201041514 本發明之化合物I及II以及IV及組合物分別適用作殺真菌 劑。其因可對抗廣泛範圍植物病原性真菌之突出效用而著 名’該等植物病原性真菌包括土壤傳播之真菌,尤其來源 , 於根腫菌綱(Plasmodiophoromycetes)、霜黴卵菌綱 (Per〇n〇Sp〇romyCetes)(同義詞卵菌綱(〇〇mycetes))、壺菌綱 (Chytridi〇mycetes)、接合菌綱(Zyg〇mycetes)、子囊菌綱 (Ascomycetes)、擔子菌綱(Basidi〇myCetes)及半知菌綱 Q (DeUter〇Inycetes)(同義詞不完全菌綱(Fungi imperfecti))。 二具有王身效用且其可在作物保護中用作葉面殺真菌 劑、拌種殺真菌劑及土壤殺真菌劑。此外,其適用於防治 尤其出現於木材或植物之根的有害真菌。 II及IV及組合物在防治各種栽培植物Wherein R, R, R, L, L, L and L4 have one of the general meanings or specifically one of the preferred meanings given above for compounds I and II; except for the following compounds, wherein R1 and R2 are both 曱Base, R3 is hydrogen 'L1, L3 and L4 are hydrogen, l2 is gas and ^ is a double bond. Compound IX is a valuable intermediate in the preparation of compounds I and II (see Compounds 5 and 12). Of course, the above-mentioned limitations of the compounds I and II (i.e., at least one of Li, L2, ^ and L4 are not hydrogen) are also effective for the compounds iv, iVA, v, VA, VIA, VII, VIII and IX. The invention further relates to an agricultural composition comprising at least one compound of formula I, II and/or IV as defined above, or an agriculturally acceptable salt thereof, and a liquid or solid carrier. Suitable carriers and auxiliaries and other active compounds which may also be included in the compositions of the invention are defined below. 147474.doc -82 - 201041514 The compounds I and II and IV and compositions of the invention are each suitable for use as a fungicide. It is known for its outstanding utility against a wide range of phytopathogenic fungi. These phytopathogenic fungi include soil-borne fungi, especially from the genus Plasmodiophoromycetes, downy mildew (Per〇n〇). Sp〇romyCetes) (synonym 〇〇mycetes), Chytridi〇mycetes, Zyg〇mycetes, Ascomycetes, Basidi〇myCetes and DeUter〇Inycetes (synonym Fungi imperfecti). It has a king effect and can be used as a foliar fungicide, a seed dressing fungicide and a soil fungicide in crop protection. Furthermore, it is suitable for the control of harmful fungi which occur especially in the roots of wood or plants. II and IV and compositions in the control of various cultivated plants

本發明之化合物I、 (諸如穀類,例如,丨、 147474.doc -83· 201041514 葉;香蕉;藤本植物(鮮食葡萄(taMe grape)及葡萄汁葡萄 藤);蛇麻子;草;天然橡膠植物或觀賞植物及森林植 物,例如花、灌木、闊葉樹或常綠樹,例如針葉樹)上; 及植物繁殖材料(諸如種子)及此等植物之作物材料上之眾 多植物病原性真菌中尤其重要。 化合物I、Π及IV及其組合物較佳分別用於防治大田作物 上之眾多真菌,該等大田作物諸如為馬鈐薯、甜菜、菸 草、小麥、黑麥、大麥、燕麥、稻、玉米、棉花、大豆、、 油菜、豆科植物、向曰[咖唯或甘蔗;水果;藤本植 物;觀賞植物;或蔬菜,諸如黃瓜、番祐、豆類或南瓜。 應瞭解術5吾「植物繁殖材料」表示可用於繁殖植物之植 物之所有生殖部分(諸如種子)及營養性植物材料,諸如插 枝及塊莖(例如馬鈴薯)。其包括種子、根、果實、塊莖、 :莖、根莖、嫩芽、芽及其他植物部分,包括籽苗及幼 田,其在發牙後或露土後移植。亦可在移植之前藉由浸潰 或澆注進行整體或局部處理來保護此等幼苗。 以化合物I、II及…及其組合物處理植物繁殖材料較佳分 別用於防治榖類(諸如小麥、黑麥、大麥及燕麥);稻、玉 米、棉花及大豆上之眾多真菌。 術語「栽培植物」應理解為包括已藉由育種、突變誘發 或遺傳工程進行改造之植物,包括(但不限於)市售或研發 t ^ ^ a # 1 ^ A ( ^ http://www.bio.org/speeches/ pubs/吻H_products.asp)。經遺傳改造之植物為遺傳物質 已藉由使用重組屬技術進行改造而在天然情形下不能藉 147474.doc -84 · 201041514 由雜交育種、突變或天然重組容易地獲得之植物。通常已 將一或多個基因整合至經遺傳改造之植物的遺傳物質中以 改良植物之某些特性。此等遺傳改造亦包括(但不限於)例 如藉由糖基化或聚合物添加對蛋白質、募肽或多肽進行靶 向轉譯後修飾,諸如異戊烯化、乙醯化或法呢基化 (farnesylated)部分或 PEG部分。 作為育種或遺傳工程之習知方法之結果,使得已藉由育 _ 種、突變誘發或遺傳工程進行改造之植物例如耐受特定類 〇 別除草劑之施用,該等除草劑諸如為羥基苯基丙酮酸二加 氧酶(HPPD)抑制劑;乙醯乳酸合成酶(ALS)抑制劑,諸如 磺醯脲(例如參看 US 6,222,100、WO 01/82685、WO 00/ 26390 ' WO 97/41218 ' WO 98/02526 ' WO 98/02527 ' WO 04/106529、WO 05/20673、WO 03/14357、WO 03/13225、 WO 03/143 56、WO 04/16073)或咪唑啉酮(例如參看US 6,222,100 ' WO 01/82685 ' WO 00/026390 ' WO 97/41218 ' q WO 98/002526、WO 98/02527、WO 04/106529、WO 05/20673、WO 03/014357、WO 03/13225、WO 03/14356、 WO 04/16073);浠醇丙酮醯莽草酸-3-磷酸合成酶 (enolpyruvylshikimate-3-phosphate synthase,EPSPS)抑制 . 劑,諸如草甘膦(glyphosate)(例如參看WO 92/00377);麩· 胺醯胺合成酶(GS)抑制劑,諸如草兹膦(glufosinate)(例如 參看EP-A 242 236、EP-A 242 246)或二苯曱腈除草劑 (oxynil herbicide)(例如參看 US 5,559,024)。藉由育種(突 變誘發)之習知方法已使得若干栽培植物耐受除草劑,例 147474.doc -85- 201041514 如使得Clearfield®夏季油菜(can〇ia,BASF SE, Germanyy^ x米坐琳s同,例如甲氧咪草終(imazainox)。遺傳工程改造 方法已用以使得諸如大豆、棉花、玉米、甜菜及油菜之栽 培植物耐受諸如草甘膦及草銨膦之除草劑,其中一些可以 商標名RcmndupReady⑧(草甘膦耐受型,Monsant〇,U S A.) 及 LibertyLink®(草銨膦耐受型,Bayer Cr〇pScience, Germany)購得。 此外,亦涵蓋藉由使用重組DNA技術能夠合成一或多 权%蟲蛋白之植物,該殺昆蟲蛋白尤其已知為細菌桿菌屬 (…,尤其蘇雲金芽孢桿菌(如以& Μ謂·心以⑼…) 者,諸如δ-内毒素,^列如CryIA(b)、CrylA⑷、CryIF、Compounds I of the invention, (such as cereals, for example, alfalfa, 147474.doc-83·201041514; bananas; vines (taMe grape and grape vine); hops; grass; natural rubber plants or Ornamental plants and forest plants, such as flowers, shrubs, broad-leaved trees or evergreen trees, such as conifers; and plant propagation materials such as seeds, and many plant pathogenic fungi on crop materials of such plants are particularly important. Compounds I, sputum and IV and combinations thereof are preferably used to control a plurality of fungi on field crops, such as horse yam, sugar beet, tobacco, wheat, rye, barley, oats, rice, corn, Cotton, soybean, rapeseed, legume, sorghum [caffe or sugar cane; fruit; vine; ornamental plant; or vegetable, such as cucumber, yuyou, beans or pumpkin. It should be understood that the "plant propagation material" refers to all reproductive parts (such as seeds) and vegetative plant materials, such as cuttings and tubers (such as potatoes), which can be used to propagate plants. It includes seeds, roots, fruits, tubers, stems, rhizomes, shoots, buds and other plant parts, including seedlings and young crops, which are transplanted after or after exposure. These seedlings can also be protected by whole or partial treatment by dipping or pouring prior to transplantation. Treatment of plant propagation material with compounds I, II and ... and combinations thereof is preferably used to control mites (such as wheat, rye, barley, and oats); and numerous fungi on rice, corn, cotton, and soybeans. The term "cultivated plants" is understood to include plants that have been engineered by breeding, mutation induction or genetic engineering, including but not limited to, commercially available or developed t ^ ^ a # 1 ^ A ( ^ http://www. Bio.org/speeches/ pubs/ kiss H_products.asp). A genetically engineered plant is a genetic material that has been modified by the use of recombinant genus techniques and cannot be naturally borrowed by 147474.doc -84 · 201041514 plants readily obtained by cross breeding, mutation or natural recombination. One or more genes have typically been integrated into the genetic material of a genetically engineered plant to modify certain characteristics of the plant. Such genetic engineering also includes, but is not limited to, targeted post-translational modification of proteins, peptides or polypeptides, such as prenylation, acetylation or farnesylation, by, for example, glycosylation or polymer addition ( Farnesylated) part or PEG moiety. As a result of conventional methods of breeding or genetic engineering, plants which have been engineered by breeding, mutation induction or genetic engineering are for example tolerant to the application of specific class of herbicides such as hydroxyphenyl groups. Pyruvate dioxygenase (HPPD) inhibitor; acetate lactate synthase (ALS) inhibitor, such as sulfonium urea (see, for example, US 6,222,100, WO 01/82685, WO 00/26390 'WO 97/41218 ' WO 98/02526 'WO 98/02527 'WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO 03/143 56, WO 04/16073) or imidazolinones (see for example US 6,222,100) ' WO 01/82685 'WO 00/026390 'WO 97/41218 'q WO 98/002526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/014357, WO 03/13225, WO 03/ 14356, WO 04/16073); an inhibitor of enolpyruvylshikimate-3-phosphate synthase (EPSPS), such as glyphosate (see, for example, WO 92/00377); Bran-amine indole synthase (GS) inhibitors, such as glufosinate (see, for example, EP-A 242 236, EP-A 242 246) or diphenyl hydrazine Herbicide (oxynil herbicide) (see, eg, US 5,559,024). A number of cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutation induced), for example 147474.doc -85- 201041514 such as Clearfield® summer rapeseed (can〇ia, BASF SE, Germanyy^ x m sitting s Similarly, for example, imazainox. Genetic engineering methods have been used to make cultivated plants such as soybean, cotton, corn, sugar beet and canola tolerant to herbicides such as glyphosate and glufosinate, some of which can Trade names RcmndupReady8 (glyphosate-tolerant, Monsant®, US A.) and LibertyLink® (glyfosinate-tolerant, Bayer Cr〇pScience, Germany) are also available. Also covered by the use of recombinant DNA technology a plant which synthesizes one or more poly% insect proteins, which is especially known as the genus Bacteroides (..., especially Bacillus thuringiensis (such as & Μ · 心 (9)...), such as δ-endotoxin, ^Listed as CryIA (b), CrylA (4), CryIF,

CryIF(a2)、CryllA(b)、CrylllA、CrylllB(bl)或 Cry9c ;營 ❹ 養期殺昆蟲蛋白(VIP),例如Vlpi、VIp2、vip3或 VIP3A ;拓殖線蟲之細菌(例如光桿菌屬 ΡΡ.)或嗜線蟲;f干菌屬⑷贈;spp ))之殺昆蟲蛋白; 由動物產生之毒素’諸如料素、蛛毒素、黃蜂毒素或 其他昆蟲特異性神經毒素;由真菌產生之毒素諸如鍵徽 菌毒素;植物凝集素(plant lectins),諸如婉豆或大麥凝集 素;凝集素(agghuinins);蛋白酶抑制劑,諸如胰蛋白酶 抑制劑、絲胺酸蛋白酶抑制劑 '塊莖儲藏蛋白㈣叫、 胱抑素(cysutin)或木瓜蛋白酶抑制劑;核糖體去活蛋白 (RIP),諸如1麻毒素、玉蜀黍-rip、相思子毒素(abdn)、 =瓜杆核糖體去活蛋白師n)、鸟草素(sap—或禮香膠 ”(y din) ’頒固醇代謝酶,諸如3羥基類固醇氧化酶、 147474.doc -86 - 201041514 蜆皮素-IDP-糖基-轉移酶、膽固醇氧化酶、蜆皮激素抑制 劑或HMG-CoA還原酶;離子通道阻斷劑,諸如納或妈通 道之阻斷劑;保幼激素酯酶;利尿激素受體(螺旋激肽受 體(helicokinin receptor));笑合成酶(stilben synthase)、聯 苄合成酶(bibenzyl synthase)、殼質酶(chitinase)或葡聚糖 酶(glucanase)。在本發明中,應瞭解,此等殺昆蟲蛋白或 毒素亦呈前毒素(pre-toxins)、雜交蛋白、經截短或其他修 飾之蛋白質。雜交蛋白之特徵在於蛋白質域之新組合(例 如參看 WO 02/015701)。例如在 EP-A 374 753、WO 93/007278、WO 95/34656、EP-A 427 529、EP-A 451 878、WO 03/1 8810及WO 03/52073中揭示此等毒素或能夠 合成此等毒素之遺傳改造植物的其他實例。產生此等遺傳 改造植物的方法一般為熟習此項技術者已知且描述於例如 上述公開案中。遺傳改造植物中所含之此等殺昆蟲蛋白賦 予產生此等蛋白質之植物可耐受節肢動物(athropods)之所 有分類群之有害害蟲,尤其曱蟲(鞘翅目(Coelo-ptera))、 兩翼昆蟲(雙翅目(Diptera))及蛾(鱗翅目(Lepidoptera))及線 蟲(線蟲綱(Nematoda))。能夠合成一或多種殺昆蟲蛋白之 遺傳改造植物例如描述於上述公開案中,其中一些可購 得,諸如YieldGard®(產生Cry 1 Ab毒素之玉米栽培品種)、 YieldGard® Plus(產生CrylAb及Cry3Bbl毒素之玉米栽培品 種)、Starlink®(產生Cry9c毒素之玉米栽培品種)、 Herculex® RW(產生 Cry34Abl、Cry35Abl及草胺膦-N-乙醯 基轉移酶[Phosphinothricin-N-Acetyltransferase,PAT]之玉 147474.doc -87- 201041514 米栽培品種);NuCOTN® 33B(產生Cry 1 Ac毒素之棉花栽培 品種)、Bollgard® 1(產生CrylAc毒素之棉花栽培品種)、 Bollgard® 11(產生Cryl Ac及Cry2Ab2毒素之棉花栽培品 種);VIPCOT®(產生VIP毒素之棉花栽培品種); NewLeaf®(產生Cry3 A毒素之馬鈴薯栽培品種);Bt-Xtra®、 NatureGard®、KnockOut®、BiteGard®、Protecta®、Btll (例如 Agrisure® CB),及來自 Syngenta Seeds SAS, France 之Bt 176(產生Cryl Ab毒素及PAT酶之玉米栽培品種)、來自 Syngenta Seeds S AS, France之 MIR604(產生修飾型 Cry3 A毒 素之玉米栽培品種,參看WO 03/018810)、來自Monsanto Europe S.A.,Belgium 之 MON 863(產生 Cry3Bbl 毒素之玉米 栽培品種)、來自 Monsanto Europe S.A.,Belgium 之 IPC 5 3 1 (產生修飾型Cry 1 Ac毒素之棉花栽培品種)及來自 Pioneer Overseas Corporation, Belgium之 1507(產生 CrylF 毒素及PAT酶之玉米栽培品種)。 此外,亦涵蓋藉由使用重組DNA技術能夠合成一或多種 蛋白質以增強彼等植物對細菌、病毒或真菌病原體之抗性 或耐受性之植物。此等蛋白質之實例為所謂「發病機制相 關性蛋白質」(PR蛋白質,例如參看EP-A 392 225)、植物 疾病抗性基因(例如表現來源於墨西哥野生馬鈴薯抗晚疫 馬铃鲁(So/a/iMm 之對抗馬铃兽腐疫菌 ⑽)起作用之抗性基因的馬鈴薯栽培品 種)或T4溶菌酶(例如能夠合成此等具有較強針對細菌(諸如 梨火疫病鹵aw_y/vd?ra))之抗性之蛋白質的馬铃薯 147474.doc -88 - 201041514 栽培品種)。產生此等經遺傳改造之植物的方法一般為熟 習此項技術者所已知且描述於例如上述公開案中。 此外’亦涵蓋藉由使用重組DNA技術能夠合成一或多種 蛋白質以提高生產力(例如生物質量產量、穀粒產率、澱 粉含量、油含量或蛋白質含量)、對乾旱、鹽度或其他生 長限制環境因素之耐受性或對彼等植物之害蟲及真菌、細 菌或病毒病原體之耐受性的植物。 此外’亦涵蓋藉由使用重組DNA技術含有改變量之内含 物質或新穎内含物質,尤其改良人類或動物營養之植物, 例如產生促健康長鏈ω_3脂肪酸或不飽和ω-9脂肪酸之油料 作物(例如 Nexera®油菜,D〇w Agro Sciences,Canada)。 此外’亦涵蓋藉由使用重組DNA技術含有改變量之内含 物質或新穎内含物質,尤其提高原料產量之植物,例如產 生增加量之支鏈澱粉之馬铃薯(例如Anifl〇ra®馬鈴薯, BASF SE, Germany) ° 化合物I、II及IV及其組合物分別尤其適用於防治以下植 物疾病: 觀貝植物、蔬菜(例如白色念珠菌(丄山·而))及向曰葵 (例如婆羅門參白錢菌(丄irag〇p〇g〇„is))上之白錄菌屬 (J/kgo spp.)(白銹病);蔬菜、油菜(芸苔生交鏈孢(儿 △ 或芸苔交鏈孢(儿6raiS&gt;s/cae))、甜菜(細交鍵抱 (儿ί⑼Wb))、水果、稻、大豆、馬鈴薯(例如茄交鏈孢(丄 so/am’)或互隔交鏈孢(儿⑽加m))、番茄(例如茄交鏈孢 或互隔交鏈孢)及小麥上之交鏈孢屬spp )(交鏈 147474.doc -89- 201041514 孢菌葉斑病);甜菜及蔬菜上之絲囊黴屬⑽外以 SPP.),毅類及请i上之殼二抱屬(心Spp·),例如小 麥上之小麥殼二孢(儿卜⑴以八炭疽病)及大麥上之大麥殼二 孢(丄/zorc^),平臍蠕孢屬spp.)及内臍蠕孢屬 spp.)(有性型:旋孢腔菌屬(c〇c妨〇〜心 spp·)),例如玉米上之南方葉枯病(玉蜀黍内臍蠕孢(〇. 讲吵山、))及北方葉枯病(玉米平臍蠕孢⑺· zeic〇/a)),例如縠 類上之斑點病(小麥根腐平臍蠕孢(5 ⑴·⑽㈡)及例如 稻及草皮上之稻平臍蠕孢(凡O〇;zae);穀類(例如小麥或大 麥)上之小麥白粉菌(別wmerk gTimkz··?)(原名:雀麥白粉菌 π⑽ζ·_))(白粉病);水果及漿果(例如草莓)、蔬 菜(例如萵苣、胡蘿蔔、根芹菜及甘藍)、油菜、花、藤本 植物、森林植物及小麥上之灰黴菌(5〇?〇;沿cherea)(有性 型.虽氏葡萄孢盤菌(5oirycm’m'a /Mc^re/z·⑽α):灰黴病); 萵苣上之萵苣露菌病菌/aciMcae)(霜黴病);闊葉樹 及常綠樹上之青變真菌(Ceraioc;^iiS)(同義詞長喙殼黴 (&lt;9p/n'0ii0Wa))屬(腐爛或凋萎病),例如榆樹上之榆青變真 菌(C. 荷蘭榆樹病(Dutch elm disease));玉米(例如灰 葉斑病:玉米灰斑病菌(C. zeae-wa少而?))、稻、甜菜(例如 甜菜褐斑病菌(C_ 6eiico/a))、甘蔗 '蔬菜、咖啡、大豆(例 如大五灰斑病菌(C. so_;7«a)或菊池氏斑點病菌(c. Hhc/n7)) 及稻上之斑點病菌屬(Cercowora spp.)(斑點病菌葉斑病); 番力S (例如番茄葉黴病菌(C.,W/VMW):葉黴病)及榖類上之 刀枝抱子菌屬謂spp.),例如小麥上之禾黑芽 147474.doc -90· 201041514 枝黴(C·(黑耳(black ear));榖類上之黑麥角菌 (c—γ (麥角);玉米(圓斑病菌 co^6o⑽m))、榖類(例如禾旋孢腔菌(c· ,無性型·· 小麥根腐平臍蠕孢)及稻(例如宮部旋孢腔菌(c 奶&gt;:心⑽⑽),無性型:水稻潛根線蟲⑽⑽^如))上之旋 孢腔菌(Coc妨o6〇/Wi)(無性型:平臍螺抱之長蠕孢 of 屬(葉斑病);棉(例如棉花 刺盤孢(C. g⑽烟·⑴、玉米(例如禾生刺盤孢 gr㈣:抗炭疽莖腐病(Anthracn〇se stalk r〇t))、無 核果、馬鈴薯(例如球刺盤孢(c. :黑斑病)、豆 類(例如豆刺盤孢(C. ㈣——))及大豆(例如平頭刺 盤孢(C. 或膠孢刺盤孢(c 上之 刺盤孢(CoUetotrichumX有性型··炭疽病菌⑹⑽㈣…))屬 (厌疽病)’伏革菌屬(CW/ζϋ所spp.),例如稻上之紋枯伏 革菌(C. (外鞘枯萎病);大豆及觀賞植物上之多主 棒孢病菌(Corywespora cawz’z.co/aK葉斑病);環錐孢屬 (C&gt;e/〇CO«km spp.),例如撖欖樹上之油撖欖孔雀斑菌(c ;果樹、藤本植物(例如鶴掌楸柱孢菌(c. //WWeWW) ’有性型··鵝掌楸新叢赤殼菌(ΛΓβ⑽如❿ :黑足病(Black Foot Disease))及觀賞植物上之 柱孢菌屬spp.)(例如果樹潰瘍或幼藤衰 退’有性型:叢赤殼屬spp.)或新叢赤殼菌屬 (Neonectria spp·));大豆上之半知菌φ㈣价叩肋〜 有性型:白紋病菌屬β⑽•幻X根及莖腐爛); 147474.doc •91· 201041514 腐皮殼菌屬(D/印orMe spp.),例如大豆上之大豆黑點病菌 CD. 歸)(猝倒病(damping off));玉米、穀類(諸如 大麥(例如大麥網斑病菌(D· 、網斑病)及小麥(例如小 麥德氏菌(Z)‘ «沿):褐斑病))、稻及草皮上之内 臍蠕孢(同義詞長蠕孢,有性型:核腔菌(/&gt;⑼印“Μ)) 屬’藤本植物上之埃斯卡病(五sca心頂枯病、乾枯 病),其由斑點嗜蘭孢孔菌(/?〇rwz.iz,p〇rz.a夕抓⑷(同義全可 松針層孔菌(p/jeZ/hw 、地中海層臥孔菌(厂 mediterranea)、厚孢普可尼亞蛰㈣此⑽〇心心 Ch!amyd〇Sp〇ra)(原名厚孢瓶黴(phae〇acrem〇nium 、寄生瓶黴菌(p/za⑼·謂 仏ορ/π7_)及/或扁葡萄座腔菌(如外〇5;?/zae…〇z&gt;iw扣)引 起,仁果(梨痂囊腔菌(五·外^·))、無核果(樹莓痂囊腔菌(五. ve«ek):炭疽病)及藤本植物(黑痘痂囊腔菌⑺. :炭疽病)上之痂囊腔菌屬(丑以⑽^ spp·);稻上 之稻葉黑粉菌(£n〇;/〇ma or少zae)(葉黑穗病);小麥上之黑 附球菌屬CEpicoccwm spp_)(黑黴病);甜菜(甜菜白粉菌⑺ 此))、蔬菜(例如豌豆白粉菌(凡户⑷·)),諸如葫蘆科植物 (例如二抱白粉菌(五.cz’c/zoracearwm))、甘藍、油菜(例如十 字花科白粉菌(£. crMC//erarwm))上之白粉菌屬(五 spp.K白粉病);果樹、藤本植物及觀賞樹木上之側彎孢菌 /αία)(葡萄腐病或頂枯病,無性型:拉塔假孢囊 {Cytosporina lata) &gt; 同義詞百翁盤針孢(LAerieW ό/ep/zarb)),玉米上之突臍蹲孢(五同義詞長螺 147474.doc 92· 201041514 抱)屬(例如玉米大斑突膦蠕抱(【⑽仏麵》;各種植物上 之鐮刀謂)(有性型:赤黴菌(伽州屬⑺萎 病、根或I腐爛),諸如榖類(例如小麥或大麥)上之禾轂鐮 刀菌(凡以G則·&quot;⑽⑺所)或黃色鐮刀菌(F. M/所(根腐 爛、斑點病或頭枯萋)、番祐上之尖孢鐮刀菌(P. οχ少www)、大豆上之茄病鐮刀菌(F.川/⑽〇及玉米上之串 珠錄刀菌(F· Wc/m);穀類(例如小麥或大麥)及玉 米上之禾頂囊破菌(容如&quot;所全蚀病 (take-all));穀類(例如禾穀赤黴菌(G 及稻(例如稻惡 黴赤黴菌(G. »认狀〇0 :惡苗病(Bakanae disease))上之赤 黴菌屬(G766ere//fl spp.);藤本植物、仁果及其他植物上之 圍小叢殼菌(G/〇Wae//a以叹“加幻及棉上之棉花炭疽菌(G 稻上之榖粒染色(Grainstaining)複合症;藤本植 物上之葡萄球座菌((¾⑼ari/z.a心·如e/⑴)(黑腐病);薔薇科 植物及槍柏上之膠錄邊屬⑽spp.),例如 梨上之沙賓膠銹菌((?. (銹病);玉米、穀類及稻上 之長蠕孢屬(同義詞内臍蠕孢屬,有性型:旋孢腔菌);銹 病菌屬(丑spp.),例如咖0非上之咖_聪孢銹菌(兄 (咖&gt;#葉銹病);藤本植物上之葡萄褐斑病菌 {Isariopsis c/aWspora)(同義詞葡萄分枝孢子菌 (Cladosporium W沿));大豆及棉上之菜豆殼球抱菌 {Macrophomina phaseolina)(同義詞菜豆球蛋白 (ρΛβΜ&lt;9/ζ·«))(根及莖腐爛);縠類(例如小麥或大麥)上之雪 黴鐮孢菌mWe)(同義詞雪腐鐮刀菌 147474.doc -93- 201041514 (Fwiir〜m m’va/e))(粉紅雪黴病(pink snow m〇ld));大豆上 之白粉病菌(Mz’cro印/mera山;//·Μι5α)(白粉病);褐腐病菌屬 spp.),例如核果類及其他薔薇科植物上之核果 褐腐函(Μ. /αχα)、果生叢梗孢(从yrMciic〇/fl)及仁果褐腐菌 (M. /rwcizgewa)(花及小枝枯病’褐腐病);穀類、香蕉、無 核果及落化生上之球腔卤屬spp.),諸如 小麥上之禾草根結線蟲(似 無性型··小麥殼 針孢(》Se/?ior/G ir⑴'c〇、殼針孢屬斑點病(sept〇ria blotch)) 或香焦上之斐濟球腔菌(Μ· /(/z&gt;則&amp;)(香蕉葉斑病(black Sigatoka disease));甘藍(例如芸苔根腫菌(P. 心似仏此))、油菜(例如寄生霜黴菌(p ⑴ca))、洋蒽 (例如洋蔥霜黴菌(凡c/eiyirWci〇r))、终草(於草霜徽菌(p iaZ&gt;ac/«(3))及大丑(例如大丑霜徽菌(户.fnanshuricaY)上之霜 黴菌屬(Per⑽0&gt;spora spp.)(霜黴病);大豆上之大豆銹菌 (Phakopsora pachyrhizi)反豆薯層鐫蛰〈p meib〇miaeK 大瓦 銹病);例如藤本植物(例如檸檬乾枯病菌(p 及四孢藻瓶黴(P_ ieiraip〇ra))及大豆(例如豆莖褐腐病菌(p gregWa)··莖腐爛)上之瓶梗黴屬(尸spp.);油菜 及甘藍上之甘藍黑腐菌(ρ/2〇;?ία /以別所)(根及莖腐爛)及甜 菜上之甜菜多黏菌(户· 6eiae)(根腐爛、葉斑及猝倒病);向 曰葵、藤本植物(例如葡萄生單軸黴(ρ. ν/〜〇/β):稈及葉 斑)及大豆(例如呈腐爛:菜豆疫黴(P. 似ei?H),有性型: 大豆黑點病囷phseo/orw/w))上之擬莖點黴屬 (P/zomop价spp.);玉米上之玉米褐斑病菌(户咖〜以則 147474.doc -94- 201041514 卿*)(褐斑病);&amp;種植m辣椒及韻蘆科植物(例 如辣椒疫黴菌(P·,㈣)、大豆(例如大雄疫徽菌(户 舰州;^則),同義詞大豆疫黴菌(户吻e))、馬鈴薯及番 W例如致病疫黴g(P. /咖_):晚疫病)及闊葉樹(例如 橡樹疫黴菌(P.聰㈣w) ··橡木猝死)上之疫黴菌屬CryIF (a2), CryllA (b), CrylllA, CrylllB (bl) or Cry9c; camping insecticidal protein (VIP), such as Vlpi, VIp2, vip3 or VIP3A; bacteria that colonize nematodes (eg, photobacterium genus). Or nematophagous; f genus (4) gifted; spp)) insecticidal protein; toxins produced by animals such as phytohormone, spider toxin, writh toxin or other insect-specific neurotoxin; toxins produced by fungi such as bonds Plant toxins; plant lectins, such as cowpea or barley lectin; agglutinin (agghuinins); protease inhibitors, such as trypsin inhibitors, serine protease inhibitors 'tuber storage protein (four) called, cyst Cysutin or papain inhibitor; ribosome deactivated protein (RIP), such as 1 hemp toxin, maize-rip, acacia toxin (abdn), = melon ribosome deactivated proteinist n), bird grass Prime (sap- or scented gum) (y din) 'deoxyl metabolism enzymes, such as 3 hydroxysteroid oxidase, 147474.doc -86 - 201041514 quercetin-IDP-glycosyl-transferase, cholesterol oxidase, Ecdysone inhibitor or HMG-CoA reductase; Subchannel blockers, such as blockers of Na or Ma channel; juvenile hormone esterase; diuretic hormone receptor (helicokinin receptor); stilben synthase, bibenzyl synthase (bibenzyl synthase), chitinase or glucanase. In the present invention, it is understood that these insecticidal proteins or toxins are also pre-toxins, hybrid proteins, and truncated Short or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains (see, for example, WO 02/015701), for example, in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, Other examples of such toxins or genetically engineered plants capable of synthesizing such toxins are disclosed in EP-A 451 878, WO 03/1 8810 and WO 03/52073. Methods for producing such genetically engineered plants are generally those skilled in the art. It is known and described, for example, in the above publications. The insecticidal proteins contained in genetically engineered plants confer to plants which produce such proteins tolerant pests, especially aphids, which are resistant to all taxa of arthropods (athropods). sheath Mesh (Coelo-ptera)), the two wings of insects (Diptera (Diptera)), and moths (Lepidoptera (Lepidoptera)) and nematodes (Nematoda (Nematoda)). Genetically engineered plants capable of synthesizing one or more insecticidal proteins are described, for example, in the above publication, some of which are commercially available, such as YieldGard® (a corn cultivar producing Cry 1 Ab toxin), YieldGard® Plus (creating CrylAb and Cry3Bbl toxin) Corn cultivar), Starlink® (Cry9c toxin-producing corn cultivar), Herculex® RW (producing Cry34Abl, Cry35Abl and phosphinothricin-N-acetyltransferase [Phosphinothricin-N-Acetyltransferase, PAT] jade 147474 .doc -87- 201041514 rice cultivar); NuCOTN® 33B (cotton cultivar producing Cry 1 Ac toxin), Bollgard® 1 (cotton cultivar producing CrylAc toxin), Bollgard® 11 (production of Cryl Ac and Cry2Ab2 toxin) Cotton cultivar); VIPCOT® (cotton cultivar producing VIP toxin); NewLeaf® (potato cultivar producing Cry3 A toxin); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Protecta®, Btll (eg Agrisure® CB), and Bt 176 from Syngenta Seeds SAS, France (corn cultivar producing Cryl Ab toxin and PAT enzyme) from Syng Enta Seeds S AS, MIR604 from France (corn cultivar producing modified Cry3 A toxin, see WO 03/018810), MON 863 from Monsanto Europe SA, Belgium (corn cultivar producing Cry3Bbl toxin), from Monsanto Europe SA , IPC 5 3 1 of Belgium (cotton cultivar producing modified Cry 1 Ac toxin) and 1507 (Corn cultivar producing CrylF toxin and PAT enzyme) from Pioneer Overseas Corporation, Belgium. Also included are plants which are capable of synthesizing one or more proteins by using recombinant DNA techniques to enhance the resistance or tolerance of their plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called "pathogenesis-associated proteins" (PR proteins, see, for example, EP-A 392 225), plant disease resistance genes (for example, from the wild potato of Mexico against late blight Ma Lulu (So/a) /iMm's potato cultivar against the resistance gene of Phytophthora capsici (10)) or T4 lysozyme (for example, the ability to synthesize such strong against bacteria (such as pear fire disease aw_y/vd?ra) ) the resistant protein of the potato 147474.doc -88 - 201041514 cultivar). Methods of producing such genetically engineered plants are generally known to those skilled in the art and are described, for example, in the above publication. In addition, it also covers the use of recombinant DNA technology to synthesize one or more proteins to increase productivity (eg, biomass yield, grain yield, starch content, oil content or protein content), to limit drought, salinity or other growth constraints. A plant that is tolerant to factors or tolerant to pests and fungal, bacterial or viral pathogens of their plants. In addition, 'plants that contain altered amounts of inclusions or novel inclusions, especially for improving human or animal nutrition, such as oil-producing crops that produce healthy long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids, are also encompassed. (eg Nexera® canola, D〇w Agro Sciences, Canada). In addition, 'plants that contain varying amounts of inclusions or novel inclusions, especially to increase the yield of the raw materials, such as potatoes that produce increased amounts of amylopectin (eg, Anifl〇ra® potatoes, are also included). BASF SE, Germany) ° Compounds I, II and IV and their compositions are particularly suitable for the control of the following plant diseases: horticultural plants, vegetables (eg Candida albicans (丄山·)) and hollyhocks (eg Brahman ginseng) Phytophthora (J/kgo spp.) (white rust) on white bacillus (丄irag〇p〇g〇„is); vegetables, canola (C. sinensis) Spores (Children's 6raiS&gt;s/cae)), beets (finely entangled (儿) (W), fruits, rice, soybeans, potatoes (eg, Solanum lycopersicum (丄so/am') or Alternaria (child (10) plus m)), tomato (such as Solanum solani or Alternaria spp.) and Schistosoma spp on wheat (cross-linked 147474.doc -89- 201041514 spore leaf spot); beet And the vegetables on the genus Cymbidium (10) outside the SPP.), Yi class and please on the shell of the two genus (heart Spp ·), such as wheat on wheat Diosporin (Eb (1) with eight anthracnose) and barley on barley (丄/zorc^), Helminthosporium spp.) and Helminthosporium spp.) (sexual type: spores) Phytophthora (c〇c 〇 心 心 心 心 心 心 心 ) ) ) ) ) ) 心 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方 南方(7)· zeic〇/a)), for example, a spot disease on a scorpion (wheat root rot (5 (1) · (10) (b))) and, for example, rice and turf on rice and turf (Wan O; zae); Wheat powdery mildew on cereals (eg wheat or barley) (not wmerk gTimkz··?) (formerly known as: Bacillus white powder π(10)ζ·_)) (powder disease); fruits and berries (eg strawberries), vegetables (eg lettuce) Carrot, root celery and cabbage), rapeseed, flower, vine, forest plant and gray mold on wheat (5〇?〇; along the cherea) (sexual type. Botrytis cinerea (5oirycm'm'a / Mc^re/z·(10)α): gray mold); lettuce on lettuce (AciMcae) (downy mildew); broad-leaved tree and evergreen tree (Ceraioc; ^iiS) (synonym long Shell mold (&lt;9p/n'0ii0Wa)) genus (rot or wilting), such as eucalyptus fungi on eucalyptus (C. Dutch elm disease); corn (eg gray leaf spot: corn ash) Spot disease (C. zeae-wa is rare?)), rice, sugar beet (such as beet brown spot (C_ 6eiico / a)), sugar cane 'vegetables, coffee, soybeans (such as the big five gray spot pathogen (C. so_; 7«a) or K. sphaeroides (c. Hhc/n7) and the genus Cercowora spp. (spotted leaf spot); Fanli S (eg tomato leaf mold (C., W/VMW): leaf mold) and scorpion on the scorpion genus spp.), such as black bud on wheat 147474.doc -90· 201041514 Mycobacterium (C·(black ear) )); ryegrass on cockroaches (c-γ (ergot); corn (round spot pathogen co^6o(10)m)), mites (eg Helminthosporium (c·, anamorphic wheat) Root rot] and rice (eg, Helminthosporium cerevisiae (c milk &gt;: heart (10) (10)), anamorphic: rice worm (10) (10) ^ ())) Helicobacter pylori (Coc o o6 上/Wi) (asexual type: flat umbilical snail Disease); cotton (eg, cotton thorn spores (C. g (10) smoke · (1), corn (such as thorns stalk gr (four): anti-aphid stalk rot (Anthracn 〇 stalk r〇t)), non-nuclear, potato (such as the ball Prickly ash (c.: black spot), beans (such as P. sinensis (C. (4) -)) and soybeans (such as P. sphaeroides (C. or Pseudomonas spp.) Spore (CoUetotrichumX has a sexual type · anthracnose (6) (10) (four) ...)) genus (anti-sickness) 'V. genus (CW / ζϋ s spp.), such as the Phytophthora sojae (C. Disease); multiple major spores (Corywespora cawz'z.co/aK leaf spot) on soybeans and ornamental plants; Cyclospora (C&gt;e/〇CO«km spp.), such as eucalyptus Phyllostachys pubescens (c; fruit trees, vines (such as Helminthosporium fulvum (c. //WWeWW) 'sexual type · Liriodendron chinense new sclerotium (ΛΓβ(10) such as ❿: black foot Black Foot Disease) and the genus Cysporium spp. on ornamental plants (eg if the tree ulcer or the young rat declines) has a serotype: the genus C. genus spp. or the Neonectria spp. )); soybeans Semi-known bacteria φ (four) valence ribs ~ Sexual type: Phytophthora genus β (10) • Magic X root and stem rot); 147474.doc • 91· 201041514 Phytophthora (D / India or Me spp.), such as soybean Soybean black spot disease CD. (damping off); corn, cereals (such as barley (such as barley bacillus (D·, net blotch) and wheat (such as wheat bacterium (Z)) ' «Edges: brown spot disease)), Helminthosporium snails on rice and turf (synonymous Helminthosporium, sexual type: nucleocapsid (/> (9) printed "Μ)) genus 'on the vine Ska disease (five sca heart blight, dry blight), which is caused by the genus Pseudomonas sp. (/?〇rwz.iz, p〇rz.a 夕(4) (synonymous P. sylvestris (p/) jeZ/hw, mediterranean terracotta (plant mediterranea), ssp. sputum (4) (10) 〇 heart Ch!amyd〇Sp〇ra) (formerly known as phae〇acrem〇nium, parasitic bottle mold (p/za(9)·say 仏ορ/π7_) and/or rotissus (such as lemma 5;?/zae...〇z&gt;iw buckle) caused by pomegranate (Pear sclerotium) ·)), no stone (Raspberry sac Bacteria (5. ve«ek): anthracnose) and vines (black sputum sputum (7). : anthracnose) on the genus Cysticer (Ugly (10)^ spp·); rice leaf black powder Bacteria (£n〇;/〇ma or less zae) (leaf smut); black bacterium of the genus CEpicoccwm spp_) (black mold); beet (beet powdery mildew (7) this)), vegetables (such as peas) Powdery mildew (Fanhu (4)·)), such as Cucurbitaceae (such as Brassica campestris (5. cz'c / zoracearwm)), cabbage, rapeseed (such as Brassicaceae powder (£. crMC / / erarwm)) Powdery mildew (five spp.K powdery mildew); Curvularia or αία on fruit trees, vines and ornamental trees (Grape rot or top blight, asexual type: Lata pseudocysts {Cytosporina Lata) &gt; Synonym: Baierie ό/ep/zarb), genus Fusarium oxysporum on the corn (five synonyms snail 147474.doc 92· 201041514) genus (eg corn large spotted phosphine creep) ([(10)仏面"; a variety of plants on the sickle) (sexual type: Gibberella (Gamma genus (7) wilt, root or I rot), such as mites (such as wheat or barley) Fusarium sclerophylla (G. &quot; (10) (7)) or yellow Fusarium (F. M / Institute (root rot, spot disease or head withered), Fusuke Fusarium oxysporum (P. οχ less Www), Fusarium solani on soybeans (F.chuan/(10)〇 and beetle (F·Wc/m) on corn; cereals (such as wheat or barley) and toppings on corn ( Rongru &quot;take-all); cereals (such as Gibberella gracilis (G and rice (eg, G. sinensis (G. » 〇0: Bakanae disease) Genus genus (G766ere//fl spp.); Phyllostachys pubescens, Pleurotus ostreatus and other plants on the genus C. elegans (G/〇Wae//a sighs with illusion and cotton anthracnose on cotton ( G Grain staining (Grainstaining) syndrome; Staphylococcus aureus on vine ((3⁄4(9)ari/za心·如e/(1)) (black rot); Rosaceae plant and gum on the cypress Genus (10)spp.), for example, Shabin rust fungus on pear ((?. (rust); corn, cereal, and Helminthosporium on rice (synonym umbilical, genus: Helminthosporium) Rust genus (ugly spp.), Such as coffee 0 non-coffee _ 聪 spore rust (brother (cafe &gt;# leaf rust); vines on the plant brown spot pathogen {Isariopsis c / a Wspora) (synonym grape cladosporium (Cladosporium W)) Soybean and cotton on the cabbage {Macrophomina phaseolina) (synonym pea globulin (ρΛβΜ&lt;9/ζ·«)) (root and stem rot); scorpion (such as wheat or barley) on the snow mold 镰Spore mWe) (synonymous Fusarium oxysporum 147474.doc -93- 201041514 (Fwiir~m m'va/e)) (pink snow m〇ld); powdery mildew on soybean (Mz' Cro print / mera mountain; / / · Μι5α) (powder disease); brown rot fungi spp.), for example, stone fruit and other Rosaceae plants on the nuclear brown rot (Μ. /αχα), fruit plexus (from yrMciic〇/fl) and brown rot fungus (M. /rwcizgewa) (flower and sprig blight 'brown rot'); cereals, bananas, non-nuclear and fallen spheroidal genus spp.) , such as the grass root knot nematode on wheat (like asexual type · wheat sphaeroides ("Se /? ior / G ir (1) 'c〇, sept〇 ria blotch) Fei Phytophthora (Μ· /(/z&gt;&amp;) (black Sigatoka disease); cabbage (such as Brassica oleracea (P. sinensis)), rapeseed (eg parasitic Downy mildew (p (1)ca)), artichoke (such as onion downy mildew (where c/eiyirWci〇r)), terminal grass (in the grass cream (p iaZ > ac / « (3)) and big ugly (such as large Helicobacter species (Per(10)0&gt; spora spp.) (downy mildew) on the ugly creamer (P. sinensis); Phakopsora pachyrhizi on the soybean, anti-bean layer 镌蛰 <p meib〇miaeK Rust); for example, vines (eg, lemon dry blight (p and i. pipiens) and soybeans (eg, gregwara (corpse spp.); black rot fungus (ρ/2〇;?ία / other) (cane and stem rot) on rapeseed and cabbage, and beet polymyxa (house 6eiae) on beet (root rot, Leaf spot and squatting disease; to hollyhock, vine (such as Plasmopara viticola (ρ. ν / ~ 〇 / β): stalks and leaf spots) and soybeans (for example, rot: Phytophthora sojae (P. Like ei?H) Sexual type: Soybean black spot disease 囷phseo/orw/w)) Pseudomonas spp. (P/zomop price spp.); Corn brown spot disease on corn (household coffee ~ 147474.doc -94 - 201041514 卿*) (Brown spot disease); &amp; planting m pepper and Rhododendron plants (eg Phytophthora capsici (P·, (iv)), soybean (eg Daxian bacillus (Hujianzhou; ^), synonym Phytophthora sojae (household e), potato and fruit W such as Phytophthora infestans g (P. / coffee _): late blight) and broad-leaved trees (such as Phytophthora capsici (P. Satoshi (four) w) · oak dying) Phytophthora

(/&gt;/^吵spp.)(祠萎病、根、葉、果實及莖腐病”甘 藍、油菜、㈣及其他植物上之十字花科植物根瘤病菌 (J^asmodiophora brassicaeX 根瘤病);單軸黴屬 (P/w則ρπα sPP_),例如藤本植物上之葡萄生單軸黴(户. v⑴(葡萄藤霜黴病)及向日葵上之向日葵露菌病菌π. ;薔薇科植物、蛇麻子、梨果及無核果上之叉絲 單囊殼屬(Po办spp.)(白粉病),例如蘋果上之蘋果 白粉病菌(P. ;例如穀類(諸如大麥及小麥(禾 穀多黏菌(八及甜菜(甜菜多黏菌(p 6eiae)))上之 多黏菌屬spp.)及由此傳播之病毒性疾病;榖類 (例如小麥或大麥)上之基腐病菌(户 (眼點,有性型:惡苗病菌(7^以化 F//MWC^e));各種植物上之假霜黴(户办peropora)(霜 黴病)’例如葫蘆科植物上之古巴假霜黴(jP. ⑼或蛇 麻子上之漳草.假霜黴(户· ;藤本植物上之葡萄角斑 葉焦、病逢(Pseudopezicula tracheiphila)(紅火病(jed fire disease)或羅氏病(r〇tbrenner’),無性型:瓶梗黴 (Ρ/ζζ’α/ορ/ϊορα));各種植物上之錄菌屬(PwcciWa spp.)(錢 病),例如穀類(諸如小麥、大麥或黑麥)及蘆筍(例如天門 147474.doc -95- 201041514 科柄銹菌(i&gt; 上之褐銹菌(iJn.cha)(褐銹病或 葉銹病)、條形柄銹菌(P. _•价_)(條銹病或黃銹病卜 大麥柄銹菌(户心0(矮銹病)、禾柄銹菌(户⑷(莖 錄病或黑錄病)或葉銹菌(户· )(褐錢病或葉錢病); 小麥上之偃麥草核腔菌(ore⑽抑ora 無性 型:内臍蠕孢)(褐斑病)或大麥上之圓核腔菌(尸網 斑病);梨胞黴屬spp.),例如稻上之水稻稻瘟 病菌(户· 〇7zae)(有性型:稻瘟病菌(从叹”印…: 稻熱病)及草皮及穀類上之稻瘟病菌(p V—幻;草皮、 稻 '玉i}t、小麥、棉、油菜、向日莫、大豆、甜菜、蔬菜 及各種其他植物上之腐黴菌屬(P__ spp )(猝倒病)(例如 終極腐黴菌(p. M&quot;z.mww)或瓜果腐黴菌(户 aph⑽idennatum))·’枝隔孢屬(Ra廳spp),例如大參 上之膠西格寧柱隔孢(及.co//0_c;·)(柱隔孢葉斑、生理學 葉斑)及甜菜上之甜菜柱隔孢(/?. 6ei/c〇/a);棉、稻、馬鈴 薯、草皮、玉米、油菜、馬鈴薯、甜菜、蔬菜及各種其他 植物上之絲核鹵屬(及;2Z‘ZOCic»«/i7 spp.),例如大豆上之立士 絲核菌(儿川/⑽/)(根及莖腐爛)、稻上之立枯絲核菌(外鞘 枯萎病)或小麥或大麥上之禾榖絲核菌(兄cerea/^)(絲核菌 彈簧枯萎病(Rhizoctonia spring blight));草莓、胡蘿芍、 甘藍、藤本植物及番茄上之葡枝根黴 黑黴病、軟腐病);大麥、黑麥及黑小麥上之大 麥雲紋病菌(烈少狀/?聽(雲紋斑病(scaid)); 稻上之帚梗柱孢(5W〇c/a山·謂〇ryzae)及葉鞘腐敗菌 147474.doc •96- 201041514 鞠腐病);蔬菜及田間作物上之核盤菌屬 spp.)(莖腐爛或白黴病),諸如油菜、向曰葵 (例如菌核病菌(*SWeroi/«/a 及大豆(例如齊整 小核菌(S. ro//Wi)或菌核病菌);各種植物上之殼針孢屬 (SepioWa spp·),例如大豆上之大豆褐紋菌(51· g(ye/似?)(褐 斑病)、小麥上之小麥殼針抱(51· (殼針孢斑病)及榖 類上之穎枯殼針抱(*S. ??〇6/orwm)(同義詞穎枯殼針孢 長穗菅茅斑葉病菌斑 (Stagonospora blotch));藤本植物上之葡萄白粉病 ([/«ckw/a weca/or)(同義詞粉徽病菌(£&gt;&gt;^(p/7e neca/or))(白 粉病,無性型:葡萄粉孢iwcArerz·));玉米(例如玉 米大斑病菌(*S· iwrcicwm),同義詞玉米大斑病菌 (i/e/whi/zospor/ww iwrc/cww))及草皮上之刺球腔菌屬 (Setospaeria spp.)(葉枯病);玉米(例如絲黑粉病菌(iS_ re///a⑽):絲黑穗病(Areme/ ewMi))、高粱及甘蔑上之轴黑 粉菌屬(印/^ce/oi/zeca spp.)(黑穗病);葫蘆科植物上之蒼 耳單絲殼(iSp/zaeroi/zeca /w//g/«ea)(白粉病);馬鈴薯上之馬 鈐薯粉痴菌(粉病病)及由此傳播 之病毒性疾病;穀類上之長穗营茅斑葉病菌屬 (57叹〇«〇?/?〇ra spp.),例如小麥上之穎枯殼針孢(51. ?2c»i/orww)(長穗管茅斑葉病菌斑,有性型:小麥子囊菌 (Lepiosp/zaeria ?i〇(iorwm)[同義詞小麥葉枯病菌 77〇&lt;iorwm)];馬铃薯上之馬铃薯癌腫病菌 {Synchytrium endobioticum)(馬龄集癌後病)·,外囊菌屬 147474.doc -97- 201041514 spp.),例如桃上之畸形外囊菌似)(捲 葉病)及李子上之李外囊菌(7卞_)(李袋果病)·,於草、仁 菜 大豆及棉上之根串珠徽眉 spp·)(黑根腐病)’例如根腐黴(r 同義詞根串珠 徽(CT^/flfM e/ega似));縠類上之腥黑粉菌屬(爪化如 SPP.)(普通黑穗病(comm〇n bunt)或腥黑穗病(stinking smut)),諸如小麥上之小麥腥黑粉菌(r Μη·。)(同義詞小 麥網腥黑穗病菌(r can.a),小麥腥黑穗病bunt))及 矮腥黑穗病菌(Γ· co«^*〇verja)(矮腥黑穗病(dwarf bunt)); 大麥或小麥上之麥類雪腐褐色小粒菌核病菌(办户⑹。 如〇)(灰色雪黴病);條黑粉菌屬(t/rocF出Spp·),例 如黑麥上之黑麥桿黑穗病菌(f/. 〇ccw/ia)(莖黑粉病);蔬菜 上之單孢銹菌屬spp )(銹病),該等蔬菜為諸如 豆(例如菜豆錢囷((/. 山·cw/ai⑽),同義詞豆單胞銹菌 (t/· /?/?_〇/〇)及甜菜(例如甜菜單孢銹菌(c/ ;縠類 (例如大麥散黑粉菌(K仙而)及燕麥散黑粉菌((/. αναπαβ))、玉米(例如玉蜀黍黑粉菌(ί/則少心^ :玉米黑 稳病)及甘嚴上之黑粉菌屬(仏…叩^ spp.)(散黑穗病);蘋 果(例如類果黑星菌(ρ. z’„ae《Ma仏))及梨上之黑星菌屬 (FeWwrw spp.)(痂病);及各種植物(諸如水果及觀賞植 物、藤本植物、無核果、蔬菜及田間作物)上之輪枝菌屬 (Ferih7/z·謂spp.)(;周萎病),例如草每、油菜、馬鈴薯及 番茄上之大理輪枝菌(F心/^此)。 化合物I、II及IV及其組合物亦分別適用於在保護儲存之 147474.doc -98 - 201041514 產品或及收穫物及保護材料中防治有害真菌。術語「保禮 材料」應理解為表示保護工業材料及非生活材料,諸如毒占 著劑、膠、木材、紙及紙板、紡織品 '皮革、油漆分散 液、塑膠、冷卻潤滑劑、纖維及織物以防有害微生物(諸 如真菌及細菌)侵染及破壞。在保護木材及其他材料時, 以下有害真翻尤其值得注意.子囊讀類(Ascomycetes),諸 如長喙殼黴屬spp.)、青變真菌屬 SPP·)、出芽短梗黴、擬莖點徽屬 (Sc/erop/zoma spp_)、毛殼菌屬(C/meiowz.wm spp.)、腐質徽 屬(ffumicoZa spp.)、彼得毅屬(PetrieHa spp.)、針葉宽屬 (TW&lt;^wr«5 spp_);擔子菌類(Basidiomycetes),諸如粉抱革 菌屬(Com’op/jora spp.)、革蓋菌屬(Corz’o/似 spp.)、密褐褶 孔菌屬(G/oeop/z;;//wm spp·)、香菇屬肋.《似 Spp_)、側耳 屬(P/ewroiw·? spp.)、茯苓屬spp·)、龍介蟲屬 (Serpw/fl spp.)及乾路菌屬spp.),半知菌類 (Deuteromycetes)’ 諸如麴菌屬(JaergH/Mj spp·)、分枝孢 子菌屬、青黴屬(Pem’cz7&quot;ww spp.)、木黴屬(TWc;2〇rwa spp.)、交鏈孢屬 spp·)、擬青黴屬 spp.),及接合菌類(Zygomycetes),諸如毛徽菌屬(Mwcor spp_),且另外’在保護儲存之產品及收穫物中,以下酵母 真菌值得注意:念珠菌屬(仏《心而spp·)及釀酒酵母 (iSWc/zaromyce·? cerev/sae) ° 化合物I、II及IV及其組合物可分別用於改良植物健康。 本發明亦係關於一種藉由分別用有效量之化合物I、II及/ 147474.doc -99· 201041514 ㈣及其組合物處理植物、其繁殖材料及/或植物生長地 或預定生長地來改良植物健康的方法。 術語「植物健康」應理解為表示植物及/或其收穫物之 狀況,該狀況係根據數個指標(單獨或彼此組合)判定,該 等指標諸如產量(例如生物量提高及/或有價值成分含量提 南)、植物活力(例如植物生長加快及/或葉子更綠(「變綠 效應」))、品質(例如某些成分之含量或組成提高)及對非 生物及/或生物逆境之耐受性。以上鑑別之植物徤康狀況 指標可互相依存或可互為因果。 式I、II及IV化合物可以可具有不同生物活性之不同晶體 變體存在。其同樣為本發明之標的。 二匕合物UMV可原樣或以組合物形式用於以殺真菌有 效里之活性物質處理真菌、欲保護以防真菌侵襲之或植 物、植物繁歸料(諸如種子)、土壤、表面、材料或空 間。可在真菌感染植物、植物繁殖材料(諸如種子)、土 壤、表面、材料或空間之前與之後進行施用。 可在種植或移植期間或之前用化合物I、Π及/或1¥本身 或包含至少一種化合物丨、π及/或IV之組合物預防性處理 植物繁殖材料。 本發明亦係關於包含溶劑或固體載劑及至少一種化合物 I、II及/或IV之農用化學組合物,及其防治有害真菌之用 途。 農用化學組合物包含殺真菌有效量之化合物I、/或 IV。術語「有效量」表示組合物或化合物I、II及/或…之 147474.doc -100- 201041514 量足以防治栽培植物上之有害真菌或保護材料且不對所處 理之植物產生實質性損害。此量可在寬範圍内變化且視多 種因素而定,該等因素諸如欲防治之真菌物種、所處理之 栽培植物或材料、氣候條件及所使用之特定化合物。 化合物I、II及IV及其鹽可轉化成常用類型之農用化學組 合物,例如溶液、乳液、懸浮液、撒粉、粉劑、糊劑及顆 粒劑。組合物類型視特定預定目的而定;在各情況下,其 應確保本發明化合物之精細且均一的分佈。 組合物類型之實例為懸浮液(SC、OD、FS)、可乳化濃 縮物(EC)、乳液(EW、EO、ES)、糊劑、片劑、可濕性粉 劑或撒粉(WP、SP、SS、WS、DP、DS)或顆粒劑(GR、 FG、GG、MG)(其可具水溶性或可濕性),以及用於處理諸 如種子之植物繁殖材料之凝膠調配物(GF)。 組合物類型(例如 SC、OD、FS、EC、WG、SG、WP、 SP、SS、WS、GF)通常稀釋後使用。諸如DP、DS、GR、 FG、GG及MG之組合物類型通常不稀釋即使用。 组合物係以已知方式製備(參看US 3,060,084、EP-A 707 445(關於液體濃縮物);Browning:「Agglomeration」, Chemical Engineering, 1967 年 12 月 4 日,147-48, Perry's Chemical Engineer's Handbook,第 4 版,McGraw-Hill, New York, 1963,第 8-57頁及其後内容;WO 91/13546、 US 4,172,714 、US 4,144,050 、US 3,920,442、US 5,180,587、US 5,232,701、US 5,208,030、GB 2,095,558、 US 3,299,566 ; Klingman: Weed Control as a Science (J. 147474.doc •101- 201041514(/&gt;/^ noisy spp.) (祠, disease, root, leaf, fruit and stem rot) Brassica napus, rapeseed, (four) and other plants on the cruciferous rhizobia (J^asmodiophora brassicaeX nodule disease); Monochamus (P/w ρπα sPP_), for example, Phytophthora sinensis on the vine (house. v(1) (vine vine downy mildew) and sunflower bacterium on sunflower π.; Rosaceae plant, snake Pseudostellaria, pear fruit and non-nuclear fruit of the genus Pseudomonas (Po spp.) (powder disease), such as apple powdery mildew on apples (P.; such as cereals (such as barley and wheat (polymyxa) (8 and beet (P 6eiae)) on the genus Spirulina spp.) and the viral diseases transmitted thereby; basal rot (on wheat or barley) on the base rot (household (eye) Point, sexual type: Phytophthora (7^ to F//MWC^e)); pseudo-Pythium on various plants (household peropora) (downy mildew), such as Cuban fake cream on Cucurbitaceae Mildew (jP. (9) or yarrow on hops. Fake downy mildew (household; vines on the vines, Pseudopezicula tracheiphila) (jed fire disease) or Roche disease (r〇tbrenner'), asexual type: Phytophthora (Ρ/ζζ'α/ορ/ϊορα)); PwcciWa spp. on various plants (money disease) ), such as cereals (such as wheat, barley or rye) and asparagus (such as Tianmen 147474.doc -95- 201041514 rust fungus (i&gt; rust rust (iJn.cha) (brown rust or leaf rust), Puccinia striiformis (P. _•price_) (strip rust or yellow rust disease barley rust fungus (huxin 0 (dwarf rust), Pleurotus ostreatus (household (4) (stem disease or black recorded disease) or Leaf rust (household) (brown money disease or leaf money disease); wheat sclerotium on the wheat (ore (10) inhibiting ora anamorphic: umbilical cord blood spores) (brown spot) or round nucleus on barley Bacteria (botany net spot disease); Pythium genus spp.), such as rice blast fungus (household 〇7zae) on rice (sex type: rice blast fungus (from sighs printed on: rice fever) and turf And the genus Magnaporthe oryzae (p__spp) on cereals (p V-illusion; turf, rice 'jay}}, wheat, cotton, rapeseed, yogmo, soybean, sugar beet, vegetable and various other plants Tripping disease (eg, Pythium ultimum (p. M&quot; z.mww) or Pythium genus (Aph(10)idennatum) · 'Aspergillus sp. (Ra hall spp), such as the ginseng on the ginseng column And .co//0_c;·) (column leaf spot, physiological leaf spot) and beet column spores on sugar beet (/?. 6ei/c〇/a); cotton, rice, potato, turf, corn , rapeseed, potato, sugar beet, vegetables and various other plants on the silk genus (and; 2Z'ZOCic»«/i7 spp.), such as soybean on the genus Rhizoctonia (Kichuan / (10) /) (root And stem rot), Rhizoctonia solani (Sheath wilt) on rice or Rhizoctonia solani on wheat or barley (Rhizoctonia spring blight); Straw, Rhizopus oryzae, soft rot on strawberries, carrots, vines, and tomatoes; barley worms on barley, rye, and black wheat (strong and small? Disease (scaid); scutellariae (5W〇c/a mountain, 〇ryrye) and leaf sheath spoilage 147474.doc •96- 201041514 鞠腐鞠); Sclerotinia on vegetables and field crops Belongs to spp.) Rotten or white mold), such as rapeseed, geranium (such as Sclerotinia sclerotiorum (*SWeroi/«/a and soybean (such as S. ro//Wi or Sclerotium); various plants SepioWa spp., such as soybean brown bacterium on soybean (51 g (ye/like?) (brown spot), wheat husk on wheat (51· (shell needle spore) Disease) and the scorpion on the scorpion (*S. ??〇6/orwm) (synonym of the genus Stagonospora blotch); the grape white powder on the vine Disease ([/«ckw/a weca/or) (synonymous powder pathogen (£&gt;&gt;^(p/7e neca/or)) (powder disease, asexual type: grape powder spore iwcArerz·)); corn (eg, S. cerevisiae (*S·iwrcicwm), synonymous with S. cerevisiae (i/e/whi/zospor/ww iwrc/cww)) and Setospaeria spp. Disease); corn (eg, smut (iS_re///a(10)): smut (Areme/ ewMi)), sorghum and sorghum on the axis of black genus (Print / ^ ce / oi / zeca Spp.) (Smut); Xanthium monofilament shell on Cucurbitaceae (iSp/zaeroi/zeca /w //g/«ea) (powder disease); the potato on the potato, the disease of the potato powder (powder disease) and the viral disease transmitted by it; the genus of the genus sphaeroides on the cereal (57 sigh «〇?/?〇ra spp.), for example, the genus A. oxysporum (51. ?2c»i/orww) on wheat (S. serrata), serotype: wheat ascomycetes (Lepiosp/ Zaeria ?i〇(iorwm)[synonymous wheat leaf blight 77〇&lt;iorwm)]; potato sympathy pathogen {Synchytrium endobioticum) on potato (existing post-cancerous disease), ectoside 147474 .doc -97- 201041514 spp.), such as the deformed outer bacillus on the peach (rolling leaf disease) and the outer sclerotia on the plum (7 卞 _) (Li bag fruit disease) ·, in the grass, kernel Vegetable soybean and cotton roots on the beaded eyebrows spp·) (black root rot) 'such as Rhizopus genus (r synonym root beaded emblem (CT^/flfM e/ega)); 腥 black 粉Genus (claws such as SPP.) (comm〇n bunt or stinking smut), such as wheat smut (r Μη· on wheat). (synonymous wheat smut (r can.a), wheat smut bunt) and dwarf smut (Γ·co«^*〇verja) (dwarf bunt) ); wheat, snow rot, brown sclerotium on barley or wheat (household (6). Rugao) (grey snow mold); genus genus (t/rocF out of Spp), such as rye Ryegrass smut (f/. 〇ccw/ia) (stem smut); vegetables on the genus Sphaeroides spp (rust), such as beans (such as peas money ((/ . mountain · cw / ai (10)), the synonym of Puccinia solani (t / · /? /? _ 〇 / 〇) and beets (such as the sweet menu spore rust (c / ; 縠 (such as barley powder black powder bacteria (K And the oatmeal powder ((.. αναπαβ)), corn (such as maize black powder fungus (ί / then less heart ^: corn black stable disease) and Ganshen genus genus (仏...叩^ spp.) (stained smut); apples (eg, Phytophthora capsici (ρ. z'„ae “Ma仏)) and Pseudostellaria (FeWwrw spp.) (痂); Various plants (such as fruits and ornamentals, vines, prunes, vegetables and fields) Verticillium (Ferih7/z·prespp.) (periosis), such as Verticillium dahliae (F heart/^) on grass, rapeseed, potato and tomato. , II and IV and their compositions are also suitable for the control of harmful fungi in protected storage 147474.doc -98 - 201041514 products or harvested and protective materials. The term "birthing material" shall be understood to mean the protection of industrial materials and Non-living materials such as poison-occupying agents, glues, wood, paper and paperboard, textiles 'leather, paint dispersions, plastics, cooling lubricants, fibers and fabrics to prevent infestation and destruction by harmful microorganisms such as fungi and bacteria. In the protection of wood and other materials, the following harmful effects are particularly noteworthy. Ascomycetes (such as Aspergillus sp.), Spirulina spp.), Aureobasidium, P. Genus (Sc/erop/zoma spp_), Chaetomium (C/meiowz.wm spp.), genus ffumicoZa spp., PetrieHa spp., TW&lt; ^wr«5 spp_); Basidiomycetes, such as Pseudomonas (Co M'op/jora spp.), genus genus (Corz'o/like spp.), genus Pleurotus (G/oeop/z;;//wm spp.), lentus ribs. Spp_), Pleurotus (P/ewroiw·? spp.), genus spp·), genus Serpw/fl spp. and stem genus spp., deuteromycetes such as sputum Genus (JaergH/Mj spp.), Mycobacterium spp., Penicillium (Pem'cz7&quot;ww spp.), Trichoderma (TWc; 2〇rwa spp.), Alternaria spp·), Paecilomyces Is a spp.), and Zygomycetes, such as Mwcor spp_, and additionally 'in the protection of stored products and harvests, the following yeast fungi are worth noting: Candida (仏心心spp ·) and Saccharomyces cerevisiae (iSWc/zaromyce·? cerev/sae) ° Compounds I, II and IV and their compositions can be used to improve plant health, respectively. The invention also relates to a method for improving a plant by treating the plant, its propagation material and/or plant growth or intended growth with an effective amount of each of the compounds I, II and / 147474.doc -99. 201041514 (d) and compositions thereof. Healthy method. The term "plant health" is understood to mean the condition of a plant and/or its harvest, which is determined on the basis of several indicators, either alone or in combination with one another, such as yield (eg biomass increase and/or valuable components). Content (Southern), plant vigor (eg, faster plant growth and / or greener leaves ("greening effect")), quality (such as increased content or composition of certain ingredients) and resistance to abiotic and / or biological stress Receptive. The indicators of plant health identified above may be interdependent or mutually causal. The compounds of formula I, II and IV may exist in different crystal modifications which may have different biological activities. It is also the subject of the invention. The dimethylene UMV can be used as such or in the form of a composition for the treatment of fungi with fungicidal active substances, protection against fungal attack or plants, plant vegetative (such as seeds), soil, surface, material or space. Administration can be carried out before and after the fungal infection of the plant, plant propagation material (such as seeds), soil, surface, material or space. The plant propagation material can be treated prophylactically with Compound I, hydrazine and/or 1 itself or a composition comprising at least one of the compounds 丨, π and/or IV during or prior to planting or transplanting. The invention also relates to agrochemical compositions comprising a solvent or solid carrier and at least one compound I, II and/or IV, and to the use thereof for controlling harmful fungi. The agrochemical composition comprises a fungicidally effective amount of Compound I, / or IV. The term "effective amount" means that the composition or the compound 147474.doc -100- 201041514 of the compound I, II and/or ... is sufficient to control harmful fungi or protective materials on cultivated plants and does not cause substantial damage to the treated plant. This amount can vary widely and depends on a number of factors such as the species of fungus to be controlled, the cultivated plant or material being treated, the climatic conditions and the particular compound employed. The compounds I, II and IV and their salts can be converted into a common type of agrochemical composition such as solutions, emulsions, suspensions, dusting powders, powders, pastes and granules. The type of composition will depend on the particular intended purpose; in each case it should ensure a fine and uniform distribution of the compounds of the invention. Examples of composition types are suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW, EO, ES), pastes, tablets, wettable powders or dusting (WP, SP) , SS, WS, DP, DS) or granules (GR, FG, GG, MG) (which may be water soluble or wettable), and gel formulations for treating plant propagation materials such as seeds (GF ). The type of composition (eg, SC, OD, FS, EC, WG, SG, WP, SP, SS, WS, GF) is typically used after dilution. Composition types such as DP, DS, GR, FG, GG, and MG are usually used without dilution. The compositions are prepared in a known manner (see US 3,060,084, EP-A 707 445 (for liquid concentrates); Browning: "Agglomeration", Chemical Engineering, December 4, 1967, 147-48, Perry's Chemical Engineer's Handbook, 4th edition, McGraw-Hill, New York, 1963, pp. 8-57 and thereafter; WO 91/13546, US 4,172,714, US 4,144,050, US 3,920,442, US 5,180,587, US 5,232,701, US 5,208,030, GB 2,095,558 , US 3,299,566 ; Klingman: Weed Control as a Science (J. 147474.doc •101- 201041514

Wiley &amp; Sons,New York,mi) ; Hance 等人:Weed Control Handbook (第 8版,Blackwell Scientific, 〇xf〇rd, 1989)及 Mollet,H.及 Grubemann,A·: Formulation technology (Wiley VCH Verlag,weinheim,20(h))。 農用化學組合物亦可包含農用化學組合物中常用之助 劑。分別視特定施用形式及活性物質選擇所使用之助劑。 適合助劑之實例為溶劑、固體載劑、分散劑或乳化劑 (諸如其他增溶劑、保護性膠體、界面活性劑及黏著劑)、 有機及無機增稠劑、殺細菌冑、防;東劑、消泡劑、(適當 柃)者色劑及增黏劑或黏合劑(例如用於種子處理調配物)。 適合溶劑為水、有機溶劑,諸如具有中等沸點至高沸點 之礦物油餾份’諸如煤油或柴油,此外為煤焦油及植物或 動物來源之油;脂族烴、環烴及芳族烴,例如曱苯、二曱 壞四氫萘、炫*基化萘或其衍生物;醇,諸如曱 醇、乙醇、丙、丁醇及環己醇;三醇;酉同,諸如環己 -5 γ 丁内®曰、知肪酸一曱醯胺、脂肪酸及脂肪酸酯及 強極性溶劑,例如胺,諸如Ν-曱基咣咯啶酮。 固體載劑為礦質土,諸如矽酸鹽、矽膠、滑石、高嶺 土、石灰石、石灰、白要、红玄武土黃土黏土、白雲 广夕藻土、硫酸鈣、硫酸鎂、氧化鎂、經研磨合成材 料、肥料’諸如硫酸銨、磷酸銨、硝酸銨、尿素,及植物 來源之產°口,諸如榖粕、樹皮粕、木屑及堅果殼粕、纖維 素粉及其他固體載劑。 適合界面活性劑(佐劑、濕潤劑、增黏劑、分散劑或乳 147474.doc 201041514 化劑)為芳族績酸(諸如木質素橫酸(Borresperse®型, Borregard,Norway)、苯紛續酸、萘石黃酸(Morwet® 型, Akzo Nobel,U.S.A.)及二丁基萘磺酸(Nekal® 型,BASF, Germany))及脂肪酸之鹼金屬鹽、鹼土金屬鹽及銨鹽;烷 基磺酸酯、烧基芳基續酸S旨、烧基硫酸酯、月桂基醚硫酸 酯、脂肪醇硫酸酯,及硫酸化十六醇鹽、硫酸化十七醇鹽 及硫酸化十八醇鹽、硫酸化脂肪醇二醇醚;此外以及萘或 萘磺酸與苯酚及甲醛之縮合物;聚氧化乙烯辛基苯基醚、 乙氧基化異辛基苯紛、辛基苯盼、壬基苯紛、烧基苯基聚 二醇醚、三丁基苯基聚二醇醚、三硬脂醯基苯基聚二醇 醚、烷基芳基聚醚醇、醇及脂肪醇/環氧乙烷縮合物、乙 氧基化I麻油、聚氧化乙烯烷基醚、乙氧基化聚氧化丙 烯、月桂醇聚二醇醚縮醛、山梨糖醇酯、木質素亞硫酸鹽 廢液,及蛋白質、變性蛋白質、多醣(例如曱基纖維素)、 疏水性改質澱粉、聚乙烯醇(Mowiol®型,Clariant, Switzerland)、聚叛酸酉旨(Sokolan®型,BASF, Germany)、 聚烷氧基化物、聚乙烯胺(Lupasol®型,BASF, Germany)、 聚乙烯吡咯啶酮及其共聚物。 增稠劑(亦即賦予組合物改良之流動性(亦即靜止條件下 具高黏度及攪拌期間具低黏度)的化合物)之實例為多醣及 有機及無機黏土,諸如三仙膠(Xanthan gum)(Kelzan®, CP Kelco, U.S.A.) ' Rhodopol® 23(Rhodia, France) ' Veegum® (R.T. Vanderbilt, U.S.A.)或 Attaclay®(Engelhard Corp., NJ, USA)。 147474.doc -103 - 201041514 可添加殺細菌劑以保存及安定組合物。適合殺細菌劑之 實例為基於以下之殺細菌劑:雙氣酚(dichlorophene)及笨 甲醇半甲縮醛(ICI 之 Proxel®,或 Thor Chemie 之 Acticide® RS,及R〇hm &amp; Haas之Kathon® MK),及異噻唑啉酮衍生 物’諸如烧基異噻嗤啉酮及苯并異噻唑啉酮(Th〇r chemie 之 Acticide® MBS)。 適合防凍劑之實例為乙二醇、丙二醇、尿素及甘油。 消泡劑之實例為聚矽氧乳液(諸如silik〇n® SrE,Wacker,Wiley &amp; Sons, New York, mi) ; Hance et al.: Weed Control Handbook (8th ed., Blackwell Scientific, 〇xf〇rd, 1989) and Mollet, H. and Grubemann, A·: Formulation technology (Wiley VCH Verlag , Weinheim, 20(h)). The agrochemical composition may also contain adjuvants commonly used in agrochemical compositions. The adjuvants used are selected depending on the particular application form and the active substance. Examples of suitable auxiliaries are solvents, solid carriers, dispersants or emulsifiers (such as other solubilizers, protective colloids, surfactants and adhesives), organic and inorganic thickeners, bactericidal cockroaches, anti-agents; , defoamers, (suitable) toners and tackifiers or binders (for example for seed treatment formulations). Suitable solvents are water, organic solvents, such as mineral oil fractions having medium to high boiling points such as kerosene or diesel, in addition to coal tar and oils of vegetable or animal origin; aliphatic hydrocarbons, cyclic hydrocarbons and aromatic hydrocarbons such as hydrazine Benzene, diterpenoid tetrahydronaphthalene, daunyl naphthalene or its derivatives; alcohols such as decyl alcohol, ethanol, propane, butanol and cyclohexanol; triols; the same, such as cyclohex-5 γ ® 曰, 知 曱醯 曱醯 、 、, fatty acids and fatty acid esters and strong polar solvents, such as amines, such as Ν-mercaptopurrotone. The solid carrier is mineral soil, such as silicate, tannin, talc, kaolin, limestone, lime, white, red basalt loess clay, white cloud, white sulfate, calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials. Fertilizers such as ammonium sulphate, ammonium phosphate, ammonium nitrate, urea, and plant-derived products such as alfalfa, bark, wood chips and nut shells, cellulose powder and other solid carriers. Suitable for surfactants (adjuvants, wetting agents, tackifiers, dispersants or emulsions 147474.doc 201041514) for aromatic acid (such as lignin cross-acid (Borresperse®, Borregard, Norway), benzene Acid, naphthoic acid (Morwet® type, Akzo Nobel, USA) and dibutylnaphthalenesulfonic acid (Nekal® type, BASF, Germany) and alkali metal, alkaline earth metal and ammonium salts of fatty acids; alkyl sulfonate Acid ester, alkyl aryl acid S, pyryl sulfate, lauryl ether sulfate, fatty alcohol sulfate, and sulfated cetyl salt, sulfated heptadecyl salt and sulfated stearyl salt, Sulfated fatty alcohol glycol ether; in addition to condensate of naphthalene or naphthalenesulfonic acid with phenol and formaldehyde; polyoxyethylene octylphenyl ether, ethoxylated isooctylbenzene, octylbenzene, decyl benzene Dimethyl phenyl polyglycol ether, tributyl phenyl polyglycol ether, tristearyl phenyl polyglycol ether, alkyl aryl polyether alcohol, alcohol and fatty alcohol / ethylene oxide Condensate, ethoxylated I sesame oil, polyoxyethylene alkyl ether, ethoxylated polypropylene oxide, lauryl alcohol polyglycol ether acetal, Sorbitol ester, lignin sulfite waste liquor, and protein, denatured protein, polysaccharide (eg, thioglycol), hydrophobic modified starch, polyvinyl alcohol (Mowiol® type, Clariant, Switzerland), polyglycolic acid酉 (Sokolan® type, BASF, Germany), polyalkoxylates, polyvinylamines (Lupasol® type, BASF, Germany), polyvinylpyrrolidone and copolymers thereof. Examples of thickeners (i.e., compounds which impart improved fluidity to the composition (i.e., compounds having high viscosity at rest and low viscosity during agitation) are polysaccharides and organic and inorganic clays such as Xanthan gum. (Kelzan®, CP Kelco, USA) 'Rhodopol® 23 (Rhodia, France) ' Veegum® (RT Vanderbilt, USA) or Attaclay® (Engelhard Corp., NJ, USA). 147474.doc -103 - 201041514 A bactericide may be added to preserve and stabilize the composition. Examples of suitable bactericides are bactericides based on the following: dichlorophene and stupid methanol hemiacetal (Proxel® from ICI, or Acticide® RS from Thor Chemie, and Kathon from R〇hm &amp; Haas) ® MK), and isothiazolinone derivatives such as acetoisothiazolinone and benzisothiazolinone (Acticide® MBS from Th〇r chemie). Examples of suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerin. An example of a defoamer is a polyoxyl emulsion (such as silik〇n® SrE, Wacker,

Germany 或 Rhodorsil®,Rhodia,France)、長鏈醇、脂肪 酸、脂肪酸之鹽、氟有機化合物及其混合物。 適合著色劑為低水溶性顏料及水溶性染料。可提及之實 例有以下名稱:若丹明B(rhodamin B)、C. I.顏料紅112、 c. I.溶劑紅丨、顏料藍15:4、顏料藍15」、顏料藍15:2、顏 料藍15:1、顏料藍80、顏料黃i、顏料黃13、、顏料紅 112、顏料紅48:2、顏料紅48:1、顏料紅57:1、顏料紅 53:1、顏料橙43、顏料橙34、顏料橙5、顏料綠%、顏料 綠7、顏料白6、顏料棕25、鹼性紫1〇、鹼性紫的、酸性紅 51、酸性紅52、酸性紅14、酸性藍9、酸性黃23、鹼性紅 1 〇、驗性紅10 8。 增黏劑或黏合劑之實例騎乙烯料相、聚乙酸乙稀 酯、聚乙烯醇及纖維素醚(Tylose®,shin_Etsu,Japan)。 粉劑、展佈用物質及撒粉可藉由將化合W及適當時复 他活性物質與至少一種固體載劑混合或同時研磨來製備。、 可藉由使活性物質與固體載劑黏結來製備顆粒劑,例如 147474.doc •104· 201041514Germany or Rhodorsil®, Rhodia, France), long chain alcohols, fatty acids, salts of fatty acids, fluoroorganic compounds and mixtures thereof. Suitable colorants are low water soluble pigments and water soluble dyes. Examples which may be mentioned are the following names: rhodamin B, CI Pigment Red 112, c. I. Solvent Red Rhodium, Pigment Blue 15:4, Pigment Blue 15", Pigment Blue 15: 2, Pigment Blue 15:1, Pigment Blue 80, Pigment Yellow i, Pigment Yellow 13, Pigment Red 112, Pigment Red 48:2, Pigment Red 48:1, Pigment Red 57:1, Pigment Red 53:1, Pigment Orange 43, Pigment Orange 34, Pigment Orange 5, Pigment Green%, Pigment Green 7, Pigment White 6, Pigment Brown 25, Basic Violet 1〇, Basic Violet, Acid Red 51, Acid Red 52, Acid Red 14, Acid Blue 9, Acid yellow 23, alkaline red 1 〇, test red 10 8 . Examples of tackifiers or binders are the vinyl phase, polyvinyl acetate, polyvinyl alcohol and cellulose ether (Tylose®, shin_Etsu, Japan). Powders, spreading materials and dusting can be prepared by mixing the compound W and, if appropriate, the other active substance with at least one solid carrier or simultaneously grinding. Granules can be prepared by binding the active material to a solid carrier, for example 147474.doc •104· 201041514

殼粕、纖維素粉及其他固體載劑。 顆粒劑。固體載劑 .鹽、滑石、高屬土、美 、紅玄武土、黃土、黏 酸鎂、氧化鎮、經研磨 、磷酸錄、硝酸錄、尿 、樹皮粕、木屑及堅果 0 組合物類型之實例為: 1 ·用水稀釋之組合物類型 i) 水溶性濃縮物(SL、LS) 1〇重量份本發明化合物溶解於90重量份水或水溶性溶劑 中。作為替代,添加濕潤劑或其他助劑。以水稀釋後,活 眭物貝浴解。以此方式獲得活性物質含量為10重量%之組 合物。 ii) 可分散濃縮物(DC) 〇 20重量伤本發明化合物在添加1 〇重量份分散劑(例如聚 乙烯吼咯啶酮)下溶解於70重量份環己酮中。用水稀釋得 到分散液。活性物質含量為20重量。/0。 ‘ 出)可乳化濃縮物(EC) . 15重量份本發明化合物在添加十二烷基苯磺酸鈣及蓖麻 油乙氧基化物(各5重量份)下溶解於75重量份二甲苯中。用 水稀釋得到乳液。組合物之活性物質含量為15重量%。 iv)乳液(EW、EO、ES) 25重量份本發明化合物在添加十二烷基苯磺酸鈣及蓖麻 147474. doc • 105- 201041514 '由乙氧基化物(各為5重量份)下溶解於35重量份之二曱苯 藉助於乳化機(Ultraturrax)將此混合物引入3〇重量份 水中且製成均f乳液。用水稀釋得到乳液。組合物之活性 物質含量為25重量%。 v)懸浮液(SC、〇D、Fs) f摔式球磨機中’在添加10重量份分散劑及濕潤劑及 =重ϊ份水或有機溶劑下,磨碎2()重量份本發明化合物, =到精細活性物質懸浮液。用水稀釋得到活性物質之穩定 懸洋液。組合物之活性物質含量為20重量%。 )K可刀放性顆粒劑及水溶性顆粒劑(WG、s G) ^添加5G重量份分散劑及濕潤劑下,精細研磨50重量份 :發明化合物,且藉助於技術設備(例如擠壓、喷霧塔、 ^體化床)製成水可分散或水溶性顆粒劑。用水稀釋得到 活!·生物貝之穩定分散液或溶液。組合物之活性物質含量 5〇重量%。 、 VU)水可分散性粉劑及水溶性粉劑(WP、Sp、ss、ws) 劑ΐ!子-定子研磨機中,在添加25重量份分散劑、濕渴 = 研磨75重量份本發明化合物。用水稀釋得至| 之穩定分散液或溶液。組合物之活性物質含量為 ’〕更重%。 viiO 凝膠(GF) ,拌式球磨機中,在添加1〇重量份分散劑、】 濕潤劑及7。重量份水或有機溶劑下 : 本發明化合物,得到活性物質之精細懸浮液。用水稀^ 147474.doc 201041514 到活性物質之穩定懸浮液,藉此獲得含2〇%(w/w)活性物質 之組合物。 2.不經稀釋即施用之組合物類型 ix)可撒佈粉劑(DP、DS) 精細研磨5重量份本發明化合物且與%重量份細粉狀高 嶺土緊密混合。由此得到活性物質含量為5重量%之可撒 佈組合物。 X)顆粒劑(GR、FG、GG、MG) 〇 精細研磨0_5重量份本發明化合物且與99 5重量份載劑合 併。目前方法為擠壓、喷霧乾燥或流體化床。由此得到活 性物質含量為0.5重量%之不經稀釋即施用之顆粒劑。 xi) ULV溶液(UL) 1 〇重量份本發明化合物溶解於9 〇重量份有機溶劑(例如 二甲苯)中。由此得到活性物質含量為1〇重量%之不經稀釋 即施用之組合物。 〇 農用化學組合物一般包含0.01重量。/。至95重量%、較佳 0.1重量%至90重量%、最佳〇.5重量%至9〇重量%之活性物 質。活性物質係以90%至100%,較佳95%至1〇〇%之純度 (根據NMR光譜)使用。 水溶性濃縮物(LS)、可流動濃縮物(FS)、乾燥處理用粉 劑(DS)、漿液處理用水可分散性粉劑(ws)、可溶性粉劑 (SS)、乳液(ES)、可乳化濃縮物(EC)及凝膠(GF)通常用於 處理植物繁殖材料(尤其種子)之目的。此等組合物可在稀 釋後或不經稀釋即施用於植物繁殖材料(尤其種子)。所討 147474.doc -107- 201041514 論之組合物在稀釋2至10倍後’即用型製劑之活性物質濃 度為0·01重量%至60重量%,較佳為〇」重量%至4〇重量〇/〇。 可在播種之前或播種期間進行施用。將農用化學化合物及 其組合物分別施用或處理於植物繁殖材料(尤其種子)上之 方法為此項技術中所已知,且包括繁殖材料之敷裹、塗 覆、成粒、撒粉、浸潰及溝内(in_furrow)施用方法。在— 較佳實施例中’利用不誘導發芽之方法(例如拌種、成 粒、塗覆及撒粉)在植物繁殖材料上分別施用化合物或其 組合物。 較佳貫施例中,使㈣浮液型(FS)組合物進行種巧 處理。叹組合物通常包含1至8〇〇 g/Ι活性物質、m〇〇 g/ 界面活陡劑、G至200 g/l防;東劑、〇至伽g/1黏合劑、〇至 200 g/1顏料及至多1公升溶劑(較佳為水)。 該等活性物質可藉助於喷灑、霧化、撒粉、展佈、刷 主、浸潰或傾倒按原樣使用或以其組合物形式使用,例如 =隸喷灑之溶液、錢、懸浮液、分散液、乳液、油 二液、糊劑、可撒佈產品、展佈用物質或顆粒劑之形式 使用。施用形式完全視預定目的而定;音 下本㈣〜人確保在各情況 丨王初貝侍以儘可能精細地分佈。 水性施用形式可自乳液濃縮物、糊 喷灑粉劑、油分散液)蕤由六Λ 41戈了濕性粉劑(可 糊劑或油分d 製備。為製備乳液、 _-飞油刀放液,可藉助於濕 化嶋質(原樣或已溶解於油或溶劑;劑或乳 或者’可製借由活性物質、濕湖劑、增二== W 分散劑或乳 147474.doc 201041514 化Μ及適田%· /谷劑或油構成之濃縮物,且此等濃縮物適於 用水稀釋。 *活性物質在即用型製劑中之濃度可在相對較寬之範圍内 變化。活性物質一般佔0.0001重量%至10重量%,較佳為 0.001重量%至1重量%。 該等活性物質亦可成功用於超低容量方法(11—_ volume process’ ULV)中,可施用包含%重量%以上活性 Q 物處之組合物,或甚至施用無添加劑之活性物質。 當用於植物保護時,|所需效果之種類而定,活性物質 之施用量為每公頃〇·_ kg至2 kg,較佳每公頃請5 ^至 2 kg ’更佳每公頃Q G5 kg至〇 9 kg,特^言之每公頃〇 1 至 0.75 kg。 ▲在例如藉由撒,粉、塗覆或浸透種子來處理植物繁殖材料 (諸如種子)時,每100公斤植物繁殖材料(較佳種子)一般需 要ο.1至1000 g,較佳1至1_ g,更佳1至100 g,且最佳A 〇 e100g之量的活性物質。 -佳為 虽用於保護材料或儲存產品時’活性物質之施用量視施 用區域之種類及所需效果而定。保護材料時施用量通常為 )士每立方公尺處理材料〇 〇〇1吕至2 kg,較佳0.005 g至1 kg活性物質。 可向活性物質或包含活性物質之組合物中添加各種類型 之油、濕潤劑、佐劑、除草劑、殺細菌劑、其他殺真菌劑 或殺有害生物劑’適當時直至使用之前即刻方添加(槽 混)。此等試劑可與本發明組合物以1:100至100:1,較佳 147474.doc 201041514 1:10至10:1之重量比混合。 可使用之佐劑特定言之為:有機改質聚矽氧烷,諸如 Break Thru S 240®;醇烷氧化物,諸如 Atplus 245®、 Atplus MBA 1303®、Plurafac LF 300®及 Lutensol ON 30® ; EO/PO嵌段聚合物,例如Pluronic RPE 2035®及 Genapol B® ;醇乙氧化物,諸如Lutensol XP 80® ;及二辛基磺基丁 二酸鈉,諸如 LeophenRA®。 呈殺真菌劑使用形式的本發明組合物亦可與其他活性物 質(例如除草劑、殺昆蟲劑、生長調節劑、殺真菌劑或肥 料)一起呈預混物形式存在或適當時直至使用之前即刻方 混合(槽混)。 在許多情況下,混合呈殺真菌劑使用形式之化合物I、Π 及/或IV或包含該等化合物之組合物與其他殺真菌劑可拓 寬所獲得之殺真菌活性範圍或防止發展出殺真菌劑耐藥 性。此外,在許多情況下,獲得協同效應。 可與本發明化合物聯合使用之活性物質之以下清單意欲 說明可能之組合,但不限於此: A) 嗜毯果傘素(strobilurin) 亞托敏(azoxystrobin)、醚菌胺(dimoxystrobin)、稀月亏 菌醋(enestroburin)、氟 σ密菌醋(fluoxastrobin)、克收欣 (kresoxim-methyl)、苯氧菌胺(metominostrobin)、月亏 醚菌胺(orysastrobin)、咬氧菌胺(picoxystrobin)、百 克敏(pyraclostrobin) ' α比本卡(pyribencarb)、三氟敏 (trifloxystrobin) ; 2-(2-(6-(3-氯-2-甲基-苯氧基)-5-氟- 147474.doc -110- 201041514 嘧啶-4-基氧基)-苯基)_2-甲氧基亞胺基_N_甲基-乙醯 胺、3-甲氧基-2-(2-(N-(4-甲氧基_苯基)_環丙烷_甲醯 亞胺基硫基甲基)-苯基)-丙烯酸曱酯、(2_氯 甲基苯甲氧基亞胺基)乙基]苯甲基)胺基曱酸甲酯及2_ (2-(3-(2,6-二氯苯基)-1-甲基-亞烯丙基胺基氧基甲基)_ 苯基)-2-曱氧基亞胺基甲基-乙酿胺; B) 羧醯胺 - 甲醯替苯胺(carboxanilide):本達樂(benalaxyl)、右本 達樂(benalaxyl-M)、麥鏽靈(benodanil)、百克芬 (bixafen)、白克利(boscalid)、萎鏽靈(carboxin)、曱 呋醯胺(fenfuram)、環醯菌胺(fenhexamid)、氟多寧 (flutolanil)、福拉比(furametpyr)、異派劄美 (isopyrazam)、異天尼(isotianil)、開達樂(kiralaxyl)、 滅普寧(mepronil)、滅達樂(metalaxyl)、右滅達樂 (metalaxyl-M/mefenoxam))、°夫醯胺(ofurace)、歐殺斯 (oxadixyl)、嘉保信(oxycarboxin)、°比&quot;塞菌胺 (penthiopyrad)、色達安(sedaxane)、克枯爛(tecloftalam)、 賽氟滅(thifluzamide)、汰敵寧(tiadinil)、2-胺基-4-曱 基-噻唑-5-曱醯替苯胺、2-氯-N-(l,l,3-三甲基-茚滿_ 4-基)-菸鹼醯胺、三氟聯苯-2-基)-3-二氟曱 基-1-甲基-1H-吡唑-4-甲醯胺、N-(4’-三氟曱基硫基聯 苯-2-基)-3-二氟甲基-1-曱基-1H-吡唑-4-甲醯胺、N-(2-(1,3-二甲基-丁基)-苯基)-1,3-二甲基-5-氟-1H-吡 唑-4-甲醯胺及N-(2-(l,3,3-三甲基-丁基)-苯基)-1,3-二 147474.doc -111 · 201041514 曱基-5-氟-1H-吡唑-4-曱醯胺; -叛酸基嗎琳(carboxylic morpholide): 達滅芬 (dimethomorph)、氟嗎淋(flumorph) 、 0比嗎淋 (pyrimorph); -苯甲酸醯胺:象醯菌胺(flumetover)、氟°比菌胺 (fluopicolide)、氟 0比菌醯胺(fluopyram)、座賽胺 (zoxamide)、N-(3 -乙基-3,5,5-三曱基-環己基)-3-甲醯 胺基-2-羥基-苯曱醯胺; - 其他叛酸胺:加普胺(carpropamid)、二氣西莫 (diclocymet)、雙诀酸菌胺(mandiproamid)、土徽素 (oxytetracyclin)、石夕 °塞菌胺(silthiofarm)及 N-(6-曱氧 基-吡啶-3-基)環丙烷曱醯胺; C) 唑 - 三0坐:阿紮康。坐(azaconazole)、比多農(bitertanol)、 漠克座(bromuconazole)、環克座(cyproconazole)、待 克利(difenoconazole)、達克利(diniconazole)、右達克 利(diniconazole-M)、依普座(epoxiconazole)、芬克座 (fenbuconazole)、敦啥唾(fluquinconazole)、護石夕得 (flusilazole)、護汰芬(flutriafole)、菲克利 (hexaconazole)、易胺座(imibenconazole)、依普克 口坐 (ipconazole)、滅特座(metconazole)、邁克尼 (myclobutanil)、惡 ϋ米。坐(oxpoconazole)、巴克素 (paclobutrazole)、平克座(penconazole)、普克利 (propiconazole)、丙硫菌峻(prothioconazole)、石夕敦 °坐 147474.doc -112- 201041514 (simeconazole)、得克利(tebuconazole)、四克利 (tetraconazole)、三泰茶(triadimefon)、三泰隆 (triadimenol)、滅菌。坐(triticonazole)、浠效吐 (uniconazole)、1-(4-氯-苯基)-2-([1,2,4]三嗤-1-基)-環 庚醇; - _ °坐:賽座滅(cyazofamid)、依滅列(imazalil)、稻瘦 酯(pefurazoate)、撲克拉(prochloraz)、賽福座 (triflumizole); - 苯并口米0坐:免賴得(benomyl)、貝芬替(carbendazim)、 麥穗寧(fuberidazole)、腐絕(thiabendazole); - 其他:0塞0坐菌胺(ethaboxam)、依得利(etridiazole)、 惡黴靈(hymexazole)及 2-(4-氣-苯基)-Ν·[4-(3,4-二甲氧 基-笨基)-異β惡嗤-5-基]-2 -丙-2 -快氧基-乙酿胺, D) 雜環化合物 - β比唆:扶吉胺(fluazinam)、比芬諾(pyrifenox)、3-[5-(4-氯-苯基)-2,3-二曱基-異噁唑啶-3-基]-吡啶、3-[5-(4-甲基-苯基)-2,3-二甲基-異噁唑啶-3-基]-吡啶、 2.3.5.6- 四氣-4-甲烧績酿基-π比咬、3,4,5 -三氯0比咬- 2.6- 二曱腈、&gt;1-(1-(5-溴-3-氯-吡啶-2-基)-乙基)-2,4-二 氯菸鹼醯胺、Ν-[(5-溴-3-氯-吡啶-2-基)-二氯]-2,4-二 氯-疼驗醯胺; - 嘴 D定:布瑞莫(bupirimate)、賽普洛(cyprodinil)、二 I 林(diflumetorim)、芬瑞莫(fenarimol)、富瑞综 (ferimzone)、滅派林(mepanipyrim)、氯咬(nitrapyrin)、 147474.doc • 113 - 201041514 尼瑞莫(nuarimol)、派美尼(pyrimethanil); - n底嗪:賽福寧(triforine); - n比洛:拌種 11 各(fludioxonil)、護汰寧(Hudioxonil); - 嗎琳:阿迪嗎琳(aldimorph)、嗎菌靈(dodemorph)、乙 酸嗎菌靈(dodemorph-acetate)、芬普福(fenpropimorph)、 三得芬(tridemorph); - σ底咬:苯鏽唆(fenpropidin); - 二曱醢亞胺:α坐。夫草(fluoroimide)、依普同 (iprodione)、撲滅寧(procymidone)、免克寧 (vinclozolin); - 非芳族5員雜環:凡殺同(famoxadone)、味〇坐菌酮 (fenamidone)、福天尼(flutianil)、辛售酮 (octhilinone)、撲殺熱(probenaizole)、5-胺基-2-異丙 基-3-側氧基-4-鄰曱苯基-2,3-二氫吡唑-1-硫代甲酸S-烯丙自旨; - 其他:酸化苯并°塞二α坐-S-曱醋(acibenzolar-S-methyl)、α弓卜坐續菌胺(amisulbrom)、敵菌靈(anilazine)、 保米黴素(blasticidin-S)、四氯丹(captafol)、蓋普丹 (captan)、滅蜗猛(chinomethionate)、邁隆(dazomet)、 σ米菌威(debacarb)、達滅淨(diclomezine)、野燕枯 (difenzoquat)、甲基硫酸野燕枯(difenzoquat-methylsulfate)、氛菌胺(fenoxanil)、福爾培(folpet)、 歐索林酸(oxolinic acid)、粉病靈(piperalin)、普奎那 茲(proquinazid)、百快隆(pyroquilone)、快諾芬 147474.doc -114- 201041514 E) (quinoxyfen)、咪 °坐 α秦(triazoxide)、三賽 〇坐 (tricyclazole)、2-丁氧基-6-埃-3-丙基卩克浠-4-酮、5-鼠-1-(4,6-二甲氧基-α密σ定-2-基)-2-甲基-1H-苯弁哺 唑、5-氯-7-(4-甲基哌啶-1-基)-6-(2,4,6-三氟苯基)-[1,2,4]三唑幷[1,5-a]嘧啶及5-乙基-6-辛基-[1,2,4]三唑 幷[1,5-a]嘧啶-7-基胺; 胺基甲酸酯 Ο 硫胺基曱酸酯及二硫胺基曱酸酯,諸如福美鐵 (ferbam)、鋅猛乃浦(mancozeb)、猛乃浦(maneb)、威 百故(metam)、磺菌威(methasulfocarb)、免得爛 (metiram)、曱基鋅乃浦(propineb)、得恩地(thiram)、 辞乃浦(zineb)、益穗(ziram); 胺基甲酸S旨:苯嗟菌胺(benthiavalicarb)、乙黴威 (diethofencarb)、绳黴威(iprovalicarb)、霜黴威 (propamocarb)、霜黴威鹽酸鹽、瓦芬那(valiphenal)及 ❹ N-(l-(l-(4-鼠基-本基)乙烧石黃酿基)-丁-2 -基)胺基甲酸_ (4-氟苯基)酯; F) 其他活性物質 胍類:脈(guanidine)、多寧(dodine)、多寧游離驗、 雙脈鹽(guazatine)、乙酸雙胍鹽、雙胍辛胺 (iminoctadine)、三乙酸雙胍辛胺、參(烧基苯續酸)雙 胍辛胺(iminoctadine-tris(albesilate)); 抗生素:喜賜徽素(kasugamycin)、水合鹽酸喜賜黴 素、鏈黴素(streptomycin)、多氧菌素(polyoxin)、有 147474.doc -115- 201041514 效黴素 A(validamycinA); 石肖基苯基衍生物:百蜗克(binapacryl)、消瞒通 (dinobuton)、白粉克(dinocap)、敗菌酯(nitrothal isopropyl)、四氣硝基苯(tecnazene); 有機金屬化合物:三苯錫鹽(fentin salt),諸如三苯醋 錫(fentin acetate)、三苯錫氯(fentin chloride)、三苯 經錫(fentin hydroxide); 含硫雜環基化合物:腈硫醌(dithianon)、稻瘟靈 (isoprothiolane); 有機麟化合物:護粒松(edifenphos)、福賽得 (fosetyl) ' 乙填铭(fosetyl-aluminum)、丙基喜樂松 (iprobenfos)、亞破酸及其鹽、白粉松(pyrazophos)、 脫克松(tolclofos-methyl); 有機氣化合物:四氯異苯腈(chlorothalonil)、益發靈 (dichlofluanid)、二氣紛(dichlorophen)、石黃菌胺 (flusulfamide)、六氯苯(hexachlorobenzene)、賓克隆 (pencycuron)、五氯紛(pentachlorphenole)及其鹽、熱 必斯(phthalide)、五氣硝基苯(quintozene)、曱基多保 淨(thiophanate methyl)、曱基益發靈(tolylfluanid)、 N-(4 -氣-2-石肖基-苯基)-N-乙基-4-甲基-苯績酿胺; 無機活性化合物:波多混合液(Bordeaux mixture)、乙 酸銅、氫氧化銅、氯氧化銅、鹼式硫酸銅、硫; 其他:聯苯、溴頌丙二醇(bronopol)、環氟菌胺 (cyflufenamid)、克絕(cymoxanil)、二苯胺(diphenylamin)、 147474.doc -116- 201041514 滅务辰(metrafenone)、滅粉徽素(]11丨1(^0111丫(^11)、快得 寧(oxine-copper)、調環酸鈣(pr〇hexadi〇ne_calcium)、 螺惡茂胺(spiroxamine)、曱基益發靈、N_(環丙基甲氧 基亞胺基-(6-二氟-曱氧基_2,3_二氟-苯基)_曱基笨 基乙醯胺、Ν·-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二曱 基-苯基)-Ν-乙基-Ν-甲基曱脒、ν,-(4-(4-氟-3-三氟曱 基-本乳基)_2,5 - 一甲基-苯基)-Ν-乙基-Ν-曱基甲脉、 q Ν'-(2-甲基-5-三氟曱基-4-(3-三曱基矽烷基-丙氧基)_ 苯基)-Ν-乙基-Ν-甲基甲脒、ν'-(5-二氟甲基-2-甲基-4-(3-三甲基矽烷基-丙氧基)_苯基)_Ν_乙基_Ν_甲基甲 脒、2-{1-[2-(5-曱基-3-三氟甲基比唑-1-基)-乙醯基]_ 哌啶-4-基}-噻唑-4-甲酸甲基-(l,2,3,4-四氫萘-l-基)_ 醯胺、2-{l-[2-(5-曱基-3-三氟甲基-吡唑-l-基)-乙醯 基]-哌啶-4-基}-噻唑-4-甲酸曱基-(R)-l,2,3,4-四氫萘-1-基-醯胺、乙酸6-第三丁基-8-氟-2,3-二甲基-喹啉-4-基酉曰及曱氧基-乙酸6-第二丁基-8-氣-2,3-二甲基-啥 琳_ 4 -基醋; G)生長調節劑 • 脫落酸(abscisic acid)、先曱草胺(amidochlor)、。密。定 醇(ancymidol)、6-苯曱基胺基嘌呤、芸苔素内酯 (brassinolide)、比達寧(butralin)、克美素(chlormequat) (矮壯素(chlormequat chloride))、氣化膽驗(choline chloride)、環丙酸酿胺(cyclanilide)、亞拉生長素 (daminozide)、調吱酸(dikegulac)、獲萎得 147474.doc -117- 201041514 (dimethipin)、2,6-二甲基吡啶、益收生長素 (ethephon)、氟節胺(flumetralin)、呋嘧醇 (flurprimidol)、氟噻草酯(fluthiacet)、福芬素 (forchlorfeniiron)、赤黴酸(gibbereiiic acid)、依納素 (inabenfid)、叫卜朵-3-乙酸、抑.芽素(111&amp;1以(:hydrazide)、 氟石黃醯草胺(mefluidide)、壯棉素(mepiquat)(縮節胺 (mepiquat chloride))、萘乙酸、n-6-苯曱基腺嘌呤、 巴克素(paclobutrazol)、調環酸(pr〇hexadione)(調環酸 妈)、東莉酸丙醋(prohydrojasmon)、°塞苯隆 (thidiazuron)、抑芽唑(triapenthenol)、三硫磷酸三丁 醋、2,3,5-三蛾苯甲酸、抗倒g旨(^116乂&amp;卩&amp;(:-61;11丫1)及稀 效σ坐; Η) 除草劑 - 乙醯胺:乙草胺(acetochlor)、甲草胺(alachlor)、丁草 胺(butachlor)、二甲草胺(dimethachlor)、汰草滅 (dimethenamid)、氟嗟草胺(flufenacet)、苯 °塞醯草胺 (mefenacet)、滅多草(metolachlor)、滅草胺 (metazachlor)、萘丙醯草胺(napropamide)、萘丙胺 (naproanilide)、浠草胺(pethoxamid)、丙草胺 (pretilachlor)、毒草安(propachlor)、甲氧0塞草胺 (thenylchlor); - 胺基酸衍生物:雙丙胺磷(bilanafos)、草甘膦、草銨 膦、草硫膦(sulfosate); - 芳氧基苯氧基丙酸酯:炔草酸(clodinafop)、氰氟草酯 147474.doc -118- 201041514 (cyhalofop-butyl)、°惡唾禾草靈(fenoxaprop)、D比氟禾 草靈(fluazifop)、°比氟氯禾靈(haloxyfop)、α惡峻醯草 胺(metamifop)、惡草酸(propaquizafop)、啥禾靈 (quizalofop)、喧禾糠酯(quizalofop-P-tefuryl); - 聯°比咬:敵草快(diquat)、百草枯(paraquat); - (硫代)胺基甲酸酯:磺草靈(asulam)、丁草特 (butylate)、卡草胺(carbetamide)、甜菜安(desmedipham)、 0底草丹(dimepiperate)、撲草滅(eptam)(EPTC)、戊草 丹(esprocarb)、得草滅(molinate)、坪草丹(orbencarb)、 甜菜寧(phenmedipham)、苄草丹(prosulfocarb)、稗草 畏(pyributicarb)、殺丹(thiobencarb)、野麥畏 (triallate); - 環己二酮:丁苯草酮(butroxydim)、浠草_ (clethodim)、環殺草(cycloxydim)、環苯草酮 (profoxydim)、西殺草(sethoxydim)、得殺草 (tepraloxydim)、三曱苯草酮(traik〇xydim); - 二石肖基苯胺:倍尼芬(benfluralin)、乙丁烯氟靈 (ethalfluralin)、安磺靈(oryzalin)、二甲戊樂靈 (pendimethalin)、苯胺靈(protjiamine)、氟樂靈 (trifluralin); - 一苯醚.二氟叛草峻(acifluorfen)、苯草醚 (aclonifen)、必芬諾(bifenox)、禾草靈(dicl〇fop)、氣 氟草醚(ethoxyfen)、氟磺胺草醚(fornesafen)、乳氟禾 草靈(lactofen)、乙乳氟草喊(OXyfiu〇rfen); 147474.doc -119- 201041514 • 經基苯曱腈:溴苯腈(bromoxynil)、敵草腈 (dichlobenil)、碘苯腈(ioxynil); - p米峻°林酮:0米草S旨(imazamethabenz)、曱氧11米草终、 甲基味草終(imazapic)、σ米°坐於酸(imazapyr)、σ米°坐喧 琳酸(imazaquin)、σ米。坐乙於酸(imazethapyr); -苯氧基乙酸:稗草胺〇1〇11^口1*(^)、2,4-二氯苯氧基乙 酸(2,4-D)、2,4-DB、滴丙酸(dichlorprop)、MCPA、 MCPA-硫乙基、MCPB、2 -甲-4 -氯丙酸(mecoprop); - °比°秦:氯草敏(chloridazone)、氟噠嗓草 S旨(flufenpyr-ethyl)、氟 π塞草 I旨(fluthiacet)、達草滅(norflurazone)、 達草特(pyridate); - °比 °定:胺草 °定(aminopyralid)、克草立特(clopyralid)、 0比氟草胺(diflufenican)、1 硫草定(dithiopyr)、氟咬 草酮(fluridone)、說草於(fluroxypyr)、毒赛定 (picloram)、氟 °比醯草胺(picolinafen)、°塞草咬 (thiazopyr); - 石黃醯脈:酸癌確隆(amidosulfuron)、四β坐喊項隆 (azimsulfuron)、节 π密績隆(bensulfuron)、氣 β密續隆 (chlorimuron-ethyl)、氣續隆(chlorsulfuron)、醚續隆 (cinosulfuron)、環丙嘴石黃隆(cyclosulfamuron)、乙氧 喊石黃隆(ethoxysulfuron)、&lt;•密唆績隆(flazasulfuron)、 氣》比績隆(flucetosulfuron)、氟咬。密績隆(flupyrsulfuron)、 甲臨胺績隆(foramsulfuron)、 氯0比0密續隆 (halosulfuron)、〇坐 °比 〇密石黃隆(imazosulfuron)、峨曱績 147474.doc -120- 201041514 隆(iodosulfuron)、甲磺胺磺隆(mes〇sulfur〇n)、甲磺 隆(metsulfuron-methyl)、菸嘧磺隆(nic〇sulfur〇n)、環 氧嘧磺隆(oxasulfuron)、氟嘧磺隆(primisulfur〇n)、氟 石買隆(prosulfuron)、β比鳴續隆(pyrazosuifur〇n)、颯嗔 石黃隆(rimsulfuron)、甲嘴續隆(suifonieturon)、績嘴續 隆(sulfosulfuron)、噻吩磺隆(thifensulfuron)、醚苯磺 隆(triasulfuron)、苯磺隆(tribenuron)、三氟啶磺隆 (trifloxysulfuron)、氟胺磺隆(trifiusuifuron)、三氟甲 磺隆(tritosulfuron)、1-((2-氯-6-丙基-咪唑幷[l,2-b]噠 嗪-3-基)續醯基)-3-(4,6-二曱氧基-嘴咬-2-基)脲; 三唤··草殺淨(ametryn)、草脫淨(atrazine)、氰乃淨 (cyanazine)、異戊乙淨(dimethametryn)、乙硫津 (ethiozin)、六嗪酮(hexazinone)、苯°秦草酮(metamitron)、 滅必淨(metribuzin)、撲草淨(prometryn)、西瑪津 (simazine)、特丁津(terbuthylazine)、去草淨 (terbutryn)、三 °秦氟草胺(triaziflam); 脲:綠麥隆(chlorotoluron)、殺草隆(daimuron)、敵草 隆(diuron)、伏草隆(fluometuron)、異丙隆(isoproturon)、 利榖隆(linuron)、曱苯。塞隆(methabenzthiazuron)、丁 °塞隆(tebuthiuron); 其他乙酿乳酸合成酶抑制劑:雙草醚納(bispyribac-sodium)、氯酯石夤草胺(cloransulam-methyl)、雙氣續 草胺(diclosulam)、雙氟續草胺(florasulam)、氟酮石黃 隆(flucarbazone)、〇圭 °密績草胺(flumetsulam)、石黃草0坐 147474.doc -121 - 201041514 胺(metosulam)、β密苯胺續隆(ortho-sulfamuron)、五氣 石黃草胺(penoxsulam)、丙氧項隆(propoxycarbazone)、 丙g旨草醚(pyribambenz-propyl) 、°密0定月亏草醚 (pyribenzoxim)、環自旨草醚(pyriftalid)、α密草醚 (pyriminobac-methyl)、喊沙泛(pyrimisulfan)、σ密硫草 醚(pyrithiobac)、普硫芬(pyroxasulfone)、甲氧石黃草胺 (pyroxsulam); 其他:胺σ坐草®(amicarbazone)、胺基三0坐 (aminotriazole)、莎稗填(anilofos)、說 丁草胺 (beflubutamid)、草除靈(benazolin)、苯卡巴松 (bencarbazone)、α夫草黃(benfluresate)、°比草酮 (benzofenap)、苯達松(bentazone)、苯并雙環 _ (benzobicyclon)、克草(bromacil)、漠丁 醯草胺 (bromobutide)、氟丙嘴草醋(butafenacil)、抑草石舞 (butamifos)、π坐草胺(cafenstrole)、唾酮草醋 (carfentrazone)、°引 n朵酮草 S旨(cinidon-ethlyl)、敵草索 (chlorthal)、環庚草醚(cinmethylin)、可滅蹤 (clomazone)、苄草隆(cumyluron)、環丙確酸胺 (cyprosulfamide)、麥草畏(dicamba)、野燕枯、二氟 0比隆(diflufenzopyr)、稗内臍蠕孢菌(Drechslera monoceras)、草多索(endothal)、乙0夫草石黃(ethofumesate)、 乙氧苯草胺(etobenzanid)、四α全醯草胺(fentrazamide)、 氟稀草酸(flumiclorac-pentyl)、 丙炔氟草胺 (flumioxazin)、氟&gt; 胺草。坐(flupoxam)、敗 B各草酮 147474.doc -122- 201041514Shell clams, cellulose powder and other solid carriers. Granules. Solid carrier. Salt, talc, high genus, beauty, red basalt, loess, magnesium viscous, oxidized town, ground, phosphate, nitrate, urine, bark, wood chips and nuts 0 Examples of composition types To be: 1 - Composition type diluted with water i) Water-soluble concentrate (SL, LS) 1 part by weight of the compound of the invention is dissolved in 90 parts by weight of water or a water-soluble solvent. Instead, a wetting agent or other auxiliaries are added. After dilution with water, the live cockroach shell solution. In this way, a composition having an active substance content of 10% by weight was obtained. Ii) Dispersible Concentrate (DC) 〇 20 Weight Damage The compound of the present invention is dissolved in 70 parts by weight of cyclohexanone with the addition of 1 part by weight of a dispersing agent (e.g., polyvinylpyrrolidone). Dilute with water to obtain a dispersion. The active substance content was 20% by weight. /0. 'Output' emulsifiable concentrate (EC). 15 parts by weight of the compound of the present invention was dissolved in 75 parts by weight of xylene under the addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (each 5 parts by weight). Dilute with water to give an emulsion. The active substance content of the composition was 15% by weight. Iv) Emulsion (EW, EO, ES) 25 parts by weight of the compound of the invention with the addition of calcium dodecylbenzenesulfonate and castor 147474. doc • 105- 201041514 'from ethoxylates (each 5 parts by weight) The mixture was dissolved in 35 parts by weight of diphenylbenzene by means of an emulsifier (Ultraturrax), and this mixture was introduced into 3 parts by weight of water to prepare a homogenous emulsion. Dilute with water to give an emulsion. The active substance content of the composition was 25% by weight. v) suspension (SC, 〇D, Fs) f in a throw ball mill 'grinding 2 () parts by weight of the compound of the invention with the addition of 10 parts by weight of dispersant and wetting agent and = heavy hydrazine or organic solvent, = to a fine active substance suspension. Dilute with water to obtain a stable suspension of the active substance. The active substance content of the composition was 20% by weight. K Kinellable granules and water-soluble granules (WG, s G) ^ 5G parts by weight of dispersant and wetting agent, finely ground 50 parts by weight: inventive compound, and by means of technical equipment (eg extrusion, The spray tower, the body bed) is made into a water-dispersible or water-soluble granule. Dilute with water to get live! · Stable dispersion or solution of biobe. The active substance content of the composition was 5% by weight. , VU) water-dispersible powder and water-soluble powder (WP, Sp, ss, ws) agent! In a sub-stator mill, 25 parts by weight of a dispersant, wet thirst = 75 parts by weight of the compound of the invention are ground. Dilute to a stable dispersion or solution with water. The active substance content of the composition is '&gt; In viiO gel (GF), in a ball mill, add 1 part by weight of dispersant, humectant and 7. Part by weight of water or organic solvent: The compound of the invention gives a fine suspension of the active substance. A stable suspension of the active substance is obtained by diluting with water 147474.doc 201041514, whereby a composition containing 2% by weight (w/w) of the active substance is obtained. 2. Type of composition to be applied without dilution ix) Spreadable powder (DP, DS) 5 parts by weight of the compound of the invention are finely ground and intimately mixed with % by weight of finely powdered kaolin. Thus, a spreadable composition having an active material content of 5% by weight was obtained. X) Granules (GR, FG, GG, MG) 0 Finely milled 0 to 5 parts by weight of a compound of the invention and combined with 99 parts by weight of a carrier. Current methods are extrusion, spray drying or fluidized beds. Thus, a granule which was applied without dilution at an active substance content of 0.5% by weight was obtained. Xi) ULV solution (UL) 1 〇 Parts by weight The compound of the present invention is dissolved in 9 parts by weight of an organic solvent such as xylene. Thus, a composition which is applied without dilution, having an active substance content of 1% by weight, is obtained. 〇 Agricultural chemical compositions typically comprise 0.01 weight. /. Up to 95% by weight, preferably 0.1% by weight to 90% by weight, most preferably 5% by weight to 9% by weight of the active material. The active material is used in a purity of 90% to 100%, preferably 95% to 1% by weight (according to NMR spectrum). Water-soluble concentrate (LS), flowable concentrate (FS), powder for drying treatment (DS), dispersible powder for slurry treatment (ws), soluble powder (SS), emulsion (ES), emulsifiable concentrate (EC) and gels (GF) are commonly used for the treatment of plant propagation materials, especially seeds. These compositions can be applied to plant propagation material (especially seeds) after dilution or without dilution. 147474.doc -107- 201041514 The composition of the ready-to-use preparation after the dilution of 2 to 10 times is from 0. 01% by weight to 60% by weight, preferably 〇"% by weight to 4" Weight 〇 / 〇. Administration can be carried out before or during sowing. Methods of applying or treating agrochemical compounds and compositions thereof to plant propagation materials, particularly seeds, are known in the art and include the application, coating, granulation, dusting, dipping of the propagation material. The method of application in the in_furrow. In the preferred embodiment, the compound or composition thereof is applied separately to the plant propagation material by a method that does not induce germination (e.g., seed dressing, granulation, coating, and dusting). In a preferred embodiment, the (iv) floating liquid type (FS) composition is subjected to a seed treatment. Sighing composition usually contains 1 to 8 〇〇g / Ι active substance, m 〇〇 g / interface stabilizer, G to 200 g / l anti-; East, 〇 to gamma / 1 adhesive, 〇 to 200 g /1 pigment and up to 1 liter of solvent (preferably water). The active substances may be used as they are by spraying, atomizing, dusting, spreading, brushing, dipping or pouring, or in the form of their compositions, for example, a spray solution, money, suspension, It is used in the form of a dispersion, an emulsion, an oil liquid, a paste, a spreadable product, a spreading substance or a granule. The form of application depends entirely on the intended purpose; the sound of the next (four) ~ person to ensure that in each case, the king of the first serve is as finely distributed as possible. The aqueous application form can be prepared from an emulsion concentrate, a paste spray powder, an oil dispersion, and a wet powder (a paste or an oil d). For preparing an emulsion, _-flying oil knife can be discharged. By means of humidified tannin (as is or dissolved in oil or solvent; agent or milk or 'can be made from active substance, wet lake agent, increased two == W dispersant or milk 147474.doc 201041514 phlegm and suitable field Concentrate of %·/treat or oil, and such concentrates are suitable for dilution with water. * The concentration of active substance in ready-to-use preparations can vary over a relatively wide range. Active substances generally comprise 0.0001% by weight to 10% by weight, preferably 0.001% by weight to 1% by weight. The active materials can also be successfully used in the ultra-low volume process (11-_volume process 'ULV), and can be applied at a content of more than % by weight of active Q The composition, or even the application of the additive-free active substance. When used for plant protection, depending on the type of effect required, the application amount of the active substance is 〇·_ kg to 2 kg per hectare, preferably per hectare 5 ^ to 2 kg 'better Q G5 kg to 〇 9 kg per hectare, In particular, 〇1 to 0.75 kg per hectare. ▲ Every 100 kg of plant propagation material (preferred seed) is generally required when treating plant propagation material (such as seeds) by spraying, powdering, or soaking seeds, for example. ο. 1 to 1000 g, preferably 1 to 1 g, more preferably 1 to 100 g, and most preferably an amount of A 〇e 100 g of the active material. - preferably used to protect the material or store the product The amount depends on the type of application area and the desired effect. The amount of the protective material is usually from 1 to 2 kg, preferably from 0.005 g to 1 kg of active material per cubic meter of treated material. Adding various types of oils, humectants, adjuvants, herbicides, bactericides, other fungicides or pesticides to the composition or composition containing the active substance 'When appropriate, until immediately before use (slot mixing) These agents may be combined with the compositions of the present invention in a weight ratio of 1:100 to 100:1, preferably 147474.doc 201041514 1:10 to 10:1. The adjuvants that can be used are specifically: organically modified Polyoxane, such as Break Thru S 240®; alcohol alkoxide, Such as Atplus 245®, Atplus MBA 1303®, Plurafac LF 300® and Lutensol ON 30®; EO/PO block polymers such as Pluronic RPE 2035® and Genapol B®; alcohol ethoxylates such as Lutensol XP 80®; Sodium dioctylsulfosuccinate, such as LeophenRA®. The compositions of the invention in the form of fungicides may also be present in the form of a premix with other active substances, such as herbicides, insecticides, growth regulators, fungicides or fertilizers, or as appropriate, until immediately prior to use. Square mixing (slot mixing). In many cases, the combination of the compound I, oxime and/or IV in the form of a fungicide or a composition comprising the same with other fungicides broadens the range of fungicidal activity obtained or prevents the development of fungicides. Drug resistance. In addition, in many cases, synergies are obtained. The following list of active substances which may be used in combination with the compounds of the present invention is intended to illustrate possible combinations, but is not limited thereto: A) strobilurin, azoxystrobin, dimoxystrobin, dilute month Enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, oressastrobin, picoxystrobin, Pyraclostrobin 'α than this card (pyribencarb), triflamine (trifloxystrobin); 2-(2-(6-(3-chloro-2-methyl-phenoxy)-5-fluoro- 147474. Doc -110- 201041514 pyrimidin-4-yloxy)-phenyl)_2-methoxyiminoamino_N-methyl-acetamide, 3-methoxy-2-(2-(N-( 4-methoxy-phenyl)-cyclopropane_methylene iminothiomethyl)-phenyl)-decyl acrylate, (2-chloromethylbenzyloxyimino)ethyl]benzene Methyl)amino decanoate and 2_(2-(3-(2,6-dichlorophenyl)-1-methyl-allylaminooxymethyl)-phenyl)-2 - oxime iminomethyl-ethyl ethamine; B) carboxy guanamine - carbazine Nilide): benalaxyl, benalaxyl-M, benodanil, bixafen, boscalid, carboxin, furfuryl Amine (fenfuram), fenhexamid, flutolanil, furametpyr, isopyrazam, isotianil, kiralaxyl, annihilation Mepronil, metalaxyl, metalaxyl-M/mefenoxam, ofurace, oxadixyl, oxycarboxin, ° ratio Penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4-mercapto-thiazole-5-oxime Anthranil, 2-chloro-N-(l,l,3-trimethyl-indan-4-yl)-nicotinium amide, trifluorobiphenyl-2-yl)-3-difluoroindolyl -1-methyl-1H-pyrazole-4-carboxamide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-indenyl-1H -pyrazole-4-carbamide, N-(2-(1,3-dimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4 -A Amine and N-(2-(l,3,3-trimethyl-butyl)-phenyl)-1,3-di 147474.doc -111 · 201041514 fluorenyl-5-fluoro-1H-pyrazole- 4-decylamine; - carboxylic morpholide: dimethomorph, flumorph, pyrimorph; - benzoic acid amide: chlorfenapyr ( Flumetover), fluopicolide, fluopyram, zoxamide, N-(3-ethyl-3,5,5-trimethyl-cyclohexyl) -3-carboxamido-2-hydroxy-benzoguanamine; - other oleic acid amines: carpropamid, dilocoymet, mandiproamid, earthworm (oxytetracyclin), silthiofarm and N-(6-decyloxy-pyridin-3-yl)cyclopropanoguanamine; C) azole-three-zero sitting: Azakang. Azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, Epp (epoxiconazole), fenbuconazole, fluquinconazole, flusilazole, flutriafole, hexaconazole, imibenconazole, ipukkou Sit (ipconazole), metconazole, myclobutanil, glutinous rice. Sitting (oxpoconazole), paclobutrazole, penconazole, propiconazole, prothioconazole, shi yue shou 147474.doc -112- 201041514 (simeconazole), derkeley (tebuconazole), tetraconazole, triadimefon, triadimenol, sterilization. Triticonazole, uniconazole, 1-(4-chloro-phenyl)-2-([1,2,4]triin-1-yl)-cycloheptanol; - _ ° sit: Cyazofamid, imazalil, pefurazoate, prochloraz, triflumizole; - benzophene rice 0: benomyl, befen Carbendazim, fuberidazole, thiabendazole; - others: ethaboxam, etridiazole, hymexazole, and 2-(4- Gas-phenyl)-Ν·[4-(3,4-dimethoxy-phenyl)-iso-β-oxazol-5-yl]-2 -propan-2-ethoxylated amine, D Heterocyclic compound - β 唆 唆: fluazinam, pyrifenox, 3-[5-(4-chloro-phenyl)-2,3-dimercapto-isoxazole- 3-yl]-pyridine, 3-[5-(4-methyl-phenyl)-2,3-dimethyl-isoxazol-3-yl]-pyridine, 2.3.5.6-tetragas-4 - A calcination base - π ratio bite, 3,4,5 - trichloro 0 bite - 2.6- dinitrile, &gt; 1-(1-(5-bromo-3-chloro-pyridin-2-yl) )-ethyl)-2,4-dichloronicotinium amide, hydrazine-[(5-bromo-3-chloro-pyridin-2-yl)-dichloro]-2,4- Chlorine-healing prostamine; - mouth D: bupirimate, cyprodinil, diflumetorim, fenarimol, ferimzone, chlorpyrifos (mepanipyrim), nitrapyrin, 147474.doc • 113 - 201041514 riarimol, pyrimethanil; - n-azine: triforine; - n biluo: seed dressing 11 each (fludioxonil), Hudioxonil; - Karin: adimorph, dodemorph, dodemorph-acetate, fenpropimorph, three Tridemorph; - σ bottom bite: fenpropidin; - diimine: a sit. Fluoroimide, iprodione, procymidone, vinclozolin; - non-aromatic 5-membered heterocyclic ring: famoxadone, fenamidone , flutianil, octhilinone, probenaizole, 5-amino-2-isopropyl-3-oxo-4-o-phenylene-2,3-di Hydropyrazole-1-thiocarbamic acid S-allyl; - Others: acidified benzo-sodium-s- succinic acid (acibenzolar-S-methyl), alpha sulphate (amisulbrom) , anilazine, blasticidin-S, captafol, captan, chinomethionate, dazome, σ米菌威Debacarb), diclomezine, difenzoquat, difenzoquat-methylsulfate, fenoxanil, folpet, oxolinic acid ), piperalin, proquinazid, pyroquilone, velofen 147474.doc -114- 201041514 E) (quinoxyfen), 咪°α秦 (triazoxide) ), tricyclazole, 2-butoxy-6-e-3-propyl ketone-4-one, 5-rat-1-(4,6-dimethoxy-α-density) σ定-2-yl)-2-methyl-1H-benzoxazole, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluoro Phenyl)-[1,2,4]triazolium [1,5-a]pyrimidine and 5-ethyl-6-octyl-[1,2,4]triazolium [1,5-a] Pyrimidine-7-ylamine; urethane thiol thioglycolate and dithiol phthalate such as ferbam, mancozeb, maneb, Metam, methasulfocarb, metiram, propineb, thiram, zineb, ziram; amine Formic acid S: benthiavalicarb, diethofencarb, iprovalicarb, propamocarb, propamocarb hydrochloride, valiphenal and ❹N- (l-(l-(4-Nymol-based) ethyl sulphate yellow)-butyl-2-yl)carbamic acid _ (4-fluorophenyl) ester; F) other active substances steroids: Guanidine, dodine, polyne free test, double vein salt Guazatine), diammonium acetate, iminoctadine, dioctylamine triacetate, iminoctadine-tris (albesilate); antibiotics: kasugamycin, Hydrated citric acid hydrochloride, streptomycin, polyoxin, 147474.doc -115- 201041514 validamycin A; schlossyl phenyl derivative: binapacryl , dinobuton, dinocap, nitrothal isopropyl, tetranitrobenzene (tecnazene); organometallic compound: fentin salt, such as triphenyltin acetate ( Fentin acetate), fentin chloride, fentin hydroxide; sulfur-containing heterocyclic compounds: dithianon, isoprothiolane; organic lining compound: granule pine (edifenphos), fosetyl' fosetyl-aluminum, iprobenfos, asiatic acid and its salts, pyrazophos, tolclofos-methyl; Organic gas compound: tetrachloroisophthalonitrile ( Chlorothalonil), dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pencycuron, pentachlorphenole and its salts, hot bis (phthalide), quintozene, thiophanate methyl, tolylfluanid, N-(4- gas-2-stone Schottyl-phenyl)-N-ethyl -4-Methyl-benzene styrene; inorganic active compound: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulphate, sulfur; other: biphenyl, bromine propylene glycol ( Bronopol), cyflufenamid, cymoxanil, diphenylamin, 147474.doc -116- 201041514 metrafenone, chlorpyrifos (]11丨1 (^0111丫) (^11), oxine-copper, calcium cyclate (pr〇hexadi〇ne_calcium), spiroxamine, sulfhydryl ketone, N_(cyclopropylmethoxyimino -(6-difluoro-decyloxy-2,3-difluoro-phenyl)-indolyl acetamide, Ν--(4-(4-chloro-3-trifluoro) -Phenoxy)-2,5-diamidino-phenyl)-indole-ethyl-indole-methyl oxime, ν,-(4-(4-fluoro-3-trifluoromethyl)-ben乳)),2,5-monomethyl-phenyl)-indole-ethyl-indole-indenyl group, q Ν'-(2-methyl-5-trifluoromethyl-4-(3-tri) Mercaptoalkyl-propoxy)-phenyl)-indole-ethyl-indole-methylformamidine, ν'-(5-difluoromethyl-2-methyl-4-(3-trimethyl)矽alkyl-propoxy)-phenyl)_Ν_ethyl_Ν_methylformamidine, 2-{1-[2-(5-fluorenyl-3-trifluoromethylpyrazol-1-yl) -ethinyl]-piperidin-4-yl}-thiazole-4-carboxylic acid methyl-(l,2,3,4-tetrahydronaphthalenyl-l-yl)-decylamine, 2-{l-[2 -(5-mercapto-3-trifluoromethyl-pyrazole-l-yl)-ethenyl]-piperidin-4-yl}-thiazole-4-carboxylic acid fluorenyl-(R)-l,2 , 3,4-tetrahydronaphthalen-1-yl-decylamine, 6-t-butyl-8-fluoro-2,3-dimethyl-quinolin-4-ylindole and decyloxy-acetic acid 6-Second-butyl-8-gas-2,3-dimethyl-啥琳_4-based vinegar; G) Growth regulators • Abscisic acid, amidochlor. dense. Ancymidol, 6-phenylhydrazinyl hydrazine, brassinolide, butralin, chlormequat (chlormequat chloride), gasification test (choline chloride), cyclanilide, daminozide, dikegulac, 147474.doc -117- 201041514 (dimethipin), 2,6-dimethyl Pyridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfeniiron, gibbereiiic acid, enamel (inabenfid), called prato-3-acetic acid, bud bud (111 &amp; 1 to (: hydrazide), fluorite, mefluidide, mepiquat (mepiquat chloride) ), naphthaleneacetic acid, n-6-phenylhydrazinyl adenine, paclobutrazol, pr〇hexadione (adjusted ring acid mom), prohydrojasmon (prohydrojasmon), ° benzophenone ( Thidiazuron), triapenthenol, tributyl sulphate, 2,3,5-trimoung benzoic acid, anti-reverse g (^116乂&amp;;卩&amp;(:-61;11丫1) and thinning σ sitting; Η) Herbicide - acetamamine: acetochlor, alachlor, butachlor, two Dimethachlor, dimethenamid, flufenacet, mefenacet, metolachlor, metazachlor, naproxen (napropamide), naproanilide, pethoxamid, pretilachlor, propachlor, thenyl chloride; - amino acid derivative: dipropylamine phosphate (bilanafos), glyphosate, glufosinate, sulfosate; - aryloxyphenoxypropionate: clodinafop, cyhalofop 147474.doc -118- 201041514 (cyhalofop- Butyl), fenoxaprop, D fluazifop, ° haloxyfop, metamifop, propaquizafop, 啥Quizalofop, quizalofop-P-tefuryl; - 联比 bite: diquat, paraquat; (thio)urethane: asulam, butarate, carbeamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb ), triallate; - cyclohexanedione: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim ), tepraloxydim, traik〇xydim; - succinyl aniline: benfluralin, ethalfluralin, oryzalin, dimethyl Pendimethalin, protjiamine, trifluralin; - monophenyl ether; acifluorfen, aclofenf, bifenox, grass Spirit (dicl〇fop), ethoxyfen, fensulfame (fornesafen), lactofluoxam (lactofe n), HFyfiu〇rfen; 147474.doc -119- 201041514 • benzoyl nitrile: bromoxynil, dichlobenil, ioxynil; p m ° ° Lin Ketone: 0 m grass S (imazamethabenz), 曱 oxygen 11 m grass end, methyl tamarind (imazapic), σ m ° sit in acid (imazapyr), σ m ° sit 喧 acid ( Imazaquin), σ meters. Sodium acylate (imazethapyr); - phenoxyacetic acid: oxachlorin 〇1〇11^ mouth 1*(^), 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4 -DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, 2-methyl-4-chloropropionic acid (mecoprop); - ° ratio ° Qin: chloridazone, flufen Flufenpyr-ethyl, fluthiacet, norflurazone, pyridate; - ° ratio: aminopyralid, gram (clopyralid), 0 compared to diflufenican, dithiopyr, fluridone, fluroxypyr, picloram, fluoropyrazine Picolinafen), ° thiazopyr; - scutellariae: amidosulfuron, azylsulfuron, πsulfuron, bensulfuron Chlorimuron-ethyl), chlorsulfuron, cinosulfuron, cyclosulfamuron, ethoxysulfuron, &lt;•flazasulfuron, Gas ratio Flucetosulfuron, fluorine bite. Flupyrsulfuron, foramsulfuron, halo 0 0, halosulfuron, 〇 ° ° im sulf 黄 147 147 147 147 147 147 147 147474.doc -120- 201041514 Iodosulfuron, messulfuron-methyl, metsulfuron-methyl, nicsulfuron-methyl, oxasulfuron, flusulfuron Primisulfur〇n, prosulfuron, pyrazosuifur〇n, rimsulfuron, suifonieturon, sulfosulfuron , thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, trifiusuifuron, tritosulfuron, 1 -((2-chloro-6-propyl-imidazolium [l,2-b]pyridazin-3-yl)-indolyl)-3-(4,6-dimethoxy-mouth bit-2- Urinary; amenity · ametryn, atrazine, cyanazine, dimethametryn, ethiozin, hexazine (hexazinone), metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, tri Triaziflam; urea: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron ), benzene. Methabenzthiazuron, tebuthiuron; other lactic acid synthase inhibitors: bispyribac-sodium, cloransulam-methyl, acenachlor (diclosulam), florasulam, flucarbazone, flumetsulam, scutellaria 0 147474.doc -121 - 201041514 amine (metosulam), Ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyrimoxixim ), pyrifalid, pyrimiminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, methoxyxachlor (pyroxsulam); Others: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, benzocabone Bencarbazone), benfluresate, benzofenap, Bentazone, benzobicyclon, bromacil, bromobutide, butafenacil, butamifos, π oxalate (cafenstrole), carfentrazone, cinidon-ethlyl, chlorthal, cinmethylin, clomazone, benzylidene Cumaryluron, cyprosulfamide, dicamba, wild swallow, diflufenzopyr, drenchlera monoceras, endothal , ethofumesate, etobenzanid, fentrazamide, flumiclorac-pentyl, flumioxazin, fluoro&gt ; amine grass. Sit (flupoxam), defeat B oxalicone 147474.doc -122- 201041514

(fluorochloridone)、吱草酮(flurtamone)、茚草酮 (indanofan)、異α惡草胺(isoxaben)、異σ惡嗤草酮 (isoxaflutole)、環草定(lenacil)、敵稗(propanil)、戊 块草胺(propyzamide)、二氯 D奎'# 酸(quinclorac)、11 奎草 酸(quinmerac)、甲基石黃草酮(mesotrione)、甲基石申 酸、萘草胺(naptalam)、炔惡草酮(oxadiargyl)、惡草 酮(oxadiazon)、惡嗪草酮(oxaziclomefone)、環戊 °惡草 酮(pentoxazone)、α坐淋草醋(pinoxaden)、雙唾草腈 (pyraclonil)、π比草醚(pyraflufen-ethyl)、匹拉石黃托 (pyrasulfotol)、节草啥(pyrazoxyfen)、比拉 α坐諾 (pyrazolynate)、滅藻酿(quinoclamine)、°密 °定肪草醚 (saflufenacil)、績草酮(sulcotrion)、曱石黃草胺 (sulfentrazone)、特草定(terbacil)、特咬酮 (tefuryltrione)、特伯酮(tembotrione)、嗟卡巴腙 (thiencarbazone)、托潘腙(topramezone)、4-經基-3-[2-(2-甲氧基-乙氧基甲基)-6-三氟曱基-吼啶-3-羰基]-雙環[3.2.1]辛-3-烯-2-酮、(3-[2-氯-4-氟-5-(3-曱基-2,6-二側氧基-4-三氟甲基-3,6-二氫-211-嘧啶-1-基)-苯 氧基]-。比°定-2-基乳基)-乙酸乙自旨、6 -胺基-5-氯-2-壤丙 基-唯咬-4-曱酸甲醋、6 -氣- 3- (2 -壤丙基-6-甲基-苯乳 基)-噠嗪-4-醇、4-胺基-3-氣-6-(4-氯-苯基)-5-氟比 啶-2-甲酸、4-胺基-3-氯-6-(4-氯-2-氟-3-甲氧基-苯 基)-吡啶-2-曱酸甲酯及4-胺基-3-氯-6-(4-氯-3-二曱胺 基-2-氟-苯基)-吡啶-2-曱酸甲酯; 147474.doc -123- 201041514 i) 殺昆蟲劑 - 有機(硫代)磷酸酯:歐殺松(acephate)、亞滅松 (azamethiphos)、毅速松(azinph〇s-methyl)、陶斯松 (chlorpyrifos)、甲基陶斯松(chl〇rpyrifos-methyl) ' 克 芬松(chlorfenvinphos)、大利松(diazinon)、二氯松 (dichlorvos)、雙特松(dicrotophos)、大滅松 (dimethoate)、一 硫松(disulfoton)、愛殺松(ethion)、 撲滅松(fenitrothion)、芬殺松(fenthi〇n)、加福松 (isoxathion)、馬拉松(malathion)、達馬松 (methamidophos)、滅大松(methidathion)、曱基巴拉 松(methyl-parathion)、美文松(mevinphos)、亞素靈 (monocrotophos)、滅多松(oxydemeton-methyl)、巴拉 奥克松(paraoxon)、巴拉松(parathion)、賽達松 (phenthoate)、裕必松(phosalone)、益滅松(phosmet)、 福賜米松(phosphamidon)、福瑞松(phorate)、巴賽松 (phoxim)、亞特松(pirimiphos-methyl)、布飛松 (profenofos)、普硫松(prothiofos)、殺普松(sulprophos)、 樂本松(tetrachlorvinphos)、託福松(terbufos)、三落松 (triazophos)、三氣松(trichlorfon); - 胺基甲酸醋:棉靈威(alanycarb)、得滅克(aldicarb)、 免敵克(bendiocarb)、本夫克(benfuracarb) '加保利 (carbaryl)、加保扶(carbofuran)、丁基加保扶 (carbosulfan)、芬諾克(fenoxycarb)、吱線威 (furathiocarb)、滅賜克(methiocarb)、納乃得 -124- 147474.doc 201041514 (methomyl)、歐殺滅(oxamyl)、比加普(pirimicarb)、 安丹(propoxur)、硫雙威(thiodicarb)、α坐騎威 (triazamate);(fluorochloridone), flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, Propyzamide, quinclorac, quinmerac, mesotrione, methyl sulphate, naptalam, alkyne Oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, π Pyraflufen-ethyl, pyrasulfotol, pyrazoxyfen, pyrazzolynate, quinoclamine, saflufenacil ), sulcotrion, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topan ( Topramezone), 4-carbyl-3-[2-(2-methoxy-ethoxymethyl)-6-trifluorodecyl-acridin-3-carbonyl ]-Bicyclo[3.2.1]oct-3-en-2-one, (3-[2-chloro-4-fluoro-5-(3-indolyl-2,6-di-oxy-4-phenyl) Fluoromethyl-3,6-dihydro-211-pyrimidin-1-yl)-phenoxy]-.pyridyl-2-yllacyl)-acetic acid, 6-amino-5-chloro -2-Lactinyl-only bite-4-methyllic acid methyl vinegar, 6-gas-3-(2-propionic propyl-6-methyl-phenyllacyl)-pyridazin-4-ol, 4-amine 3--3-6-(4-chloro-phenyl)-5-fluoropyridin-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methyl Methyl oxy-phenyl)-pyridine-2-decanoate and 4-amino-3-chloro-6-(4-chloro-3-didecylamino-2-fluoro-phenyl)-pyridine-2 - methyl decanoate; 147474.doc -123- 201041514 i) insecticides - organic (thio) phosphates: acephate, azamethiphos, azainph〇s-methyl ), chlorpyrifos, chl〇rpyrifos-methyl 'chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate ), disulfoton, ethion, fenitrothion, fenthi〇n, isoxath Ion), marathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton- Methyl), paraoxon, parathion, phenthoate, phosalone, phosmet, phosphamidon, frisson Phorate), phoxim, pirimiphos-methyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, tofufos ), triazophos, trichlorfon; - urethane acetal: alanycarb, aldicarb, bendiocarb, benfuracarb Carbaryl, carbofuran, carbosulfan, fenoxycarb, furathiocarb, meticarb, and nadine-124- 147474 .doc 201041514 (methomyl), oxamyl, bicap (pirimicarb), propoxur, thiodicarb, alpha triazamate;

擬除蟲菊酯(pyrethroid):雅列寧(allethrin)、畢芬寧 (bifenthrin)、賽扶寧(cyfluthrin)、赛洛寧 (cyhalothrin)、賽齡寧(cyphenothrin)、賽滅寧 (〇丫卩61*11^1;111411)、亞滅寧(&amp;1卩1^-〇7卩61&gt;11161]11411)、0-赛滅 寧、ξ-賽滅寧(zeta-cypermethrin)、第滅寧 (deltamethrin)、益化利(esfenvalerate)、依芬寧 (etofenprox)、芬普寧(fenpropathrin)、芬化利 (fenvalerate)、依普寧(imiprothrin)、λ-賽洛寧 (lambda-cyhalothrin)、百滅寧(permethrin)、普亞列寧 (prallethrin)、除蟲菊醋 I及 II、異列滅寧(resmethrin)、 石夕護芬(silafluofen)、福化利(tau-fluvalinate)、七氟菊 SI (tefluthrin)、治滅寧(tetramethrin)、泰滅寧 (tralomethrin)、拜富寧(transfluthrin)、丙氧菊醋 (profluthrin)、四氟曱醚菊醋(dimefluthrin); 昆蟲生長調節劑:a)曱殼素(chitin)合成抑制劑:苯甲 醯·脲:克福隆(chlorfluazuron)、賽滅淨(cyromazine)、 二福隆(diflubenzuron)、氟環腺(flucycloxuron)、氟芬 隆(flufenoxuron)、六伏隆(hexaflumuron)、祿芬隆 (lufenuron)、諾瓦隆(novaluron)、得福隆(teflubenzuron)、 三福隆(triflumuron);布芬淨(buprofezin)、苯蟲鱗 (diofenolan)、合賽多(hexythiazox)、依殺蜗(etoxazole)、 147474.doc -125- 201041514 克芬蜗(clofentazin) ; b)规皮激素拮抗劑:合芬隆 (halofenozide)、滅芬諾(methoxyfenozide)、得芬諾 (tebufenozide)、印楝素(azadirachtin) ; c)保幼激素類 似物(juvenoid) ··百利普芬(pyriproxyfen)、美賜平 (methoprene)、芬諾克(fenoxycarb) ; d)脂質生物合成 抑制劑:賜派芬(spirodiclofen)、 螺甲蜗酿 (spiromesifen)、螺蟲乙酉旨(spirotetramate); 菸鹼受體促效劑/拮抗劑化合物:可尼丁 (clothianidin)、達特南(dinotefuran)、益達胺 (imidacloprid)、賽速安(thiamethoxam)、稀咬蟲胺 (nitenpyram)、亞滅培(acetamiprid)、賽果培 (thiacloprid)、1-(2-氣-噻唑-5-基曱基)-2-硝亞胺基-3,5-二甲基-[1,3,5]三氮雜環己烷; GABA拮抗劑化合物:安殺番(endosulfan)、乙蟲清 (ethiprol)、芬普尼(fipronil)、凡尼普羅(vaniliprol)、 氟蟲腈(pyrafluprol)、派瑞樂(pyriprol)、5-胺基-1-(2,6-二氯-4-甲基-苯基)-4-胺亞磺醯基-1H-吼唑-3-硫 代甲酸醯胺; 巨環内酯殺昆蟲劑··阿巴汀(abamectin)、因滅汀 (emamectin)、密滅汀(milbemectin)、林皮沒丁 (lepimectin)、賜諾殺(spinosad)、斯平托蘭 (spinetoram); 粒線體電子傳輸抑制劑(METI)I殺蟎劑:芬殺蟎 (fenazaquin)、畢達本(pyridaben)、得芬瑞 -126- 147474.doc 201041514 (tebufenpyrad)、脫芬瑞(tolfenpyrad)、氟芬内林 (flufenerim); METI II及III化合物:亞跟蜗(acequinocyl)、福瑞姆 (fluacyprim)、愛美松(hydramethylnon); 解偶聯劑(Uncoupler):克凡派(chlorfenapyr); 氧化構酸化抑制劑:錫蜗丹(cyhexatin)、汰芬諾克 (diafenthiuron)、芬布錫(fenbutatin oxide)、殿蜗多 ❹ (propargite); 蜆皮干擾化合物(moulting disruptor compound):賽滅 淨(cryomazine); 混合功能氧化酶抑制劑:協力精(piperonyl butoxide); 鈉通道阻斷劑:因得克(indoxacarb)、氰氟蟲腙 (metaflumizone); 其他:苯氣嗔 °秦(benclothiaz)、畢芬載(bifenazate)、 ο 培丹(cartap)、氟尼胺(flonicamid)、咬蟲丙醚 (pyridalyl)、派滅淨(pymetrozine)、硫、硫賜安 (thiocyclam)、氟蟲酿胺(flubendiamide)、勉安勃 (chlorantraniliprol)、賽培(cyazypyr)(HGW86);塞諾 0比芬(cyenopyrafen)、°比氟硫磷(flupyrazofos)、丁氟 瞒酯(cyflumetofen)、安米氟美(amidoflumet)、辂驗硫 璃(imicyafos)、雙三說蟲脲(bistrifluron)及柏亞羅 (pyrifluquinazon) ° 本發明此外係關於農用化學組合物,其包含至少一種化 H7474.doc -127- 201041514 合物I、II及/或IV(組分1)與至少一種適用於植物保護之例 如選自A)組至I)組之其他活性物質(組分2)(尤其為另一殺 真菌劑’例如一或多種來自如上所述之A)組至F)組的殺真 菌劑)及必要時一種適合溶劑或固體載劑的混合物。因為 許多彼等混合物在相同施用量下顯示較高之對抗有害真菌 之效率,所以其尤其受關注。此外,以化合物^及/或 IV與至少一種如上所述來自A)組至F)組之殺真菌劑的混合 物對抗有害真菌比以個別化合物I、IV或來自A)組至F) 組之個別殺真菌劑對抗彼等真菌更有效。藉由施用化合物 I、II及/或IV連同至少一種來自A組至J)組之活性物質,可 達成協同效應,亦即達成大於個別作用之簡單加和(協同 混合物)。 根據本發明,應瞭解,施用化合物卜π及/或1¥連同至 少一種其他活性物質表示至少一種式卜π及/或1¥化合物 及至少一種其他活性物質以殺真菌有效量同時出現於作用 部位(亦即待防治之有害真菌或其生境,諸如感染植物、 植物繁殖材料(尤其為種子)、表面、材料或土壤,以及待 受保護以免真菌侵襲之植物 '植物繁殖材料(尤其為種 子)、土壤、表面、材料或空間)。此可藉由同時(聯合(例 如以槽混合物之形式)或分別地))或連續地施用化合物工、Η 或及至^種其他活性物質來達成,其中在個別施 用之間的時間間隔經選擇以確保首先施用之活性物質在施 用其他活性物質之時仍以足量存在於作用部位。施用順序 對於本發明之工作並不重要。 147474.doc 128· 201041514 在一元混合物’亦即包含一種化合物I、π或Z V(組分J) 及另/舌性物質(組分2)(例如一種來自A)組至I)組之活性 物質)的本發明組合物中’組分1與組分2之重量比一般視 所用活性物質之特性而定,其通常在1:100至100:1之範圍 内、左吊在1-50至50:1之範圍内’較佳在i:2〇至20:1之範 圍内,更佳在1:10至10:1之範圍内且特定言之在1:3至3:1 之範圍内。 〇 在二元混合物,亦即包含一種化合物I、II及/或IV(組分 1)及第一其他活性物質(組分2)及第二其他活性物質(組分 3)(例如兩種來自A)組至1}組之活性物質)的本發明組合物 中’組分1與組分2之重量比視所用活性物質之特性而定, 其較佳在1:50至50:1之範圍内且尤其在1:10至1〇:1之範圍 内’且組分i與組分3之重量比較佳在1:5〇至5〇:1之範圍内 且尤其在1:10至1〇:1之範圍内。 組分可個別地或彼此部分或完全混合後用來製備本發明 〇 之組合物。其亦可進一步以組合組合物(諸如分裴部分之 套組)之形式封裝及使用。 在本發明之一個實施例中,套組可包括一或多種(包括 所有)可用以製備標的農用化學組合物之組分。舉例而 言’套組可包含一或多種殺真菌劑組分及/或佐劑組分及/ 或杈昆蟲劑組分及/或生長調節劑組分及/或除草劑。—戍 多種組分可已組合在一起或經預調配。在套組中提供兩種 以上組分之彼等實施例中,組分可已組合在一起且按原樣 封裝於諸如小瓶、瓶、罐、小袋、袋或小罐之單一容考 147474.doc -129- 201041514 中。在其他實施例中,可將套組之兩種或兩種以上組分分 別封裝,亦即不預調配。因此,套組可包括一或多個個別 容器,諸如小瓶、罐、瓶、小袋、袋或小罐,各容器含有 農用化學組合物之個別組分。在兩種形式中,套組之一種 組分可與其他組分分開施用或一起施用或以製備本發明組 合物之本發明組合組合物的組分之形式施用。 使用者通常自动劑寬裝置(predosage device)、背負式喷 霧器、噴霧槽或噴灑機施用本發明之組合物。此處,農用 化學組合物係由水及/或緩衝液補足至所需施用濃度,適 當時可添加其他助劑,且因此獲得本發明之即用型噴霧液 體或農用化學組合物。每公頃農業有效面積通常施用5〇公 升至500公升,較佳1〇〇公升至4〇〇公升即用型喷霧液體。 根據一個實施例,本發明組合物之個別組分,諸如套組 之。卩分或二元或三元混合物之部分,可由使用者本人在喷 霧槽中混合’且適當時可添加其他助劑(槽混)。 在另一貫施例中,本發明組合物之個別組分或部分預混 、-且刀’例如包含化合物!、11及/或1¥及/或來自A)組至〗)組 杜物貝的組分,可由使用者在喷霧槽中混合且適當時 可添加其他助劑及添加劑(槽混)。 在另—番 貫施例中’本發明組合物之個別組分或部分預混 ’且刀’例如包含化合物I、Π及/或IV及/或來自A)組至I)組 之/舌丨生物質的組分’可聯合(例如在槽混之後)施用或連續 施用。 已3化合物1、II及/或IV(組分1)及至少一種選自A)組之 147474.doc -130- 201041514 嗜毬果傘素且尤其選自以下之活性物質(組分2)的混合物亦 較佳:亞托敏、醚菌胺、氟嘧菌酯、克收欣、肟醚菌胺、 啶氧菌胺'百克敏及三氟敏。 包含化合物I、II及/或IV(組分丨)及至少一種選自B)組之 羧醯胺且尤其選自以下之活性物質(組分2)的混合物亦較 佳:百克芬、白克列、色達安、環醯菌胺、滅達樂、異哌 劄美、右滅達樂、呋酿胺、達滅芬、氟嗎啉、氟吼菌胺 (°比考苯胺(picobenzamid))、座賽胺、加普胺、雙炔酿菌胺 及N-(3,,4,,5,-三氟聯苯-2-基)-3-二氟曱基」-甲基_1H_吡唑_ 4-甲酿胺。 包含化合物I、II及/或IV(組分1)及至少一種選自c)組之 唑且尤其選自以下之活性物質(組分2)的混合物較佳:環克 座、待克利、依普座、氟喹唑、護矽得、護汰芬、滅特 座、邁克尼、平克座、普克利、丙硫菌嗤、三泰芬、三泰 隆、得克利、四克利、滅菌唑、撲克拉、赛座滅、免賴 得、貝芬替及噻唑菌胺。 包含化合物I、II及/或IV(組分1)及至少一種選自D)組之 雜環化合物且尤其選自以下之活性物質(組分2)的混合物亦 較佳:扶吉胺、賽普洛、芬瑞莫、滅派林'派美尼、賽福 寧、護汰寧、嗎菌靈、芬普福、三得芬、苯鏽啶、依普 同、免克寧、凡殺同、咪唑菌酮、撲殺熱、普奎那茲、酸 化苯并噻二唑-s_甲酯、四氯丹、福爾培、氰菌胺、快諾 芬及5-乙基-6-辛基-[1,2,4]三唑幷[l,5-a]嘧啶-7-基胺。 包含化合物I、II及/或IV(組分1}及至少一種選自E)組之 147474.doc • 131 - 201041514 胺基曱酸酯且尤其選自鋅錳乃浦、免得爛、曱基鋅乃浦、 得恩地、纈黴威、苯噻菌胺及霜黴威之活性物質(組分2)的 混合物亦較佳。 包含化合物I、II及/或IV(組分1)及至少一種選自F)組之 殺真菌劑且尤其選自以下之活性物質(組分2)的混合物亦較 佳:腈硫藏、三苯錫鹽(諸如三苯醋錫)、福賽得、福賽得 鋁、h3po3及其鹽、四氯異苯腈、益發靈、甲基多保淨、 乙酸銅、氫氧化銅、氯氧化銅、硫酸銅、硫、克絕、滅芬 農及螺惡茂胺。 因此,本發明此外係關於組合物,其包含一種化合物 I、II及/或IV(組分1)及另一活性物質(組分2),該另一活性 物質係選自表B之第B-1至B-346行之「組分2」一欄。 另一實施例係關於表B中所列之組合物B-1至B-346,其 中表B之一列在各情況下對應於包含一種在本說明書中之 個別化式I、II或IV化合物(組分1)及所討論之列中所述的 來自A)組至I)組之各別其他活性物質(組分2)的殺真菌組合 物。所述組合物較佳包含協同有效量之活性物質。 表B :包含一種個別化化合物I、II或IV及來自A)組至I) 組之另一活性物質的組合物 混合物 組分1 組分2 B-1 一種個別化化合物I、II或IV 亞托敏 B-2 一種個別化化合物I、II或IV 醚菌胺 B-3 一種個別化化合物I、Π或IV 稀两菌酯 B-4 一種個別化化合物I、II或IV 氟嘧菌酯 B-5 一種個別化化合物I、II或IV 克收欣 147474.doc •132· 201041514Pyrethroid: allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cytophenone (〇丫卩61*) 11^1;111411), arsenic (&amp;1卩1^-〇7卩61&gt;11161]11411), 0-saiding ning, ξ-saiperingin (zeta-cypermethrin), dying (deltamethrin ), esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, lambda-cyhalothrin, and fentanin Permethrin), prallethrin, pyrethrum vinegar I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin , tetramethrin, tralmethrin, transfluthrin, profluthrin, dimefluthrin; insect growth regulator: a) chitin (chitin) synthetic inhibitor: benzamidine·urea: chlorfluazuron, cyromazine, difulong (di Flubenzuron), flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron ); buprofezin, diofenolan, hexythiazox, etoxazole, 147474.doc -125- 201041514 clefentazin; b) cutaneous hormone antagonism Agents: hafenofozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids · pyriproxyfen, Metoprene, fenoxycarb; d) Lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramate; nicotinic receptors Agent/antagonist compound: clothianidin, dinotefuran, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, Thiacloprid, 1-(2-gas-thiazide -5-ylindenyl)-2-nitroimino-3,5-dimethyl-[1,3,5]triazide; GABA antagonist compound: endosulfan, B Ethiprol, fipronil, vaniliprol, pyrafluprol, pyriprol, 5-amino-1-(2,6-dichloro-4 -Methyl-phenyl)-4-amine sulfinyl-1H-indazole-3-thiocarbamic acid guanamine; macrolide lactone insecticide · abatin (abamectin), dueitin (emamectin ), milbemectin, lepimectin, spinosad, spinetoram; mitochondrial electron transport inhibitor (METI) I acaricide: fentanyl (fenazaquin), pyripaben, phenanthrene-126-147474.doc 201041514 (tebufenpyrad), defenfenpyrad, flufenerim; METI II and III compounds: sub-volute Acequinocyl), fluacyprim, hydramethylnon; uncoupler: chlorfenapyr; oxidative acidification inhibitors: cyhexatin, diafenthiuron ), fenbuxie (fenbu) Tatin oxide), propargite; moulting disruptor compound: cryomazine; mixed-function oxidase inhibitor: piperonyl butoxide; sodium channel blocker: Indoxacarb, metaflumizone; others: benclothiaz, bifenazate, á cartap, flonicamid, bitumin (pyridalyl), pymetrozine, sulfur, thiocyclam, flubendiamide, chlorantraniliprol, cyazypyr (HGW86); Seno 0 bis ( Cyenopyrafen), ° flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluron and pyrifluquinazon The invention further relates to an agrochemical composition comprising at least one H7474.doc-127-201041514 compound I, II and/or IV (component 1) and at least one suitable for plant protection, for example selected from A ) other actives from group I to group I) (Component 2) set fungicide) and, if necessary, a mixture of a suitable solvent or a solid carrier (in particular a further fungicide 'as described above, for example, one or more from the group A) to F). Because many of their mixtures show higher efficiency against harmful fungi at the same application rate, they are of particular interest. Furthermore, mixtures of compounds and/or IV with at least one fungicide from groups A) to F) as described above are resistant to harmful fungi than individual compounds I, IV or from groups A) to F) Fungicides are more effective against their fungi. By administering Compounds I, II and/or IV together with at least one active substance from Groups A to J), a synergistic effect can be achieved, i.e., a simple addition (co-mixture) greater than the individual effects is achieved. According to the present invention, it is to be understood that the administration of the compound π and/or 1 ¥ together with at least one other active substance means that at least one compound of the formula π and/or 1¥ and at least one other active substance are simultaneously present in the site of action in a fungicidal effective amount. (ie harmful fungi or their habitat to be controlled, such as infected plants, plant propagation material (especially seeds), surface, material or soil, and plants 'plant propagation material (especially seeds) to be protected from fungal attack, Soil, surface, material or space). This can be achieved by simultaneously (in combination (e.g., in the form of a mixture of tanks) or separately) or continuously, the compounding agent, hydrazine or and other active substances, wherein the time interval between individual administrations is selected It is ensured that the active substance applied first is still present in sufficient quantity at the site of action when other active substances are applied. The order of application is not critical to the work of the present invention. 147474.doc 128· 201041514 In a one-component mixture, ie an active substance comprising a compound I, π or ZV (component J) and a further/tongue substance (component 2) (for example a group from group A) to group I) The weight ratio of component 1 to component 2 in the composition of the invention generally depends on the nature of the active substance used, which is usually in the range of 1:100 to 100:1, and the left suspension is in the range of 1-50 to 50. The range of :1 is preferably in the range of i:2〇 to 20:1, more preferably in the range of 1:10 to 10:1 and in particular in the range of 1:3 to 3:1. 〇 in a binary mixture, ie comprising a compound I, II and / or IV (component 1) and a first other active substance (component 2) and a second other active substance (component 3) (eg two from The weight ratio of component 1 to component 2 in the composition of the invention of group A to group 1} depends on the nature of the active substance used, preferably in the range of 1:50 to 50:1. And especially in the range of 1:10 to 1〇:1 and the weight of component i and component 3 is preferably in the range of 1:5〇 to 5〇:1 and especially 1:10 to 1〇 Within the range of 1:1. The components may be used in the preparation of the compositions of the present invention either individually or partially or completely with one another. It may also be further packaged and used in the form of a combination composition such as a set of branching parts. In one embodiment of the invention, the kit can include one or more (including all) components that can be used to prepare the subject agrochemical composition. By way of example, the kit may comprise one or more fungicide components and/or adjuvant components and/or an insecticide component and/or a growth regulator component and/or a herbicide. —戍 Multiple components can be combined or pre-formulated. In embodiments in which more than two components are provided in a kit, the components may have been combined and packaged as such in a single vial, vial, vial, sachet, pouch or canister, 147474.doc - 129- 201041514. In other embodiments, two or more components of the kit may be packaged separately, i.e., not pre-configured. Thus, the kit can include one or more individual containers, such as vials, cans, bottles, sachets, bags or cans, each containing an individual component of the agrochemical composition. In either form, one component of the kit can be administered separately or together with the other components or in the form of a component of the combination composition of the invention for preparing the compositions of the invention. The user typically applies the composition of the present invention to a predosage device, a knapsack sprayer, a spray tank or a sprayer. Here, the agrochemical composition is made up of water and/or buffer to the desired application concentration, and other auxiliaries may be added as appropriate, and thus the ready-to-use spray liquid or agrochemical composition of the present invention is obtained. The agricultural effective area per hectare is usually applied from 5 liters to 500 liters, preferably 1 liter to 4 liters of ready-to-use spray liquid. According to one embodiment, the individual components of the compositions of the invention, such as kits. Part of the split or binary or ternary mixture may be mixed by the user himself in the spray tank' and other additives may be added as appropriate (tank mix). In another embodiment, the individual components or portions of the compositions of the present invention are premixed, and the knives&apos;, for example, comprise a compound! , 11 and / or 1 ¥ and / or from the group A) to the group) The components of the durum shell can be mixed by the user in the spray tank and other additives and additives (tank mix) can be added as appropriate. In another embodiment, 'individual components or portions of the composition of the invention are premixed' and the knives comprise, for example, compounds I, hydrazine and/or IV and/or from group A) to group I) The component ' of the biomass can be applied in combination (eg, after tank mixing) or continuously. 3 compounds 1, II and/or IV (component 1) and at least one selected from the group consisting of 147474.doc-130-201041514 lycopene and especially selected from the following active substances (component 2) Mixtures are also preferred: atramine, fenfluramine, fluoxastrobin, kexinxin, epothilone, oxystrobin 'baikemin and trifluoro-sensitive. Mixtures comprising the compounds I, II and/or IV (component oxime) and at least one carboxamide selected from the group B) and especially selected from the following active substances (component 2) are also preferred: baifen, white Krebs, chrome, cycloheximide, chlorhexidine, isoprazol, dextromethorphan, furosemide, damiden, flumorph, flufenamide (picobenzamid) ), acesulfamide, gupamine, diacetylenic acid and N-(3,4,5,-trifluorobiphenyl-2-yl)-3-difluoroindolyl-methyl_1H _Pyrazole_ 4-cartoamine. Preferably, the mixture comprising the compound I, II and/or IV (component 1) and at least one azole selected from the group consisting of c) and especially selected from the group consisting of the following active ingredients (component 2): cyclourea, holly, yi Prosthetic, fluoroquinazole, hydrazine, defoliation, thiophene, micney, pingke, pugli, propionate, trimethoate, three tailong, dexclily, tikili, sterilized azole, Poker, race, kill, free, befenfen and ethaboxam. Mixtures comprising a compound I, II and/or IV (component 1) and at least one heterocyclic compound selected from the group D) and especially selected from the following active substances (component 2) are also preferred: chloramine, race Proc, Fenremo, Defen's 'Peimeni, Saifuning, Riding Ning, Boojingling, Fenfufu, Sandefene, Benzene, Yiputong, Kekening, Fanzhitong , Imidazolidone, chlorpyrifos, pluratin, acidified benzothiadiazole-s-methyl ester, tetrachlorodan, fordene, cyanamide, vebufen and 5-ethyl-6-octyl- [1,2,4] Triazolium [l,5-a]pyrimidin-7-ylamine. 147474.doc comprising a compound I, II and/or IV (component 1} and at least one selected from the group consisting of E) • 131 - 201041514 Amino phthalate and especially selected from the group consisting of zinc manganese, smear, sulphide zinc Mixtures of active substances (component 2) of Naipu, Dean, M. carbendazim, and chlorfenapyr are also preferred. Mixtures comprising a compound I, II and/or IV (component 1) and at least one fungicide selected from the group F) and especially selected from the following active substances (component 2) are also preferred: nitrile sulfide, three Benzene salt (such as triphenyl vinegar), forsythia, forex aluminum, h3po3 and its salts, tetrachloroisophthalonitrile, Yifaling, methyl chlorhexate, copper acetate, copper hydroxide, copper oxychloride , copper sulfate, sulfur, gram, extinction and snail amine. Accordingly, the present invention further relates to a composition comprising a compound I, II and/or IV (component 1) and another active substance (component 2) selected from the group B of Table B. -1 to B-346 in the "Component 2" column. Another embodiment relates to compositions B-1 to B-346 listed in Table B, wherein one of the tables B is in each case corresponding to comprising an individual compound of formula I, II or IV in the present specification ( Fungicidal composition of component 1) and the respective other active substances (component 2) from groups A) to I) described in the column in question. The composition preferably comprises a synergistically effective amount of active material. Table B: Composition Mixtures comprising an individual compound I, II or IV and another active substance from Groups A) to I) Component 1 Component 2 B-1 An individualized compound I, II or IV Tomin B-2 An individualized compound I, II or IV. Esteramine B-3 An individualized compound I, hydrazine or IV dipyridyl ester B-4 An individualized compound I, II or IV fluoxastrobin B -5 an individualized compound I, II or IV 克收欣147474.doc •132· 201041514

混合物 組分1 組分2 B-6 一種個別化化合物I、II或iv 苯氧菌胺 B-7 一種個別化化合物I、II或IV 肪醚菌胺 B-8 一種個別化化合物I、II或IV 啶氧菌胺 B-9 一種個別化化合物I、II或IV 百克敏 B-10 一種個別化化合物I、II或IV °比本卡 B-ll 一種個別化化合物I、π或IV 三氟敏 B-12 一種個別化化合物I、π或IV 2-(2_(6-(3-氣-2_甲基-苯氧基)-5-氟-嘧 咬基氧基)-苯基)-2-曱氧基亞胺基-N-甲基-乙醯胺 B-13 一種個別化化合物I、π或IV 2·(鄰((2,5-二甲基苯氧基亞甲基)苯 基)-3-甲氧基丙烯酸甲酯 B-14 一種個別化化合物I、II或IV 3-曱氧基-2-(2-(N-(4-甲氧基-苯基)-環 丙烷甲醯亞胺醯基硫基甲基)-苯基)-丙烯酸曱酯 B-15 一種個別化化合物I、II或IV 2-(2-(3-(2,6-二氣苯基)-1-甲基-亞烯 丙基胺基氧基曱基)-苯基)-2-甲氧基 亞胺基-N-曱基-乙醯胺 B-16 一種個別化化合物I、II或IV 本達樂 B-17 一種個別化化合物I、π或IV 右本達樂 B-18 一種個別化化合物I、II或IV 麥鏽靈 B-19 一種個別化化合物I、II或IV 百克芬 B-20 一種個別化化合物I、π或IV 白克利 B-21 一種個別化化合物I、π或IV 萎鏽靈 B-22 一種個別化化合物I、Π或IV 甲°夫酿胺 B-23 一種個別化化合物I、II或IV 環醯菌胺 B-24 一種個別化化合物I、π或IV 氟多寧 B-25 一種個別化化合物I、II或IV 福拉比 B-26 一種個別化化合物I、II或IV 異略劄美 B-27 一種個別化化合物I、π或rv 異天尼 B-28 一種個別化化合物I、II或IV 開達樂 B-29 一種個別化化合物I、Π或IV 滅普寧 B-30 一種個別化化合物I、II或rv 滅達樂 B-31 一種個別化化合物I、Π或IV 右滅達樂 B-32 一種個別化化合物I、π或IV D夫醯胺 147474.doc •133· 201041514 混合物 組分1 組分2 B-33 一種個別化化合物I、Π或IV 歐殺斯 B-34 一種個別化化合物I、II或IV 嘉保信 B-35 一種個別化化合物I、II或IV 吡噻菌胺 B-36 一種個別化化合物I、II或IV 色達安 B-37 一種個別化化合物I、II或IV 克枯爛 B-38 一種個別化化合物I、Π或IV 賽氟*滅 B-39 一種個別化化合物I、Π或IV 汰敵寧 B-40 一種個別化化合物I、II或IV 2-胺基-4-甲基-噻唑-5-曱酸苯胺 B-41 一種個別化化合物I、II或IV 2·氯-N-(l,l,3-三曱基-茚滿-4-基)-菸 鹼醯胺 B-42 一種個別化化合物I、II或IV 三氟聯苯-2-基)-3-二氟甲 基-1-曱基-m-吡唑-4-曱醯胺 B-43 一種個別化化合物I、II或IV N-(4L三氟曱基硫基聯苯-2-基)-3-二 氟曱基-1-甲基-1H-吡唑-4-曱醯胺 B-44 一種個別化化合物I、II或IV N-(2-(l ,3-二曱基-丁基)-苯基)-1,3-二 曱基-5-氟-1H-吡唑-4-甲醯胺 B-45 一種個別化化合物I、II或IV N-(2-(l,3,3-三甲基-丁基)-苯基)-1,3-二曱基-5-氟-1H-吡唑-4-曱醯胺 B-46 一種個別化化合物I、II或IV 達滅芬 B-47 一種個別化化合物I、II或IV 氟嗎嚇 B-48 一種個別化化合物I、II或IV 丁11比嗎琳 B-49 一種個別化化合物I、II或IV 氟醯菌胺 B-50 一種個別化化合物I、II或IV 氟°比菌胺 B-51 一種個別化化合物I、II或IV 氟吼菌醯胺 B-52 一種個別化化合物I、Π或IV 座賽胺 B-53 一種個別化化合物I、II或IV N-(3-乙基-3,5,5-三曱基-環己基)_3·曱 醯胺基-2-羥基-苯甲醯胺 B-54 一種個別化化合物I、Π或IV 加普胺 B-55 一種個別化化合物I、II或IV 二氣西莫 B-56 一種個別化化合物I、Π或IV 雙炔醯菌胺 B-57 一種個別化化合物I、Π或IV 土黴素 B-58 一種個別化化合物I、Π或IV 矽噻菌胺 B-59 一種個別化化合物I、Π或IV N-(6-曱氧基-吡啶-3-基)環丙烷曱酸 醯胺 147474.doc -134- 201041514Mixture Component 1 Component 2 B-6 An individualized compound I, II or iv phenoxybamine B-7 An individualized compound I, II or IV of the fascinamide B-8 an individualized compound I, II or IV oxystrobin B-9 an individualized compound I, II or IV baikemin B-10 an individualized compound I, II or IV ° than this card B-ll an individualized compound I, π or IV trifluoro-sensitive B-12 An individualized compound I, π or IV 2-(2_(6-(3-gas-2-methyl-phenoxy)-5-fluoro-pyrimidinyloxy)-phenyl)-2 - anthracene imino-N-methyl-acetamide B-13 an individualized compound I, π or IV 2 · (o((2,5-dimethylphenoxymethylene)phenyl) )-3-methoxymethyl acrylate B-14 An individualized compound I, II or IV 3-decyloxy-2-(2-(N-(4-methoxy-phenyl)-cyclopropane A醯iminomethylthiomethyl)-phenyl)-decyl acrylate B-15 An individualized compound I, II or IV 2-(2-(3-(2,6-di-phenyl)-1 -Methyl-allylaminooxyindolyl)-phenyl)-2-methoxyimino-N-indenyl-acetamide B-16 An individualized compound I, II or IV Dale B-17 is an individualized I, π or IV 右本达乐B-18 An individualized compound I, II or IV 麦麦灵B-19 An individualized compound I, II or IV 克克芬B-20 An individualized compound I, π Or IV White Klein B-21 An individualized compound I, π or IV Brassin B-22 An individualized compound I, hydrazine or IV A bromoamine B-23 An individualized compound I, II or IV cyclic oxime Insecticidal B-24 An individualized compound I, π or IV Fluonine B-25 An individualized compound I, II or IV Furabi B-26 An individualized compound I, II or IV 27 An individualized compound I, π or rv Isopron B-28 An individualized compound I, II or IV Kadule B-29 An individualized compound I, oxime or IV thiophene B-30 An individualized compound I , II or rv 达达乐 B-31 an individualized compound I, hydrazine or IV dextromethorphan B-32 an individualized compound I, π or IV D-flinamide 147474.doc •133· 201041514 mixture component 1 Component 2 B-33 An individualized compound I, oxime or IV Ou Xi Si B-34 An individualized compound I, II or IV Jia Baoxin B-35 Compound I, II or IV, 1 and 2, an individualized compound I, II or IV, an individual compound I, II or IV, a gram of B-38, an individualized compound I, Π or IV 赛 fluoro * B-39 an individualized compound I, hydrazine or IV carbene B-40 an individualized compound I, II or IV 2-amino-4-methyl-thiazole-5-decanoic acid Aniline B-41 An individualized compound I, II or IV 2 · chloro-N-(l,l,3-trimethyl-indan-4-yl)-nicotinium amide A-specific compound I , II or IV trifluorobiphenyl-2-yl)-3-difluoromethyl-1-indenyl-m-pyrazole-4-nonylamine B-43 an individualized compound I, II or IV N- (4L trifluoromethylsulfenylbiphenyl-2-yl)-3-difluorodecyl-1-methyl-1H-pyrazole-4-decylamine B-44 an individualized compound I, II or IV N-(2-(l,3-Dimercapto-butyl)-phenyl)-1,3-dimercapto-5-fluoro-1H-pyrazole-4-carboxamide A-B-45 Compound I, II or IV N-(2-(l,3,3-trimethyl-butyl)-phenyl)-1,3-didecyl-5-fluoro-1H-pyrazole-4-indole Indoleamine B-46 An individualized compound I, II or IV daxanphene B-47 an individualized compound I, II or I V Fluorine B-48 An individualized compound I, II or IV D. 11 Bilin B-49 An individualized compound I, II or IV Fluorizine B-50 An individualized compound I, II or IV Fluoride °Bistamine B-51 An individualized compound I, II or IV fluoxetine B-52 An individualized compound I, hydrazine or IV-sodium amide B-53 An individualized compound I, II or IV N- (3-ethyl-3,5,5-tridecyl-cyclohexyl)_3·nonylamino-2-hydroxy-benzamide A-B-54 An individualized compound I, hydrazine or IV gupamine B -55 an individualized compound I, II or IV dioxazole B-56 an individualized compound I, hydrazine or IV diacetylidin B-57 an individualized compound I, hydrazine or IV oxytetracycline B-58 An individualized compound I, hydrazine or IV thiastrobin B-59 an individualized compound I, hydrazine or IV N-(6-decyloxy-pyridin-3-yl)cyclopropanoic acid decylamine 147474.doc - 134- 201041514

混合物 組分1 組分2 B-60 一種個別化化合物I、II或IV 阿紮康唾 B-61 一種個別化化合物I、II或IV 比多農 B-62 一種個別化化合物I、II或IV 溴克座 B-63 一種個別化化合物I、II或IV 環克座 B-64 一種個別化化合物I、II或IV 待克利 B-65 一種個別化化合物I、II或IV 達克利 B-66 一種個別化化合物I、II或IV 右達克利 B-67 一種個別化化合物I、II或IV 依普座 B-68 一種個別化化合物I、II或IV 芬克座 B-69 一種個別化化合物I、II或IV 氟喧°坐 B-70 一種個別化化合物I、II或IV 護A夕得 B-71 一種個別化化合物I、II或IV 護汰芬 B-72 一種個別化化合物I、II或IV 菲克利 B-73 一種個別化化合物I、II或IV 易胺座 B-74 一種個別化化合物I、II或IV 依普克唾 B-75 一種個別化化合物I、II或IV 滅特座 B-76 一種個別化化合物I、II或IV 邁克尼 B-77 一種個別化化合物I、II或IV 惡咪唑 B-78 一種個別化化合物I、II或IV 巴克素 B-79 一種個別化化合物I、II或IV 平克座 B-80 一種個別化化合物I、II或IV 普克利 B-81 一種個別化化合物I、II或IV 丙硫菌。坐 B-82 一種個別化化合物I、II或IV 矽氟唑 B-83 一種個別化化合物I、II或IV 得克利 B-84 一種個別化化合物I、II或IV 四克利 B-85 一種個別化化合物I、II或IV 二黍分 B-86 一種個別化化合物I、II或IV 三泰隆 B-87 一種個別化化合物I、II或IV 滅菌吐 B-88 一種個別化化合物I、II或IV 稀效。坐 B-89 一種個別化化合物I、II或IV 1-(4-氣-苯基)-2-([1,2,4]三唑-1-基)-環 庚醇 B-90 一種個別化化合物I、II或IV 赛座滅 B-91 一種個別化化合物I、II或IV 依滅列 147474.doc -135- 201041514 混合物 組分1 組分2 B-92 一種個別化化合物I、II或IV 硫酸依滅列 B-93 一種個別化化合物I、II或IV 稻癌酯 B-94 一種個別化化合物I、II或rv 撲克拉 B-95 一種個別化化合物I、II或IV 賽福座 B-96 一種個別化化合物I、II或IV 免賴得 B-97 一種個別化化合物I、II或IV 貝芬替 B-98 一種個別化化合物I、II或IV 麥穗寧 B-99 一種個別化化合物I、II或IV 腐絕 B-100 一種個別化化合物I、Π或IV °塞D坐菌胺 B-101 一種個別化化合物I、II或IV 依得利 B-102 一種個別化化合物I、II或IV 惡黴靈 B-103 一種個別化化合物I、II或IV 2-(4-氯-苯基)-N-[4-(3,4-二曱氧基-苯 基)-異噁唑-5-基]-2-丙-2-炔氧基-乙 醯胺 B-104 一種個別化化合物I、II或IV 扶吉胺 B-105 一種個別化化合物I、II或IV 比芬諾 B-106 一種個別化化合物I、II或IV 3-[5-(4-氯-苯基)-2,3-二甲基-異噁唑 淀-3-基]-°比咬 B-107 一種個別化化合物I、II或IV 3-[5-(4-曱基-苯基)-2,3-二曱基-異噁 嗤嗔-3-基]比〇定 B-108 一種個別化化合物I、II或IV 2,3,5,6-四氣-4-曱烧續醯基 B-109 一種個別化化合物I、II或IV 3,4,5-三氯-吡啶-2,6-二曱腈 B-110 一種個別化化合物I、II或IV Ν-(1-(5·〉臭-3-氣-17比 °定-2-基)-乙基)_ 2,4-二氯-菸鹼醯胺 B-lll 一種個別化化合物I、II或IV Ν-((5-溴-3-氯-吼啶-2-基)-曱基)-2,4-二氣-菸鹼醯胺 B-112 一種個別化化合物I、II或IV 布瑞莫 B-113 一種個別化化合物I、II或IV 賽普洛 B-114 一種個別化化合物I、II或IV -—乳林 B-115 一種個別化化合物I、II或IV 芬瑞莫 B-116 一種個別化化合物I、II或IV 富瑞綜 B-117 一種個別化化合物I、II或IV 滅派林 B-118 一種個別化化合物I、II或IV 氣啶 B-119 一種個別化化合物I、II或IV 尼瑞莫 147474.doc -136- 201041514Mixture Component 1 Component 2 B-60 An individualized compound I, II or IV Azakol saliva B-61 An individualized compound I, II or IV than a polynutrient B-62 an individualized compound I, II or IV Bromo-B-63 An individualized compound I, II or IV Cyclosyl-B-64 An individualized compound I, II or IV. Kelly B-65 An individualized compound I, II or IV Dakley B-66 Individualized compound I, II or IV dextran B-67 an individualized compound I, II or IV Eptrix B-68 an individualized compound I, II or IV Fenke B-69 an individualized compound I, II or IV 喧 坐 ° B-70 An individualized compound I, II or IV A Bide B-71 An individualized compound I, II or IV Refractory B-72 An individualized compound I, II or IV Fickley B-73 An individualized compound I, II or IV Easy amine block B-74 An individualized compound I, II or IV Eppo saliva B-75 An individualized compound I, II or IV 76 An individualized compound I, II or IV McKinney B-77 An individualized compound I, II or IV Imidazole B-78 An individualized I, II or IV Bark B-79 An individualized compound I, II or IV Dink B-80 An individualized compound I, II or IV Puckley B-81 An individualized compound I, II or IV Sulfur. S-B-82 an individualized compound I, II or IV fluorazole B-83 An individualized compound I, II or IV De Klee B-84 An individualized compound I, II or IV Si Keli B-85 An individualization Compound I, II or IV Diterpenoid B-86 An individualized compound I, II or IV Santarem B-87 An individualized compound I, II or IV Sterilization B-88 An individualized compound I, II or IV effect. S-B-89 an individualized compound I, II or IV 1-(4-a-phenyl)-2-([1,2,4]triazol-1-yl)-cycloheptanol B-90 Compound I, II or IV 赛赛灭 B-91 An individualized compound I, II or IV 灭 147474.doc -135- 201041514 Mixture component 1 Component 2 B-92 An individualized compound I, II or IV Sulfuric acid thiophene B-93 An individualized compound I, II or IV Rice cancer ester B-94 An individualized compound I, II or rv Poker La B-95 An individualized compound I, II or IV Safford B -96 An individualized compound I, II or IV, free of B-97, an individualized compound I, II or IV, befenate B-98, an individualized compound I, II or IV, wheat spike B-99, an individualized Compound I, II or IV, B-100, an individualized compound I, hydrazine or IV °, D-coccidamine B-101, an individualized compound I, II or IV, an individual compound I, II or IV carbendazim B-103 an individualized compound I, II or IV 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isodine Azole-5-yl]-2-prop-2-ynyloxy-acetamide B-104 Compound I, II or IV GIJ-B-105 An individualized compound I, II or IV Tefino B-106 An individualized compound I, II or IV 3-[5-(4-chloro-phenyl) -2,3-Dimethyl-isoxazol-3-yl]-° ratio B-107 an individualized compound I, II or IV 3-[5-(4-mercapto-phenyl)-2 ,3-dimercapto-isoindol-3-yl]pyridine B-108 an individualized compound I, II or IV 2,3,5,6-tetraki-4-indole thiol B -109 An individualized compound I, II or IV 3,4,5-trichloro-pyridine-2,6-dicarbonitrile B-110 An individualized compound I, II or IV Ν-(1-(5·〉 Odor-3-gas-17 ratio °-2-yl)-ethyl)_ 2,4-dichloro-nicotinium amide B-lll An individualized compound I, II or IV Ν-((5-bromo) -3-Chloro-acridin-2-yl)-indenyl)-2,4-diqi-nicotinamide B-112 An individualized compound I, II or IV Bremer B-113 An individual compound I, II or IV 赛普洛 B-114 An individualized compound I, II or IV - - B-115 an individualized compound I, II or IV fenrimyl B-116 an individualized compound I, II or IV Furui Comprehensive B-117 An individualized compound I, II or IV chlorpyrifos B-1 18 An individualized compound I, II or IV anhydropyridine B-119 an individualized compound I, II or IV Nerimo 147474.doc -136- 201041514

混合物 組分1 組分2 B-120 一種個別化化合物I、II或IV 派美尼 B-121 一種個別化化合物I、II或IV 賽福寧 B-122 一種個別化化合物I、II或IV 拌種咯 B-123 一種個別化化合物I、II或IV 護汰寧 B-124 一種個別化化合物I、II或IV 阿迪嗎淋 B-125 一種個別化化合物I、II或IV 嗎菌靈 B-126 一種個別化化合物I、II或IV 乙酸嗎菌靈 B-127 一種個別化化合物I、II或IV 芬普福 B-128 一種個別化化合物I、II或IV 三得芬 B-129 一種個別化化合物I、II或IV 苯鏽啶 B-130 一種個別化化合物I、II或IV °坐°夫草 B-131 一種個別化化合物I、II或IV 依普同 B-132 一種個別化化合物I、II或IV 撲滅寧 B-133 一種個別化化合物I、II或IV 免克寧 B-134 一種個別化化合物I、II或IV 凡殺同 B-135 一種個別化化合物I、II或IV 坐菌酮 B-136 一種個別化化合物I、II或IV 福天尼 B-137 一種個別化化合物I、II或IV 辛。S嗣 B-138 一種個別化化合物I、II或IV 撲殺熱 B-139 一種個別化化合物I、II或IV 5-胺基-2-異丙基-4-鄰甲苯基-2,3-二 氫-吡唑-1-硫代曱酸S-烯丙酯 B-140 一種個別化化合物I、II或IV 酸化苯并噻二唑-S-曱酯 B-141 一種個別化化合物I、II或IV 吲唑磺菌胺 B-142 一種個別化化合物I、II或IV 敵菌靈 B-143 一種個別化化合物I、II或IV 保米黴素 B-144 一種個別化化合物I、II或IV 四氯丹 B-145 一種個別化化合物I、II或IV 蓋普丹 B-146 一種個別化化合物I、II或IV 滅蟎猛 B-147 一種個別化化合物I、II或IV 邁隆 B-148 一種個別化化合物I、II或IV 喃菌威 B-149 一種個別化化合物I、II或IV 達滅淨 B-150 一種個別化化合物I、II或IV 野燕枯 B-151 一種個別化化合物I、II或IV 甲基硫酸野燕枯 U7474.doc -137· 201041514 混合物 組分1 組分2 B-152 一種個別化化合物I、II或IV 氰菌胺 B-153 一種個別化化合物I、II或IV 福爾培 B-154 一種個別化化合物I、II或IV 歐索林酸(OxolinsSure) B-155 一種個別化化合物I、II或IV 粉病靈 B-156 一種個別化化合物I、II或IV 普奎那茲 B-157 一種個別化化合物I、II或IV 百快隆 B-158 一種個別化化合物I、II或IV 快諾芬 B-159 一種個別化化合物I、II或IV σ米0坐嗓 B-160 一種個別化化合物I、II或IV 三賽唑 B-161 一種個別化化合物I、II或IV 2-丁乳基-6·埃-3-丙基-17克稀-4-網 B-162 一種個別化化合物I、II或IV 5-氣-1-(4,έ-二曱乳基-嘴°定-2-基)-2_ 甲基-1Η-苯并咪唑 B-163 一種個別化化合物I、II或IV 5-氣-7-(4-曱基-哌啶-1 -基)-6-(2,4,6-三苯基)-[1,2,4]三唑幷[1,5-a]嘧啶 B-164 一種個別化化合物I、II或IV 5-乙基-6-辛基-[1,2,4]三唑幷[1,5-a]嘧 咬_7_基胺 B-165 一種個別化化合物I、II或IV 福美鐵 B-166 一種個別化化合物I、II或IV 鋅錳乃浦 B-167 一種個別化化合物I、II或IV 錳乃浦 B-168 一種個別化化合物I、II或IV 威百故 B-169 一種個別化化合物I、II或IV 績菌威 B-170 一種個別化化合物I、II或IV 免得爛 B-171 一種個別化化合物I、II或IV 甲基鋅乃浦 B-172 一種個別化化合物I、II或IV 得恩地 B-173 一種個別化化合物I、II或IV 辞乃浦 B-174 一種個別化化合物I、II或IV 益穗 B-175 一種個別化化合物I、π或rv 乙黴威 B-176 一種個別化化合物I、II或IV 苯噻菌胺 B-177 一種個別化化合物I、II或rv 纈黴威 B-178 一種個別化化合物I、II或IV 霜黴威 B-179 一種個別化化合物I、II或IV 霜黴威鹽酸鹽 B-180 一種個別化化合物I、II或IV 瓦芬那 B-181 一種個別化化合物I、II或IV N-(l-(l-(4-氰基苯基)乙烷磺酿基)-丁-2-基)胺基甲酸-(4-氟苯基)酯 147474.doc -138- 201041514Mixture Component 1 Component 2 B-120 An Individualized Compound I, II or IV Pimeni B-121 An Individualized Compound I, II or IV Safranine B-122 An Individualized Compound I, II or IV Mix Species B-123 An individualized compound I, II or IV 护宁B-124 An individualized compound I, II or IV Adimorphine B-125 An individualized compound I, II or IV carbendazim B-126 An individualized compound I, II or IV carbendazim B-127 An individualized compound I, II or IV Fenfen B-128 An individualized compound I, II or IV Sanden B-129 An individualized compound I, II or IV Benzilidine B-130 An individualized compound I, II or IV ° S. sylvestris B-131 An individualized compound I, II or IV Ep. B-132 An individualized compound I, II Or IV Fighting B-133 An Individualized Compound I, II or IV Free Kein B-134 An Individualized Compound I, II or IV Anyone with B-135 An Individualized Compound I, II or IV Coccidiones B -136 An individualized compound I, II or IV Futinyl B-137 An individualized compound I, II or IV octane. S嗣B-138 An individualized compound I, II or IV chilling heat B-139 An individualized compound I, II or IV 5-amino-2-isopropyl-4-o-tolyl-2,3-di Hydrogen-pyrazole-1-thiodecanoic acid S-allyl ester B-140 An individualized compound I, II or IV acidified benzothiadiazole-S-decyl ester B-141 An individualized compound I, II or IV Carbazolidin B-142 An individualized compound I, II or IV carbendazim B-143 an individualized compound I, II or IV poliomycin B-144 an individualized compound I, II or IV IV Chlordane B-145 An individualized compound I, II or IV Captan B-146 An individualized compound I, II or IV 螨 螨 B B-147 An individualized compound I, II or IV Milon B-148 Individualized compound I, II or IV acesulfame B-149 an individualized compound I, II or IV chlorpyrifos B-150 an individualized compound I, II or IV wild swallow B-151 an individualized compound I, II or IV methyl sulphate sulphate U7474.doc -137· 201041514 mixture component 1 component 2 B-152 an individualized compound I, II or IV cyanamide B-153 an individualized compound I, II Or IV Forbes B-154 An individualized compound I, II or IV Oxolins Sure B-155 An individualized compound I, II or IV Powder B-156 An individualized compound I, II or IV Puccinaz B-157 An individualized compound I, II or IV bailong B-158 an individualized compound I, II or IV vebufen B-159 an individualized compound I, II or IV σ米0 sits嗓B-160 an individualized compound I, II or IV trioxazole B-161 an individualized compound I, II or IV 2-butyl lactyl-6·e-3-propyl-17 g dilute-4-net B-162 An individualized compound I, II or IV 5-gas-1-(4, fluorene-difluorenyl-mouth-but-2-yl)-2_methyl-1 fluorene-benzimidazole B-163 Individualized compound I, II or IV 5-gas-7-(4-mercapto-piperidin-1 -yl)-6-(2,4,6-triphenyl)-[1,2,4] Imidazolium [1,5-a]pyrimidine B-164 an individualized compound I, II or IV 5-ethyl-6-octyl-[1,2,4]triazolium [1,5-a]pyrimidine Bite_7_ylamine B-165 An individualized compound I, II or IV Ferrocene B-166 An individualized compound I, II or IV Zinc Manganese B-167 An individualized compound I, II or IV Manganese B-168 An individualized compound I, II or IV Weifang B-169 An individualized compound I, II or IV C-B-170 An individualized compound I, II or IV is free of B-171. Compound I, II or IV methyl zinc Napo B-172 An individualized compound I, II or IV Dean B-173 An individualized compound I, II or IV Reina B-174 An individualized compound I, II Or IV Yisui B-175 an individualized compound I, π or rv. carbendazim B-176 an individualized compound I, II or IV phenothiamine B-177 an individualized compound I, II or rv B-178 An individualized compound I, II or IV. Mildew B-179 An individualized compound I, II or IV. Downyzine hydrochloride B-180 An individualized compound I, II or IV Waffenina B- 181 An individualized compound I, II or IV N-(l-(l-(4-cyanophenyl)ethanesulfonyl)-butan-2-yl)carbamic acid-(4-fluorophenyl) Ester 147474.doc -138- 201041514

混合物 組分1 組分2 B-182 一種個別化化合物I、II或IV 多寧 B-183 一種個別化化合物I、II或IV 多寧游離驗 B-184 一種個別化化合物I、II或IV 雙胍鹽 B-185 一種個別化化合物I、II或IV 乙酸雙胍鹽 B-186 一種個別化化合物I、II或IV 雙胍辛胺 B-187 一種個別化化合物I、II或IV 三乙酸雙胍辛胺 B-188 一種個別化化合物I、II或IV 參(烷基苯磺酸)雙胍辛胺 B-189 一種個別化化合物I、II或IV 喜賜黴素 B-190 一種個別化化合物I、II或IV 水合鹽酸喜賜黴素 B-191 一種個別化化合物I、II或IV 多氧菌素 B-192 一種個別化化合物I、II或IV 鏈黴素 B-193 一種個別化化合物I、II或IV 有效黴素A B-194 一種個別化化合物I、II或IV 百蟎克 B-195 一種個別化化合物I、II或IV 大克爛(Dicloran) B-196 一種個別化化合物I、II或IV 消蟎通 B-197 一種個別化化合物I、II或IV 白粉克 B-198 一種個別化化合物I、II或IV 献菌 S旨(Nitrothal-isopropyl) B-199 一種個別化化合物I、II或IV 四氣硝基苯 B-200 一種個別化化合物I、II或IV 三苯錫鹽 B-201 一種個別化化合物I、II或IV 腈硫醌 B-202 一種個別化化合物I、Π或IV 稻癌靈 B-203 一種個別化化合物I、Π或IV 護粒松 B-204 一種個別化化合物I、Π或IV 福赛得、福赛得鋁 B-205 一種個別化化合物I、π或IV 丙基喜樂松 B-206 一種個別化化合物I、Π或IV 亞磷酸(H3P〇3)及衍生物 B-207 一種個別化化合物I、Π或IV 白粉松 B-208 一種個別化化合物I、π或rv 脫克松 B-209 一種個別化化合物I、II或IV 四氯異苯腈 B-210 一種個別化化合物I、Π或IV 益發靈 B-211 一種個別化化合物I、π或IV 二氯盼 B-212 一種個別化化合物I、II或IV 磺菌胺 B-213 一種個別化化合物I、Π或IV 六氣苯 B-214 —種個別化化合物I、II或IV 賓克隆 147474.doc •139- 201041514 混合物 組分1 _____ _______| 組分2 B-215 一種個別化化合物I、II或IV -- ^^笨酚及鹽 B-216 一種個別化化合物I、II或IV 斯 B-217 一種個別化化合物I、II或IV 硝基苯 B-218 一種個別化化合物I、II或IV 甲基多保淨 B-219 - - 一種個別化化合物I、II或IV 曱基益發靈 B-220 一種個別化化合物I、II或IV N-(4-氣-2-硝基-苯基)-N-乙基-4-甲 基-苯磺醯胺 B-221 一種個別化化合物I、II或IV 波多混合液 B-222 一種個別化化合物I、II或IV 乙醆鋼 B-223 一種個別化化合物I、II或IV 氫氧化銅 B-224 一種個別化化合物I、II或IV 氯氧化銅 B-225 一種個別化化合物I、II或IV 鹼式硫酸銅 B-226 一種個別化化合物I、II或IV 硫 B-227 一種個別化化合物I、II或IV 聯苯 B-228 一種個別化化合物I、Π或IV 溴硝丙二醇 B-229 一種個別化化合物I、II或IV 環氟菌胺 B-230 一種個別化化合物I、II或IV 克絕 B-231 一種個別化化合物I、II或IV 二苯胺 B-232 一種個別化化合物I、II或IV 滅芬農 B-233 一種個別化化合物I、II或IV 滅粉黴素 B-234 一種個別化化合物I、II或IV 快得寧 ... B-235 一種個別化化合物I、II或IV 調環酸鈣 B-236 一種個別化化合物I、II或IV 螺惡茂胺 B-237 一種個別化化合物I、II或IV 曱基益發靈 _ B-238 一種個別化化合物I、II或IV N-(環丙基甲氧基亞胺基-(6-二氟甲 氧基-2,3-二氟-笨基)-曱基)-2-苯基乙 醯胺 B-239 一種個別化化合物I、II或IV N’-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二曱基-苯基)-N-乙基-N-曱基甲脒 B-240 一種個別化化合物I、II或IV N,-(4-(4-氟_3·三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒 B-241 一種個別化化合物I、II或IV - Ν·-(2-甲基-5-三氟甲基-4-(3-三甲基 矽烷基-丙氧基)-苯基)-Ν-乙基-Ν-甲 基f脒 147474.doc -140· 201041514 混合物 組分1 組分2 B-242 一種個別化化合物I、II或IV N'-(5-二氟曱基-2-甲基-4-(3-三曱基 矽烷基-丙氧基)-苯基)-N-乙基-N-曱 基甲脒 B-243 一種個別化化合物I、II或IV 2-{1-[2-(5-曱基-3-三氟曱基比唾-1-基)-乙驢基]-旅°定-4-基}-°塞°坐-4-曱酸 曱基-(1,2,3,4-四氣萘-1-基)-醯胺 B-244 一種個別化化合物I、II或IV 2-{1-[2-(5-曱基-3-三氟甲基比。坐-1-基)-乙酿基]-略咬-4-基}-嗔'•坐-4-甲酸 甲基-(R)-l,2,3,4-四氫萘-1-基-醯胺 B-245 一種個別化化合物I、II或IV 乙酸6-第三丁基-8-氟-2,3-二甲基-喹 淋-4-基西旨 B-246 —種個別化化合物I、II或IV 曱氧基-乙酸6-第三丁基·8·氟-2,3-二 甲基-啥淋-4-基脂 B-247 一種個別化化合物I、II或IV 加保利 B-248 一種個別化化合物I、II或IV 加保扶 B-249 一種個別化化合物I、II或IV 丁基加保扶 B-250 一種個別化化合物I、II或IV 納乃得硫雙威(Methomylthiodicarb) B-251 一種個別化化合物I、II或IV 畢芬寧 B-252 一種個別化化合物I、II或IV 赛扶寧 B-253 一種個別化化合物I、II或IV 赛滅寧 B-254 一種個別化化合物I、II或IV ~· ·— 亞滅寧 B-255 一種俩別化化合物I、II或IV — ξ-赛滅寧 第滅寧 B-256 一種個別化化合物I、II或IV B-257 一種個別化化合物I、II或IV 益化利 B-258 一種個別化化合物I、II或IV λ-赛洛寧 B-259 一種個別化化合物I、II或IV 百滅寧 B-260 一種個別化化合物I、II或IV —--... 七氟菊酯 B-261 一種個別化化合物I、II或IV 一福隆 B-262 一種個別化化合物I、II或IV 氣分隆 B-263 一種個別化化合物I、II或IV 祿芬隆 B-264 一種個別化化合物I、II或IV •— 得福隆 B-265 一種個別化化合物I、II或IV 螺蟲乙醋 B-266 一種個別化化合物I、II或IV 可尼丁 B-267 一種個別化化合物I、II或IV 達特南 147474.doc -141 - 201041514 混合物 組分1 組分2 B-268 一種個別化化合物I、Π或IV 益達胺 B-269 一種個別化化合物I、Π或IV 賽速安 B-270 一種個別化化合物I、II或IV 亞滅培 B-271 一種個別化化合物I、Π或IV 賽果培 B-272 一種個別化化合物I、II或IV 安殺番 B-273 一種個別化化合物I、Π或IV 芬普尼 B-274 一種個別化化合物I、II或IV 阿巴汀 B-275 一種個別化化合物I、II或IV 因滅汀 B-276 一種個別化化合物I、π或rv 賜諾殺 B-277 一種個別化化合物I、II或IV 斯平托蘭 B-278 一種個別化化合物I、Π或IV 愛美松 B-279 一種個別化化合物I、II或IV 克凡派 B-280 一種個別化化合物I、II或IV 芬布錫 B-281 一種個別化化合物I、II或IV 因得克 B-282 一種個別化化合物I、II或IV 氰氟蟲踪 B-283 一種個別化化合物I、Π或IV 氟*尼胺 B-284 一種個別化化合物I、Π或IV 氟蟲酸胺 B-285 一種個別化化合物I、Π或IV 剋安勃 B-286 一種個別化化合物I、Π或IV 賽培(HGW86) B-287 一種個別化化合物I、II或IV 丁氟蟎酯 B-288 一種個別化化合物I、II或IV 乙草胺 B-289 一種個別化化合物I、II或IV 汰草滅 B-290 一種個別化化合物I、II或IV 滅多草 B-291 一種個別化化合物I、II或IV 滅草胺 B-292 一種個別化化合物I、II或IV 草甘膦 B-293 一種個別化化合物I、II或IV 草銨膦 B-294 一種個別化化合物I、II或IV 卓硫鱗 B-295 一種個別化化合物I、II或IV 炔草酸 B-296 一種個別化化合物I、Π或IV 噁唑禾草靈 B-297 一種個別化化合物I、Π或IV °比氟禾草靈 B-298 一種個別化化合物I、Π或IV °比氟氣禾靈 B-299 一種個別化化合物I、Π或IV 百草枯 B-300 一種個別化化合物I、II或IV 甜菜寧 -142- 147474.doc 201041514Mixture Component 1 Component 2 B-182 An individualized compound I, II or IV Donin B-183 An individualized compound I, II or IV Donin free test B-184 An individualized compound I, II or IV Salt B-185 An individualized compound I, II or IV biguanide salt B-186 An individualized compound I, II or IV Bis-octylamine B-187 An individualized compound I, II or IV diammonium triacetate B- 188 An individualized compound I, II or IV (alkyl benzene sulfonic acid) bis octylamine B-189 An individualized compound I, II or IV gibberellin B-190 An individualized compound I, II or IV hydrated Sibutamic acid hydrochloride B-191 an individualized compound I, II or IV polyoxin B-192 an individualized compound I, II or IV streptomycin B-193 an individualized compound I, II or IV A B-194 An individualized compound I, II or IV Baikeke B-195 An individualized compound I, II or IV Dicloran B-196 An individualized compound I, II or IV B-197 An individualized compound I, II or IV White powder gram B-198 An individualized compound I, II or IV Nitrothal-isopropyl B-199 An individualized compound I, II or IV Tetranitrobenzene B-200 An individualized compound I, II or IV Triphenyltin salt B-201 An individualized compound I, II or IV nitrile sulfonium B-202 an individualized compound I, hydrazine or IV rice cancer B-203 an individualized compound I, hydrazine or IV granules B-204 an individualized compound I, hydrazine or IV forsythia得,福赛得铝B-205 An individualized compound I, π or IV propyl chelsson B-206 an individualized compound I, hydrazine or IV phosphorous acid (H3P〇3) and derivative B-207 Compound I, hydrazine or IV white pine B-208 An individualized compound I, π or rv Dexampone B-209 An individualized compound I, II or IV Tetrachloroisocyanonitrile B-210 An individualized compound I, Π Or IV Yifaling B-211 an individualized compound I, π or IV dichloroproline B-212 an individualized compound I, II or IV sulfaminide B-213 an individualized compound I, hydrazine or IV hexabenzene B -214 - Individualized compound I, II or IV Bin clone 147474.doc • 139- 201041514 Mixture component 1 _____ _______| Divided into 2 B-215 an individualized compound I, II or IV - ^^ phenol and salt B-216 an individualized compound I, II or IV bis-B-217 an individualized compound I, II or IV nitrobenzene B-218 An individualized compound I, II or IV Methylpoly-B-219 - - an individualized compound I, II or IV thiol valproate B-220 an individualized compound I, II or IV N-( 4-Gas-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide B-221 An individualized compound I, II or IV mixture B-222 An individualized compound I , II or IV Ethidium Steel B-223 An Individualized Compound I, II or IV Copper Hydroxide B-224 An Individualized Compound I, II or IV Copper Chloride B-225 An Individualized Compound I, II or IV Alkali Copper sulphate B-226 an individualized compound I, II or IV sulphur B-227 an individualized compound I, II or IV biphenyl B-228 an individualized compound I, hydrazine or IV bromide B-229 an individual Compound I, II or IV Cyclosporine B-230 An individualized compound I, II or IV gram-B-231 An individualized compound I, II or IV Diphenylamine B-232 An individualized compound I, II or IV fenfenin B-233 an individualized compound I, II or IV chlorfenapyr B-234 an individualized compound I, II or IV fast-bending... B-235 Individualized Compound I, II or IV Calcium Hydrate B-236 An Individualized Compound I, II or IV Spirooxamine B-237 An Individualized Compound I, II or IV 曱基益发灵_ B-238 An Individual Compound I, II or IV N-(cyclopropylmethoxyimino-(6-difluoromethoxy-2,3-difluoro-indolyl)-indenyl)-2-phenylacetamidine Amine B-239 An individualized compound I, II or IV N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-diindenyl-phenyl)-N- Ethyl-N-mercaptomethyl hydrazine B-240 An individualized compound I, II or IV N,-(4-(4-fluoro-3·trifluoromethyl-phenoxy)-2,5-dimethyl Alkyl-phenyl)-N-ethyl-N-methylformamidine B-241 An individualized compound I, II or IV - Ν·-(2-methyl-5-trifluoromethyl-4-(3) -trimethyldecyl-propoxy)-phenyl)-oxime-ethyl-oxime-methylf脒147474.doc -140· 201041514 mixture component 1 component 2 B-242 an individualized compound I, II or IV N'-(5-difluorodecyl-2-methyl 4-(3-tridecylsulfanyl-propoxy)-phenyl)-N-ethyl-N-mercaptomethylhydrazine B-243 An individualized compound I, II or IV 2-{1-[ 2-(5-fluorenyl-3-trifluoromethyl)pyran-1-yl)-ethenyl]-branches-4-yl}-°°°°坐-4-曱酸曱--1 , 2,3,4-tetranaphthalen-1-yl)-nonylamine B-244 An individualized compound I, II or IV 2-{1-[2-(5-mercapto-3-trifluoromethyl) ratio.坐-1-yl)-ethyl aryl]-slightly -4-yl}-嗔'• sit-4-carboxylic acid methyl-(R)-l,2,3,4-tetrahydronaphthalen-1-yl - indoleamine B-245 an individualized compound I, II or IV acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quino-4-yl-Western B-246 Compound I, II or IV methoxy-acetic acid 6-tert-butyl·8·fluoro-2,3-dimethyl-indole-4-yl lipid B-247 an individualized compound I, II or IV plus Poly B-248 An individualized compound I, II or IV plus B-249 An individualized compound I, II or IV Butyl plus B-250 An individualized compound I, II or IV Methomylthiodicarb B-251 An individualized compound I, II or IV Bifenin B-252 An individualized compound I, II or IV Safranine B-253 An individualized compound I, II or IV Saining B-254 An individualized compound I, II or IV ~··--Arbenin B-255 A two-part compound I, II or IV — ξ-赛灭宁第灭宁 B-256 An individualized compound I, II or IV B-257 An individualized compound I, II or IV Yi Bili B-258 An individualized compound I, II or IV λ-race洛宁 B-259 An individualized compound I, II or IV Benzene B-260 An individualized compound I, II or IV —-... Tefluthrin B-261 An individualized compound I, II or IV-Fulong B-262 An individualized compound I, II or IV gas-branched B-263 An individualized compound I, II or IV Ruffolon B-264 An individualized compound I, II or IV •-隆 B-265 An individualized compound I, II or IV spirotetraacetone B-266 an individualized compound I, II or IV cotinine B-267 an individualized compound I, II or IV Datnam 147474.doc -141 - 201041514 Mixture component 1 Component 2 B-268 An individualized compound I, hydrazine or IV EDTA B-269 An individualized compound I, hydrazine or IV acesulfan B-270 an individualized compound I, II or IV sub-examination B-271 An individualized compound I, hydrazine or IV 赛果培B-272 An individualized compound I, II or IV amphibious B-273 An individualized compound I, hydrazine or IV fenp B-274 An individualized compound I, II or IV Abatine B-275 An individualized compound I, II or IV Indomethacin B-276 Differentiation of Compound I, π or rv. B-277 An individualized compound I, II or IV Spinoline B-278 An individualized compound I, hydrazine or IV Amesson B-279 An individualized compound I, II or IV Kfanti B-280 An individualized compound I, II or IV Fenbuxet B-281 An individualized compound I, II or IV Indac B-282 An individualized compound I, II or IV Cyanofluoride Insect B-283 An individualized compound I, hydrazine or IV fluoroquinone B-284 An individualized compound I, hydrazine or IV flufenic acid amine B-285 An individualized compound I, hydrazine or IV gram B -286 An individualized compound I, hydrazine or IV 赛培(HGW86) B-287 An individualized compound I, II or IV Butylated fluoro ester B-288 An individualized compound I, II or IV Acetochlor B-289 An individualized compound I, II or IV oxacin B-290 an individualized compound I, II or IV chlorpyrifos B-291 an individualized compound I, II or IV chlorfenapyr B-292 an individualized compound I, II or IV Glyphosate B-293 An individualized compound I, II or IV glufosinate B-294 An individualized compound I, II or IV Sulfur scale B-295 An individualized compound I, II or IV acetyl oxalic acid B-296 An individualized compound I, hydrazine or IV oxazolyl herb B-297 An individualized compound I, hydrazine or IV ° than fluweed Ling B-298 An individualized compound I, hydrazine or IV ° than fluorine fluorhexidine B-299 An individualized compound I, hydrazine or IV Paraquat B-300 An individualized compound I, II or IV Beet Ning-142- 147474.doc 201041514

混合物 組分1 組分2 B-301 一種個別化化合物I、II或IV 烯草S同 B-302 一種個別化化合物I、II或IV 環殺草 B-303 一種個別化化合物I、II或IV 環苯草酮 B-304 一種個別化化合物I、II或IV 西殺草 B-305 一種個別化化合物I、II或IV 得殺草 B-306 一種個別化化合物I、II或IV 二甲戊樂靈 B-307 一種個別化化合物I、II或IV 苯胺靈 B-308 一種個別化化合物I、II或IV 氟樂靈 B-309 一種個別化化合物I、II或IV 三氟羧草醚 B-310 一種個別化化合物I、II或IV 溴苯腈 B-311 一種個別化化合物I、II或IV 咪草酯 B-312 一種個別化化合物I、II或IV 曱氧咪草菸 B-313 一種個別化化合物I、II或IV 甲基咪草菸 B-314 一種個別化化合物I、II或IV _唾終酸 B-315 一種個別化化合物I、II或IV 咪α全喧琳酸 B-316 一種個別化化合物I、II或IV 咪唑乙菸酸 B-317 一種個別化化合物I、II或IV 2,4-二氣苯氧基乙酸(2,4-D) B-318 一種個別化化合物I、II或IV 氣草敏 B-319 一種個別化化合物I、II或IV 克草立特 B-320 一種個別化化合物I、II或IV 氟草菸 B-321 一種個別化化合物I、II或IV 毒莠定 B-322 一種個別化化合物I、II或IV 氟吡醯草胺 B-323 一種個別化化合物I、Π或IV 苄0S續隆 B-324 一種個別化化合物I、II或IV 氣嘧磺隆 B-325 一種個別化化合物I、II或IV 環丙0S績隆 B-326 一種個別化化合物I、II或IV 碘甲磺隆 B-327 一種個別化化合物I、II或IV 曱確胺續·隆 B-328 一種個別化化合物I、II或IV 甲磺隆 B-329 一種個別化化合物I、II或IV 菸嘧磺隆 B-330 一種個別化化合物I、II或IV 砜嘧磺隆 B-331 一種個別化化合物I、II或IV 氣胺續隆 B-332 一種個別化化合物I、II或IV 草脫淨 B-333 一種個別化化合物I、II或IV 六°秦酮 147474.doc •143- 201041514 混合物 組分1 組分2 B-334 一種個別化化合物I、II或IV 敵草隆 B-335 一種個別化化合物I、II或IV 雙氟磺草胺 B-336 一種個別化化合物I、II或IV 普硫芬 B-337 一種個別化化合物I、II或IV 苯達松 B-338 一種個別化化合物I、II或IV 吲哚輞草酯 B-339 一種個別化化合物I、II或IV 環庚草醚 B-340 一種個別化化合物I、II或IV 麥草畏 B-341 一種個別化化合物I、II或IV 二氟吡隆 B-342 一種個別化化合物I、II或IV 二氯喹啉酸 B-343 一種個別化化合物I、II或IV 喹草酸 B-344 一種個別化化合物I、II或IV 曱基磺草酮 B-345 一種個別化化合物I、II或IV 嘧啶肟草醚 B-346 一種個別化化合物I、II或IV 托潘腙 已知稱作組分2之活性物質、其製備及其對抗有害真菌 之活性(參考:http://www.alanwood.net/pesticides/);此等 物質可購得。亦已知藉由IUPAC命名法描述之化合物、其 製備及其殺真菌活性(參考Can. J. Plant Sci. 48(6),5 87-94, 1968 ; EP-A 141 317 ; EP-A 152 031 ; EP-A 226 917 ; EP-Mixture Component 1 Component 2 B-301 An individualized compound I, II or IV olefin grass S and B-302 an individualized compound I, II or IV cyclosporin B-303 an individualized compound I, II or IV Cyclopentanone B-304 an individualized compound I, II or IV chlorpyrifos B-305 an individualized compound I, II or IV chlorpyrifos B-306 an individualized compound I, II or IV Ling B-307 An Individualized Compound I, II or IV Aniline B-308 An Individualized Compound I, II or IV Trifluralin B-309 An Individualized Compound I, II or IV Acifluorfen B-310 An individualized compound I, II or IV bromoxynil B-311 An individualized compound I, II or IV Imazethin B-312 An individualized compound I, II or IV Azoxystrobin B-313 An individualization Compound I, II or IV methyl imazethapyr B-314 an individualized compound I, II or IV _ salivation acid B-315 an individualized compound I, II or IV imi-alpha phthalic acid B-316 an individual Compound I, II or IV Imidazoic acid B-317 An individualized compound I, II or IV 2,4-diphenoxyacetic acid (2,4-D) B-318 An individualized compound I, II or IV oxacillin B-319 an individualized compound I, II or IV gram of rituximab B-320 an individualized compound I, II or IV fluroxypyr B-321 an individualized compound I, II or IV chlorpyrifos B-322 an individualized compound I, II or IV fluroxypyramine B-323 an individualized compound I, hydrazine or IV benzyl oxatoxin B-324 an individualized compound I, II Or IV sulfometuron B-325 an individualized compound I, II or IV Cyclopropanol 0S chlorinated B-326 an individualized compound I, II or IV iodosulfuron B-327 an individualized compound I, II or IV 曱 胺 续 · 隆 B-328 An individualized compound I, II or IV Methsulfuron B-329 An individualized compound I, II or IV Nicosulfuron B-330 An individualized compound I, II or IV Sulfolosulfuron-B-331 An individualized compound I, II or IV gas amine sulphide B-332 An individualized compound I, II or IV Astragalus B-333 An individualized compound I, II or IV Ketone 147474.doc • 143- 201041514 Mixture Component 1 Component 2 B-334 An individualized compound I, II or IV diuron B-335 Individualized compound I, II or IV diflufenacil B-336 an individualized compound I, II or IV profenofin B-337 an individualized compound I, II or IV bentazon B-338 Compound I, II or IV Valeric acid ester B-339 An individualized compound I, II or IV cycloheptyl ether B-340 an individualized compound I, II or IV dicamba B-341 an individualized compound I, II or IV diflupiron B-342 an individualized compound I, II or IV quinclorac B-343 an individualized compound I, II or IV quinoxalate B-344 an individualized compound I, II or IV Sulfosone B-345 an individualized compound I, II or IV pyrimidine ether B-346 an individualized compound I, II or IV Topan, an active substance known as component 2, its preparation and Activity against harmful fungi (Ref: http://www.alanwood.net/pesticides/); such materials are commercially available. Compounds described by the IUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci. 48(6), 5 87-94, 1968; EP-A 141 317; EP-A 152 031 ; EP-A 226 917 ; EP-

A 243 970 ; EP-A 256 503 ; EP-A 428 941 ; EP-A 532 022 ; EP-A 1 028 125 ; EP-A 1 035 122 ; EP-A 1 201 648 ; EP-A 1 122 244, JP 2002316902 ; DE 19650197 ; DE 10021412 ; DE 102005009458 ; US 3,296,272 ; US 3,325,503 ; WO 98/46608 ; WO 99/14187 ; WO 99/24413 ; WO 99/27783 ; WO 00/29404 ; WO 00/46148 ; WO 〇〇/ 65913 ; WO 01/54501 ; WO 01/56358 ; WO 02/22583 ; WO 02/40431 ; WO 03/10149 ; WO 03/11853 ; WO 03/14103 ; WO 03/16286 ; WO 03/53 145 ; WO 03/61388 ; WO 03/ 147474.doc -144- 201041514A 243 970; EP-A 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US 3,296,272; US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 〇 WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53 145; WO 03/61388; WO 03/147474.doc -144- 201041514

66609 ; WO 03/74491 ; WO 04/49804 ; WO 04/83193 ; WO66609; WO 03/74491; WO 04/49804; WO 04/83193; WO

05/120234 ; WO 05/123689 ; WO 05/123690 ; WO 05/ 63721 ; WO 05/87772 ; WO 05/87773 ; WO 06/15866 ; WO 06/87325 ; WO 06/87343 ; WO 07/82098 ; WO 07/90624) ° 可將活性物質之混合物藉由常見方式,例如藉由對於化 合物I、II及/或IV之組合物既定之方式製備為除活性成分 之外亦包含至少一種惰性成分之組合物。 關於此等組合物之常見成分,參考對於含有化合物I、II 及/或IV之組合物給出之說明。 如式I、II及IV化合物,本發明之活性物質的混合物適用 作殺真菌劑。其因對抗廣泛範圍之植物病原性真菌之突出 效用而著名,該等植物病原性真菌尤其來自子囊菌綱、擔 子菌綱、半知菌綱及霜黴卵菌綱(同義詞卵菌綱)。另外, 提及關於化合物及分別含有化合物I、II及/或IV之組合物 的殺真菌活性之說明。 本發明之另一態樣係關於種子,其每100 kg種子包含0·1 g至10 kg之量的至少式I、II及/或IV化合物。 化合物I、II及IV及其醫藥學上可接受之鹽亦適於治療人 類及動物之疾病(尤其作為抗徽劑之用途),適於治療癌症 及治療病毒感染。如不同於術語「殺真菌劑」之術語「抗 黴劑」係指一種對抗動物病原性或人類病原性真菌,亦即 對抗動物、尤其哺乳動物及鳥類中之真菌的藥物。 因此,本發明之另一態樣係關於一種包含至少一種式 I、II及/或IV化合物及/或至少一種其醫藥學上可接受之鹽 147474.doc -145- 201041514 及醫藥學上可接受之載劑的藥物。 適合醫藥學上可接受之鹽尤其為化合物I、II及/或IV之 生理上耐受之鹽’特定言之為與生理上可接受之酸形成的 酸加成鹽。適合有機酸及無機酸的實例為鹽酸、氫溴酸、 磷酸、硫酸、CrC4烷基磺酸(諸如曱烷磺酸)、芳族磺酸 (諸如苯磺酸及甲苯磺酸)、乙二酸、順丁烯二酸、反丁烯 二酸、乳酸、酒石酸、己二酸及苯甲酸。其他適合酸描述 於例如 Fortschritte der Arzneimittelforschung ’ 第 10卷,第 224頁及其後内容,Birkhauser Verlag,Basle 及 Stuttgart, 1966中,其全部内容係以引用的方式明確併入本文中。 適合載劑為例如溶劑、載劑、賦形劑、黏合劑及通常用 於醫藥調配物之類似物,下文就個別投藥類型以例示性方 式加以描述。 本發明之另一態樣係關於化合物I、Η及IV或其醫藥學上 可接受之鹽用於製備抗黴藥物;亦即用於製備治療及/或 預防人類病原性及/或動物病原性真菌感染之藥物的用 途。本發明之另一態樣係關於式〗、丨丨及/或化合物或其 醫藥學上可接受之鹽用於製備治療癌症之藥物的用途。本 毛明之另一悲樣係關於式j、Η及/或Ιν化合物或其醫藥學 上可接受之鹽用於製備治療或預防病毒感染之藥物的用 途。 式I、II及/或IV化合物及/或其醫藥學上可接受之鹽適用 於治療、抑制或控制腫瘤細胞之生長及/或增殖及與其相 關之病症因此,其適用於治療溫血脊椎動物之癌症該 147474.doc -146· 201041514 為人 犬、 用於 前列 胃、 等溫血脊椎動物例如為哺乳動物及鳥類,特定士之 類,以及其他哺乳動物,特定言之為有用家畜,諸★ 貓、豬、反芻動物(牛、羊、山羊、野牛等)、馬及島 諸如雞、火雞、鴨、鵝、珍珠雞及其類似動物。 式I、II及IV化合物及/或其醫藥學上可接受之鹽適 治療以下器官之癌症或癌性病症:乳房、肺、腸、WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; 07/90624) ° A mixture of active substances may be prepared in a conventional manner, for example by a combination of the compositions of the compounds I, II and/or IV, in addition to the active ingredient and comprising at least one inert ingredient. . With regard to the common ingredients of such compositions, reference is made to the description given for compositions containing compounds I, II and/or IV. As the compounds of the formulae I, II and IV, mixtures of the active substances according to the invention are suitable as fungicides. It is known for its outstanding utility against a wide range of phytopathogenic fungi, especially from the Ascomycetes, Basidiomycetes, Deuteromycetes and Downy mildews (synonym Oomycetes). Additionally, reference is made to the fungicidal activity of the compounds and compositions comprising Compounds I, II and/or IV, respectively. Another aspect of the invention relates to a seed comprising at least a compound of formula I, II and/or IV in an amount from 0.1 g to 10 kg per 100 kg of seed. The compounds I, II and IV and their pharmaceutically acceptable salts are also suitable for the treatment of diseases in humans and animals, especially as anti-infective agents, for the treatment of cancer and for the treatment of viral infections. The term "anti-fungal agent" as used herein, which is different from the term "fungicide", refers to a drug that is resistant to animal pathogenic or human pathogenic fungi, i.e., against fungi in animals, particularly mammals and birds. Accordingly, another aspect of the invention relates to a pharmaceutically acceptable salt comprising at least one compound of the formula I, II and/or IV and/or at least one pharmaceutically acceptable salt thereof 147474.doc-145-201041514 and pharmaceutically acceptable The carrier drug. Suitable salts for pharmaceutically acceptable salts, especially the physiologically tolerated salts of the compounds I, II and/or IV, are specifically acid addition salts with physiologically acceptable acids. Examples of suitable organic and inorganic acids are hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, CrC4 alkylsulfonic acid (such as decanesulfonic acid), aromatic sulfonic acids (such as benzenesulfonic acid and toluenesulfonic acid), oxalic acid. , maleic acid, fumaric acid, lactic acid, tartaric acid, adipic acid and benzoic acid. Other suitable acids are described, for example, in Fortschritte der Arzneimittelforschung ’ vol. 10, page 224 et seq., Birkhauser Verlag, Basle and Stuttgart, 1966, the entire contents of which are hereby incorporated by reference. Suitable carriers are, for example, solvents, carriers, excipients, binders, and the like which are normally used in pharmaceutical formulations, which are described below in the exemplary manner for individual modes of administration. Another aspect of the invention relates to the use of the compound I, guanidine and IV or a pharmaceutically acceptable salt thereof for the preparation of an antifungal drug; that is, for the preparation of a therapeutic and/or prophylactic and/or animal pathogenicity. The use of drugs for fungal infections. Another aspect of the invention is the use of a formula, a hydrazine and/or a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of cancer. Another grief of this invention relates to the use of a compound of formula j, hydrazine and/or quinone or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment or prevention of a viral infection. The compounds of the formula I, II and/or IV and/or their pharmaceutically acceptable salts are suitable for the treatment, inhibition or control of the growth and/or proliferation of tumor cells and the conditions associated therewith, and are therefore suitable for the treatment of warm-blooded vertebrates Cancer 147474.doc -146· 201041514 For human dogs, for the forefront of the stomach, isothermal blood vertebrates such as mammals and birds, specific people and the like, and other mammals, specifically for useful livestock, all ★ Cats, pigs, ruminants (cattle, sheep, goats, bison, etc.), horses and islands such as chickens, turkeys, ducks, geese, guinea fowl and the like. The compounds of the formulae I, II and IV and/or their pharmaceutically acceptable salts are suitable for the treatment of cancer or cancerous conditions of the following organs: breast, lung, intestine,

GG

腺、皮膚(黑色素瘤)、腎臟、膀胱、口、喉、食道、 卵巢、胰腺、肝臟及腦或CNS。 、式Ι、π及…化合物及/或其醫藥學上可接受之鹽適用於 冶療溫ik脊椎動物之病毒感染,該等溫血脊椎動物例如為 哺乳動物及鳥類,特定言之為人類,以及其他哺乳動物: 特定言之為有用家畜,諸如犬、猶、猪、反离動物(牛、 羊山羊、野牛等)、馬及鳥類,諸如雞、火雞、鴨、 鶴、珍珠雞及其類似動物。其適詩治療病毒感染,如反 轉錄病毒感染(諸如mv及HTLV)、流感病毒感染、鼻病毒 感染、疱疹及其類似病毒。 可以常用方式(例如經口、靜脈内、肌肉内或皮下)投與 2發明之化合物。對於經口投與,可將活性化合物例如與 惰性稀釋劑或與可食用載劑混合;可將其包埋於硬明膠膠 囊或軟明膠膠囊中’可將其壓縮為錠劑或可將其直接與食 飼料/見合。活性化合物可與賦形劑混合且以不可消化 錠劑、口腔錠、片劑、丸劑、膠囊、懸浮液、飲劑、糖漿 j/、頒似物之形式投與。此等製劑應含有至少〇.1%活性化 5 製劑之組成當然可變化。以所討論之製劑(劑量單 147474.doc -147· 201041514 位)的重里计’其通常包含2重量%至重量%活性化合 物。本發明之化合物!的較佳製劑每經口劑量單位包含1〇 至1000 mg活性化合物。 U 齊1丸劑、膠囊及其類似物可另外包含以下組 分:黏合劑’諸如黃蓍膠、阿拉伯膠(gum arabic)、玉米 殿粉或明膠;賦形劑’諸如磷酸二約;崩解劑,諸如玉米 殿粉、馬鈴薯澱粉、褐藻酸及其類似物;滑動劑,諸如硬 月曰酸鎖,甜味劑,諸如蔗糖、乳糖或糖精丨及/或香料, 諸如胡椒薄荷、香草及其類似物。膠囊可另外包含液體載 劑。亦可使用修改劑量單位之特性的其他物質。舉例而 言,鍵劑、丸劑及膠囊可塗有謝蘭克(scheUack) '糖或其 混合物。除活性化合物之外’糖榮或飲劑亦可包含糖(或 其他甜味劑)、對經基苯甲酸甲g旨或㈣基苯甲酸丙醋(作 為防腐劑)、著色劑及/或香料。活性化合物製劑之組分在 所用量下當,然必須為醫藥級純且無毒。此外,可將活性化 合物調配為控制釋放活性化合物之製劑,例如調配為延遲 釋放製劑。 亦可非經腸或腹膜内投與活性化合物。可用水,使用適 合濕潤劑(諸如經丙基纖維素)來製備活性化合物或其鹽之 溶液或懸浮液。亦可使用甘油、液體聚乙二醇及其混物 在油中製備分散液。此等製劑經常另外包含防腐劑以防止 微生物生長。 意欲用於注射之製劑包含無菌水溶液及分散液,以及供 製備無菌溶液及分散液之無菌散劑。該製劑必須足夠液化 147474.doc -148· 201041514 以便注射。其在製備及儲存條件下必須穩定且其必須受保 護以防受微生物污染。載劑可為溶劑或分散介質:、:如 水、乙醇、多元醇(例如甘油、丙二醇或液體聚乙二醇)、 其混合物及/或植物油。 【實施方式】 由以下非限制性實例進一步說明本發明。 I.合成實例 0 k 5_(2_三氟甲基_4_氯·苯甲基)·Κ5-疏基-[1,2,4]三嗤小基 曱基)-2,2-二甲基環戊醇 1-1醛醇縮合反應 使2,2 一甲基%戊酮(4.00 g,35.66 mmol)及4-2-三氟1甲 基-4-氯苯曱醛(7_44 g,35.66 mmol)於60 mL乙醇中之混合 物冷卻至0〇C。逐滴添加10% NaOH(45 mL)且在室溫下攪 掉混合物1.5小時。在減壓下濃縮混合物且添加丨〇〇/〇 HC1(20 mL)。用 CH2C12(3x50 mL)萃取水相。用 1〇% ❹ HC1(20 mL)洗滌合併之有機萃取物,經MgS04乾燥,過濾 且在真空下蒸發。粗醇醛產物(9.0 g)不經任何進一步純化 即用於下一反應中。 • 1.2氫化 , 在室溫下在標準條件下,在THF(200 mL)中在活性阮尼 錄(Raney-Nickel)(10 mol%)存在下(預先用THF洗滌)氫化 步驟1.1中所獲得之產物(9.0 g)維持1〇小時。經矽藻土過濾 反應;昆合物,且滤液經MgS〇4乾燥。在真空中移除溶劑, 得到粗產物(5.0 g) ’其不經任何進一步純化即用於下一反 147474.doc -149- 201041514 應中。 1.3 5-(2-三氟甲基_4-氣-苯甲基三唑―卜基甲基)_ 2,2-二曱基環戊醇 在惰性氛圍下向含氫化鈉(1.85 g,73.44 mmol)之N_曱 基吡咯啶酮(25 mL)中逐份添加碘化三曱基氧化毓(6 92 g,31.48 mmol)且攪拌(直至氫氣釋放停止)。接著,緩慢 添加粉末狀[1,2,4]-二》垒(2.92 g,42.39 mmol)且繼續撥拌 30分鐘。隨後添加步驟1&gt;2之中間物(5 〇〇 g,19 94 mm〇1) 及異丙醇(25 mL)。在l〇(TC下再攪拌反應混合物4小時。添 加水(30 mL)且用MTBE(3x50 mL)萃取水相。用水(3〇 mL) 及鹽水(30mL)洗滌合併之有機萃取物,經MgS〇4乾燥且在 真空下蒸發。利用急驟層析(矽膠,環已烷:乙酸乙酯95:5 至60:40)純化粗產物,得到標題產物(〇 73 g,12%)。 H NMR (400 MHz,CDC13) δ 8.17 (s, 1H), 8.00 (s, 1H), 7.60 (d, 1Η), 7.40 (dd, 1H), 7.30 (d, 1H), 4.30 (dd, 2H), 4.00 (bs, 1H), 2.90-2.70 (m, 2H), 2.30-2.40 (m, 1H), 1.85-1.50 (m,3H), 1.35-1.25 (m, 1H),1〇〇 (s,3H),〇 5〇 (s,Gland, skin (melanoma), kidney, bladder, mouth, throat, esophagus, ovary, pancreas, liver and brain or CNS. a compound of the formula π, π, and/or a pharmaceutically acceptable salt thereof, for use in the treatment of viral infections in warm ik vertebrates, such as mammals and birds, specifically humans, And other mammals: specific animals that are useful, such as dogs, juveniles, pigs, animals (bovine, goat, bison, etc.), horses and birds, such as chickens, turkeys, ducks, cranes, guinea fowls and their Similar to animals. It is suitable for treating viral infections such as retroviral infections (such as mv and HTLV), influenza virus infections, rhinovirus infections, herpes and similar viruses. The compound of the invention can be administered in a conventional manner (e.g., orally, intravenously, intramuscularly, or subcutaneously). For oral administration, the active compound can be mixed, for example, with an inert diluent or with an edible carrier; it can be enclosed in hard gelatin capsules or soft gelatin capsules, which can be compressed into tablets or can be directly Meet with foodstuffs. The active compound can be mixed with excipients and administered in the form of a non-digestible lozenge, an oral lozenge, a tablet, a pill, a capsule, a suspension, a drink, a syrup, or an exemplified substance. These formulations should contain at least 0.1% active ingredient. The composition of the formulation may of course vary. Based on the weight of the formulation in question (dose of single dose 147474.doc - 147. 201041514), it typically comprises from 2% by weight to about 2% by weight of active compound. Preferred formulations of the compounds of the invention comprise from 1 to 1000 mg of active compound per oral dosage unit. U Qi 1 pills, capsules and the like may additionally comprise the following components: binders such as tragacanth, gum arabic, corn powder or gelatin; excipients such as diammonium phosphate; disintegrants Such as corn house powder, potato starch, alginic acid and the like; slip agents such as hard lauric acid locks, sweeteners such as sucrose, lactose or saccharin and/or spices, such as peppermint, vanilla and the like Things. The capsule may additionally comprise a liquid carrier. Other substances that modify the characteristics of the dosage unit can also be used. For example, the binders, pills and capsules may be coated with scheUack 'sugar or a mixture thereof. In addition to the active compound, 'sugar or drink may also contain sugar (or other sweeteners), for benzoic acid or propyl benzoate (as a preservative), colorants and/or fragrances. . The components of the active compound formulation, when used in amounts, must be pharmaceutically pure and non-toxic. In addition, the active compound can be formulated as a formulation for controlled release of the active compound, for example, as a delayed release formulation. The active compound can also be administered parenterally or intraperitoneally. A solution or suspension of the active compound or a salt thereof can be prepared in water using a suitable wetting agent such as propylcellulose. Glycerin, liquid polyethylene glycol, and mixtures thereof can also be used to prepare dispersions in oil. These formulations often additionally contain a preservative to prevent microbial growth. The preparations intended for injection comprise sterile aqueous solutions and dispersions, as well as sterile powders for the preparation of sterile solutions and dispersions. The formulation must be sufficient to liquefy 147474.doc -148· 201041514 for injection. It must be stable under the conditions of manufacture and storage and must be protected from microbial contamination. The carrier can be a solvent or dispersion medium: such as water, ethanol, polyol (for example glycerol, propylene glycol or liquid polyethylene glycol), mixtures thereof and/or vegetable oils. [Embodiment] The present invention is further illustrated by the following non-limiting examples. I. Synthesis Example 0 k 5_(2_Trifluoromethyl_4_chloro·benzyl)·Κ5-sulfenyl-[1,2,4]triammonium fluorenyl)-2,2-dimethyl Base cyclopentanol 1-1 aldol reaction, 2,2-methyl-methylpentanone (4.00 g, 35.66 mmol) and 4-2-trifluoromethyl-4-chlorobenzaldehyde (7_44 g, 35.66 The mixture of mmol) in 60 mL of ethanol was cooled to 0 °C. 10% NaOH (45 mL) was added dropwise and the mixture was stirred at room temperature for 1.5 hours. The mixture was concentrated under reduced pressure and hydrazine / EtOAc (1 mL). The aqueous phase was extracted with CH2C12 (3×50 mL). The combined organic extracts were washed with EtOAc (EtOAc)EtOAc. The crude aldol product (9.0 g) was used in the next reaction without any further purification. • 1.2 hydrogenation, obtained under standard conditions in a hydrogenation step 1.1 in THF (200 mL) in the presence of active Raney-Nickel (10 mol%) (previously washed with THF) The product (9.0 g) was maintained for 1 hour. The reaction was filtered through celite, and the residue was dried and filtered. The solvent was removed in vacuo to give a crude material (5. <RTI ID=0.0></RTI> </ RTI> </ RTI> </ RTI> which was used in the next reverse 147474.doc-149-201041514. 1.3 5-(2-trifluoromethyl_4-a-benzyltriazole-buylmethyl)_ 2,2-dimercaptocyclopentanol to sodium hydride (1.85 g, 73.44) under an inert atmosphere Methyl decyl ruthenium iodide (6 92 g, 31.48 mmol) was added portionwise in mmol of N_decylpyrrolidone (25 mL) and stirred (until hydrogen evolution ceased). Next, the powdered [1,2,4]-di-base (2.92 g, 42.39 mmol) was slowly added and mixing was continued for 30 minutes. The intermediate of step 1 &gt; 2 (5 〇〇 g, 19 94 mm 〇 1) and isopropanol (25 mL) were subsequently added. The reaction mixture was stirred for an additional 4 hours at EtOAc (EtOAc) (EtOAc) (EtOAc (EtOAc) The crude product was purified by EtOAc (EtOAc m. 400 MHz, CDC13) δ 8.17 (s, 1H), 8.00 (s, 1H), 7.60 (d, 1Η), 7.40 (dd, 1H), 7.30 (d, 1H), 4.30 (dd, 2H), 4.00 ( Bs, 1H), 2.90-2.70 (m, 2H), 2.30-2.40 (m, 1H), 1.85-1.50 (m, 3H), 1.35-1.25 (m, 1H), 1〇〇(s, 3H), 〇5〇(s,

基曱基)-2,2-二甲基環戍醇Base group)-2,2-dimethylcyclononanol

著,添加硫(0.22 g,6.59 mmol),且 T心/谷液·中添加1.6 M n-BuLi之 mmol),且繼續授摔i〇分鐘。接 mmol),且再繼續擾掉15小時。 147474.doc •150- 201041514 反應完成後,添加飽和NH4C1溶液,且用乙酸乙酯 mL)萃取水相。用水洗滌合併之有機萃取物,經MgS〇4乾 燥,且在減壓下移除溶劑。利用急驟層析(矽膠,環已烷. 乙酸乙酯95:5至60:40)純化粗產物,得到標題產物 g,48%) 〇 Ή NMR (400 MHz, CDC13) δ 12.3 (bs, 1H), 7.85 (s, 1H), 7.60 (d,1H),7.45-7.30 (m, 2H),4.40 (dd, 2H),4.00 (bs 〇 1H), 2.90-2.70 (m, 2H), 2.55-2.40 (m, 1H), 1.30-1.85 (mj 4H), 1.10 (s,3H), 0.82 (s, 3H)。 HPLC-MS 滞留時間(質量):3 827 min(42〇) 類似地製備實例2之化合物。 2. 5-(3,4-二氣-笨曱基巯基-[^斗]三唑4基甲基)_ 2,2-二曱基環戊醇 HPLC-MS滯留時間(質量):3 857 min(386) Π.對抗有害真菌之作用之實例 〇 藉由以下實驗證明式I及式II化合物之殺真菌作用: A)溫室測試 將活性物質分別或一起調配成包含25 mg活性物質之儲 備溶液,使用丙酮及/或二曱亞砜(DMS〇)混合物及乳化劑 Wettol EM 31(基於乙氧基化烷基酚之具有乳化及分散作用 之濕潤劑)補足該儲備溶液至丨〇 m卜其中溶劑/乳化劑之體 積比為99:1。隨後使用水補足該溶液至丨〇〇 ^1。用所述溶 劑/乳化劑/水混合物稀釋該儲備溶液至下文給出之活性物 質濃度。 147474.doc • 151 - 201041514 使用實例1 :針對大豆上由大豆鑛菌引起之大豆錄病的 治癒作用 用大丑銹病(大豆鏽菌)之孢子懸浮液接種盆栽大豆籽苗 之葉子。隨後將植物置放於大氣濕度高(9〇%至95%)且溫 度為20-24。(:之腔室中24小時。在此期間,孢子萌發且= 管穿透至葉組織中。隨後在溫度在23〇c與27。〇之間且相對 大氣濕度為60%至80%之溫室中再培養測試植物。兩天 後,用具有下述活性物質濃度之上述水溶液噴灑植物至溢 流點(runoff point)。乾燥懸浮液後,在溫度在23。〇與27它 之間且相對大氣濕度為60%至8〇%之溫室中再培養植物i 〇 天。隨後目測判定葉子上銹病發展之程度。 活性化合物 濃度[ppm] 生長[%] -(對照組) - 70 實例1 300 7 實例2 300 0 使用實例2 :針對小麥上由小麥殼針孢引起之殼針孢屬 斑點病之保護作用 用具有下述活性物質濃度之水性懸浮液喷灑盆栽小麥籽 苗之葉子至溢流點。乾燥懸浮液後24小時,用小麥殼針孢 之孢子懸浮液接種經處理之植物。隨後將植物置放於大氣 濕度高(約100%)且溫度為之腔室中4天,且隨後置 放於相對大氣濕度為約70%且溫度為18-22°C之腔室中。21 天後’目測判定葉子上銹病發展之程度,表示為佔整個葉 子表面之百分比。 147474.doc •152. 201041514Sulfur (0.22 g, 6.59 mmol) was added, and 1.6 M n-BuLi in the T/heart solution was added, and the dropping was continued for a few minutes. Take mmol) and continue to disturb for 15 hours. 147474.doc •150- 201041514 After the reaction was completed, a saturated NH 4 Cl solution was added and the aqueous phase was extracted with ethyl acetate. The combined organic extracts were washed with water, dried over MgSO 4 and evaporated. Purification of the crude product by flash chromatography eluting EtOAc (EtOAc:EtOAc , 7.85 (s, 1H), 7.60 (d, 1H), 7.45-7.30 (m, 2H), 4.40 (dd, 2H), 4.00 (bs 〇1H), 2.90-2.70 (m, 2H), 2.55-2.40 (m, 1H), 1.30-1.85 (mj 4H), 1.10 (s, 3H), 0.82 (s, 3H). HPLC-MS residence time (mass): 3 827 min (42 Torr) The compound of Example 2 was similarly prepared. 2. 5-(3,4-diqi- albino fluorenyl-[^]triazole 4-ylmethyl)_ 2,2-dimercaptocyclopentanol HPLC-MS retention time (mass): 3 857 Min(386) Π. Examples of the action against harmful fungi 证明 The fungicidal action of the compounds of formula I and formula II is demonstrated by the following experiments: A) Greenhouse test The active substances are separately or together formulated into a stock solution containing 25 mg of active substance. Using acetone and/or a mixture of disulfoxide (DMS) and an emulsifier Wettol EM 31 (a humectant having emulsification and dispersion based on ethoxylated alkylphenol) to make up the stock solution to The solvent/emulsifier volume ratio was 99:1. This solution is then supplemented with water to 丨〇〇 ^1. The stock solution is diluted with the solvent/emulsifier/water mixture to the active substance concentration given below. 147474.doc • 151 - 201041514 Use example 1: Cure for soybean disease caused by soybean ore in soybeans Leaves of potted soybean seedlings are inoculated with a spore suspension of large rust (soybean rust). The plants are then placed in a high atmospheric humidity (9〇% to 95%) and at a temperature of 20-24. (: 24 hours in the chamber. During this period, the spores germinate and = the tube penetrates into the leaf tissue. Then in the greenhouse at a temperature between 23 ° C and 27. 且 and a relative atmospheric humidity of 60% to 80% The test plants were incubated again. Two days later, the plants were sprayed to the runoff point with the above aqueous solution having the following active substance concentrations. After drying the suspension, the temperature was between 23. 〇 and 27 and relatively atmospheric Plants were further cultured in a greenhouse with a humidity of 60% to 8〇%. The degree of rust development on the leaves was then visually determined. Active compound concentration [ppm] Growth [%] - (control) - 70 Example 1 300 7 Example 2 300 0 Use example 2: Protection against the genus Aspergillus spp. caused by A. sinensis on wheat The leaves of potted wheat seedlings were sprayed to the overflow point with an aqueous suspension having the following active substance concentrations. 24 hours after drying the suspension, the treated plants were inoculated with a spore suspension of S. cerevisiae. The plants were then placed in a chamber with high atmospheric humidity (about 100%) and temperature for 4 days, and then placed. Relative atmospheric humidity of about 70% and temperature A chamber of 18-22 ° C in .21 days' extent of the rust development on the leaves was visually determined, expressed as a percentage of the entire leaf of the subsurface. 147474.doc • 152. 201041514

活性化合物 濃度[ppm] 生長[%] -(對照組) _ 90 實例1 300 t 3 實例2 300 15 147474.doc 153-Active Compound Concentration [ppm] Growth [%] - (Control) _ 90 Example 1 300 t 3 Example 2 300 15 147474.doc 153-

Claims (1)

201041514 七、申請專利範圍: 1_式I及式II三唑化合物,201041514 VII. Patent application scope: 1_ Formula I and Formula II triazole compounds, ^Ny^s(〇)nR4 N-N^Ny^s(〇)nR4 N-N L2 ClL2 Cl 其中 L1及L4彼此獨立地選自氫、漠、破、Ci_Ci。炫基、CA。 函烧基、氧基及Ci_Ci〇鹵烷氧基; L及L彼此獨立地選自氫、鹵素、Ci_Ci〇烷基、Ci-C⑺鹵 说基、氡基及Ci_Ci〇鹵烷氧基; 限制條件為L1、l2 ' l3及L4中至少一者不為氫;Wherein L1 and L4 are independently selected from the group consisting of hydrogen, indifference, breaking, and Ci_Ci. Hyun, CA. a calcinyl group, an oxy group and a Ci_Ci 〇haloalkoxy group; L and L are independently selected from the group consisting of hydrogen, halogen, Ci_Ci 〇 alkyl, Ci-C(7)halo group, fluorenyl group and Ci_Ci 〇haloalkoxy; At least one of L1, l2 'l3 and L4 is not hydrogen; R及R2彼此獨立地選自氫、Ci_Ci〇烷基、Ci_Ci〇鹵烷基、 Cl-C1G烷氧基烷氧基; R 係選自氫、C1-C10烷基、CVCn)画烷基、CVCu烷氧 基及Cl-CiO鹵烧氧基; R4係選自氫、CVCw烷基、Ci-Cw li烷基、(:2-(:10烯 基、c2-c10鹵烯基、c2-c10炔基、c2-c10鹵炔基、 〇3-(:10環烷基、c3-c10_環烷基、苯基、苯基-CrC4 烧基,其中最後2個提及之基團中之苯基部分可具 有1、2、3、4或5個取代基R8’及含有1、2或3個選 147474.doc 201041514 自&quot;及s之雜原子作為環成員的5員 部分不餘和或芳族雜環,其中 3個取代基R8;或在n為。可具有 二’選 * P(=Q)R6R7、Μ及式 ΙΠ基團,R and R2 are independently of each other selected from the group consisting of hydrogen, Ci_Ci 〇 alkyl, Ci_Ci 〇 haloalkyl, Cl-C1G alkoxy alkoxy; R is selected from hydrogen, C1-C10 alkyl, CVCn) alkyl, CVCu Alkoxy and Cl-CiO halo alkoxy; R4 is selected from hydrogen, CVCw alkyl, Ci-Cw li alkyl, (: 2-(:10 alkenyl, c2-c10 haloalkenyl, c2-c10 alkyne a phenyl group in the group of the last two mentioned The moiety may have 1, 2, 3, 4 or 5 substituents R8' and 5, 4 or 3 selected 147474.doc 201041514 from &quot; and s heteroatoms as ring members. a heterocyclic ring in which three substituents R8; or n is n. may have two 'selective* P(=Q)R6R7, anthracene and anthracene groups, L ' L、L ' L4 ^ R1 . R2 „ r3 及R係如式I及式II所定 義; #為與該分子之其餘部分的連接點;L ' L, L ' L4 ^ R1 . R2 „ r3 and R are as defined in formula I and formula II; # is the point of attachment to the rest of the molecule; 係選自氫、(^-(11丨0按美、r r I 丞 Cl_Cl〇鹵烷基、(:2-(:]0烯 b-c10鹵炔基 基、C2-C1G_ 稀基、C2_CiG炔基、( C3-C4烧基、c3_c1Qi環烷基、笨基、苯基-CA 烧基,其中最後2個提及之基團中之苯基部分可具 有1、2、3、4或5個取代紅8,含有丨、2或3個選自 N、Ο及S之雜原子作為環成員的5員或6員飽和、部 分不飽和或芳族雜環,其中該雜 個取代(娜、綱R5、稱^ -P( = Q)R6R7及 Μ ; 147474.doc 201041514 R係選自氫、Ci-C10烷基、(:!-(:!〇鹵烷基、cVCw烷氧 基、&lt;^-(:1()_烷氧基、Ci_CiG胺基烷基、c3_CiG環烷 基、6-(:10鹵環烷基、苯基、苯基_c丨_c4烷基、苯 氧基’其中最後3個提及之基團中之苯基部分可具 有1、2、3、4或5個取代基r8,含有工、2或3個選自 Ν、Ο及S之雜原子作為環成員的5員或6員飽和、部 分不飽和或芳族雜環,其中該雜環可具有丨、2或3 〇 個取代基R8,及NR9R10 ; R6及R7彼此獨立地選自Cl_CiG烷基、Ci_Ciq_烷基、C2_ c10烯基、c2-c1Q_ 烯基、C2_Cig炔基、C2_Ci(^炔 基、c3-c1G環烧基、c3_Ci()鹵環烧基、烧氧 基、CVCw鹵烷氧基、Ci_c4烷氧基_Ci_c丨〇烷基、 c,-c4炫氧基-Cl_Cl()烷氧基、Ci_CiG烷硫基、 鹵烷硫基、(:2-(:10烯氧基、c2_Cl〇稀硫基、c2_Ci〇快 氧基、C2-C1G炔硫基、c3_ClG_環烷氧基、C3_Ci@ ◎ 烷硫基、苯基、苯基-q-C4烷基、苯氧基、苯硫 基、苯基-Ci-C4烷氧基及NRnR12 ; 各R8獨立地選自鹵素、硝基、CN、Ci_C4烷基、Ci_c_ 烷基、烷氧基、Ci-CU鹵烷氧基及NR13R14 ; r9係選自氫及c〗-c8烷基; R10係選自氫、cvc:8烷基、苯基及苯基_Ci_c4烷基; 或R與R1G —起形成直鍵C4或Cs伸烷基橋或基團 -CH2CH2OCH2CH2-或-CH2CH2NR15CH2CH2-; R&quot;係選自氫及CVC8烷基; 147474.doc 201041514 R12係選自氫、cvc8烷基、苯基及苯基-CVC4烷基; 或R11與R12—起形成直鏈(34或(:5伸烷基橋或基團 -ch2ch2och2ch2-或-CH2CH2NR15CH2CH2-; 13 R 在每次出現時獨立地選自氫及&lt;:1-(:8烷基; R14在每次出現時獨立地選自氫、Cl-C8烷基、笨基及苯 基-C】-C4烷基; 或Rl3與Rl4—起形成直鏈c4或c5伸烷基橋或基團 -CH2CH2〇CH2CH2-或-CH2CH2NR15CH2CH2-; R15在每次出現時獨立地選自氫及匚丨-^烷基; Q 為〇或s ; M 為金屬陽離子相等物或式(NRaRbRcRd)+之銨陽離 子,其中Ra、Rb、Rc及Rd彼此獨立地選自氫、Cl_ c10烷基、苯基及苯曱基,其中最後2個提及之基團 中之本基部分可具有1、2或3個獨立地選自以下之 取代基:鹵素、CN、硝基、CVC4烷基、CVC4鹵烧 基、C〗-C4烷氧基、Ci-Q鹵烷氧基及NR13R14 ; η 為 0、1、2或 3 ; =為單鍵或雙鍵; 及其農業上可接受之鹽。 2·如請求項1之式I及式II化合物,其中L2及L3彼此獨立地 選自氫、鹵素、Ci-C*烧基、C^-C*鹵烧基、c^-CU院氧基 及匚!-^鹵烷氧基。 3·如請求項2之式I及式II化合物,其中L2及L3彼此獨立地 選自氫、氯、曱基、ch2f、chf2、cf3、甲氧基、0CH2F、 147474.doc 201041514 〇CHF2&amp;〇Cf3。 4·如請求項3之式ι及式II化合物,其中L2及L3彼此獨立地 選自氫及氣。 . 5.如前述請求項中任一項之式I及式II化合物,其中L1及L4 彼此獨立地選自氫、C丨-C4烷基、G-C4鹵烷基、cvc4烷 氧基及c!-C4鹵烷氧基。 6.如請求項5之式I及式π化合物,其中L1及L4彼此獨立地 〇 選自氫、甲基、CH2F、CHF2、CF3、甲氧基、OCH2F、 〇chfa〇Cf3。 7·如請求項6之式I及式π化合物,其中L1及L4彼此獨立地 選自氫及CF3。 8. 如前述請求項中任一項之式〗及式π化合物,其中Li、 L2、L3及L4中僅一者不為氫。 9. 如前述請求項中任一項之式〗及式Π化合物,其中ri&amp;r2 彼此獨立地選自氫、曱基、乙基及三氟甲基,較佳兩者 ◎ 均為甲基。 10·如則述請求項中任一項之式j及式π化合物,其中r3係選 自氫、曱基、乙基及三氟甲基,較佳為氫。 11·如月述請求項中任一項之化合物,其中R5係選 自Cl^4烧基、Cl_C2齒燒基、G-C4烧氧基、Cl-C2_烧氧 基、苯基、苯氧基及NR9Rl〇,其中R9為氫,Rl0係選自 氫、CrC4烷基及笨基。 12.如:逑研求項中任一項之式工及式η化合物,纟中係選 自氣Cl C4烧基' •中邮5、-S(0)2R5、-CN、Μ及式 147474.doc 201041514 III基團。 13. 如請求項12中任一項之式i及式II化合物’其中R4係選自 氫、CVC4烷基、c3-C4烷基羰基、CVC4烷氧基羰基、 -(:(=〇)Ν(Η)(ν(:4烷基、CVC4烷基磺醯基、CN及式III基 團。 14. 如請求項13之式I及式Π化合物,其中R4為氫、CN或曱 基。 15. 如前述請求項中任一項之式j及式π化合物,其中R4a係選 自氫、CrCU烷基及Cl_c4_烷基。 16. 如前述請求項中任一項之式1及式1][化合物,其中n為〇。 17. —種式IV化合物,It is selected from the group consisting of hydrogen, (^-(11丨0 by mei, rr I 丞Cl_Cl〇 haloalkyl, (: 2-(:]0 ene b-c10 haloalkynyl, C2-C1G_ dilute, C2_CiG alkynyl) , (C3-C4 alkyl, c3_c1Qi cycloalkyl, phenyl, phenyl-CA alkyl, wherein the phenyl moiety of the last two mentioned groups may have 1, 2, 3, 4 or 5 substitutions Red 8, a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring containing ruthenium, 2 or 3 heteroatoms selected from N, oxime and S as ring members, wherein the hetero-substitution (Na, Gang R5) , ^ -P( = Q)R6R7 and Μ; 147474.doc 201041514 R is selected from hydrogen, Ci-C10 alkyl, (:!-(:!! haloalkyl, cVCw alkoxy, &lt;^- (:1()-alkoxy, Ci_CiG aminoalkyl, c3_CiG cycloalkyl, 6-(:10 halocycloalkyl, phenyl, phenyl-c丨_c4 alkyl, phenoxy) The phenyl moiety of the three mentioned groups may have 1, 2, 3, 4 or 5 substituents r8 containing 5 or 3 heteroatoms selected from the group consisting of ruthenium, osmium and S as ring members. a 6-membered saturated, partially unsaturated or aromatic heterocyclic ring wherein the heterocyclic ring may have a fluorene, 2 or 3 substituents R8, and NR9R 10; R6 and R7 are independently of each other selected from the group consisting of Cl_CiG alkyl, Ci_Ciq_alkyl, C2_c10 alkenyl, c2-c1Q-alkenyl, C2_Cig alkynyl, C2_Ci (^ alkynyl, c3-c1G cycloalkyl, c3_Ci() Halocycloalkyl, alkoxy, CVCw haloalkoxy, Ci_c4 alkoxy-Ci_c丨〇alkyl, c,-c4 methoxy-Cl_Cl() alkoxy, Ci_CiG alkylthio, haloalkylthio , (: 2-(:10 alkenyloxy, c2_Cl〇 dilute thio, c 2 —Ci 〇 methoxy, C 2 -C 1 G alkynyl, c 3 —ClG —cycloalkoxy, C 3 —Ci@ ◎ alkylthio, phenyl, phenyl -q-C4 alkyl, phenoxy, phenylthio, phenyl-Ci-C4 alkoxy and NRnR12; each R8 is independently selected from the group consisting of halogen, nitro, CN, Ci_C4 alkyl, Ci_c_alkyl, alkoxy , Ci-CU haloalkoxy and NR13R14; r9 is selected from hydrogen and c--c8 alkyl; R10 is selected from hydrogen, cvc: 8 alkyl, phenyl and phenyl-Ci_c4 alkyl; or R and R1G is formed from a hydrogen bond, a cvc8 alkyl group, a benzene group, and a group of -CH2CH2OCH2CH2- or -CH2CH2NR15CH2CH2-; And phenyl-CVC4 alkyl; or R11 and R12 together form a straight chain (34 or ( : 5 alkylene bridge or group -ch2ch2och2ch2- or -CH2CH2NR15CH2CH2-; 13 R is independently selected from hydrogen and &lt;: 1-(:8 alkyl) at each occurrence; R14 is independently selected at each occurrence From hydrogen, Cl-C8 alkyl, phenyl and phenyl-C]-C4 alkyl; or Rl3 together with Rl4 form a linear c4 or c5 alkyl bridge or a group -CH2CH2〇CH2CH2- or -CH2CH2NR15CH2CH2- R15 is independently selected from hydrogen and hydrazine-alkyl at each occurrence; Q is hydrazine or s; M is a metal cation equivalent or an ammonium cation of the formula (NRaRbRcRd)+, wherein Ra, Rb, Rc and Rd Independently from each other are selected from the group consisting of hydrogen, Cl_c10 alkyl, phenyl and phenyl fluorenyl, wherein the benzyl moiety of the last two mentioned groups may have 1, 2 or 3 substituents independently selected from: Halogen, CN, nitro, CVC4 alkyl, CVC4 haloalkyl, C-C4 alkoxy, Ci-Q haloalkoxy and NR13R14; η is 0, 1, 2 or 3; = single bond or double Key; and its agriculturally acceptable salt. 2. A compound of formula I and formula II according to claim 1, wherein L2 and L3 are independently selected from the group consisting of hydrogen, halogen, Ci-C* alkyl, C^-C* haloalkyl, c^-CU alkoxy And hey! -^haloalkoxy. 3. A compound of formula I and formula II according to claim 2, wherein L2 and L3 are independently selected from the group consisting of hydrogen, chloro, decyl, ch2f, chf2, cf3, methoxy, 0CH2F, 147474.doc 201041514 〇CHF2& Cf3. 4. The compound of formula 3 and the compound of formula II, wherein L2 and L3 are independently selected from hydrogen and gas. 5. A compound of formula I and formula II according to any of the preceding claims, wherein L1 and L4 are, independently of each other, selected from the group consisting of hydrogen, C丨-C4 alkyl, G-C4 haloalkyl, cvc4 alkoxy and c !-C4 haloalkoxy. 6. The compound of formula I and formula π according to claim 5, wherein L1 and L4 are independently of each other selected from the group consisting of hydrogen, methyl, CH2F, CHF2, CF3, methoxy, OCH2F, 〇chfa〇Cf3. 7. The compound of formula I and formula π of claim 6, wherein L1 and L4 are independently selected from hydrogen and CF3. 8. The compound of any of the preceding claims and the compound of formula π, wherein only one of Li, L2, L3 and L4 is not hydrogen. 9. The formula of any one of the preceding claims, wherein the ri&amp;r2 is independently of one another selected from the group consisting of hydrogen, decyl, ethyl and trifluoromethyl, preferably both of which are methyl. 10. The compound of formula j and formula π, wherein R3 is selected from the group consisting of hydrogen, mercapto, ethyl and trifluoromethyl, preferably hydrogen. The compound of any one of the preceding claims, wherein R5 is selected from the group consisting of Cl^4 alkyl, Cl_C2 dentate, G-C4 alkoxy, Cl-C2_alkoxy, phenyl, phenoxy And NR9Rl〇, wherein R9 is hydrogen, and R10 is selected from the group consisting of hydrogen, CrC4 alkyl and stupid. 12. For example, the formula of the formula and the compound of the formula η, the middle of which is selected from the group consisting of gas Cl C4 burnt base '•中邮5, -S(0)2R5, -CN, Μ and 147474 .doc 201041514 III group. 13. The compound of formula i and formula II according to any one of claim 12, wherein R4 is selected from the group consisting of hydrogen, CVC4 alkyl, c3-C4 alkylcarbonyl, CVC4 alkoxycarbonyl, -(:(=〇)Ν (Η) (ν(:4 alkyl, CVC4 alkylsulfonyl, CN and a group of formula III. 14. The compound of formula I and the formula ,, wherein R4 is hydrogen, CN or fluorenyl. The compound of the formula j and the formula π, wherein R4a is selected from the group consisting of hydrogen, CrCU alkyl and Cl_c4_alkyl. 16. Formula 1 and Formula 1 according to any one of the preceding claims. [Compound, wherein n is hydrazine. 17. - a compound of formula IV, 、L及L4係如請求項1至1 0中任 其中 Rl、R2、R3、L1、L2、 一項所定義; 如下化合物除外,其中 L3及L4為氫,L2為氯, R及R2均為甲基,R3為氫, i =為雙鍵。 18· 一種式IVA化合物, 147474.doc 201041514, L and L4 are as defined in the claims 1 to 10, wherein R1, R2, R3, L1, L2, except for the following compounds, wherein L3 and L4 are hydrogen, L2 is chlorine, R and R2 are Methyl, R3 is hydrogen, and i = double bond. 18. A compound of formula IVA, 147474.doc 201041514 其中Rl、R2、R3、、[2、1^及1^4係如請求項1〇中任 19.Ο 一項所定義。 一種式V化合物,Wherein Rl, R2, R3, and [2, 1^, and 1^4 are as defined in the item 19.Ο of claim 1). a compound of formula V, 20.Ο 一項所定義。 一種式VI化合物,20. 一项 One definition. a compound of formula VI, 21. 一項所定義。 一種式VII化合物, 147474.doc (VII)20104151421. One definition. a compound of formula VII, 147474.doc (VII) 201041514 一項所定義;且 L3及L4係如請求項1至1 〇中任 R14 為 η或 C(0)0R15,其中 R 係選自氫、CVCw烷基、CVCw鹵烷基、c3_ Cio環烷基' c3-C10_環烷基、苯基、苯基_c丨, C4烷基’其中最後2個提及之基團中之苯基部 分可具有1、2、3、4或5個取代基R8,及含有 1、2或3個選自N、〇及3之雜原子作為環成員 的5員或6員飽和、部分不飽和或芳族雜環, 其中該雜環可具有1、2或3個取代基R8 ,其中 R係如請求項1中所定義。 22. —種式VIII化合物, ?\ ^uR3 L1One is defined; and L3 and L4 are as claimed in claims 1 to 1 wherein R14 is η or C(0)0R15, wherein R is selected from hydrogen, CVCw alkyl, CVCw haloalkyl, c3_Cio cycloalkyl ' c3-C10_cycloalkyl, phenyl, phenyl-c丨, C4 alkyl' wherein the phenyl moiety of the last two mentioned groups may have 1, 2, 3, 4 or 5 substituents R8, and a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1, 2 or 3 heteroatoms selected from N, oxime and 3, wherein the heterocyclic ring may have 1, 2 or Three substituents R8, wherein R is as defined in claim 1. 22. — a compound of formula VIII, ?\ ^uR3 L1 其中κ、R、14^、1^、1^及1^4係如請求項1至10中任—項 所定義,且R&quot;係如請求項21中所定義。 項 (VIII) 23· —種式IX化合物, 147474.doc (IX) 201041514 Q R3Wherein κ, R, 14^, 1^, 1^, and 1^4 are as defined in any one of claims 1 to 10, and R&quot; is as defined in claim 21. Item (VIII) 23 - Compound of formula IX, 147474.doc (IX) 201041514 Q R3 係如請求項1至10中任 其中 Rl、R2、R3 一項所定義; R3為氫’ Ll、L3及L4為氫,L2為氯, 〇 如下化合物除外,其中 R1及R2均為曱基 且=為雙鍵。 24. -種農業組合物,其包含至少一種如請求項^至财任 -項之式卜Π及/或以化合物或其農業上可接受之鹽, 及液體或固體載劑。 25. —種如請求項1至18中任一瑁夕τ ττ 丫作項之式I、II及/或IV化合物的 用途,其係用於防治有害真菌。 26. —種防治有害真菌之方法,t 八T用有效I之至少式I、π 及/或W化合物處理該等真菌、其生境,或欲保護以免受 真菌侵襲之材料或植物’或土壞或繁殖材料其中化合 物I、II及IV係如請求項1至18中任—項所定義。 27. 一種種子,每100 kg種子包含0.1 g至H) kg之量的至少式 I、II及/或IV化合物’其中化合物卜Htv係如請求項i 至18中任一項所定義。 28. —種醫藥組合物,其包含至少一種如請求項丨至。中任 一項之式I、II及/或IV化合物或其醫藥學上可接受之 鹽’及至少一種醫藥學上可接受之載劑。 147474.doc -9- 201041514 29. 30. 医1如》月求項1至1 8中任一項之式J、Η或化合物或其 醫:予上可接受之鹽的用途’其係用於製備治療癌症或 病毒感染之藥物或用於製備抗黴藥物。 一種治療癌症或病毒感染或對抗動物病原性或人類病原 性真菌之方法,其包含以至少一種如請求項丨至18中任 一項之式I、II及/或IV化合物、以至少—種其醫藥學上 可接受之鹽或以如請求項28之醫藥組合物治療有需要之 個體。 147474.doc 10- 201041514 四、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式:As defined in any one of claims 1 to 10, wherein R1, R2, and R3 are defined; R3 is hydrogen 'L1, L3 and L4 are hydrogen, and L2 is chlorine, except for the following compounds, wherein R1 and R2 are sulfhydryl groups and = is a double bond. 24. An agricultural composition comprising at least one of the formulas of the claims to the financial formula and/or the compound or an agriculturally acceptable salt thereof, and a liquid or solid carrier. 25. Use of a compound of formula I, II and/or IV as claimed in any one of claims 1 to 18 for the control of harmful fungi. 26. A method of controlling harmful fungi, wherein at least one of the fungi, the habitat thereof, or the material or plant to be protected from fungal attack or the soil is damaged by at least a compound I, π and/or W of effective I Or a propagation material wherein the compounds I, II and IV are as defined in any one of claims 1 to 18. 27. A seed comprising from 0.1 g to H) kg of at least one compound of formula I, II and/or IV per 100 kg of seed&apos; wherein compound Htv is as defined in any one of claims i to 18. 28. A pharmaceutical composition comprising at least one of the claims as claimed. A compound of formula I, II and/or IV, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier. 147474.doc -9- 201041514 29. 30. The use of formula J, sputum or a compound of any of the following claims 1 to 18 or its use: the use of a salt of acceptable use A medicament for treating cancer or a viral infection or for preparing an antifungal drug. A method of treating a cancer or a viral infection or against an animal pathogenic or human pathogenic fungus, comprising at least one compound of formula I, II and/or IV according to any one of claims 18 to 18, at least A pharmaceutically acceptable salt or a pharmaceutical composition according to claim 28 is used to treat an individual in need thereof. 147474.doc 10- 201041514 IV. Designated representative map: (1) The representative representative of the case is: (none) (2) The symbolic symbol of the representative figure is simple: 5. If there is a chemical formula in this case, please reveal the best display invention. Characteristic chemical formula: 147474.doc -2-147474.doc -2-
TW099113195A 2009-04-24 2010-04-26 Triazole compounds carrying a sulfur substituent II TW201041514A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09158756 2009-04-24

Publications (1)

Publication Number Publication Date
TW201041514A true TW201041514A (en) 2010-12-01

Family

ID=41719228

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099113195A TW201041514A (en) 2009-04-24 2010-04-26 Triazole compounds carrying a sulfur substituent II

Country Status (3)

Country Link
AR (1) AR076427A1 (en)
TW (1) TW201041514A (en)
WO (1) WO2010149414A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103596934A (en) * 2011-05-31 2014-02-19 株式会社吴羽 Triazole compound and use thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013084770A1 (en) * 2011-12-05 2013-06-13 株式会社クレハ Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant
US20150119579A1 (en) * 2012-04-18 2015-04-30 Kureha Corporation Method for producing triazolylmethyl cycloalkanol derivative and triazolylmethyl cycloalkanol derivative-containing composition
KR101885219B1 (en) * 2013-08-27 2018-08-14 시노켐 코포레이션 Applications of Substituent Benzyloxy Group Containing Ether Compounds for Preparing Antitumor Drugs
UA121030C2 (en) 2014-03-20 2020-03-25 Міцуі Кемікалз Аґро, Інк. Plant disease control composition and method for controlling plant disease by application of same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07614B2 (en) * 1986-08-08 1995-01-11 呉羽化学工業株式会社 Novel tricyclic azole derivative, method for producing the same, and agricultural / horticultural fungicide containing the derivative as an active ingredient
JPH0625140B2 (en) * 1986-11-10 1994-04-06 呉羽化学工業株式会社 Novel azole derivative, method for producing the same and agricultural / horticultural drug of the derivative
CA2006309C (en) * 1988-12-29 2001-12-18 Jean Hutt Azolylmethylcyclopentane benzylidene fungicide
JPH03197464A (en) * 1989-12-16 1991-08-28 Basf Ag Substituted azolylmethylcycloalkanol and bactericide containing same
JPH07138234A (en) * 1993-11-11 1995-05-30 Kureha Chem Ind Co Ltd Production of azolymethylcycloalkanol derivative
DE19520096A1 (en) * 1995-06-01 1996-12-05 Bayer Ag Cycloalkane benzylidene derivatives
DE19520098A1 (en) * 1995-06-01 1996-12-05 Bayer Ag Triazolylmethyl-cyclopentanols
DE19617282A1 (en) * 1996-04-30 1997-11-06 Bayer Ag Triazolyl mercaptide
DE19617461A1 (en) * 1996-05-02 1997-11-06 Bayer Ag Acylmercapto triazolyl derivatives
DE19619544A1 (en) * 1996-05-15 1997-11-20 Bayer Ag Triazolyl disulfides
DE19620407A1 (en) * 1996-05-21 1997-11-27 Bayer Ag Thiocyano-triazolyl derivatives
DE19620590A1 (en) * 1996-05-22 1997-11-27 Bayer Ag Sulfonyl-mercapto-triazolyl derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103596934A (en) * 2011-05-31 2014-02-19 株式会社吴羽 Triazole compound and use thereof
CN104529918A (en) * 2011-05-31 2015-04-22 株式会社吴羽 Triazole compound and use thereof
CN103596934B (en) * 2011-05-31 2015-08-19 株式会社吴羽 Triazole compound and utilization thereof

Also Published As

Publication number Publication date
AR076427A1 (en) 2011-06-08
WO2010149414A1 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
US10442777B2 (en) Use of substituted oxadiazoles for combating phytopathogenic fungi
US10358426B2 (en) Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
AU2016363493A1 (en) Substituted oxadiazoles for combating phytopathogenic fungi
TW201103920A (en) Triazole compounds carrying a sulfur substituent X
EA024331B1 (en) USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI RESISTANT TO Qo INHIBITORS
BR112014000319B1 (en) USES OF FORMULA I COMPOUNDS, COMPOUNDS, PHYTOPATHOGENIC FUNGI METHODS, FORMULA I COMPOUND PREPARATION PROCESSES AND AGROCHEMICAL COMPOSITION
TW201103919A (en) Fungicidal mixtures
CN101888999B (en) Pyridylmethyl-sulfonamide compounds
TW201103429A (en) Triazole compounds carrying a sulfur substituent XI
CA2950802A1 (en) Substituted [1,2,4]triazole and imidazole compounds as fungicides
US10112913B2 (en) Substituted [1,2,4]triazole and imidazole compounds as fungicides
TW201103921A (en) Fungicidal mixtures
TW201103430A (en) Triazole compounds carrying a sulfur substituent XII
CA3056347A1 (en) Substituted oxadiazoles for combating phytopathogenic fungi
US20110015065A1 (en) Substituted Sulfonic Acid Amide Compounds
TW201041514A (en) Triazole compounds carrying a sulfur substituent II
TW200924645A (en) Fungicidal compounds, processes for their preparation and their use for controlling harmful fungi, and compositions comprising them
WO2011069912A1 (en) Triazole compounds, use thereof and agents containing said compounds
US20110003691A1 (en) Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides
TW201043139A (en) Triazole compounds carrying a sulfur substituent III
US20100317516A1 (en) Sulfonamide Compounds And Their Use As Fungicide
TW200940513A (en) Pyrimidylmethyl sulfonamide compounds
WO2011069916A1 (en) Triazole compounds, use thereof as a fungicide, and agents comprising same
TW201041513A (en) Triazole compounds carrying a sulfur substituent I
WO2011069894A1 (en) Triazole compounds, use thereof, and agents containing same